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Abstract 
The PhD project explored the issues that influenced primary care physician 
adherence to clinical guideline prescribing recommendations. The project was 
based on three linked studies that used different methodologies. The first study 
was a systematic review (overview) of systematic reviews supported by a 
selective review of theories of behaviour change. It aimed to identify effective 
methods of improving primary care prescribing. It concluded that multi-faceted 
interventions were not necessarily more effective than single interventions. The 
review resulted in taxonomy of interventions to change prescribing behaviour 
that summarised the effectiveness of different interventions. 
The second study was the qualitative study. It was designed and analysed with 
the help of theoretical insights from the theory of planned behaviour (TPB) and 
the findings of the reviews. Data were analysed using framework method. The 
analysis identified seven important themes for implementing clinical guideline 
prescribing recommendations in primary care: 'credibility of content', 'credibility 
of source', 'presentation', 'influential people', 'organisational factors', 'disease 
characteristics' and 'dissemination strategy'. Secondary analysis resulted in a 
simple model for implementation of guidelines in primary care. The taxonomy of 
interventions was updated using the findings of the qualitative study. 
The qualitative study was exploited for the design of the third study tools (i. e. 
the surveys' questionnaires). The validity of different methods of sample size 
calculation for TPB surveys was also assessed. Two stratified random samples 
of GPs in England were studied. The surveys directly assessed the merits of 
TPB for understanding GP prescribing. They measured GPs'attitudes and 
beliefs and their intentions to prescribe according to clinical guidelines for 
asthma and of statins. Prescribing data were obtained from routine data 
sources. TPB explained some of the variations in asthma and statins 
prescribing intentions and behaviours. The surveys demonstrated that GPs 
views and beliefs contributed to the variations in their prescribing. They also 
suggested that the effects of GPs' beliefs on their prescribing were not 
necessarily mediated through their behavioural intentions. 
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Patient No. 1: Lev Nikolayevitch Tolstoy. 
Sanguine temperament. His illusion is that he 
can change others'lives by words 
Troyat, 1970; quoted from Horder et al, 1986. 
Chapter 1. Introduction to the Study of 
Adherence to Guidelines and Evidence (SAGE) 
The subject of this thesis is to explore the issues that influence primary care 
physicians in following prescribing guidelines. In this chapter the background to 
the thesis is explained and an outline of the rest of the thesis is presented. 
1.1. The dilemma of implementing new (and not so new) 
innovations 
Health care innovations, including prescribing, usually take a long time before 
being implemented in practice. It took about fifty years (from 1747 to 1795) for 
the British navy, and a further 70 years until 1865 for merchant fleet, to use 
lemon juice for the prevention of scurvy (Haines and Jones, 1994). Arguably 
nowadays many innovations take much shorter to be implemented, but the 
expectations are now greater. Policy-makers, patients, managers and general 
public like to see new innovations being implemented in clinical practice soon 
after their effectiveness being examined and approved; and those innovations 
for which there are no evidence of support or are questioned by research to be 
excluded from practice. Health professionals are keen to implement'new' 
advances, but this often means using more expensive interventions with limited 
advantage or questionable effectiveness. Several examples exist. A study in 
12 
1966 indicated that tetracycline, a'wonder drug', took only seventeen months to 
be prescribed by all physicians in four communities of Illinois (Rogers, 1995b). 
Furthermore, it was estimated that as much as a quarter of high technology 
health services, namely cardiac and vascular surgeries, might not have been 
required (Borowitz and Sheldon, 1993). The dilemma of evidence-based health 
care starts here: what are the best ways of helping health professionals keeping 
abreast of now innovations, while doing it in a 'conscientious, explicit, and 
judicious' manner (Sackett et al, 1996) i. e. avoiding innovations with 
questionable effectiveness and efficiency? 
1.2. Clinical practice guidelines and behaviour change 
Governments as well as pharmaceutical industry and charitable organisations 
spend a lot of resources on medical and clinical research. In comparison, little is 
spent on the implementation of available evidence (Eddy, 1982). 
The profession has placed huge value on developing the basic science 
of medicine, it has not emphasised the process by which the science is 
translated into practice (Eddy, 1982; quoted from Lomas and Haynes, 
1988, p 78). 
Similarly, little work has been done on understanding how to influence GPs' 
practice (Horder et al, 1986). Most of behaviour change interventions have been 
based on the assumption that clinicians would change if they are given 
information (Soumerai et al, 1989). These assumed models of changes are 
called 'production-dissemination' (Wood et al, 1998) or'information deficit' 
models of behaviour change (Schwartz et al, 1989; Marteau et al, 2002). 
Relying on these models of change, interventionists endeavoured to improve 
quality of care by providing more information on safety, efficacy and cost- 
effectiveness of intended behaviours. The inevitable outcome of this approach 
has featured in abundance of information delivered to medical practitioners 
(Hibble et al, 1998). In 1991, Tong predicted that decision makers and clinical 
practitioners would use consensus reports (guidelines) more and more. Her 
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reasoning was that clinicians were 'bombarded by information', faced 
'conflicting viewpoints' and were 'uncertain about what to uphold as a value or 
recognise as a facf. 
Several studies have shown that in the era of uncertainty health care 
providers vary substantially in what they provide (Eddy, 1984). Clinical practice 
guidelines are sought as tools to reduce variation in health care and to reduce 
cost (Borowitz and Sheldon, 1993; O'Brien et al, 2000) and more importantly to 
improve quality of patient care (Feder et al, 1999). Increasingly the research 
findings are summarised in guidelines and a new industry has appeared 
concerned with guideline development and implementation (Freemantle et al, 
1998). Many clinical guidelines have no clear implementation plans and are 
mainly intended as tools for information transfer. However, research suggests 
that doctors may not use guidelines as the main source of information (Timpka 
et al, 1989). Also the majority of clinical guidelines have not been through 
rigorous production processes, making it more difficult for clinicians to follow 
their recommendations (Grilli et al, 2000; Graham et al, 2001). It is even 
claimed that the quality of guidelines is declining (Hasenfeld and Shekelle, 
2003). Clinical guidelines should be viewed as health technologies and their 
effectiveness should be evaluated as any other technology (Grimshaw and 
Russell, 1993). Evaluation of guideline implementation programmes involves 
careful planning and requires dedicated resources. Multi-stage studies using 
qualitative and quantitative methods have been recommended (Campbell et al, 
2000a). Still many believe that the experience in (evaluation of) guideline 
implementation is limited if not scarce (Wensing et al, 1999). 
'The success of clinical practice guidelines depends ... on their 
widespread application in routine medical practice' (Mittman et al, 1992, p 413). 
If not implemented, guidelines are 'words without action' (Lomas, 199 1), even 
though guidelines can create awareness and work as 'words that indirectly lead 
to action' (Rogers, 1995b). Many guidelines fail the implementation phase. 
Some scholars raise concerns that clinical guideline implementation is in danger 
of 'failing' after its rapid rise (Smith, 2000). The question is which interventions 
are more effective for implementation of guidelines? Historically, the evidence 
on this has been limited. When trying to investigate the available evidence for 
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the best methods of influencing GP behaviour, Horder et al (1986) were 
surprised of the scarcity of evidence. Even where there was evidence, it had 
rarely been acted upon, resulting in waste of scarce resources. A systematic 
review in 1992 found very limited support for the effectiveness of continuing 
medical education programmes (Davis et al, 1992). Nonetheless, in 1994 it was 
estimated that still around 2000 pounds per GP was spent on continuing 
medical education (Haines and Jones, 1994). 
In recent years there have been a lot of attempts to identify effective 
ways of using clinical guidelines in behaviour change - see Grimshaw and 
Russell (1993) as a pioneering example - but important questions remain. For 
some generic questions, there may never be a concrete answer, e. g. what is 
the best method to implement guidelines? Although it is argued for long that 
single strategies are less likely to change clinical practice (Stocking, 1992), this 
is not much of comfort. Multi-facet interventions are costly and more difficult to 
implement. Why some guidelines were more successfully implemented than the 
others? Was it because of the differences in quality of guidelines, setting, 
clinical condition or dissemination strategies? Previous studies suggested that 
enthusiastic clinicians or'innovators' achieved more with poor guidelines than 
what others achieved with better quality guidelines (North of England Study of 
Standards and Performance in General Practice, 1992a; North of England 
Study of Standards and Performance in General Practice, 1992b). Why did 
some dissemination strategies (e. g. educational outreach visits) work well in 
influencing prescribing in some settings (Avorn and Sournerai, 1983) but not in 
other settings (Freemantle et al, 2002)? 
1.3. Why study prescribing? 
Prescribing is one of the most prominent activities of primary care physicians 
and other off ice-based doctors. Soumerai et al (1989) estimated that about 75% 
of visits to office-based doctors end up in prescribing. Several forces influence 
physician prescribing. Among those are pharmaceutical companies. It has been 
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estimated that in the early 1980s about $1.5 billion was spent on drug detailing 
in the USA (Pippalla et al, 1995). Health systems' resources to influence 
provider behaviour are easily dwarfed by these figures. This is another reason 
for furthering attempts for better understanding of provider behaviour and 
methods to influence it. 
The WHO refers to the ideal state of prescribing, distribution and use of 
drugs as 'rational drug use' and provides this definition: 
The rational use of dnigs requires that patients receive medications 
appropriate to their clinical needs, in doses that meet their own individual 
requirements for an adequate period of time, and at the lowest cost to 
them and their community, WHO conference of experts Nairobi 1985, 
cited in (Le Grand et al, 1999; Holloway, 2004). 
Inappropriate use of drugs can be the result of a variety of situations. 
Prescribed drug may not be appropriate for patient need, it may be expensive 
(for patient or system) or it may not be acceptable for personal, cultural or social 
reasons. Clinicians may prescribe medicines of no value because of perceived 
patient pressure or placebo effects. They may also prescribe where medication 
does not provide any benefit over'wait and see' approach. Irrational prescribing 
may also be the result of under prescribing of required medicines. This is more 
often the case for management of chronic diseases or in primary and secondary 
prevention practices. Chrischilles and Gondek (1997) suggested that 
appropriateness of prescribing should be assessed at three levels. The first 
level is whether any medication is at all warranted (alternatives are non-drug 
treatment or no treatment). The second level is to establish which drug is 
preferred based on efficacy, effectiveness and safety. The third level focuses on 
technical issues of prescribing such as dosage, duration, monitoring and drug 
interactions (Chrischilles and Gondek, 1997). Although this is a useful 
categorisation, it should be noted that these three levels are correlated and non- 
exclusive. For example decision to prescribe is usually linked to the availability 
of appropriate medicines. Similarly a drug may not be suitable for an individual 
patient because of dosage, monitoring, duration or interactions. It is also not 
clear why efficiency, or simply cost, is not included among issues that affect the 
appropriateness of prescribing. 
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Irrational use of drugs is not always because of physicians. Appropriately 
prescribed medicines may be used inappropriately. Patients may not use the 
specified doses of medicines in appropriate intervals or for prescribed durations. 
Also the role of dispensers should not be overlooked. In many countries 
pharmacies are allowed to prescribe a range of drugs without physician (or 
other clinician) prescription. Over-the-counter prescriptions may play a role in 
irrational use of drugs. Dispensers may also prescribe drugs that require a 
prescription without prescription. This phenomenon is not uncommon in many 
countries (Dinarvand and Nikzad, 2000, Hafeez et al, 2004). It is also part of 
another problem which is self-medication. In countries where the medicines 
market is not adequately regulated, patients may decide on what they need and 
obtain it freely from dispensers. The problem of irrational use of drugs may be 
the result of system failure. Inadequate financial support for patients with 
chronic or serious infectious diseases and substantial co-payments put 
disadvantaged groups in unfavourable situation in terms of access to drugs. 
Prescribing costs have been growing 6-8% per year in the global context 
(Le Grand et al, 1999). In Australia in one year prescribing costs rose more than 
23% (Beilby and Silagy, 1997), and in the USA the prescribing expenditure 
increased thirteen-fold in only thirty years from 1960-1990 (Pippalla et al, 1995). 
Most prescribing costs happen in primary care. It is estimated that only a 
quarter of drug expenditure happens within hospitals and the rest are due to 
office-based activities (Chrischilles and Gondek, 1997). In 1995, GP prescribing 
amounted to 11 % of total NHS spending (Majeed et al, 1997). Therefore, 
focusing on quality and cost of prescribing in primary care is important and vital. 
In particular if one considers that inappropriate prescribing often results in 
significant morbidities for patients and avoidable consequent charges for 
societies and health systems. 
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1.4. What is primary care? 
In the past thirty years, different definitions have been provided for general 
practitioner (GP) or primary care physician (PCP) (Table 1.1). These definitions 
have endeavoured to present the ideal content of general practice and the 
characteristics that separates it from other medically qualified professions 
(Olesen et a[, 2000). 
TABLE 1.1. DEFINITIONS OF GENERAL PRACTITIONER (GP) OR PRIMARY CARE PHYSICIAN (PCP) 
Definition Source 
The general practitioner is a licensed medical graduate who gives personal, Leeuwenhorst, 
primary and continuing care to individuals, families and a practice population 19741 
irrespective of age, sex and illness. It is the synthesis of these functions which 
is unique 
Primary care physicians are medically qualified physicians who provide Institute of 
primary health care. Primary health care provides integrated, easy to access, Medicine; 
health care services by clinicians who are accountable for addressing a large Vanselow et 
majority of personal health care needs, developing a sustained and continuous al, 1995 
relationship with patients, and practising in the context of family and 
community 
The general practitioner is a specialist trained to work in the front line of a Olesen et al, 
healthcare system and to take the initial steps to provide care for any health 2000 
problem(s) that patients may have. The general practitioner takes care of 
individuals in a society, irrespective of the patient's type of disease or other 
personal and social characteristics, and organises the resources available in 
the healthcare system to the best advantage of the patients. The general 
practitioner engages with autonomous individuals across the fields of 
prevention, diagnosis, cure, care, and palliation, using and integrating the 
sciences of biomedicine, medical psychology, and medical sociology 
Medical health care professionals providing first contact and on-going care to Bowerand 
patients, regardless of the patient's age, gender or presenting problem Sibbald, 1999 
1 Quoted from Olesen et al, 2000 
General practice or primary care is different from other health care settings in 
terms of its organisation, focus, patient case-mix and patient-doctor relationship. 
Also the composition of health care team is different. The reaction of GPs to a 
given condition (e. g. a patient with low back pain) may not be similar to that of a 
consultant physician, a surgeon or a tertiary care specialist. Despite the 
definitions (Table 1.1) general practice or primary care is not the same thing in 
different countries. The level of PCP specialisation is variable. In many 
countries (e. g. the UK) PCPs have to take some training in primary care (as a 
resident, registrar or trainee) before they qualify for the job. However in some 
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other countries (e. g. Iran) PCPs are general physicians. Even in countries with 
specialised training, PCP may mean different things. In the USA some 
community office-based general paediatricians or internists are rightly 
considered as PCPs. In the UK there are many GPs with special interest (e. g. in 
diabetes, asthma, dermatology), who tend to spend part of their office time 
practicing it and may receive referrals from their peers. In certain countries (e. g. 
Canada) different parts of the health system have different primary care 
structures. 
There is 'no magic bullet' for provider behaviour change (Oxman et al, 
1995). An effective intervention in some circumstances (e. g. in hospital setting) 
may be less effective or ineffective in other circumstances (e. g. in primary care). 
In that sense, the issue of health professional behaviour is not different from 
health care itself. There is no 'wonder drug' to treat all conditions in all 'patients'. 
Understanding the behaviour of PCPs requires careful studies in primary care. 
Selective approaches would help health services researchers to identify the 
questions for which there are answers and the questions that require further 
investigations. 
1.5. What is the thesis about? 
The thesis aimed to explain variation in primary care prescribing in accordance 
to the best available evidence (i. e. clinical guidelines), using theory-based 
approaches. The thesis presents the findings of a health services research 
study. The study benefited from the contribution of a few academic disciplines 
including health psychology, health policy, epidemiology and biostatistics. More 
importantly the primary findings were the results of different research 
methodologies: systematic reviewing of evidence, qualitative analysis of 
interview data and large-scale mailed surveys. These methodologies were used 
at different stages of the study. Methods used for this thesis can be found in 
Chapters 2,4,6 and 7. The Theory of Planned Behaviour (TPB) was the major 
theory used in the thesis. The study started with a wide approach (within 
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primary care prescribing) and as progressed through the stages focused on 
prescribing for specific clinical conditions. 
The study started with an overview of systematic reviews (Chapter 2). 
The overview was used to collate the available knowledge in terms of the 
effectiveness of interventions to improve prescribing in primary care. The 
overview was not limited to any specified clinical conditions. It covered several 
interventions likely to influence prescribing. It concluded with an updated and 
improved taxonomy (the SAGE taxonomy) of interventions summarising what 
was known about the effectiveness of different interventions. The overview also 
concluded that the widely held view on the effectiveness of multi-faceted 
interventions could be misleading. 
Chapter 3 reports the findings of a selective review of theories of 
behaviour change. The theories were derived from different academic 
disciplines. The chapter was intended to contribute to the understanding of 
variations observed in the effectiveness of the interventions. The review was 
used for improving the taxonomy developed in Chapter 2. In this chapter the 
potential merits of TPB for explaining variation in primary care prescribing were 
also presented. 
Chapter 4 reports the findings of a qualitative study of GlOs and academic 
of primary care in Britain. The qualitative study focused on views and concerns 
of GPs about factors that contributed to the success (or failure) of clinical 
guidelines in promoting effective prescribing in primary care. Five clinical 
conditions were specifically considered in the interviews. These were 
depression, menorrhagia, statins for coronary heart disease (CHID) prevention, 
asthma and epilepsy. The TPB was used in the design of the interview plan and 
in devising the framework for data analysis. Based on the qualitative study two 
clinical conditions (asthma and statins for CHID prevention) were identified to be 
used in the surveys. The qualitative analysis resulted in identifying seven main 
themes (and 30 sub-themes) for implementation of prescribing 
recommendations. Not all the themes were relevant to interventions, but using 
those which were, the taxonomy of intervention was further developed. Based 
on secondary analysis of the qualitative data and the thematic framework, a 
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simple model for the implementation of clinical guidelines for prescribing in 
British primary care was developed (Chapter 5). 
Before conducting the surveys, it was noted that previous TPB studies 
had mostly shunned the issue of sample size estimation. Methodological 
analyses were conducted to establish the optimal methods of sample size 
calculation for a TPB study (Chapter 6). The findings could be useful for sample 
size calculation of any study using linear regression analysis. The results of two 
national surveys of GPs intentions to prescribe in accordance with clinical 
guidelines for asthma and prescribe statins for the prevention of CHID are 
reported in Chapter 7. The surveys were based on TPB. The questionnaires 
were developed based on the findings of the qualitative study (Chapter 4). The 
surveys examined the theory as if it provided better understanding of GPs' 
variation in attitudes towards, and intentions to use clinical guidelines. The 
surveys also assessed TPB's ability in explaining prescribing variation, using 
routinely collected dispensing data. 
Chapter 8 is the final chapter of the thesis. In this chapter a summary of 
the findings and important discussions and implications as well as main 
limitations were provided. It concluded that the TPB had important potentials for 
guideline implementation and GP prescribing. It also summarised the main 
policy and research implications of the thesis. 
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Belief in education as a method of influencing general 
practitioners is confirmed. But gains in knowledge, 
skills and changes in behaviour seem harder to 
achieve. 
Horder, Bosanquet and Stocking, 1986 
Chapter 2: Overview of systematic reviews. 
Effective interventions for improving physician 
prescribing in primary care 
Z 1. Background 
This chapter presents the results of an overview (i. e. systematic review) of 
systematic reviews of health professional behaviour change interventions with 
focus on physician prescribing in primary care (i. e. PCP prescribing). The 
results of the review in terms of the effectiveness of different interventions for 
improving PCP prescribing are presented. The chapter ends with a table (Table 
2.1) summarising and categorising the findings in the taxonomy of interventions. 
Implementation of clinical guidelines and changing physician behaviour 
has proved difficult. Within the last two decade several systematic reviews of 
provider behaviour change have been published. These reviews attempted to 
summarise the state of the art and knowledge by identifying the effectiveness 
(and sometimes efficiency) of specific interventions to improve provider 
behaviour. In turn, the results of the systematic reviews have been summarised 
in few overviews of systematic reviews (Conroy and Shannon, 1995; Bero et al, 
1998; NHS Centre for Reviews and Dissemination, 1999; Cantillon and Jones, 
1999; Durieux et al, 2000; Smith, 2000; Grimshaw et al, 2001). 
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One earlier and frequently cited overview focused on the effectiveness of 
different interventions to improve the implementation of research evidence 
(Bero et al, 1998). Eighteen eligible systematic reviews were included in that 
study. Berc, et al found that many primary studies included in systematic 
reviews were methodologically flawed. Given the observed effect sizes were 
small, this might have resulted in erroneous conclusions. They also observed 
few studies performing economic evaluation. Another shortcoming identified by 
Bero et al was lack of generalisability. Many primary studies had originated from 
North America. Even in their North American context most studies had been 
conducted by small number of researchers in limited range of settings. 
Nonetheless the overview had important conclusions; mainly it discouraged use 
of passive dissemination of educational materials. This conclusion has been 
repeated in several studies published since Bero et al (1998). 
Another widely disseminated overview of systematic reviews was 
published as an Effective Health Care bulletin (NHS Centre for Reviews and 
Dissemination, 1999). It updated Bero et al (1998) study. Forty-four studies 
were included in this update. NHS CRD (1999) was effectively more than an 
overview of systematic reviews. It included a review of a number of theories of 
behaviour change, and addressed different practical and organisational issues 
that might inhibit evidence implementation. These latter sections of the overview 
did not follow a systematic approach. Hence NHS CRD (1999) was an 
authoritative publication for enhancement of evidence implementation and 
provider behaviour change. This was likely to have improved the relevance and 
usefulness of the report, but might have negatively affected its reliability. The 
report highlighted six recommendations on the front page. The level of evidence 
behind these recommendations varied, but this was not acknowledged. The 
longer version of NHS CRD (1999) appeared two years later as Medical Care 
supplement (Grimshaw et al, 2001). Forty-one systematic reviews were 
included in this later publication. Like its predecessor, it covered the period until 
mid 1998. The reviews were from a dispersed range of 27 medical journals. The 
authors found high variability in quality of the systematic reviews. They also 
found the meta-analyses performed in nine reviews were inappropriate because 
of high levels of heterogeneity and unit of error analyses in original papers 
(Grimshaw et al, 2001). They discussed the findings under three categories of 
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'systematic reviews of broad strategies, 'systematic reviews of specific 
interventions' and 'systematic reviews of interventions for specific behaviours'. 
The study had some conclusions that were relevant to prescribing. It concluded 
that educational outreach visits were effective in changing prescribing. 
Grimshaw et al (2001) also concluded that audit had variable effectiveness. 
They also concluded that multi-faceted interventions were more likely to be 
effective and invited researchers to try to disentangle these in order to identify 
the effective elements within multi-faceted approaches. They also sought further 
studies with formal economic evaluation. The main conclusions of this overview 
were in essence similar to the earlier Bero et al (1998) study. 
One overview was published in French (Durieux et al, 2000). The 
overview focused on using clinical guidelines for behaviour change. It did not 
discuss prescribing behaviour as a separate outcome (personal 
correspondence with Pierre Durieux). Other overviews of systematic reviews 
employed less systematic approaches. One earlier study focused on 
implementation of clinical guidelines in primary care, but did not pursue a 
systematic approach and there was little focus on prescribing (Conroy and 
Shannon, 1995). A later study focused on the effectiveness of continuing 
medical education in general practice (Cantillon and Jones, 1999). Primary 
studies as well as systematic reviews were included in this overview. The 
reporting of the findings did not follow a systematic approach and studies which 
were unlikely to be systematic reviews or high quality primary research were 
reported in the result section of the paper. The study had limited findings from 
interventional studies that were relevant to prescribing. One important finding 
was that the effects of educational interventions might be short-lived (Cantillon 
and Jones, 1999). 
Smith (2000) reviewed meta-analyses and 'structured' reviews of 
interventions to change physician behaviour. He also reviewed a number of 
theories of behaviour change and included primary studies as well as 
systematic reviews. However, it was unclear why for some interventions primary 
studies were considered and for other interventions they were not. Perhaps the 
author intended to fill in the evidence gap where there were no systematic 
reviews, but the methods of identifying the gaps were not explained. The two 
24 
major findings of the overview were similar to those reported by others: no 
intervention was effective in all circumstances, and multi-faceted approaches 
were more likely to succeed in behaviour change (Smith, 2000). The overview 
had a reasonable focus on prescribing but did not distinguish between 
prescribing in primary care and other settings. It reported that educational 
outreach, audit and feedback and clinical guidelines were effective in changing 
prescribing in selected situations. Smith concluded 'in the language of clinical 
medicine, we must diagnose the lesion (why change is not adopted) before 
prescribing therapy (a change strategy)' (p 16S). Lack of an explicit systematic 
approach in the latter three overviews made their findings more prone to biases 
because of selective reporting (Conroy and Shannon, 1995; Cantillon and 
Jones, 1999; Smith, 2000). 
None of the aforementioned overviews of systematic reviews focused 
explicitly on prescribing. The need for more focused approaches to provider 
behaviour change is well established (Grimshaw and Russell, 1993; Oxman et 
al, 1995). In line with the objectives of the thesis, this chapter presents the 
findings of the overview of systematic reviews of provider behaviour change for 
PCP prescribing (Mulrow, 1994). The overview covered all interventions to 
improve prescribing regardless of whether they used clinical guidelines or not to 
ensure all relevant studies were included. The results were also used to update 
and improve taxonomies of interventions for prescribing behaviour change. 
Therefore, the objectives of the overview were summarised as follows: 
2.1.1. Objectives 
The overview had two main objectives: 
> To evaluate the effectiveness of interventions to improve primary care 
prescribing. 
> To provide updated taxonomy of interventions for improving primary care 
prescribing. 
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2.2.1. Inclusion and exclusion criteria 
Time frame 
> Systematic reviews published from 1980 to 2001 were considered 
eligible for inclusion. 
> The existence of any update for the included Cochrane reviews was 
checked in 2004 (Cochrane Database, Issue 2, Chichester, UK: John 
Wiley & Sons). 
Study designs 
> Systematic reviews of interventional studies were included. 
> Systematic reviews that included (cluster) randomised controlled trials 
(incl. balanced incomplete block, randomised crossover, and simple 
randomised trials), interrupted time series (ITS) and controlled before- 
and-after studies (controlled by other doctors or untargeted behaviour, 
switchback designs) were deemed eligible (Grimshaw and Russell, 
1993). 
> Included systematic reviews could have considered other types of 
studies, but only evidence from aforementioned study designs was 
eligible for inclusion in the overview. 
> Reviews of the methodological quality of published studies, studies 
without explicit research methodology and those of bibliographic nature 
for published or ongoing research were not eligible (Bero et al, 1998). 
> Earlier versions of updated systematic reviews were excluded unless the 
updates had a shift in focus or incomplete reporting. 
> Other study designs were discussed but not'included' in the overview. 
These studies were valuable in discussing the effectiveness of 
interventions for which there was limited evidence in systematic reviews. 
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Participants 
> Systematic reviews that did not exclude primary studies of PCP 
prescribing were eligible. 
> PCPs were defined as all physicians working in primary care that fulfilled 
the aforementioned definitions (Table 1.1) and were inclusive of GPs, 
family doctors, family physicians, family practitioners and family medicine 
specialists. 
> In this overview, the definition excluded physicians in training (i. e. 
students, residents, trainees). 
Physician activities in nursing homes or community hospitals only were 
also excluded. 
Included systematic reviews could have considered health care providers 
other than PCPs, but only evidence from studies of PCPs was eligible for 
inclusion. 
Interventions 
> Any strategy or combination of strategies to promote effective or efficient 
prescribing in primary care was considered. 
> The strategies included, but were not limited to, continuous medical 
education (CME), audit and feedback, peer review, reminders, quality 
improvement cycles (continuous quality improvement, total quality 
management), clinical guideline implementation programmes, 
computerised systems, patient education, educational outreach visits, 
local opinion leaders, financial incentives, remuneration schemes, non- 
monetary rewards or penalties, interventions involving change in the 
formulary, mailouts and mass media campaigns and inter-professional 
strategies. The definitions used for different interventions are provided in 
the Glossary. 
Outcome measures 
> It was expected that included systematic reviews would report a wide 
range of outcomes. The focus of the overview was on prescribing. All 
outcomes relevant to primary care prescribing were considered, including 
data recording, prescribing, cost and patient outcomes. 
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Data from test environments (role playing, paper patients, vignettes, 
. simulation cases etc. ) were excluded. 
> Papers were excluded if the only relevant outcomes were prescribing 
knowledge or attitude. 
Vaccination, exercise prescribing and investigatory prescribing (i. e. 
laboratory tests, radiology etc) were excluded. 
As a working definition, systematic reviews of the effectiveness of provider 
behaviour change interventions which did not exclude primary care physician 
prescribing were eligible for inclusion in the overview of systematic reviews. The 
included studies were required to meet the previously stated inclusion and 
exclusion criteria. 
2.2.2. Search strategy 
Given the broad perspective of the potentially relevant systematic reviews, 
different approaches were followed to ensure eligible systematic reviews were 
identified. Several alternative search strategies were devised and tested. In the 
end it was decided to use a search strategy previously tested for a broad 
perspective overview of systematic reviews (Grimshaw et al, 2001). The search 
combined a validated systematic review search with a search for provider 
behaviour change interventions (Appendix 11-1). The search was not limited to 
any setting (e. g. primary care), provider (e. g. PCPs), behaviour (e. g. 
prescribing) or language; therefore, it was sensitive enough to ensure 
potentially eligible studies were not missed. It was used to search Medline and 
Embase (1980 - 200 1) with slight adaptation. The search was complemented 
using following approaches. Forward citation searches for three broadly cited 
systematic reviews (Grimshaw and Russell, 1993; Oxman et al, 1995; Davis et 
al, 1995) were conducted in Science Citation Index and Social Science Citation 
Index databases (provided by Web of Knowledge - then Web of Science, 
MIMAS, University of Manchester). The Cochrane Library (Chichester: John 
Wiley & Sons) - inclusive of DARE (Database of Abstracts of Reviews of 
Effectiveness, CRD, University of York) and HTA (Health Technology 
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Assessment) - were also searched. The Cochrane database search was 
updated in 2004 to consider any potential updates of already included Cochrane 
reviews. References already included in the author's personal database and 
those known by his advisers were also considered. The bibliographic references 
of the included studies, previous overviews of systematic reviews and relevant 
editorials were also searched. Bibliographic search was iterative and was 
repeated for every identified literature. In total about twelve thousand titles were 
considered. All studies that appeared to be reviews of provider behaviour 
change interventions were flagged for more detailed assessment. After careful 
consideration against the inclusion criteria, the full-texts of 109 papers that 
appeared to be reviews of behaviour change interventions were ordered. Out of 
those, seventy-two reviews were excluded from the overview. List of the 
excluded studies and the reasons for exclusion are provided in Appendix 11-3. 
2.2.3. Methods of the review 
Definitions, criteria for inclusion and data extraction strategy were agreed upon. 
The titles and abstracts of identified studies were scanned before ordering the 
papers. All papers likely to be efigible were ordered. The papers were excluded 
according to the criteria. After the first round of data extraction, the excluded 
and included papers were checked again and the extracted data was re- 
examined. Any doubt or discrepancy was solved by reference to the original 
papers. When necessary the abstracts or full-texts of primary studies included 
in systematic reviews were considered. Data was extracted from the systematic 
reviews; and exceptionally from primary studies in case there was any 
uncertainty. Primary study studies were also checked to ensure the eligibility for 
inclusion (e. g. meeting the overview's inclusion criteria in terms of setting, 
provider, outcome behaviour and study design) and the accuracy or 
completeness of data reported in the systematic reviews. Data were analysed 
using narrative synthesis. The effectiveness of single strategies and different 
combinations of strategies were noted in the analysis. The gene ralisability of the 
systematic reviews' conclusions to PCP prescribing was noted. It was decided a 
priori to compare discordant systematic reviews following a published algorithm 
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(Jadad et al, 1997). The algorithm was meant for comparing reviews with 
discordant results, but not reviews with discordant interpretation of results. 
Jadad et al (1997) suggested that if the results of two or more systematic 
reviews were discordant, certain steps should be followed. The steps included 
comparing review questions, included studies, inclusion criteria, review quality 
and data extraction and analytical strategies. 
Quality of systematic reviews was assessed by taking notes of different 
methodological aspects of the reviews, including search strategies, inclusion 
criteria, data synthesis strategies, data extraction and whether the reviews' 
conclusions were supported by the data (Oxman, 1994). No attempts were 
made to 'formally' assign quality scores to the systematic reviews. Apparent 
shortcoming in quality and methods of systematic reviews were stated in the 
evidence table (Appendix 11-2). The shortcomings were identified by checking 
the primary studies included in the reviews (whenever discrepancies were 
observed) as well as the methods and reporting of the systematic reviews. 
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2.3. Findings 
2.3.1. Description of systematic reviews 
Thirty-three systematic reviews (39 papers) that met the inclusion criteria were 
located (Lomas and Haynes, 1988; Soumerai et al, 1989; Mugford et al, 1991; 
NHS Centre for Reviews and Dissemination, 1994; Wensing and Grol, 1994; 
Grimshaw et al, 1995; Pippalla pt al, 1995; Yano et al, 1995; Anderson and 
Lexchin, 1996; Balas et al, 1996; Beilby and Silagy, 1997; Chrischilles and 
Gondek, 1997; Freemantle et al, 1997; Thomson O'Brien et al, 1997; Hunt et al, 
1998; Shortell et al, 1998; Wensing et al, 1998; Bower and Sibbald, 1999; Gill et 
al, 1999; Giuffrida et al, 1999; Le Grand et al, 1999; Thomson O'Brien et al, 
1999; Walton et al, 1999; Zwarenstein et al, 1999; Bower and Sibbald, 2000; 
Chaix-Couturier et al, 2000; Gosden et al, 2000; Zwarenstein and Bryant, 2000; 
Zwarenstein et al, 2000; Armour et al, 2001; Gosden et al, 2001; Gross and 
Pujat, 2001; Lewin et al, 2001; Mitchell and Sullivan, 2001; Ratanawijitrasin et 
al, 2001; Thomson O'Brien et al, 2001; Walton et al, 2001; Grilli et al, 2002; 
Jamtvedt et al, 2003). 
The included reviews updated eleven previous systematic reviews 
(Haynes et al, 1984; Haynes and Walker, 1987; Raisch, 1990a; Raisch, 1990b; 
Davis et al, 1992; Grimshaw and Russell, 1993; Johnston et al, 1994; Oxman et 
al, 1995; Sullivan and Mitchell, 1995; Davis et al, 1999; Gosden et al, 1999). 
The majority of the included studies had been published as Cochrane reviews 
(13 papers). One Cochrane review had been withdrawn, but it was included in 
the overview since there were no update or substituting review (Freemantle et 
al, 1997). One review was published in a bulletin and the rest in 18 different 
journals. Journals were in different categories of general and internal medicine 
(9 papers), health services and quality of care (6 papers), pharmacy (3 papers), 
preventive care and social medicine (2 papers) and general practice (1 paper). 
The included reviews' first authors were based in ten different countries: the 
USA and the UK (9 reviews each), Canada (8 reviews), Australia, France, Italy, 
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Kenya, Norway, Thailand and the Netherlands (one review each). The country 
of location was assessed based on the first authors' affiliations as provided on 
the papers. 
The studies had different points of focus. In terms of the target 
behaviour, nine reviews focused on prescribing (Sournerai et al, 1989; Pippalla 
et al, 1995; Anderson and Lexchin, 1996; Chrischilles and Gondek, 1997; Gill et 
al, 1999; Le Grand et al, 1999; Walton et al, 1999; Ratanawijitrasin et al, 2001; 
Gross and Pujat, 2001; Walton et al, 2001), one on provision of mental health 
care (Bower and Sibbald, 2000; Bower and Sibbald, 1999) and one on patient- 
centred care (Lewin et al, 2001). In the latter review the impact of interventions 
to improve patient-centred care on provider behaviour (including prescribing) 
was assessed. Other reviews were not limited to any specific behaviour. Many 
reviews focused on the effectiveness of specific interventions to improve 
provider behaviour. Of those, three reviews focused on different types of audit 
and feedback (Mugford et al, 1991; Beilby and Silagy, 1997; Jamtvedt et al, 
2003), four reviews considered financial incentives (Chaix-Couturier et al, 2000; 
Gosden et al, 2001; Armour et al, 2001; Gosden et al, 2000; Giuffrida et al, 
1999) and three focused on computerised systems (Hunt et al, 1998; Walton et 
al, 1999; Mitchell and Sullivan, 2001; Walton et al, 2001). For each of the 
following interventions one systematic review was included: mass media 
interventions (Grilli et al, 2002), doctor-nurse relationship (Zwarenstein and 
Bryant, 2000), inter-professional education (Zwarenstein et al, 1999; 
Zwarenstein et al, 2000), substitution or consultation-liaison models of mental 
health care (Bower and Sibbald, 2000; Bower and Sibbald, 1999), local opinion 
leaders (Thomson O'Brien et al, 1999), educational outreach (Thomson O'Brien 
et al, 1997), printed educational material (Freemantle et al, 1997), COI (Shortell 
et al, 1998), CME (Thomson O'Brien et al, 2001), physician profiling and peer 
review (Balas et al, 1996) and national drug policies in less developed countries 
(Ratanawijitrasin et al, 2001). Five systematic reviews had wider appeals and 
covered different interventions for different sets of behaviours (Lomas and 
Haynes, 1988; NHS Centre for Reviews and Dissemination, 1994; Wensing and 
Grol, 1994; Grimshaw et al, 1995; Yano et al, 1995; Wensing et al, 1998; Gross 
and Pujat, 2001), of which three focused on implementation of clinical 
guidelines (NHS Centre for Reviews and Dissemination, 1994; Wensing and 
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Grol, 1994; Grimshaw et al, 1995; Wensing et al, 1998; Gross and Pujat, 2001). 
All but nine reviews were not limited to primary care and considered data from 
different health care settings (Soumerai et al, 1989; Wensing and Grol, 1994; 
Yano et al, 1995; Anderson and Lexchin, 1996; Beilby and Silagy, 1997; 
Wensing et al, 1998; Bower and Sibbald, 2000; Mitchell and Sullivan, 2001; 
Gosden et al, 2001; Gosden et al, 2000; Giuffrida et al, 1999; Bower and 
Sibbald, 1999). All but two reviews were not limited to any set of countries or 
regions of the world. Both studies considered evidence from less developed 
countries only (Le Grand et al, 1999; Ratanawijitrasin et al, 2001). Some 
reviews although were not confined to a given country, but were more tuned to 
the needs of the health system of that country, e. g. Canada (Anderson and 
Lexchin, 1996) and the USA (Shortell et al, 1998). 
Many primary studies were included in more than one systematic review. 
The systematic reviews included 1173 counts of primary studies between 
themselves, of which 165 counts of papers (representing about 80 unique 
studies) met the overview's inclusion criteria (i. e. appropriately designed 
interventional studies of improving PCP prescribing). About a quarter of those 
80 studies were included in more than one review, with some being included in 
more than six systematic reviews (e. g. Avorn and Sournerai, 1983; Schaffner et 
al, 1983), hence the total of 165. Details of all included systematic reviews and 
their corresponding primary studies are presented in the evidence table 
(Appendix 11-2). Several Cochrane reviews had not been updated for periods of 
up to four years (in 2001), despite the Cochrane Collaboration's objective of 
updating reviews every 1-2 years. Many were not still updated in summer 2004 
increasing the delay to up to seven years. 
2.3-2. Quality of systematic reviews 
As noted in previous overviews of systematic reviews (Bero et al, 1998; 
Grimshaw et al, 2001) the quality of systematic reviews varied greatly. Attention 
to the included primary studies was informing since other threats that could 
invalidate the results of systematic reviews were identified. Some examples of 
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important quality issues are presented in here and further details are reported in 
Appendix 11-2. 
The majority of the reviews synthesised the data using narrative 
synthesis techniques, although the methods were often left unexplained. 
Underlying variations in the primary studies is the main barrier to quantitative 
synthesis of data in systematic reviews of provider behaviour. Biases due to low 
transparency of the analytical method could not be excluded. The methodology 
of narrative synthesis is still developing. The UK ESRC Methods Programme is 
providing guidance for undertaking 'narrative synthesis' which may help 
standardisation of the technique (Economic & Social Research Council, 2003). 
One review conducted random effects model meta-analysis based on the 
standardised mean differences of the outcomes (Walton et al, 1999; Walton et 
al, 2001). Two systematic reviews used 'vote counting' and 'z transformation' 
methods and performed quantitative meta-analyses (Balas et al, 1996; Gill et al, 
1999). Both reviews acknowledged that there was a great degree of 
heterogeneity in the data, which undermined the validity of the quantitative 
approaches. A further review used meta-analysis while the validity of using this 
approach was questionable (Pippalla et al, 1995). 
Three reviews went beyond their stated objectives. Two separate 
systematic reviews of prescribing included non-prescribing primary studies. One 
study included primary studies of laboratory test ordering, while it was aimed at 
assessing the interventions to influence prescribing (Pippalla et al, 1995). The 
same review also included a totally irrelevant non-interventional study (see 
Appendix 11-2 for details). Mother review included studies of preventive 
behaviour, while its objective was to assess the impacts of clinical guidelines in 
drug utilisation reviews (Chrischilles and Gondek, 1997). A further review 
included a study with strong educational outreach component as a study of 
provision of costing information which might be misleading (Beilby and Silagy, 
1997). 
The search strategies of a few reviews, including two Cochrane reviews, 
seemed to have important shortcomings as they missed relevant primary 
studies included in other reviews (Wensing and Grol, 1994; Pippalla et al, 1995; 
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Beilby and Silagy, 1997; Chrischilles and Gondek, 1997; Shortell et al, 1998; 
Freemantle et al, 1997; Gross and Pujat, 2001; Jamtvedt et al, 2003). There 
were also occasional misses of duplicate publications of primary studies in the 
systematic reviews (Appendix 11-2). 
There were errors in classifications of primary studies in terms of their 
designs or approaches, which might have hampered the validity of the 
systematic reviews' conclusions. An interesting example was obtained by 
comparing two reviews of studies from developing countries (Le Grand et a[, 
1999; Ratanawijitrasin et al, 2001). Both reviews included an earlier study of the 
effectiveness of essential drugs programmes in Yemen (Hogerzeil et al, 1989; 
Walker et al, 1990). Le Grand et al (1999) referred to the study as a randomised 
trial, while Ratanawijitrasin et al (2001) identified the same research as a post- 
only controlled trial. Checking the original papers of the primary study revealed 
that it was a post-only controlled trial. In another example a primary study 
(Lobach and Hammond, 1994) was considered as prescribing study in 
Chrischilles and Gondek (1997) and not as such in Mitchell and Sullivan (2001). 
Chrischilles and Gondek included evidence from primary studies without 
reported prescribing outcomes and used evidence from those studies to draw 
conclusions for prescribing. One of the systematic reviews wrongly classified 
two RCTs as non-randomised and one CBA as a randomised study (Le Grand 
et al, 1999). Similarly, another review did not notify an RCT as such 
(Chrischilles and Gondek, 1997). A review with quantitative analysis included 
three separately published analyses of one intervention in the quantitative 
synthesis as separate studies (Pippalla et al, 1995). Similarly a CBA study was 
considered as RCT in Balas et al (1996) review. 
The reviews varied in the definitions they used for the interventions. This 
was sometimes because of using non-standard definitions (Lomas and Haynes, 
1988) or because of joining some interventions together in one category in 
order to simplify the analysis processes (Gill et al, 1999). 
In total twenty-three interventions were identified in the literature. The 
following sub-sections of the chapter report the identified evidence for the 
effectiveness of different interventions. Competence oriented interventions are 
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introduced first. Then performance oriented and social influence interventions 
are discussed. Next the interventions involving physical support, financial 
incentives and non-voluntary strategies are presented. Finally a distinct 
subsection discusses the evidence for the effectiveness of multi-faceted 
interventions. Further information about all included systematic reviews and 
important discussions about the implications or methods of the reviews are 
included in the evidence table (Appendix 11-2; as the table is too long to be 
included in the text). 
2.3.3. Continuing medical education (CME) and inter- 
professional education 
Educational interventions are among the most common interventions to improve 
provider behaviour. The effectiveness of didactic CME, interactive CME and 
inter-professional education is discussed in here. 
A Cochrane review assessed the effectiveness of CME meetings and 
workshop in improving provider performance and patient outcomes (Thomson 
O'Brien et al, 2001). The review was an update of a series of previous reviews 
(Davis et al, 1992; Davis et al, 1995; Davis et al, 1999). Older studies had wider 
inclusion criteria and included interventions other than CME (Davis et al, 1992; 
Davis et al, 1995). The Cochrane review in total included 32 studies of which 30 
were RCTs. The review concluded that interactive workshops could result in 
moderately large changes in provider performance, while didactic sessions 
were generally ineffective. Four included RCTs focused on prescribing in 
primary care. An RCT of didactic approach in Sri Lanka suggested no additional 
effects from educational seminar over and above the effects resulted from an 
educational newsletter in reducing antibiotic injection rates (Angunawela et al, 
1991). Workshops of interactional group discussions were evaluated against no 
intervention in another RCT conducted in Indonesia. The intervention had 
moderate to large effects in reducing intramuscular injection rate (Hadiyono et 
al, 1996). Mixed methods including three educational seminars were used in an 
RCT in Zambia to improve prescribing, with small but statistically significant 
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effects on average number of drugs per prescription (Bexell et al, 1996). An 
RCT of theory based educational seminars for general paediatricians in 
community practices improved asthmatic patients' outcomes and practitioners' 
prescribing (Clark et al, 1998). The outcomes of the primary care prescribing 
studies supported the general conclusion of the review. 
A further study was included in a systematic review of clinical guideline 
implementation in primary care (Wensing and Grol, 1994; Wensing et al, 1998). 
This was a CBA study of tutorial sessions reporting improvements in physician 
antibiotic prescribing in the intervention group (Klein et al, 1981). 
There was no evidence of effect for inter-professional education. A 
Cochrane review (Zwarenstein et al, 1999; Zwarenstein et al, 2000) failed to 
include even a single study on the effects of inter-professional education on 
process or patient outcomes. The review was not limited to any specific 
outcome (prescribing or other outcomes). Lack of evidence may be due to the 
complexity of devising the intervention and evaluating it, although it is possible 
to plan such intervention. It may also be the result of professionals and others 
perceiving no equipoise in here. Studies are required to assess the effects of 
these interventions. 
2.3.4. Mailed printed educational material and mailed national 
warning campaigns 
Several systematic reviews discussed the effectiveness of mailed printed 
educational materials. A Cochrane review assessed the effectiveness of printed 
educational materials in changing provider performance and patient outcomes 
(Freemantle et al, 1997). They considered primary studies regardless of the 
method of the delivery of printed material including mass mailing, delivery by 
hand or personal mailing. The review included eleven studies of which two 
targeted prescribing in primary care. In both studies mailed educational 
materials resulted in small non-significant reductions in inappropriate 
prescribing. In a Dutch RCT the intervention's effect on undesirable 
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antispasmodics was very modest (Denig et al, 1990). In the second RCT 
inappropriate prescribing reduced by 4% (reported 3% in Freemantle et al, 
1997) in the group receiving mailed educational material (Avorn and Sournerai, 
1983). Freemantle and colleagues (1997) pointed out that the small changes 
observed from the intervention might have been cost-effective. The reviewers 
also questioned the evidence base of educational material provided in these 
two studies, suggesting doubtful evidence base might have contributed to the 
small effects. In the end the authors concluded that the value of printed material 
in comparison to no intervention was uncertain. 
Another systematic review of prescribing in primary care, Sournerai et al 
(1989), included two studies from the USA assessing the effects of mailed 
printed educational material. One RCT was mentioned earlier in this section 
(Avorn and Sournerai, 1983). The investigators performed an economic 
evaluation on the results of the trial and concluded that mailed educational 
material intervention was cost-effective (Sournerai and Avorn, 1986). The 
review also reported the results of a CBA study in which attractively designed 
mail brochures did not reduce inappropriate antibiotic prescribing (Schaffner et 
al, 1983). Soumerai et al (1989) concluded that the evidence did support the 
effectiveness of the intervention, but they pointed out that it might be cost- 
effective. A further systematic review (Lomas and Haynes, 1988) included 
Avorn and Sournerai (1983) as well as another RCT that reported no significant 
effects from weekly educational materials on the management of hypertension 
(Evans et al, 1986). The review then concluded 'the resources currently being 
spent on the production and distribution of such material [printed educational 
material] can be diverted into more effective approaches' (Lomas and Haynes, 
1988, p 87). A more recent systematic review also considered both studies 
included in Sournerai et al (1989) and concluded that educational material 
mailouts seemed to be ineffective (Gross and Pujat, 2001). 
Similarly Gill et al (1999) concluded that printed educational materials 
were less effective than other interventions in improving prescribing. This 
conclusion was based on evidence from a mixture of different health care 
settings. However, for this overview attention to the relevant subgroup of 
included studies (i. e. from primary care) revealed that in 2 out of 4 included 
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studies printed educational material significantly improved antibiotic prescribing. 
Le Grand et al (1999) review included a three-arm clustered RCT from Sri 
Lanka. The 'newsletter only' campaign resulted in a reduction of 7.4% in 
antibiotic prescribing (Angunawela et al, 1991). This reduction was similar to the 
reduction observed in the 'newsletter plus seminar' group and was further than 
the change in the control group (0.4%). However, the differences were not 
statistically significant probably owing to the lack of power (15 health centres, 
45 prescribers). 
A systematic review of prescribing in primary care identified five ITS 
studies assessing the effects of mailed national warning campaigns on 
prescribing (Soumerai et al, 1989). Three European studies (two from Britain 
and one from Sweden) demonstrated important and statistically significant 
reductions in the use of chloramphenicol (Wade and Hooh, 1972), pressurised 
aerosols for asthmatic patients (Inman and Adelstein, 1969) and dipyrone 
(Bottiger and Westerholm, 1973). Studies also reported reductions in the rate of 
associated serious adverse events. In all studies mailed national warnings to 
doctors were accompanied by publication of letters and articles in professional 
journals. Fourth study had been conducted in the USA and failed to 
demonstrate any reduction in the use of propoxyphene as a result of the 
intervention (Soumerai et al, 1987a). A further study from Northern Ireland 
reported a downward trend in barbiturate use in line with the secular trend that 
had existed before the campaign (King et al, 1980). It seemed the campaigns 
were most successful when the medications had serious adverse reactions and 
were unlikely to have potential for abuse. Scientific media support was also 
important (Soumerai et al, 1989). 
2.3.5. Mass media campaigns 
A Cochrane review assessed the impacts of mass media campaigning on the 
utilisation of health services (Grilli et al, 2002). It included 20 studies and 
concluded media campaigning could result in intended influence on utilisation. 
The authors argued that in order to achieve the objectives, efforts should be 
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made to ensure that media were used appropriately. The review identified few 
studies with acceptable quality attempting to evaluate the effects of mass media 
campaigning on prescribing. 
The authors included two ITS studies with prescribing outcomes. A 
Canadian study evaluated the use of mass media campaigning to reduce 
calcium-channel blocker prescribing as the first line of treatment for 
hypertension (Maclure et al, 1998). Another study from the USA assessed the 
impact of the campaign on reducing the use of aspirin in children to prevent 
Reye's syndrome (Soumerai et al, 1992). Both studies demonstrated significant 
reductions (Grilli et al, 2002). The reviewers noticed that most campaigns in 
areas other than prescribing were meant to increase health care utilisation. 
2.3.6. Participatory guideline development 
There was very limited evidence on the effectiveness of this intervention. A well 
designed British BIB study of guideline implementation for five common 
paediatric conditions concluded that participatory guideline development 
improved prescribing for all five conditions by 8% on average. The groups 
receiving the guidelines, but not involved in its production, did not improve as 
such (North of England Study of Standards and Performance in General 
Practice, 1992a; North of England Study of Standards and Performance in 
General Practice, 1992b). This study was included in two systematic reviews 
(Grimshaw et al, 1995; Wensing et al, 1998). In another British study a group of 
GPs developed audit criteria for monitoring patients receiving digoxin. They 
distributed the criteria and discussed them with other GPs. One year follow up 
suggested that only those who were involved in the development of the criteria 
actually implemented it (Anderson et al, 1988). This was included in Grimshaw 
et al (1995). Another review, Soumerai et al (1989), included a USA CBA study. 
The study observed that an intervention involving participatory guideline 
development improved prescribing in the development site in comparison to the 
control, but did not improve prescribing in another site that received the 
guideline. Also the observed effects in the development site were mainly due to 
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the adherence of those physicians who were directly involved in the 
development of the guideline (Bush et al, 1979). The findings suggested that on 
the whole the intervention might not be cost-effective, if only those who 
developed a guideline actually used it. One explanation for this questionable 
effectiveness was that participatory guidelines might not be seen as credible by 
non-participating clinicians (Grimshaw et al, 1995). 
2.3.7. Inter-professional shared care and inter-professional 
relationship 
A Cochrane review assessed the effects of on-site mental health workers 
(including clinical psychologists) in primary care on the care provided for 
patients and provider performance (Bower and Sibbald, 2000; Bower and 
Sibbald, 1999). The review assessed the effects of the intervention on the care 
provided by physicians for the patients directly receiving shared care ('direct 
effects') and for those patients who were not subject to shared care ('indirect 
effects'). They also identified two models of on-site mental health worker care: 
the substitution model and the consultation-liaison model, although there were 
some degrees of overlap between the models. In total, 38 studies were included 
in the review of which 28 studies were considered eligible for prescribing 
outcome analysis (Bower and Sibbald, 1999). The substitution model resulted in 
some improvement in direct care, but no change in PCP prescribing was 
observed in three CBA studies assessing indirect care (Pharoah, 1996; Coe et 
al, 1996; Baker et al, 1996). The reviewers concluded that there was evidence 
of no effect from the substitution model of mental health care intervention on 
PCP prescribing (Bower and Sibbald, 1999). For the consultation-liaison model 
the evidence was mixed, both for 'direct' and 'indirect' effects on patient care 
(see Appendix 11-2). The reviewers concluded that (modest) effects were likely 
to be observed if the mental health worker liaison-consultation model was part 
of a multi-faceted intervention. 
The effects of the interventions to improve inter-professional 
relationships on PCIP behaviour are not clear. A Cochrane review of doctor- 
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nurse relationship included two primary studies, neither conducted in primary 
care settings (Zwarenstein and Bryant, 2000). The evidence from secondary 
care suggested improved doctor-nurse relationship might enhance process and 
patients outcomes. Lack of evidence in this area might be due to the complexity 
of design and evaluation of the intervention. Inter-professional relationships and 
interactions are essential parts of modern primary care and more evidence in 
this area is required. 
2.3.8. Educational outreach visits 
A Cochrane review included eighteen RCTs of educational outreach visits or 
academic detailing (Thomson O'Brien et al, 1997). Thirteen studies were on 
prescribing. Positive effects were observed from all prescribing studies (some 
non-significant). The reviewers identified four different models of educational 
outreach visits. The review concluded that educational outreach visits were 
effective in reducing inappropriate prescribing. The effects were usually small to 
moderate but of clinical importance. The cost-effectiveness of the intervention, 
especially models involving outreach visits plus other interventions or those with 
subsequent visits was not well established. Nine included studies had 
prescribing outcomes and were conducted in primary care. A Belgian study of 
GPs evaluated the effect of one educational visit by a specially trained GP and 
educational materials compared to no intervention to reduce benzodiazepine 
prescribing (Berings et al, 1994). A Swedish study attempted to improve 
prescribing of lipid lowering drugs for patients with hyperlipidaernia (Diwan et al, 
1995). A UK study assessed the effectiveness of a single outreach visit and 
educational materials compared to no intervention in improving NSAIDs 
prescribing. The positive effects lasted for at least five months (Newton-Syms et 
al, 1992). Another British study used educational outreach visits as well as 
clinical guidelines (educational material) and follow up prompts to improve 
quality of asthma care. The intervention resulted in improved quality of asthma 
prescribing (Feder et al, 1995). A USA study reported reduction in the use of 
propoxyphene, cerebral and peripheral vasodilators and cephalexin in 
physicians identified as high prescribers (Avorn and Soumerai, 1983). The 
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improvements lasted for at least nine months and were cost-effective (Sournerai 
and Avorn, 1986). A study conducted in Indonesia compared two interventions 
(educational outreach visits and formal seminar, both accompanied by 
educational material) with no intervention to improve drug use in the 
management of acute diarrhoea in children. They reported that the seminar 
resulted in significantly greater changes than the educational outreach visits. 
Both interventions resulted in significant improvement compared with the 
control. The outreach visits were less costly than the seminar ($0.77 US versus 
$3.30 US per participant) (Santoso et al, 1996). One trial of outreach visits plus 
audit and feedback reported important improvements in prescribing (McConnell 
et al, 1982). A USA study attempted to reduce the use of high cost NSAIDs and 
increase the use of ibuprofen and salicylates by providing clinical pharmacy 
services in an HMO. The intervention was not cost-effective (Stergachis et al, 
1987). An Australian RCT of GPs aimed to reduce benzodiazepine prescribing. 
The relative difference between the intervention and control groups was not 
statistically significant (Yeo et al, 1994; de Burgh et al, 1995). 
The above systematic review included RCTs only. Some of the trials 
were also included in other reviews (Chrischilles and Gondek, 1997; Le Grand 
et al, 1999). A more recent review (Gross and Pujat, 2001) included another 
RCT from Australia that had found educational outreach increased the use of 
effective and cheap antibiotics and reduced the use of more expensive 
antibiotics (Ilett et al, 2000). Other reviews provided evidence of effectiveness 
from other designs. Wensing and Grol (1994), as well as others, included two 
papers based on a CBA study that found educational outreach an effective 
intervention in reducing long term diazepam prescribing (Ray et al, 1986) and 
inappropriate antibiotic prescribing (Schaffner et al, 1983). Another review 
(Grimshaw et al, 1995) identified a CBA study using educational outreach to 
implement a clinical guideline for improving anti-ulcer treatment. Checking the 
original paper revealed that statistically significant improvement was observed 
one month after the intervention. However, the improvement was not anymore 
significant two months after the intervention (Raisch et al, 1990). A meta- 
analysis of interventions to change prescribing concluded that one-to-one 
meetings (educational outreach) were effective methods of improving 
prescribing (Pippalla et al, 1995). 
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2.3.9. Audit and feedback (with or without peer review) 
A Cochrane review assessed the impact of audit and feedback on provider 
performance and patient outcomes (Jamtvedt et al, 2003). The review included 
85 RCTs. The included studies covered a range of different audit and feedback 
interventions including performance feedback, cost feedback, written or verbal 
feedback and peer review feedback. The review's overall conclusion was that 
audit and feedback might be effective, but the supportive evidence was patchy 
and the effects tended to be small to moderate. It also concluded that the 
effectiveness was correlated with baseline compliance (i. e. the lower the 
compliance, the more effective the intervention) and had no correlation with the 
complexity of the target behaviour. Among all studies included in the review 
seven studies were conducted in primary care and had prescribing outcomes. 
Two studies compared 'audit and feedback alone' with 'no intervention' 
(O'Connell et al, 1999; Mainous et al, 2000). Both studied observed no 
significant effects from the intervention. Audit and feedback plus educational 
outreach were effective in reducing tetracycline prescribing (McConnell et al, 
1982) and similar interventions were effective in a multi-centre study in three 
(out of four) European countries to improve prescribing for asthma (Veninga et 
al, 1999). One multi-faceted intervention was ineffective in reducing the average 
number of prescribed drugs (Kafuko et al, 1999). Canadian researchers 
evaluated audit and feedback plus educational material intervention against no 
intervention control. As a result, reduction in prescribing costs and improvement 
in the choice of first line drug was achieved in the intervention group (Hux et al, 
1999). This RCT was also included in Gross and Pujat (1999) review. In a 
separate review, Lomas and Haynes concluded that computerised audit and 
feedback mechanisms improved prescribing in primary care (Lomas and 
Haynes, 1988). 
Other reviews included non-RCT evidence. Wensing and Grol (1994) 
identified two CBA studies assessing the effectiveness of peer review audit and 
feedback. One study observed that the intervention group enjoyed less increase 
in prescribing charges than the control (Harris et al, 1985). The second study 
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observed a decrease in prescribing costs per patient per DIDID as a result of the 
intervention, while there was no significant decrease in the amount of 
prescriptions (Lassen and Kristense, 1992). A later update of their systematic 
review concluded that single interventions using feedback were more effective 
than feedback plus information transfer (Wensing et al, 1998). The review by 
Mugford et al (199 1) included a British CBA study assessing the impact of 
meetings plus number and cost of prescription feedback to GPs twice a year for 
two years. The intervention group's prescription rate per patient fell more than 
the control group (Harris et al, 1984). Gill et al (1999) found audit and feedback 
an effective method of behaviour change. Beilby and Silagy (1997) reviewed the 
effects of costing information feedback on performance. Their review did not 
provide any further evidence of effect than what already discussed. 
2.3.10. Reminders (including computerised systems) 
A systematic review of computerised advice on drug dosage included fifteen 
studies all conducted in secondary care (Walton et al, 1999; Walton et al, 2001). 
The reviewers failed in identifying any studies conducted in primary care. The 
reviewers concluded that computer support improved achievement of target 
drug dosages with less adverse outcomes. 
Most evidence on the effectiveness of reminders originated from 
preventive care (Hunt et al, 1998; Mitchell and Sullivan, 2001) and there was 
limited evidence for prescribing. Sournerai et al (1989) included an ITS study 
that followed the implementation of a reminder system for the antibiotic 
treatment of streptococcal pharyngitis. Four years of time series data 
demonstrated marked reduction in the percentage of untreated patients as a 
result of computer generated reminders. The effect disappeared as soon as the 
reminders stopped (Barnett et al, 1978). A systematic review assessed the 
impact of computers on primary care consultations (Mitchell and Sullivan, 
2001). The review included two interventional studies with positive effects from 
computerised reminders on prescribing (McDonald et al, 1980; Jones et al, 
1996), but the evidence was not strong (see Appendix 11-2). Using the evidence 
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from preventive care and prescribing in secondary care, it could be extrapolated 
that the reminder systems may be effective in specific areas of prescribing, for 
example targeting poly-pharmacy, preventive prescribing or drug interactions 
where it is easy for the physician to forget, and a simple reminder can be of 
great help. In these scenarios reminders would correct the errors of omission 
via acting as secretarial reminders (Soumerai et al, 1989). 
2.3.11. Patient mediated interventions 
A Cochrane review assessed the effectiveness of the interventions to promote 
patient-centred health care in improving patient-provider consultation process, 
provider performance and patient outcomes (Lewin et al, 2001). Seventeen 
studies were included in the review. One RCT was performed in primary care 
and reported prescribing outcomes (Clark et al, 1998). In this study patient- 
centred training for providers plus condition-specific training for both providers 
and asthmatic patients and their parents was evaluated against no intervention. 
Parents of children in the intervention group were significantly more likely to 
report that the paediatrician had prescribed inhaled anti-inflammatory medicine 
for the child and also that the paediatricians had given the family a written plan 
for adjusting the treatment at home when symptoms change. Gill et al (1999) 
included four studies involving patient mediated interventions to improve 
primary care prescribing. All reported positive outcomes. A further Cochrane 
review of audit and feedback (Jamtvedt et al, 2003) included an RCT that 
compared audit and feedback alone with audit and feedback plus patient 
education and concluded adding patient education did not change the outcome 
(Mainous et al, 2000). 
2.3.12. Local opinion leaders 
A Cochrane review assessed the impacts of interventions using local opinion 
leaders on provider performance and patient outcomes (Thomson O'Brien et al, 
1999). The reviewers identified and included eight high quality primary studies. 
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None of the studies were conducted in primary care. Seven out of eight studies 
used a sociometric questionnaire with questions on humanity, communications 
and knowledge for identification of opinion leaders (Hiss et al, 1978). The 
review identified mixed effects as a result of the intervention. It also noticed that 
the activities of opinion leaders were not always known; so even if there was 
evidence of effect it would be difficult to replicate the intervention elsewhere. 
The absence of any high quality study from primary care may be the result of 
the inherent difficulties in identifying opinion leaders in primary care (Thomson 
O'Brien et al, 1999). An earlier systematic review had also failed to identify any 
evidence for the effectiveness of local opinion leaders or 'educationally 
inf luentials' in primary care (Lomas and Haynes, 1988). 
2.3.13. Continuous quality improvement (COI) 
A systematic review assessed the effects of CQI programmes on provider 
performance and patient outcomes in different health care settings (Shortell et 
al, 1998). The investigators included 42 single-site primary studies of which only 
two were randomised trials. They also included 13 multi-site studies of which 
one was RCT, one was CBA and three were still in progress. Only one study 
met the overview's inclusion criteria. A three-arm RCT in the USA compared 
educational visits plus CQI with educational visits alone (Goldberg et al, 1998). 
The control group received no interventions. The outcomes were prescribing for 
hypertension and depression. The arm including CQI did not improve over and 
above the other intervention group. The review concluded that the findings of 
primary studies could not be linked to the CQI because of weak designs. It 
argued that the observed failure of the CQI in improving the services were due 
to inappropriate choice of target behaviour or poor implementation of COI 
(Shortell et al, 1998). Both arguments support the finding that CQI is not 
appropriate for every scenario and may be ineffective. 
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2.3.14. Financial incentives 
Four systematic reviews assessed the impacts of different forms of financial 
incentives on physician behaviour (Giuffrida et al, 1999; Gosden et al, 2000; 
Chaix-Couturier et al, 2000; Gosden et al, 2001; Armour et al, 2001). A 
systematic review of different financial incentives included 89 primary studies of 
which seven were RCTs (Chaix-Couturier et al, 2000). Only one RCT 
(conducted in the USA) was on primary care prescribing, in which the authors 
assessed the impact of disclosing the threshold for financial sanctions on 
provider behaviour (Nyman et al, 1995). The disclosure resulted in reduction in 
prescriptions. The reviewers also used evidence from other studies and warned 
that financial incentives should be used carefully as they might cause conflicts 
of interests between different providers and also between the health system and 
other public sectors (Chaix-Couturier et al, 2000). The second review (Armour 
et al, 2001) assessed the effects of bonus systems and included seven studies 
of which one was ITS and two were RCTs. None were on prescribing in primary 
care. The authors concluded that bonus payments and explicit financial 
incentive had mixed effects on provider behaviour and on quality of care. 
Two further reviews were published as Cochrane reviews (Giuffrida et al, 
1999; Gosden et al, 2000) and were also jointly published elsewhere (Gosden 
et al, 2001). One review assessed the impact of target payment on PCIP 
behaviour and managed to include only two studies (both on immunisation); 
only one of them demonstrated significant change as a result of target payment 
(Giuffrida et al, 1999). The authors identified no studies of prescribing. The 
other systematic review assessed the impact of different remuneration systems 
(fee-for-service, capitation and salary) on PCIP behaviour (Gosden et al, 2000). 
It included four primary studies and concluded that fee-for-service was likely to 
increase utilisation. The conclusion was mainly based on those studies (three 
out of four) that had no prescribing outcomes. The only study with prescribing 
outcome was a large CBA study from Denmark assessing the effects of adding 
fee-for-service payment to capitation on repeat prescription rates (Krasnik et al, 
1990). Contrary to the investigators' expectations, statistically significant 
reduction in repeat prescription was observed in the intervention group while no 
such effect was observed in the control group. The reviewers interpreted this 
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finding as implying 'PCPs do not respond to financial incentives or the level of 
the fee was not sufficient to encourage such behavidue (Gosden et al, 2000, p 
8). Neither explanation easily justified the significant reduction that followed the 
introduction of the fee. 
In general four systematic reviews failed to provide solid evidence on the 
effects of different financial incentives on primary care prescribing. Given that it 
is possible to design good quality studies to evaluate the effects remuneration 
systems on prescribing, it is surprising that the research evidence from high 
quality studies is so scarce. 
2.3.15. National drug policies, essential drug programmes and 
regulatory approaches 
One systematic review of national drug policies and essential drug programmes 
failed to identify any study from developing countries that satisfied the minimum 
requirements of this overview in terms of the research design (Ratanawijitrasin 
et al, 2001). However, the reviewers' concluded that essential drug programmes 
in developing countries might result in more appropriate use of the medications 
in primary care. It was worth noting that these programmes in developing 
countries usually involved multi-faceted interventions including increase in the 
supply of essential drugs as well as education and training. Ratanawijitrasin and 
colleagues also assessed the effects of policies such as de-registration, upward 
reclassification (e. g. from OTC to prescription only) or downward reclassification 
(e. g. from physician prescription only, to other health professionals' prescription 
or OTC). Again no reliable evidence was identified, but it hinted that unintended 
outcomes were likely. Unintended outcomes included inappropriate use of other 
drugs in response to de-registration or upward reclassification. The reviewers 
also found that de-registration on its own was not equivalent to the removal of a 
medication from use. Unintended outcomes of downward reclassification 
included increased dispensing of the drugs by unqualified personnel 
(Ratanawijitrasin et al, 2001). Although the above mentioned consequences 
seemed logical, they were not evaluated in properly designed studies. This was 
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especially required in order to quantify cost, benefits and consequences of 
these policies. For example downward reclassification of oral re-hydration 
solutions (ORS) for the treatment of diarrhoea in many countries might have 
resulted in inappropriate use of the products, but the benefits might have 
outweighed the adverse consequences. 
Another group of interventions involved restricting physician prescribing 
choice by limited formularies. This method could be the result of national 
policies or take place locally (e. g. in PCOs). A meta-analysis of prescribing 
interventions concluded that prescribing restrictions by formularies were 
effective (Pippalla et al, 1995). This finding was based on three primary studies 
that Pippalla and colleagues included in their review. Unfortunately, the 
methods and findings of the review were not fully reported. It was not even 
possible to establish which primary studies had been used. 
2.3.16. Multi-faceted interventions 
A systematic review of prescribing by Gill et al (1999) concluded that multi- 
faceted interventions were successful in just less than half (49%) of the 
interventions. Similarly, analysis of studies from primary care setting would have 
concluded that only 10 out of 19 interventions resulted in intended 
improvements in prescribing (Gill et al, 1999, Table 3). This achievement rate 
was less than 'patient mediated interventions' and 'audit and feedback' and was 
comparable to 'mailed printed educational material only' interventions (Appendix 
11-2). Gross and Pujat (2001) concluded that multi-faceted interventions were 
effective methods of improving antibiotic prescribing. They included three CBA 
studies using multi-faceted strategies, all of which reported improvements in 
prescribing (Perez-Cuevas et al, 1996; Gonzales et al, 1999; Saint et al, 1999). 
A systematic review concluded that feedback only interventions were 
more successful than interventions that comprised feedback and information 
transfer (Wensing et al, 1998). In line with this conclusion a Cochrane review of 
audit and feedback used the evidence from a few studies to conclude that there 
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was no evidence suggesting that multi-faceted interventions were more 
effective than audit and feedback alone (Jamtvedt et al, 2003). Similar 
conclusion could have been made based on evidence from primary care 
prescribing studies only. An RCT in primary care compared CQl plus 
educational visits with educational visits and assessed prescribing for 
hypertension and depression (Goldberg et al, 1998). The CQl plus educational 
visits had no advantage over educational visits for neither of the outcomes 
(Shortell et al, 1998). Angunawela et al (1991) reported the results of a cluster 
randomised trial in which the newsletter only intervention was as effective as 
the newsletter plus seminar intervention in reducing antibiotic prescribing (-7.4% 
versus -7.3%). 
Another Cochrane review of on-site mental health worker care effects on 
PCP performance suggested that the interventions were more likely to succeed 
in changing antidepressant prescribing if the intervention was related to multi- 
faceted consultation-liaison interventions involving education, patient-based 
consultation and feedback and reorganisation of services (Bower and Sibbald, 
1999). The effects of these interventions tended to be limited to patients directly 
in the care of mental health care workers; PCPs did not seem to change their 
behaviour when caring for other patients. 
51 
Z4. Discussion 
2.4.1. Limitations 
The search strategy might have been improved by explicit searches of other 
databases. Limiting the main searches to certain databases might have resulted 
in loss of relevant reviews. However the iterative approaches that followed the 
original searches, including forward searching and bibliographic searches, could 
have overcome this limitation. The search strategy deemed reasonably 
comprehensive since it identified at least two systematic reviews (Pippalla et al, 
1995; Chrischilles and Gondek, 1997) that had not been picked up by the earlier 
overviews of systematic reviews with comprehensive search strategies (NHS 
CRID, 1999; Grimshaw et al, 2001). 
The overview was limited to systematic reviews. Like any other research 
method, explicit inclusion criteria meant that potentially useful evidence was left 
out. For example if primary studies were not included in the systematic reviews, 
they were not identifiable in this method. Given that several systematic reviews 
were included, little important evidence should have been missed. Despite this, 
and especially for interventions with limited evidence base, important evidence 
may still be available from studies that were not included in the reviews. This 
was particularly true for national drug policies and regulatory interventions 
(2.3.15). For example a non-systematic review of evidence reported that 
budgetary restrictions for prescribing in Germany resulted in sharp reductions in 
the number of prescriptions (Bloor and Freemantle, 1996) hence had positive 
outcomes. On the other hand, a USA study concluded that policy of payment 
restriction for prescribed medicines (under Medicaid programme) resulted in 
under-prescribing of certain drugs, including vital pharmaceuticals such as 
insulin and cardiovascular medications (Sournerai et al, 1987b). Considering 
that there was very limited evidence for the effects of regulatory strategies 
available from the systematic reviews, evidence like this could be informative. 
Also for educational outreach visits recent studies (Freemantle et al, 2000; 
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Watson et al, 2001; Freemantle et al, 2002; Banait et al, 2003; Ricordeau et al, 
2003; Crotty et al, 2004) that were not included in the overview provided a 
mixed picture of effectiveness, with some demonstrating no effects because of 
the intervention. This was different from the systematic reviews' evidence where 
most included studies found educational outreach effective (2.3.8). 
Inclusion of studies in the overview, data extraction and data synthesis 
were conducted by one reviewer. This could be a threat to the validity of the 
findings of the overview. Definitions, criteria for inclusion of studies and 
analytical methods were agreed between the reviewer and his adviser. Attempts 
were made to reduce the likelihood of bias by re-checking of the included and 
excluded studies and data extraction forms. Also all the results and analyses 
were reviewed by the adviser to ensure methodological approaches were 
followed. The adviser had extensive experience in teaching methods of 
systematic reviewing and conducting systematic reviews, including reviews of 
provider behaviour change (Girmshaw and Russell, 1993; Russell et al, 2000). 
The reviewer received extensive training on the methods of systematic 
reviewing before the conduct of the overview and since then has taught 
systematic reviewing techniques and contributed to a few ongoing reviews 
including three Cochrane reviews. 
Although quality of systematic reviews was assessed by attention to the 
methodological quality of the review and also the included primary studies 
(Appendix 11-2), no attempts were made to assign quality scores to the included 
systematic reviews. This may have resulted in the loss of understanding of 
variation between the outcomes of different reviews. It may also have resulted 
in the loss of understanding of the validity of the reviews' conclusions. Low 
quality studies tend to report larger effects and quality scoring is a method of 
examining the validity of the findings (Moher et al, 1998). However, previous 
studies concluded that formal quality scores of clinical trials of interventions 
were unlikely to explain the observed variations in effect sizes (Juni et al, 1999; 
Balk et al, 2002). A recent study examined the relationship between different 
measures of quality and the treatment effect sizes in RCTs included in 
published meta-analyses (Balk et al, 2002). The study failed to identify any 
relationship between the reported effect sizes and the quality measures. The 
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authors concluded 'it should not be assumed that any given quality measures 
will necessarily explains the effects found (ibid, p 289 1). Quality score were 
less useful in explaining variation in outcomes where the interventions were 
complicated and less standardised (Balk et al, 2002), which is the case for 
provider behaviour change interventions. It is not clear how the quality of 
systematic reviews correlates with the outcomes. However, it is known that 
even high quality systematic reviews are subject to variations in the 
interpretation of their findings. In Ezzo et al (2001) study, two independent 
methodologists interpreted the conclusions of some Cochrane reviews using 
explicit criteria; then the reviews' authors were asked to provide their 
interpretation of the conclusions based on same criteria. Ezzo et al 
demonstrated that the methodologist readers interpreted the reviews' 
conclusions differently from what the authors had intended. It is also known that 
high quality systematic reviews do not necessarily reach valid conclusions. A 
comparison of three high quality systematic reviews of pain relief for patients 
with sciatica demonstrated important differences between the reviews 
(Hopayian, 2001). These variations were not captured by Oxman and Guyatt 
(1988; 1991) quality assessment index. As pointed out by Hopayian, one 
reason could be that the application of quality assessment tools did not require 
any knowledge of the included studies. In the overview presented in this chapter 
due care was given to the primary studies included in the systematic reviews. 
Also in this overview careful attention was paid to the evidence base of 
conclusions presented in the systematic reviews. This should have overcome 
some of the concerns about understanding the quality of included systematic 
reviews. The consideration of primary studies included in the reviews was 
conducted also because of technical reasons. The overview focused on 
physician prescribing in primary care, while many reviews had wider inclusion 
criteria. Therefore, the results of even high quality systematic reviews could 
have been invalid in here if they were based on studies other than PCP 
prescribing. 
Some of the systematic reviews were already out of date in 2001 and still 
were not updated in 2004. This was particularly striking for the Cochrane 
reviews. It seemed that the Cochrane review groups were facing difficulties in 
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achieving the objective of providing timely and valid systematic reviews of 
evidence in the area of health care provider behaviour change. 
2.4.2. Interpretation of evidence in the systematic reviews 
The evidence from primary investigations was not consistently interpreted in 
different systematic reviews. This was perhaps the most important concern for 
the validity of the findings of the included systematic reviews. A very interesting 
example was observed from a study (De Santis et al, 1994) included in three 
systematic reviews. This was an Australian RCT of mailed educational materials 
followed by educational outreach visit to improve antibiotic prescribing for 
tonsillitis in primary care. One systematic review referred to this as a study 
which observed little improvement as a result of the intervention (Gross and 
Pujat, 2001). Another systematic review used a much more positive tone and 
reported that the intervention group resulted in better compliance with targeted 
behaviour than the control group (Anderson and Lexchin, 1996). A further 
review again reported the findings as positive, but made the mistake of 
identifying the review as a CBA study rather than RCT (Chrischilles and 
Gondek, 1997). 
A further example was based on the interpretation of the findings of an 
American CBA study in different systematic reviews (Schaffner et al, 1983). The 
study had four arms: educational outreach by pharmacist, educational outreach 
by physician, mailed printed educational material and no intervention control 
group. A systematic review of antibiotic prescribing referred to this study as a 
study that demonstrated both pharmacist-led and physician-led educational 
outreach as effective programmes (both statistically significant compared with 
the control) although the physician-led approach was more effective (Gross and 
Pujat, 2001). An earlier systematic review of ambulatory care prescribing 
referred to this primary study as if it demonstrated the pharmacist-led 
educational outreach was not effective, and then tried to dispute the finding 
using other information (Soumerai et al, 1989). Both reviews had acceptable 
quality, but paid attention to different details from the same study. Another 
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primary study (Ray et al, 1986) was a matter of dispute between systematic 
reviewers. Three systematic reviews emphasised the positive finding of the 
study: reduction in diazeparn prescribing for long term users in the intervention 
group (Wensing and Grol, 1994; Grimshaw et al, 1995; Yano et al, 1995). 
Conversely another systematic review paid attention to the finding that overall 
diazeparn prescribing in the intervention and control groups remained the same 
despite the intervention (Soumerai et al, 1989). 
Another study was included in two systematic reviews (Gehlbach et al, 
1984). This primary study was conducted on residents and therefore its 
evidence was beyond the scope of the overview. It was however referred to in 
this overview since the variation in interpretation provides an important lesson. 
A BMJ systematic review (Mitchell and Sullivan, 2001) concluded from it that 
computerised feedback increased generic prescribing. Details of feedback 
messages were not reported in the review or in the additional table provided on 
the BMJ website. On the other hand, Beilby and Silagy's (1997) review 
concluded from the same paper that the provision of cost information 
computerised feedbacks to GlPs would increase generic prescribing. It seemed 
that Mitchell and Sullivan (2001) had taken the liberty of choosing what to report 
and what not to report from the primary data. This incomplete reporting was in 
line with the objectives of their review: the effects of computers on behaviour. 
However, their incomplete reporting deprived readers from understanding 
potential interactions between the content of the feedback and its computerised 
delivery. 
The flaws in the results went beyond the interpretation of the primary 
studies. There were occasions when the systematic reviews got to conclusions 
that were based on unsafe interpretation of the results and the reviews had 
provided no data in support of the claim. For example Beilby and Silagy (11997) 
concluded that'academic detailing may be more appropriate for prescribing and 
computerised feedback for test ordering (p 92). To get to this conclusion, head 
to head comparisons of computerised feedback and academic detailing for both 
prescribing and test ordering were required. Beliby and Silagy did not report any 
such comparisons. Indeed they reported two trials (one on computerised 
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feedback and the other on academic detailing) that both succeeded in 
improving prescribing behaviour (Appendix 11-2). 
The systematic review by Gosden et al (2001) suggested the effects of 
remuneration systems on prescribing were small and not as economic theories 
suggested. In contrast, an earlier review concluded that financial incentives 
were effective interventions for changing prescribing in primary care (Chaix- 
Couturier et al, 2000). The main reason for these conflicting conclusions was 
that the reviewers used different methods. While the former review excluded 
studies other than RCT, CCT, CBA and ITS, the latter review included other 
study designs that were more prone to bias (Appendix 11-2). 
2.4.3. The effectiveness of multi-faceted interventions 
The claim that multi-faceted interventions are more effective than single 
interventions is not new (Lomas and Haynes, 1988) and is probably correct in 
general. Most previous overviews concluded that multi-faceted interventions 
were the most effective approaches in changing behaviour (Bero et al, 1998; 
NHS Centre for Reviews and Dissemination, 1999; Smith, 2000; Grimshaw et 
al, 2001). The logic is that if a specific behaviour is targeted from different fronts 
and the factors that hinder the behaviour are tackled using different strategies, 
then it is more likely to achieve the behaviour change. However, there are a few 
important issues that should be taken into account when considering the 
effectiveness of multi-faceted interventions. 
First, multi-faceted interventions might not be as cost-effective of single 
interventions. By definition the cost of implementing a multi-faceted intervention 
including interventions A and B is more than implementing either A or B. 
Therefore, if the incremental benefits of adding B to A is less than the extra 
costs involved, then it may be wiser to stick to the single strategy and use 
resources for more efficient interventions. 
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Second, the overview findings did not support the claim that'the degree 
of change appears to be directly proportionate to the number, type, and 
intensity of interventions proposed (quoted from Davis in Beaudry 1989, p 286). 
The evidence suggested that some combinations of interventions were more 
effective than single strategies (Wensing and Grol, 1994; Wensing et al, 1998). 
But the evidence did not suggest that the relationship was linear. On the 
contrary, there was evidence suggesting that some combinations did not do 
better than single strategies (Wensing et al, 1998; Jamtvedt et al, 2003). Also 
there was no linear relationship between the intensity of an 'effective' 
intervention and its incremental effectiveness. In a rare attempt to quantify the 
link between the intensity of behaviour change programmes with their 
effectiveness, a systematic review (excluded from this overview since it was 
updated by other reviews) compared the effectiveness of CME programmes of 
different lengths of from one day to more than a year (Beaudry, 1989). The 
reviewer concluded that there was a link between the intensity of CME 
programmes (in terms of length) and their effectiveness. However, a close look 
at his analysis suggested that the only true difference between the length of 
programmes and effectiveness was between programmes of one day length 
and others with any length of time. The effect sizes of CME programmes lasting 
from 2-6 days to more than a year were very close to each other with large 
standard deviations (ibid, p 295). 
Third, one should not forget that the absolute costs of implementation 
matter to health systems. Out of proportion emphasis on the effectiveness of 
multi-faceted interventions may discourage decision makers from doing 
anything at all for a given behaviour, just because they cannot meet the total bill 
for a comprehensive multi-front strategy. Given that almost in every country 
resources available for health care are less than public expectation, hugely 
expensive quality improvement programmes are not welcome. Policy-makers 
should not be discouraged from looking for less costly (and perhaps less 
effective) behaviour change strategies. 
And finally, the issue of health care system and provider capacity to 
improve is also important. Not all changes in the process of care translate into 
improvement in health care. A multi-faceted intervention may be effective when 
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there is an important gap between the quality of care given to a group of 
patients and the expected standards. But when quality of care reaches a 
minimum standard (which should be defined) then doing more of the 
intervention may waste resources and hamper the good will of clinicians that 
cannot respond to the initiative as well as before. 
On the other hand the evidence (not included in this overview) hints that 
sometimes very simple and low cost interventions can be effective. A 
systematic review identified three UK studies (two RCTs and one CBA) in which 
clinical guidelines for radiological investigations were mailed to GPs without any 
other implementing activities (Grimshaw et al, 1995). Two of the clinical 
guidelines were developed locally (non-participatory) and one was a national 
guideline. All three studies observed significant improvement as a result of the 
intervention. A further study suggested although the effect size from passive 
dissemination is usually small, but it may be a cost-effective method of 
changing physician behaviour (Mason et al, 2001). Also a recent Latin Square 
design (Pocock, 1983) study compared a multi-faceted intervention with passive 
implementation of clinical guidelines for asthma and angina in British primary 
care (Wright et al, 2003). They observed comparable improvements in both 
arms of the study. These are similar to evidence included in the systematic 
review about the effectiveness of multi-faceted interventions (2.3.16) and mailed 
printed educational material (2.3.4). 
In conclusion, the frequently repeated message that 'multi-faceted 
interventions are more effective' can be misleading. It should be replaced with 
evidence-based messages identifying the effectiveness of specific combinations 
of interventions in different circumstances. The issue of cost should be 
highlighted to ensure that meagre resources are not diverted to limited areas of 
quality improvement. 
2.4.4. Definitions and terminology 
The terminology and the definitions of widely used terms in the area of provider 
behaviour change have evolved through the time, making it difficult to introduce 
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valid and applicable taxonomies of interventions. There was a lot of variation in 
the interventions for assessing the effectiveness of intervention for changing 
provider behaviour. Smith (2000) provided several examples of how the 
definitions might be misleading or difficult to understand. Even when standard 
terminology was being used, still there was room for variation (Smith, 2000). 
That was one of the reasons why systematic reviews were difficult to perform, 
and the overall gene ralisab i lity of their findings was limited. 
Undertaking reviews to identify promising implementation techniques is 
difficult, because of the complexity inherent in the interventions, the 
variability in the methods used, and the difficulty of generalising study 
findings across health care settings (Bero et al, 1998, p 468). 
A good example of misleading definitions could be seen in one the most 
commonly used interventions: continuous medical education (CME). Formal 
CME programmes were started in 1930s in the US (Beaudry, 1989). They were 
aimed at increasing the knowledge and competence of participating 
professionals and hence improving their practices. Since then there had been 
some changes in the meaning and applicability of the CIVIE. In earlier 
systematic reviews that were performed since 1980s there was a tendency to 
include all interventions aimed at improving professional practice under the 
CME title (Haynes et al, 1984; Beaudry, 1989; Davis et al, 1992; Davis et al, 
1995). This inclusive approach was intentional. Davis argued 
Distinction between the two appear to be artificial, and have the effect of 
placing CME in its traditional non-practice-related (away from practice) 
mode, from which position it would appear to be less than optimally 
effective, or from which it would appear to be designed more for mass 
consumption than tailored to individual needs (quoted from Beaudry, 
1989, p 286). 
Despite this, progress in the field of provider behaviour change resulted in a 
need for clear and exclusive definitions. Therefore more recent reviews of CME 
by the same researchers excluded interventions other than formal out of 
practice educational strategies (Davis et al, 1999). The ambiguity in definition 
was not limited to the interventions and was present for 'setting', 'provider' and 
'behaviour'. For example investigators have assigned different meanings to 
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tprimary care. Some investigators expanded it to include not only hospital 
outpatient clinics but also emergency rooms (Soumerai et al, 1989). 
2.4.5. An updated taxonomy of the interventions 
Different taxonomies of interventions were introduced in the systematic reviews. 
A frequently cited taxonomy was developed by Lomas and Haynes (1988). In 
their taxonomy they divided different interventions according to the target 
(individual; geographic or speciality community) and whether they were service 
specific or general. Then they categorised the interventions under 'patient- 
centred', 'educational', 'administrative', and 'economic' subgroups. This 
taxonomy is more or less out of date. It also has the limitation of putting several 
of the most frequently used interventions under the category of 'administrative' 
interventions. Similarly, others categorised interventional strategies for 
improving drug use into four groups of: educational, managerial (i. e. 
'administrative'), financial and regulatory (Le Grand et al, 1999). 
EPOC Cochrane Review Group developed a practical and useful 
taxonomy of interventions. It provided reasonably exclusive definitions for 
different interventions. The definitions offered by EPOC are provided in many of 
their systematic reviews (e. g. Jamtvedt et al, 2003; Thomson O'Brien et al, 
1997) and they are also presented in the glossary of important terms in this 
thesis (Glossary). The taxonomy does not provide higher level relationships 
between different interventions. Another taxonomy of interventions was 
developed by Grol and Wensing through a series of publications (Grol, 1992; 
Wensing and Grol, 1994; Wensing et al, 1998). Their taxonomy provided a 
higher level relationship by dividing the strategies into 'voluntary' and 'non- 
voluntary'. At the next stage the voluntary strategies were divided into those 
targeting 'internal motivation' and those targeting 'external motivation' (Wensing 
and Grol, 1994). At the next level the interventions were categorised as 
'competence oriented', 'performance oriented', 'social pressure', 'structural 
arrangements' and 'financial'. The original taxonomy is several years old now 
and some of the definitions used in it are not in widespread circulation anymore. 
For examples they used feedback instead of audit and feedback and individual 
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instruction instead of educational outreach. Some interventions discussed in 
this chapter were not included in Grol and Wensing's taxonomy. It had other 
shortcomings. It was built on the importance of the source of 'motivation' 
(internal or external) on behaviour change. Although there is theoretical support 
for the role of motivation in behaviour change, it still lacks empirical backing. 
The other problem was that some interventions targeted both internal and 
external motivation (e. g. peer comparison audit and feedback). Despite all 
these, the structure of the taxonomy was sound and helped distinguishing 
different features of the interventions. Table 2.1 offers an updated version of the 
taxonomy, using the evidence from the overview of systematic reviews of 
behaviour change interventions. It has also been expanded by addition of the 
interventions not included in the original taxonomy. Along with the taxonomy, 
the evidence was summarised using a simple coding system in terms of the 
effectiveness, the costs and the durability of different interventions. The 
taxonomy presented in Table 2.1 will be further improved using the evidence 
from the following chapters of the thesis. 
The results of the overview confirmed that after about twenty years of 
systematic research on provider behaviour change there remained a lot of 
unanswered questions. Summary of the findings including areas of uncertainty 
in the effectiveness of the change interventions are presented in Table 2.1. 
Apart from the question of whether interventions are effective in bringing about 
any changes, there remain more questions on the cost (in its broader sense) of 
implementing the interventions, and the durability of the changes invoked 
because of the interventions. Many studies of clinician behaviour have short 
follow up. Therefore not much is known of the durability of the intervention 
effects. Occasional studies with long term follow up provide some insight. A 
three year follow up of a successful intervention for improving GPs' 
management of depression showed that GP performance was back to pre- 
intervention levels (Cantillon and Jones, 1999). More accurate estimation of the 
durability of the effects can also inform decision analysis models and cost- 
effectiveness analyses. Thus future research should include economic 
evaluation and longer periods of follow up. 
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TABLE 2.1. SAGE TAXONOMY OF INTERVENTIONS, VERSION 1. STRATEGIES TO IMPROVE 
PHYSICIAN PERFORMANCE: EFFECTIVENESS, COSTS, AND LIKELIHOOD OF DURABILITY OF 
EFFECTS FOR PRIMARY CARE PRESCRIBING. 
Intervention Effect Cost Durability 
Voluntary Internal Competence CME (didactic) 0 Low Short 
motivation oriented 
CME (interactive) ++ Medium ? 
IP education ? Medium ? 
Mailed printed +/0 Low ? Short 
material 
Mailed national + Low Medium to 
warnings $ long 
Participatory + High Wediurn to 
guideline devel. long 
IP shared care 0 ? High Short 
(substitution) 
113 shared care +/0 ? High ? 
(cons ult. -liaison) 
Mass media + Low Wedium 
Performance Audit and feedback5 + Low to ? 
oriented medium 
Reminders (usually ?+ Low to Short 
computer sys. ) medium 
Educational ? ++ Low to Short to long 
outreach high 
External Social Influence Peer review ? Wediurn ? 
motivation to high 
Patient mediated + Low to ? 
medium 
Local opinion ? ? Medium ? 
leaders to high 
CQI ? Wedium ? 
to high 
Physical Practice support ? 1.7 ? 
support 
Essential drug ? 
programmes Z 
Financial Financial incentives Low to ? Short to 
incentives high medium 
Non- Reimbursement and ? ? 
voluntary budgetary policies 
Rules, obligations ? ? ? 
Restricted formulary + ? Wedium to 
long 
De-registration ? ? 
reclassification 
*Adapted from (Grol, 1992; Wensing and Grol, 1994). IP: Inter-professionat, ++: strong evidence suggests positive 
(intended) effects, +: limited evidence suggests positive (intended) effects, 0: evidence of 'no effecV, +/0: variable 
effectiveness, ?: no evidence of effect, U no evidence of effect, however less reliable evidence suggests positive 
effects, ? +/-: no evidence of effectt likelihood of positive and negative (intended and unintended) effects, $ it usually 
also has an element of social influence, %R usually Incorporates competence oriented approaches, $$ It usually has 
elements of physical support and competence oriented approaches. 
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The results also question the applicability of unqualified theoretical 
reasoning to practice before empirical testing. The findings have cautious 
implications for the effectiveness of some theory based interventions (such as 
those based on participatory guideline development) and on occasions provides 
evidence of effects in opposite direction of what suggested by theory (e. g. for 
financial incentives). On the other hand it demonstrated that other theory based 
interventions that had been under scrutiny for longer periods the evidence was 
in line with theoretical expectations. Interestingly didactic CIVIE was almost 
always ineffective in changing behaviour, while interactive CIVIE was effective. 
For many others there was simply no evidence of effect for PCP prescribing (for 
example local opinion leaders, peer review, CQI). It is just repeating the already 
known reality that human behaviour is complex and theoretical reasoning may 
need fine tuning before it is applied to real practice. Unfortunately the ability to 
perform this fine tuning is very limited since most of research on quality 
improvement and provider behaviour change is conducted without attention to 
the theoretical bases. 
The results once again demonstrated the level of variation in the 
effectiveness of the interventions. Many interventions vary in their effectiveness 
in different contexts and settings. A selective review of theories of behaviour 
change is presented in Chapter 3 to enhance the understanding of behaviour 
change interventions and to inform the following stages of the study. Qualitative 
research methods are powerful strategies in identifying the reasons for 
variations, especially as it is not possible to devise interventional studies to 
assess every possible source of variation. Chapter 4 reports the findings of a 
qualitative study aimed to explain why some clinical guidelines and pieces of 
evidence appear to have been more successfully implemented in general 
practice and changed prescribing. The findings of Chapters 3 and 4 are also 
used for improving the taxonomy on interventions presented in 2.1. 
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Theory, research, and practice are a continuum along 
which the skilled professional should move with ease. 
... Theory and research are not solely the province of the academic, just as practice is not solely the field of 
the practitioner. 
Glanz, Rimer and Lewis, 2002a, pp 22-23 
A theoty has only the alternative of being right or 
wrong. A model has a third possibility. it might be right 
but irrelevant. 
Manfred Eigen; quoted from Diamond, 1989, p 253. 
Chapter 3: Theories and models of behaviour 
change 
3.1. Definitions and objectives 
3.1.1. Why this review of important theories was required? 
The chapter reports a selective review of theories and models to facilitate 
understanding of guideline implementation and prescribing behaviour change. 
Specifically those theories were reviewed that could enhance understanding of 
the variations observed in the effectiveness of different interventions and the 
results of the overview of systematic reviews presented in previous chapter 
(Table 2.1). The links between the theories and interventions were highlighted 
in the text after introducing each theory (or group of relevant theories). The links 
were then summarised in Table 3.3 presented towards the end of the chapter. 
The chapter ended with summarising why theory of planned behaviour (TPB) 
was chosen for detailed assessment in the following stages of the project. 
An extensive literature search was unable to find an authoritative review 
article or textbook which outlined major theories that explained variations in 
clinician behaviour. The most useful textbook identified was Glanz et al (2002) 
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on health promotion and education. Although some important theoretical 
approaches, especially economic theories were missing from this text, a range 
of psychological, sociological and organisational approaches were presented 
and compared. Among the review articles, Grol's review of theoretical 
approaches for practice change was very useful to start from, but it was far from 
complete and lacked details (G rol, 1997). Ferlie (1997) covered only the 
theories applicable to the level of organisation and above. NHS CRID (1999) 
included brief overview of a few theories of behaviour change at individual and 
organisation levels. Moulding et al (1999) considered handful of theories in 
developing their model for clinical guideline implementation. Ashford et al 
(1999) wrote a thoughtful, but less recognised, review. It covered relevant 
theories briefly. The paper left out some important and increasingly used 
theories such as the TPB. 
3.1.2. What is 'theory' and why theories are required? 
Defining the term 'theory' is not straightforward. It has several definitions which 
vary between and within academic disciplines. Some famous and more recent 
definitions of the theory are presented in the Table 3.1. Within the definitions 
offered in the table, the first definition is probably the most objective one since it 
sets criteria for a theory. 
TABLE 3.1. DEFINITIONS OF THEORY (ADAPTED FROM GLANZ ET AL, 2002B). 
Definition Source 
A set of interrelated constructs (concepts), definitions, and propositions that Kerlinger, 
presents a systematic view of phenomena by specifying relations among 1986, p9 
variables, with the purpose of explaining and predicting phenomena. 
A systematic explanation for the observed facts and laws that relate to a Babbie, 1989, 
particular aspect of life. p 46 
A set of relatively abstract and general statements that collectively purport to Chaftez, 1978, 
explain some aspects of the empirical world p2 
There are more controversies on what 'models' are and how they differ 
with or relates to theories. Some argue that theories are different since they are 
more likely to be abstract and take concrete meanings when applied to specific 
situations (Resnicow et al, 2002). A further distinction is that 'unlike theories, 
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models cannot be falsified and pertain more to the context of discovery than to 
the context ofidstification' (Davidson, 1998, p 35). Another distinction between 
model and theory is that the models are likely to incorporate more than one 
theory into their structure to improve their empirical value. Others tackle the 
problem of definition by using the term 'mid-range theories, referring to theories 
which are less abstract and can be applied to practice (Paterson et al, 2001). 
The two terms are frequently used interchangeably (e. g. see Checkland, 1981; 
Davidson, 1998; Riemsma et al, 2002). This confusion in the application of the 
terms is very common (also see a leading theorist's paper: Ajzen, 1998). 
Hence, the chapter does not separate theories from models. 
Health services research is criticised for empiricism. 'While much of 
health services research is empirical, the more ambitious studies tly to avoid 
the trap of empiricisni (Ferlie, 1997, p 184). On the other hand there are 
limitations in theories and their applications. Ajzen once wrote: 
... our theoretical models have failed to generate many insights that 
could not have emerged without them. ... these comments are not meant to imply, however, that non-theoretical interventions based on common 
sense are likely to be as effective as interventions based on existing 
theoretical models ... (Ajzen, 1998, pp 738-9). 
Much of clinical behaviour change literature is based on the assumption 
that clinicians change if they are given information (Kanouse and Jacoby, 1988; 
Marteau et al, 2002). Few studies have tested the theoretical models that 
acknowledge the psychological and organisational processes which precede 
provider behaviour (Raisch, 1990a; Grol, 1997; Bero et al, 1998; Marteau et al, 
2002). Over-reliance on empirical evidence might result in proposals that offer 
few new avenues over what is already known (Greco and Eisenberg, 1993). 
Using theory informed approaches might enhance the effectiveness of clinical 
guideline implementation in general and appropriate prescribing in particular 
(Raisch, 1990b; Grol, 1997). Theories give scholars the opportunity of 
approaching problems even before starting data collection and provide them a 
framework for thinking (Fuchs, 2000). Despite all these, most of the work for the 
establishment of theoretical basis for behaviour change has been around what 
previous research has shown to work (e. g. see Davis and Taylor-Vaisey, 1997). 
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This seemingly evidence-based approach lacks coherent theoretical basis and 
therefore may fail to recognise its limitations and weaknesses (Ferlie, 1997). 
Individual theories seldom explain all the complexities and delicacies of 
provider behaviour (Rosko and Broyles, 1988; Davis et al, 1995). This view has 
been augmented further with the emergence of new concepts such as 
knowledge transfer (Davis et al, 2003). 'Knowledge transfer' accommodates a 
variety of theories from different disciplines for the purpose of facilitating 
provider behaviour change. For health services research there are few things as 
useful as 'good' theories (Glanz et al, 2002). 'Theotyprovides a sound basis for 
action. ... if action 
is to be effective, the theoiy must be adequate and 
appropriate to the task ... a good theory 
(Mullins, 2002a, p 52). 
3.1.3. Categorisation of theories 
Theories of behaviour change are categorised along different dimensions. The 
most common approach is to group theories according to their academic 
disciplines. If this approach is to be followed, then the first task is to identify 
relevant disciplines. One author argued that 'behavioural scienco'could be 
viewed from the perspective of three disciplines of psychology, sociology and 
anthropology (Mullins, 2002a). He acknowledged that other social sciences and 
their sub-divisions played their parts and that there was overlap between the 
disciplines (ibid, p 24). To complement the list, theories from disciplines of 
management, economics, public policy and politics should also be included. 
Categorisation of the theories along the lines of the disciplines has serious 
disadvantages. First, it has made it difficult to identify competing theories of 
behaviour change. Second, it has resulted in discipline specific jargons. For 
example, Fuchs (2000) claimed that academic disciplines had no shared 
concepts. Jargons also limit communication within the disciplines as theoretical 
concepts are assigned different terms in different theories (Smedslund, 2000). 
And finally, it is difficult to draw the boundaries of different disciplines. 
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Theories are sometimes categorised according to the level of their 
application. For example, theories can be divided into three groups of individual 
level (also known as micro level) theories, group level theories and 
organisational level theories (meso level) (Iles and Sutherland, 2001; Rashidian, 
2004b). In psychology in particular, there is a tendency to add a level between 
individual and group levels, called interpersonal (Glanz et al, 2002a). Large- 
scale level (macro level) is also required to accommodate public policy theories 
(Shiffman et al, 2002). This hierarchical approach has a few shortcomings. One 
is that many theories are applicable to more than one level. That leads to 
another disadvantage, which is not all scholars agree on the level of application 
of the theories. The third shortcoming is that these levels tend to correspond to 
disciplines, therefore may not add much benefit over the traditional approach. 
Ajzen (1998) categorised the theories of human behaviour according to 
their level of generality. He explained that some theories only applied to specific 
types of behaviours. He called these models or theories as content-specific. 
The alternative group of theories applied to range of behaviours; and settings 
and were called content-free. Ajzen viewed TPB and social cognitive theory as 
content-free theories. There are other methods of classifying the theories in the 
literature (e. g. see Abraham et al, 1998; Bekker et al, 1999). 
In this chapter the theories are introduced in an implicit order of main 
disciplines. Hence on a few occasions the borders between the disciplines are 
deliberately ignored, in order to add to the depth of discussion. The review was 
selective and meant to capture theories more frequently applied to the field of 
quality improvement via seeking change in clinician behaviour. The chapter 
starts with introducing theories in the field of organisational behaviour and 
management. Then relevant theoretical concepts from the economics discipline 
are introduced. The diffusion of innovation which is a cross discipline theory is 
explained next. Then sociological and socio-psychological theories are 
presented. In the end psychological theories are discussed. It should be noted 
that most theories are originally developed to explain the behaviour of groups 
other than health care providers, such as consumers, managers and individual 
health related behaviour. The differences between health care provider 
behaviour and other types of behaviour should be taken into account. 
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3.2. Theories of provider behaviour change 
3.2.1. Organisational and management theories of behaviour 
The study of organisational behaviour has been defined as 'the study and 
understanding of individual and group behaviour, and pattems of structure in 
order to help improve organisational performance and effectivenese (Mullins, 
2002a, p 20). It originates from organisational sociology (Ferlie, 2001) and is 
'the systematic study of the behaviour of individuals, groups and organisations, 
(Ovretveit, 2001, p 2). Organisational studies have close links with policy 
analysis. While policy analysis tends to apply to higher (macro) levels of state or 
government, organisational studies tend to focus on the level of 'firms' (Ferlie, 
2001). Organisational approaches focus on change and improvement from the 
point of view of organisation as a whole. They maintain that change in individual 
usually follows change in organisation. Therefore, organisational change may 
be sought for the purpose of facilitating the process of change in individuals, for 
example to enhance clinical guideline implementation (Curry, 2000). Individuals 
play roles in change processes, but that is because of their positions within 
organisations (e. g. as leaders, managers or key people). Change in individual 
behaviour is also sought for the sake of achieving organisational objectives. 
Another advantage of the organisational approach is in its ability to theorise 
sources of pressure on medical profession. These sources of pressure are the 
triple constraints of new public policies, new governance structures and the 
desire to remain self-regulated (Sheaff et al, 2003). Some investigators, namely 
Chester Barnard, tried to develop a new science of organisation connecting 
organisation theory, economics and law (Williamson, 1995). More recent 
scholars maintain that although organisational behaviour is closely linked with 
the general discipline of management, research in this area tends to draw on 
other disciplines and uses a variety of methods and methodological approaches 
(Ovretveit, 2001). 
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Berwick (1996) provided powerful messages on organisational 
improvements. First he asserted that not all changes in systems were 
improvements, but all improvements were due to change. His second message 
was that effective changes (or'real improvements') came from changing 
systems and not from changes that happened within systems. System approach 
towards health care improvement differs with the traditional practices where 
improvement is sought by tackling the problem areas (staff, instruments, 
methods). Another development in the field of organisational change is derived 
from complexity theory (Miller et al, 1998). Health care organisations are 
collections of independent but interacting systems with unclear or fuzzy 
boundaries, similar to complex natural systems (e. g. biological or physical; 
Plsek and Greenhalgh, 2001). Complexity theory puts more emphasis on the 
link between the different elements of the organisations than those elements 
themselves (Plsek and Wilson, 2001; Wilson et al, 2001). Hence, emphasis on 
removing the barriers to change and considering the roles of the different 
elements within organisation is not as productive as understanding how 
different elements of complex and adaptive organisations interact and improving 
those interactions. The theory also suggests that establishing minimum 
standards (specifications) is more effectives than detailed planning as it 
provides more room for creative improvement (Plsek and Wilson, 2001). 
Another group of approaches originated in organisational and 
management theories are famously known as 'total quality management' or 
'continuous quality improvement' (Berwick, 1989). It has been defined as 
'philosophy of continual improvement of the processes associated with 
providing a good or service that meets or exceeds consumer expectatione 
(Shortell et al, 1998, p 594). It is based on four inter-correlated dimensions that 
are required for its success: strategic, cultural, technical and structural (Shortell 
et al, 1998). Despite considerable attention and resources attracted by this 
appealing approach to improving health care systems, its evidence base is still 
limited (Blumenthal and Epstein, 1996; Shortell et al, 1998; see 2.3.13 and 
Tables 2.1 and 3.3). 
Like some other concepts in the field of management, leadership has 
been interpreted in different and sometimes confusing approaches (Parker, 
71 
1994; Mullins, 2002b) and 'has been the subject of an extraordinary amount of 
dogmatically stated nonsense' (Barnard, 1997 reprint, p 89). Barnard (1997) 
thought leadership was dependant on 'the individual' (i. e. leader), the followers 
and the conditions (e. g. settings). It is not clear whether the followers are those 
who follow the leader or those who are expected to follow the leader. What 
most agree on is that management and leadership, while interrelated, are 
different. The 7-S model of organisational framework could be used for this 
distinction (Iles and Sutherland, 2001; Mullins, 2002b). According to the model, 
managers focus on 'strategy', 'structure' and 'systems'. On the other hand 
leaders are more likely to focus on soft Ss, which are 'style', 'staff', 'skills' and 
'Shared goals (values)' (Mullins, 2002b). Ambiguity over the definition makes it a 
difficult concept for systematic evaluation. The concept of clinical leadership is 
used for the analysis of the role of opinion leaders in behaviour change and 
norm transfer (Mittman et al, 1992; see 2.3.12). Theoretically it is possible to 
assume that improving leadership skills of GPs may improve their influence 
over other team members. GP managers can also use their leadership skills to 
promote the values which the health system stands for, and improve the morale 
of their colleagues (Pendleton and King, 2002). Fulfilling these roles in the 
current climate of high pressure and lack of resources may prove difficult. 
Leader influence may also lead to change in practice despite evidence. 
Therefore, focusing on leadership should always be accompanied by other 
interventions. 
Interest in the concept of leadership (including medical leadership) is 
growing (Pendleton and King, 2002; Ham, 2003). However, its role in evidence- 
based behaviour change - apart from what is achieved by opinion leaders - is 
less clear (Flottorp et al, 1998). In primary care, GPs have traditionally played 
the leadership role. This role has developed further within the new primary care 
organisations. GPs' roles as clinical governance leads have been described 
using the soft bureaucracy concepts (Sheaff et al, 2003). Soft bureaucracy is 
used for explaining organisations with rigid external appearance and loosely 
coupled internal practice (as opposed to hierarchical bureaucracy; Williamson, 
1995). Sheaf et al (2003) argued that the emergence of primary care groups 
and trusts (PCOs) has enabled the GPs to play leading roles within soft 
managerial structures. These roles can be used for the promotion of evidence- 
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based medicine, although the level of success is uncertain. Soft bureaucracy 
implies that GPs in managerial roles use three different legitimating strategies to 
influence their peers while preventing negative reactions (Sheaff et al, 2003). 
The most common approach is instrumental legitimating, in which the GPs 
argue the managerial decisions are made to achieve the organisation's broader 
objectives (e. g. better quality of care). The next legitimating approach is political 
legitimating meaning that managers' power originates from voluntary transfer of 
power from subordinates. Soft coercion or liberal legitimating is the approach in 
which change is promoted on the basis that it prevents the external threats on 
professional independence (Sheaff et al, 2003). Nonetheless the effectiveness 
of interventions based on leadership in changing provider behaviour is uncertain 
(Tables 2.1 and 3.3). 
In recent years there has been growing interest in the concept of 
organisational learning and in attempts to view (or transform) the NHS bodies 
as (or into) learning organisations (Davies and Nutley, 2000; Carroll and 
Edmondson, 2002). Organisational learning is defined as 'a process of 
increasing the capacity for effective organisational action through knowledge 
and understandincl (Carroll and Edmondson, 2002, p 51). The appeal of 
organisational learning in the NHS is in its promise of enabling continuous 
improvement. With ever changing health technologies and practices, the notion 
of learning how to learn is bound to be very interesting. Organisational learning 
is thought to be profoundly dependant on effective leadership (Carroll and 
Edmondson, 2002). A learning organisation in turn is an organisation that is 
capable of using different levels of learning to achieve continuous change and 
improvement, 'an organisation which facilitates the learning of all its members 
and continuously transforms itself (Pedler, Boydell and Burgoyne, quoted from 
Hicks, 2002, p 358). Five key characteristics are defined for a learning 
organisation (lies and Sutherland, 2001): structure (flat managerial hierarchy, 
team work, systems thinking), information systems (sophisticated), human 
resource (personnel as creators and users of organisational learning), culture 
(promote openness, creativity and experimentation) and leadership (effective, 
open and risk-taking). What is presented makes clear that learning organisation 
encompasses a variety of complicated theories and concepts hence it is difficult 
to implement and evaluate. Applying such framework in its full picture to small 
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organisations (e. g. general practices) requires resources that might not be 
available to practices but few large partnerships. PCOs may also lack the 
required level of interconnection with practices to enable them to establish a full 
learning organisation framework. However, the theory offers some insights that 
could provide benefits to general practice. Levitt and March (1995) explained 
that organisations were history dependent and were based more on routines 
than on intentions. This is an indispensable insight for general practice and is in 
line with the medical tradition of valuing case reports (March et al, 2003). No 
evidence of effect was found for the application of organisational learning and 
learning organisation concepts to improve primary care prescribing (Table 2.1). 
Organisational theories helped the development of new ways of re- 
arranging the workforce in health service by encouraging team working (e. g. 
see Berwick, 1996; Priestley et al, 2004). Organisational variables are known to 
influence the implementation of evidence-based innovations (Dobbins et al, 
2001). Whether this influence is causal or correlational is less clear. lies and 
Sutherland (2001) performed a selective review of organisational change 
models and theories. They looked for evidence of the effectiveness of more 
commonly used models and theories and found minimal evidence. This finding 
is acknowledged by other investigators (Ovretveit, 2001), and similar results 
were reached in the overview of systematic reviews (Tables 2.1 and 3.3). Better 
understanding of the nature of organisational change, and identifying effective 
interventions is a dire need. Attempts should be made to provide evidence base 
for change management interventions, e. g. from carefully designed case- 
studies as well as interventional studies (Ferlie et al, 2001; Rashidian, 2004b). 
3.2.2. Economic theories of behaviour 
The theory of the firm is the economists' theory of organisation and 
organisational behaviour. This theory has evolved throughout recent decades. 
According to the neoclassical theorists, 
the firm is a collection or set of feasible production plans, presided over 
by a manager who, buying and selling inputs and outputs in a spot 
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market, chooses the plan that maximises owners'welfare (Hart, 1995, p 
155). 
Welfare is usually represented by profit, but in a health care organisation it can 
be defined as satisfying health needs, cost reduction or achieving quality targets 
and often combination of these. If a GP principal is considered as the owner 
and manager of the practice, the model assumes that the GP will aim to 
maximise his or her welfare by balancing earning and leisure time (Zazove and 
Klinkman, 1998). The theory of firm does not answer the question of how the 
firm or organisation maximises its 'welfare', neither does it explain the structure 
of the firm (Hart, 1995). 
The principal-agent theory or agency relationship, developed in late 
1970s, introduces a series of conflicts of interest between different players 
within an organisation which arise from asymmetries of information (Hart, 1995). 
The principal-agent theory explains that the owners of firm do not have access 
to the same information that the manager has. Therefore, the owners try to link 
the managers profit to their own (e. g. by giving the manager a share of the 
profit). This theory, like the neoclassical one, is silent about the structure of the 
organisation. Information asymmetries and their impact on health care markets 
are widely used in explaining insurer-patient relationship, where three types of 
information asymmetries exist: adverse selection, hidden information moral 
hazard and hidden action moral hazard (Jack, 2000). In all of these 
asymmetries, the problem arises from the unawareness of the insurer from the 
patient's (insured) previous health status (adverse selection), the patient's 
status in accordance with its insurance claims (hidden information) and the 
patient's preventive or dangerous behaviour which may put his or her in less or 
more need of costly treatments (hidden action). The principal-agent theory has 
been applied to patient-doctor relationship, where the doctor acts as an agent 
for 'the often ignorant, insecure and potentially irrational patienr and the doctor 
has much more information about the choices available to the patient (Jensen 
and Mooney, 1990, p 9). The doctor's benefit or preference may not be in line 
with the patient's best interest or choice, hence an imperfect agency (McPake et 
al, 2002). Williams (1988) described this imperfect agency relationship as: 
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The PATIENT is there to give the DOCTOR all the information the 
DOCTOR needs in order that the DOCTOR can make a decision, and 
the PATIENT should then implement that decision once the DOCTOR 
has made it. 
The perfect agency exists when 'patient' is replaced by 'doctor' (and vice versa) 
in the quoted text. A further principal-agent relationship in medical care exists 
between the doctors and the hospital or primary care managers, or generally 
the health system (Fuchs, 2000). The health system's best interest may be to 
see doctors are 'efficient' (Mooney, 1995), but this may not be in line with 
doctors' preference. There may be other similar relations as doctors are 
considered accountable to different professional and political bodies (Royal 
College of General Practitioners, 1985; Pendleton and King, 2002; Checkland et 
al, 2004). GPs are expected to behave as agency to a minimum of two groups: 
the patients and the PCOs' clinical and non-clinical managers. G Ps also control 
access to many secondary and tertiary health services through their gate- 
keeping roles in the NHS. All these issues cause further conflicts as the 
principals (patients on one hand and managers on the other hand) may not 
have similar agendas and seek conflicting roles from their agents (i. e. GPs). 
Some suggest that the gate-keeping role may help GPs to behave more as 
informed agent on behalf of the patients (Phelps, 2000), but as explained 
conflicting roles may prevent this from happening. The other potential problem 
in patient-doctor agency relationship is that GPs may not be aware of all the 
available treatment, preventive or diagnostic options for the patient (Folland et 
al, 2004). Clinical guidelines are able to improve this aspect by informing 
doctors of standard care. Guidelines can also improve patients' awareness of 
options available to them and hence help patients in establishing a more 
informed relationship with their agents (GPs). 
Demand is 'the quantity of a good or service a consumer will purchase at 
different prices during a given period of timd (Rosko and Broyles, 1988, p 58). 
The traditional neoclassical demand theory is based on the assumption that 
people make their decisions rationally to maximise their utility, based on their 
preferences and within the boundaries of their income and the prices of goods 
or services. The price paid for the health or health services can be represented 
in monetary or non-monetary terms (e. g. waiting time). In this sense each 
individual (consumer) is arational economic man'or'homo economicus'. For 
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these 'rational' individuals, health and health care are only two among many 
commodities that they have preferences for (Jack, 2000). This rational 
explanation of demand may not represent health care due to a variety of 
peculiarities such as imperfect agency relationship. There are other models of 
explaining demand for health. Grossman's human capital theory asserts that 
consumers invest in themselves through health, education and training to 
increase their earning (Folland et al, 2004, p 125). Health is viewed as a 'capital 
good' or 'stoke variable' in the investment model of demand (Rosko and 
Broyles, 1988; Jack, 2000). People inherit health and the value of health 
depreciates over time. Therefore, people seek health care because they seek 
health. In this model, the demand for health is in pursue of two benefits. One is 
the benefit in terms of improved utility achieved as a result of better health. The 
second benefit is called the investment benefit. It refers to the fact that a 
healthier person spends more time in other beneficial activities such as work 
and leisure, and better health improves its capacity to benefit from health. This 
model has become popular at policy level after the World Bank's World 
Development Report on investing in health (World Bank, 1993; Jack, 2000). In 
reality, the production of health depends on a range of variables of which only 
one is health care. Evidence shows that the marginal benefits of health care in 
the production of health are small, and are 'nearly on the flat of the [health 
production function] curvd (Folland et al, 2004, p 84). 
Demand for health care has a further peculiarity as it can be induced by 
the supplier (provider), namely the clinician. It was estimated that as much as a 
quarter of high technology health services provided to patients were not 
required (Borowitz and Sheldon, 1993). An important fraction of these services 
might be supplier-induced. Some strikingly huge regional variations observed in 
medical care were considered to be induced by providers (McPherson et al, 
1982; Raskin, 1991; Parchman 1995). Although most studies originate from the 
USA or UK, the phenomenon is not limited to any single country (Ellison et a[, 
2003; Rudge et al, 2003; Miranda et al, 2003; Roudot-Thoraval et al, 2003). The 
outcome of health care is often uncertain and the natural course of a disease 
without treatment is often unknown for individual patients. These factors and the 
complexity of medical care result in the analysis of a lot of information by the 
doctor before a decision is made (Rosko and Broyles, 1988). The way the 
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physician interprets the information and the way it is presented to the patient 
has detrimental effect on the demand for health care, hence the term supplier- 
induced demand. The supplier-induced demand also happens as a result of 
imperfect agency relationship in which the doctor puts his benefits ahead of the 
patient's best interest (McPake et al, 2002). Some physicians tend to refer their 
patients for further investigation or treatment in which the physicians have 
financial interest (Iglehart, 1991). The rate of this behaviour in an open access 
health system may be as high as 40% (Pippalla et al, 1995). Theoretically, 
clinical guidelines can reduce the supplier-induced demand. Clinical guidelines 
may improve decision making by organising evidence-based information and 
reduce geographical variation by defining standard care. For example the 
dissemination of a national clinical guideline resulted in the reduction of surgical 
operations for the treatment of glue ear in the NHS (Black and Hutching, 2002). 
On the other hand, demand theory suggests that the observed reduction in 
surgery for glue ear may have happened as a result of demand shift to other 
providers, e. g. private sector (Black and Hutching, 2002) or towards other 
surgical procedures (Borowitz and Sheldon, 1993). 
Not all evidence points towards the inducement as the cause of variation 
in health care. A review of the uptake of different surgical approaches for breast 
cancer concluded that physician-induced demand was not the main cause of 
variation (Greer et al, 2002). Organisational variables (e. g. waiting time and 
expenditure caps) affect the level of inducement independent of physician 
characteristics (Reinhardt, 1999). Physicians' inducement ability is also limited 
by factors such as reputation, patient education, other professionals' views, 
other patients'views and the views of patient's family and friends (Rosko and 
Broyles, 1988; Greer et al, 2002). Generally speaking, inducement is more likely 
to happen in fee-for-service health markets. 
Demand theory can be applied to the G Ps' behaviour of implementing 
guidelines in another way. A perfect GP can be defined as someone whose aim 
is to maximise the patients level of health, or their utility, or to maximise the 
society's level of health or utility (Miettinen et al, 2002; Blank, 2002). All these 
are legitimate. Assume a (perfect) GP's aim is to maximise patient's health. The 
patient's health itself is an intermediary to other maximands for the GP such as 
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professional gain or satisfaction. The maximand may also be quality 
benchmarks (and accompanying financial rewards) or meeting budgetary 
targets through reducing further treatment costs. On the other hand, uncertainty 
implies that GP cannot be'sure'of the validity of clinical guideline 
recommendations when applied to the individual patient and of the effects of 
other alternatives decisions on the patient's outcomes. The outcome of care is 
also highly dependant on the patient's behaviour. Therefore, even a clear 
choice of maximand does not necessarily predict the target behaviour or the 
GP's clinical recommendation. It is also clear that the choice of maximand in 
health service is not always straightforward. The role of the clinicians and their 
behaviours will be even less predictable if all the legitimate maximands are 
considered (Miettinen et al, 2002). It is equally comprehensible to assume many 
GPs observe no conflict between the patient and societal maximands, if the 
GPs consider themselves responsible for the health of their patients within 
certain boundaries especially limited resources (Royal College of General 
Practitioners, 1985; Blank, 2002). 
Health systems may use remuneration strategies to put the patient's 
outcome maximand in line with the clinician's financial and professional gain, for 
example by offering bonus payments for better patient outcomes or 
improvement in process variables (Armour et al, 2001). Economic theories 
suggest different remuneration systems (e. g. capitation, salary, fee for service, 
target payment) influence process and patient outcomes depending on the 
setting and the way the remuneration is applied (Chaix-Couturier et al, 2000; 
Gosden et al, 2001). Target payment has a long history in British primary care. 
For example target payment for family planning services started in 1975 and for 
immunization in 1965. Many believe target payment has been effective in 
increasing the adoption of some preventive and screening services (Horder et 
al, 1986). The evidence on the effectiveness of interventions involving change 
in remuneration systems was not conclusive (see 2.3.14; also Rashidian et al, 
2005), although it hinted towards facilitating quality improvement and reducing 
prescribing costs (Chaix-Couturier et al, 2000). Also, the overview of systematic 
reviews suggested that the effects of financial incentives on GP behaviour was 
mixed and sometimes against expectations (2.3.14; Tables 2.1 and 3.3). 
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3.2.3. Diffusion of innovation theory 
New technologies and innovations gradually diffuse among organisations and 
individuals. It may take several years, even decades, before an innovation is 
widely used among its potential target groups (Haines and Jones, 1994). 
Technologies diffuse with different speeds and one technology may be adopted 
faster in some settings and groups than the others (Berwick, 2003). The 
diffusion usually follows a logistic S-shaped curve (Rogers, 1995b; Folland et al, 
2004). Diffusion of innovation theory describes the process of the dissemination 
of a new technology through certain channels in a social system (Moulding et al, 
1999). It is meant to explain the variations in adoption and to answer questions 
like who adopts an innovation and how (Folland et al, 2004). The diffusion of 
innovation theory (Greer, 1977; Greer, 1985; Rogers, 1995a; Rogers, 1995b), 
focuses on 'the normal processes by which information is received, circulated, 
and assessed (Greer, 1988, p 6). Therefore, the theory is less concerned with 
why some dissemination strategies fail (or succeed) in changing behaviour, 
than how it happens. It suggests that potential adopters go through five stages 
of knowledge, persuasion, decision, implementation and confirmation to get to 
the confident use of innovation (Rogers, 1995a; Rogers, 1995b; see 3.2.5 for 
other examples of stage-based models). The notion of rationality of behaviour 
change inherent in the diffusion of innovation is one of its major limitations 
(Moulding et al, 1999). The separation of formed technologies from dynamic 
ones to some extent rectifies this limitation (Greer, 1988). Greer argued many 
technologies developed as they diffused, hence called dynamic; and dynamicity 
affected their adoption. She hypothesised the assumptions of classical diffusion 
theory would be met for technologies which were fully formed before their 
release. Formed technologies, e. g. CT scanners and fetal monitors, diffuse fast 
compared with the bulk of medical innovations which are normally accompanied 
with a great deal of uncertainties (Greer, 1988). 
Economists have offered an extra angle to the theory by adding the profit 
motive to the existing information channels (Escarce, 1996; Folland et al, 2004). 
Hence technologies that increase profit would be adopted earlier. Unlike 
economic markets, most health systems provide little room for doctors to reap 
the benefits of technologies and doctors have little financial incentive to 
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innovate (Phelps, 2000). Regulatory systems manage the profitability of new 
technologies and the monetary and non-monetary costs of their adoption 
(Folland et al, 2004). Regulatory systems, e. g. NICE in England and Wales, use 
guidelines to affect the adoption rates and shift the diffusion curves. 
Many clinical guidelines are perceived as new technologies. The 
diffusion theory is used extensively in proposing strategies for the 
implementation of clinical guidelines (Mittman et al, 1992; Grilli and Lomas, 
1994; Rogers, 1995b; Moulding et al, 1999) and the development of other 
models of research utilisation (Logan and Graham, 1998). Roger theorised that 
the innovation characteristics influence the diffusion of new innovations. For 
clinical guidelines, those characteristics are the relative advantages over normal 
practice, the compatibility of the recommendations with existing beliefs and 
values, the complexity of the procedure, the 'trialability' of the procedure and the 
observabality of the outcomes (Rogers, 1995b). Despite Rogers, these 
characteristics are more than just the characteristics of the innovation and cover 
the clinical context characteristics too (Kanouse and Jacoby, 1988). 'Trialability' 
refers to the extent to which a technology can be tested in limited circumstances 
before the final decision for its adoption is made (Grilli and Lomas, 1994). The 
complexity of the technology prolongs the time required for confident 
implementation. The process of gaining confidence in using a new technology is 
known as the learning curve (Ramsay et al, 2001). Diffusion of innovation 
suggests lower levels of complexity and higher levels of trialability and 
observabality would increase the adoption rate. Grilli and Lomas (1994) found 
positive correlation between the compliance with clinical guidelines and 
trialability and negative correlation with complexity. Others found no relationship 
between the complexity of the target behaviour and the effectiveness of the 
intervention (Jamtvedt et al, 2003; see 2.3.9 and Appendix 11-2). 
According to the diffusion of innovation, opinion leaders play important 
roles in the dissemination process (Rogers, 1995a). 'Change agents' (Moulding 
et al, 1999) or'idea champions' (Greer, 1988) are very important, but these are 
not normally opinion leaders. Opinion leaders tend to be conservative in 
adoption of new technologies, therefore their role in adoption process is 
prominent when the benefits of the innovation are discernable (Greer, 1988). 
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Others suggested that opinion leaders may be among early adopters (Conroy 
and Shannon, 1995), but this is less convincing as early adopters tend to be 
younger and more risk taking (Folland et al, 2004). The overview of systematic 
reviews concluded that the role of opinion leaders in changing behaviour was 
variable and there was no evidence of effect in primary care (2.3.12; Tables 2.1 
and 3.3). 
3.2.4. Social influence, power and ecology 
The social influence theory emphasises the role that important others play in the 
individual's decision making and behaviour (Moulding et al, 1999; see also 
3.2.6). The theory is better understood if social influence and social power are 
defined. Raven and Rubin (1983) define social influence as any changes 
invoked in individual's emotions, beliefs, attitudes or behaviours by other 
individual(s). They also define social power as a 'potential influence, that is, the 
ability of some influencing agent to affect some targef (Raven and Rubin, 1983, 
p 402). The definitions suggest that there is overlap between this theory and 
theories such as the social cognitive theory and the TPB as they both theorise 
social influence in similar approaclý (Bandura, 1986; Ajzen, 1991). The social 
influence theory has been widely referred to in clinical guideline implementation 
literature (Mittman et al, 1992; Conroy and Shannon, 1995; Moulding et al, 
1999). It suggests interesting avenues for behaviour change. The theory 
proposes that social influence is usually exercised through different channels of 
information, reward, coercion, expertise, reference and identification (Raven 
and Rubin, 1983). The theory also considers the relationship of these different 
channels of influence with other factors such as the status and credibility of the 
influencing agent and the ability to monitor the behaviour. 
According to the theory, informational influence is independent of the 
influencing agent (Raven and Rubin, 1983). It is plausible to say informational 
influence is asserted by almost all clinical guidelines as guidelines are 
information sources. However, the effects of informational influence on 
behaviour are uncertain and variable (Grad et al, 1997; see also 'mailed printed 
82 
education material' in 2.3.4). Unlike information, coercion and reward are 
socially dependent on the influencing agent and also on the ability of the agent 
to monitor the behaviour (Raven and Rubin, 1983). For example, a NICE 
guideline is more likely to be implemented if NICE is perceived as capable of 
monitoring as well as rewarding or coercing. This is truer if the adherence to the 
guideline can be accurately measured. Coercion and indeed reward may take 
different forms (e. g. soft coercion in 3.2.1, ecological manipulation in here, 
financial incentives in 3.2.2). Lewin's field theory (force field analysis) is another 
theory that deals with the effects of coercion on behaviour change (Lewin, 
1951). Field theory envisages that increasing pressure may make the desired 
change more likely to happen. However, opposing forces gradually grow in 
power and so the behaviour change is inhibited or reversed. The resulting 
situation will be a stressful environment with limited desired outcomes. Thus, 
Lewin suggests that to achieve change it is more fruitful to tackle the opposing 
and inhibiting factors before and instead of increasing the pressure (Lewin, 
1951; Raven and Rubin, 1983; lies and Sutherland, 2001). 
Expert, referent and legitimate influences or powers are dependent on 
the influencing agent, but not on surveillance (monitoring) (Raven and Rubin, 
1983). These themes are close to each other and overlap to some extent. 
Referent power refers to the social influence derived from following suit of peers 
and behaviour models. If practitioners perceive that their peers follow a clinical 
guideline, they are more likely to do the same. One example of achieving 
change through referent power is when anonymous local audit results are 
circulated among all participating practitioners, while highlighting the difference 
of the individual practitioners by local norms (e. g. as part of audit and 
feedback). Legitimate powers are observed from those who are seen by other 
as legitimate sources of request for behaviour change. Concept of soft 
bureaucracy explained some of the legitimisation approaches that GPs may use 
(3-2.1). Expertise, or expertpower, might exert positive or negative influence on 
behaviour depending on the level of respect for the influencing agent. The 
influence of consultants on the GPs' prescribing is one example of the expert 
power (Armstrong et al, 1996). Using these themes, one predicts that clinical 
guidelines, especially when supported by expert opinion and based on evidence 
are likely to exert the influence on the physicians' behaviour as they are in the 
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expert position. On the other hand in many occasions the guidelines may 
reduce the expertise influence, as they will demystify the basis of the expert 
opinion and highlight the limitations and weaknesses in the evidence base of 
recommendations. Overall, the peers' beliefs and norms are considered as a 
prominent determinant of the individual's behaviour in the social influence 
(Mittman et al, 1992). Social influence as well suggests that in the presence of 
uncertainty individuals are more likely to be influenced by their peers (Mittman 
et al, 1992; see 3.2.2). 
Social judgment theory also helps the understanding of physician 
behaviour in relation to uncertainty (Hammond et al, 1977). Social judgment 
defines uncertainty as the 'zone of ambiguity ... that is the conceptual space 
between that which can be observed and that which must be inferred because it 
cannot be observed (ibid, p 3). Social judgment suggests that in situations 
where the decision makers have no direct access to the valid variables that can 
affect the decision, they use other variables (referred to as 'proximal cues') with 
limited validity and reliability for making their decisions. Proximal cues are 
usually obtained from the environment or'ecological situation' (Dowding and 
Thompson, 2003). These cues include peers'views and expectations and 
patients' signs and symptoms. Given that the proximal cues are perceived 
differently by different individuals (Ajzen, 1991), and also that different 
individuals are in contact with different cues, variation in practice is likely. 
The notion of 'uncertainty' is also very close to the judgmental error. The 
theories of human inference explain individuals make erroneous social 
judgments because of 'representativeness', 'availability', 'framing' and 
'vividness' (Raisch, 1990b). The first cause of judgmental error is the similarity 
judgment or 'representativeness', which is when the relationship between the 
events is misjudged. For example a GP may assign the recovery of the patient 
from a disease to a certain drug, while the causality is not ascertained. The 
'availability' heuristic explains that individuals use readily available memories for 
the interpretation of new information. 'Framing' explains that the way the 
information is presented affects the interpretation of it. 'Vividness' suggests that 
more interesting information is usually perceived as more important or useful. 
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The understanding of the nature of social judgment can help the methods used 
to influence prescribing and to explain variations and errors. 
Social influence theory recommends that different target groups ('social 
settings') warrant different strategies. Three types of settings identified in the 
literature are the interpersonal setting, the persuasion setting (moderate size 
groups) and the mass media setting (Mittman et al, 1992; Conroy and Shannon, 
1995). Mittman et al (1992) proposes that in interpersonal settings, normative 
and informational social influences through approaches such as academic 
detailing or apprenticeship are the most effective. In persuasion settings opinion 
leaders and auditing (continuous quality improvement) are more likely to exert 
social influence and transfer norms. The strategies used in mass media 
approaches, e. g. publications in journals, are less likely to be effective, but are 
the least demanding methods. 
Social ecology theory maintains that environmental factors influence the 
behaviour. In this regard, the theory is similar to many other theories discussed 
here. However, the theory goes further and adds that individuals also tend to 
change the environment in an interactive process (Moulding et al, 1999; see 
also 3.2.5 'social cognitive theory). One potential usage of this theory is in its 
application for exerting indirect influence on behaviour through ecological 
manipulation 'in which one person influences another by altering some aspects 
of the environment' (Raven and Rubin, 1983, p G-8). As an example, guideline 
implementation might be supported by removing a discouraged medicine from 
the formulary. The main advantage of using social manipulation rests in its 
ability in changing behaviour without target group noticing. If the target 
population become aware and are still unconvinced of the need for change, 
they may put a lot of effort to neutralise the social manipulation, as explained in 
force field analysis (lies and Sutherland, 2001). Examples of these negative 
reactions have been observed in social behaviours such as driving (Raven and 
Rubin, 1983). In the field of prescribing also the worry is that local or national 
formulary manipulations may cause problems in which' the intentions are 
subverted even if the letter of the law is followed (Horder et al, 1986, p 521). 
Direct regulatory approaches towards prescribing may achieve short term 
success. However, they neither achieve improvement in future prescribing 
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decisions, nor solve the route cause of the targeted behaviour (Raisch, 1990b). 
The social ecology theory further suggests that suitable and concurrent 
changes in environment variables and individual behaviour will increase the 
likelihood of successful change (Moulding et al, 1999). In this way, the theory 
overlaps with organisational approaches. 
Any intervention that applies all the concepts put forward by the social 
influence theory and other theories presented in here inevitably would be multi- 
faceted. The overview of systematic reviews did not find any evidence of 
effectiveness of interventions that applied these theories in their totality. 
Nonetheless, the theories help the understanding of variations observed in 
effectiveness of several different interventions presented in Tables 2.1 and 3.3, 
e. g. audit and feedback, peer review, educational outreach, financial incentives 
and some non-voluntary interventions. 
3.2.5. Transtheoretical model and social cognitive theory 
Stage-based theories maintain that behaviour changes happen as individual 
progresses through psychological stages of readiness to change (Norman and 
Conner, 1996). There are three main theories in this category: the 
transtheoretical model, the precaution adoption process model and the health 
action process approach (Riemsma et al, 2002). All three models maintain that 
for each behaviour people can be categorised into three groups: those who 
have not decided to change, those who have decided to change and those who 
are already changed (Riemsma et al, 2002). The transtheoretical model is by far 
the most frequently used model. Prochaska and DiClemente (1983) developed 
this individual level model of behaviour change in early 80s. It has been very 
popular among health promotion staff in the UK in the last decade (Riemsma et 
al, 2002). The 'stages of change', the 'processes of change' and the'levels of 
change' are the three organising constructs of the model (DiClemente and 
Prochaska, 1998). In this model a continuum of behavioural stages is defined in 
which people progress towards the goal of behaviour change. In its earlier 
versions the model was a linear continuum of four stages. Further studies 
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resulted in the development of the model so that it comprised five elements or 
stages: pre-contemplation, contemplation, preparation, action and maintenance 
(Prochaska et al, 1992). In its current form the model does not imply that the 
progress through this continuum is linear. Individuals may go forward and 
backward during the process of behaviour change before they get to the 
maintenance stage. This process is called the spiral model of the stages of 
change (Prochaska et al, 1992). Prochaska et al (1992) integrated ten 
processes into the stages of change. Processes are resembled to the engines 
that facilitate movement between stages and are derived from several diverse 
theories (DiClemente and Prochaska, 1998). Levels of change are defined to 
take into account that the individuals with one problem behaviour have other 
problems that complicate the picture and the individuals may be at different 
stages of change for each problem (DiClemente and Prochaska, 1998). The 
model implies that interventions should be tailored to individuals' readiness for 
change (Riemsma et al, 2002). 
Transtheoretical model has some limitations, mainly in its inability to 
explain what causes individuals to move between stages. It also has limited 
ability in explaining the effects of external factors (such as organisation and 
environment) on individual behaviour. Establishing the spiral movement of 
individuals between different stages requires long term longitudinal studies with 
repeated collection of data and complicated statistical analyses. Another 
limitation of this model, if applied to guideline implementation for prescribing, is 
that in most clinical scenarios it is likely to find GPs scattered at the later stages 
(namely preparation and action). At the theoretical level, the model has been 
criticised for artificial segmentation of natural continuum of change in attitudes 
and behaviours (Davidson, 1998). Davidson puts forward that pro- 
contemplation, contemplation and preparation are different levels of intention, 
and action and maintenance measure different levels of behaviour. He and 
others have argued the cut off points in distinguishing the stages are arbitrary 
(Davidson, 1998; Ogden, 2001). Sutton suggests the stages' definitions are 
logically flawed (Sutton, 2000, p 209). On the other hand, the model advocates 
hail the model's empirical success in a variety of health behaviours and different 
settings (Prochaska and DiClemente, 1998). A systematic review of randomized 
trials of stage-based interventions, however, concluded there was little evidence 
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to suggest these interventions were more successful that non-stage-based 
interventions or indeed the usual care (Riemsma et al, 2002). The 
transtheoretical model can help improving the effectiveness of interventions 
such as educational outreach and audit and feedback (Tables 2.1 and 3.3). 
Other stage theories might also help understanding of provider behaviour 
(Schmidt et al, 1990; Pathman et al, 1996). 
FIGURE 3.1. SOCIAL COGNITIVE THEORY: INTERACTION 13ETWEEN OUTCOME EXPECTANCY AND 
PERCEIVED SELF-EFFICACY IN PRODUCING THE DESIRED BEHAVIOUR 
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Adapted from Community Sport and Recreation Initiatives Project, 2000. 
Another psychological theory, social cognitive theory, is based on the 
principle of reciprocal determinism (Bandura, 1986; Baranowski et al, 2002). 
This principle suggests that three components of the individuals, their 
behaviours and their surrounding environment are constantly influencing each 
other (Baranowski et al, 2002). Social cognitive theory is content free (i. e. 
applicable to a wide range of behaviours; see 3.1.3) and has been defined as 'a 
theory of skill and competency management and cognitive behavioural control 
(Lewis, 2002, p266). The theory stems in efforts to explain human learning. A 
previous theory, operant learning, had argued that reward (or incentive) should 
be directly offered for learning to happen (Hicks, 2002, pp364-366). Albert 
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Bandura and others offered the alternative theory of social learning, which 
proposed learning occurs in a social context and is not conditional to the direct 
application of reward (Baranowski et al, 2002). The social cognitive theory was 
developed through Bandura's attempts to improve the theory of social learning 
(Bandura, 1977b; Baranowski et al, 2002). Social cognitive theory is a complex 
theory and includes several concepts (Bandura, 1998; Ogden, 2001; 
Baranowski et al, 2002). Self-efficacy is the prominent concept and the theory 
suggests that it is the main predictor of behaviour (Bandura, 1977a; Bandura, 
1986). Introduction of self-efficacy was a major theoretical improvement in the 
understanding of human behaviour (Ajzen, 1998). Self-efficacy was later 
adopted in other major theories. Its addition to the theory of reasoned action (in 
form of perceived behavioural control) resulted in formation of the TPB. 
Social cognitive theory proposes that individuals' positive (negative) 
expectations of the outcome provide the incentive for (not) performing the 
behaviour. The individuals value the expected outcomes, and these values form 
the incentives to perform the behaviours (Baranowski et al, 2002). Both values 
and expectations filter through self-efficacy. Therefore if the perceived 
outcomes of engaging in behaviour are positive and the individual has a high 
level of self-efficacy, then the behaviour is likely to happen (Fig 3.1). Self- 
efficacy can be improved through social interactions, role models, training and 
simplifying the behaviour by reducing it to distinguishable parts. The concepts 
derived from the social cognitive theory and its predecessor, social learning 
theory, can help the understating of clinical behaviour change (Oxman et al, 
1995; Davis et al, 1995). The concepts of the theory contribute to the 
understanding of several interventions, with varying levels of evidence of 
effectiveness (Table 2.1 and 3.3). 
3.2.6. Theories of planned behaviour (TPB) and reasoned action 
Theory of planned behaviour and its predecessor, theory of reasoned action, 
are among social cognition theories. Both theories are intended to explain 
volitional behaviours (Ajzen and Fishbein, 1980; Ajzen, 1985; Ajzen, 1988; 
Ajzen, 199 1) and 'they appear to imply that individuals make behavidural 
89 
decisions based upon a careful consideration of available information' (Conner 
and Sparks, 1996, p 121). The above statement can be interpreted in a way that 
these theories especially the reasoned action are models of rational behaviour. 
Montano and Kasprzyk (2002) argue against this interpretation. They explain 
both theories assume individuals as rational actors so that individuals carefully 
process information before making behavioural decisions (Conner and Sparks, 
1996). The information process may then change the underlying beliefs and 
through them the behaviour. That is regardless of whether the beliefs are 
rational or not. The assumption that individuals are rational actors is present in 
other social cognition theories (Norman and Conner, 1996) and in classical 
economic theories. 
FIGURE 3.2. THEORY OF REASONED ACTION; SIMPLIFIED SUMMARY 
D 
ATT 
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SN 
BEH: Behaviour; BI: Behavioural Intention; 
ATT: Attitude towards the behaviour; SN: Subjective Norm 
Theory of reasoned action was developed by Ajzen and Fishbein (1980). 
The theory maintains that behavioural intentions are influenced byattitude 
towards behaviour' (attitude) and 'subjective norm' (or social cognition) (Fig 
3.2). Attitude refers to the individual's overall evaluation of the behaviour. The 
emphasis on attitude towards behaviour is to distinguish it from attitude towards 
object and to prevent confusing different attitudes with each other (Montano and 
Kasprzyk, 2002). For example a GP's attitude towards asthma (object) may be 
different with his or her attitude towards prescribing a certain drug to treat 
asthma (behaviour). Theory of reasoned action maintains attitude and 
subjective norm are the determinants of behavioural intention (Conner and 
Sparks, 1996; Montano and Kasprzyk, 2002). 
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Theory of planned behaviour suggests that intention is determined by 
attitude towards the behaviour (attitude), perceived social or peer pressure 
(subjective norm) and perceived behavioural control (perceived control) (Fig 
3.3). Perceived control is the person's perception of ability to perform the 
behaviour and control over carrying out the behaviour. It is very close to 
Bandu ra's (1977) concept of self-eff icacy (Norman and Conner, 1996; see 
3.2.5). It is also similar to Triandis's concept of facilitating conditions, which is 
about those personal or environmental characteristics that modify a person's 
behaviour regardless of person's behavioural intention (Montano and Kasprzyk, 
2002). Hence, to put in jargon free context, TPB assumes that the individual 
makes his or her behavioural intentions based on three sets of beliefs and 
views: how the individual thinks of the outcome of the behaviour, how the 
individual thinks of the views of others about the behaviour (do important others 
expect or approve the behaviour) and whether the individual thinks to be 
capable of performing the behaviour (Marteau et al, 2002). 
Intention is the cornerstone of the TPB as both predicted variable and 
predictor of behaviour (Fig 3.3). It should be directly measured using a set of 
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FIGURE 3.3. THEORY OF PLANNED 13EHAVIOUR (TPB) 
question items starting with 'I intend', 'I plan', 'I want' or 'I will' (Conner and 
Sparks, 1996; Ajzen, 2002b). The intention measured in this way is called the 
goal intention (Gollwitzer, 1999). According to the TPB, the strength of intention 
is the important predictor of behaviour. If there is a weak intention, the TPB 
suggests that altering attitude, subjective norm or perceived control may 
enhance intention. There is another psychological theory called 'implementation 
intentions' that suggests specific interventions for the strengthening of intention 
(Gollwitzer, 1999; Ajzen, 2002a). The theory asserts that behavioural intention 
is more likely to lead to behaviour if the intention is specified in terms of when, 
where and how (Gollwitzer, 1999; Gollwitzer and Oettingen, 2000). Therefore, 
Gollwitzer argues, by forming implementation intention the individuals commit 
themselves to certain reactions in given circumstances; and that is more than 
desiring a certain outcome in goal intentions. He adds that formation of 
implementation intentions helps the individual to 'switch from effortful control of 
their goal-directed behaviour... to being automatically controlled by situational 
cues' (Gollwitzer, 1999, p 495). 
The theory proposes that attitude, subjective norm and perceived control 
are based on salient beliefs. Attitude arises from a set of beliefs about the 
behavioural consequences (behavioural beliefs) and evaluations of these 
consequences (outcome evaluations). Subjective norm is based on the 
individual's perceived views of others about the behaviour (normative beliefs) 
and the level of the individual's desire to adhere to the views of these people 
(motivation to comply). Likewise, perceived control is determined by individual's 
control beliefs and perceived power of those beliefs (Fig 3.3). According to the 
theory, internal and external factors might inhibit or facilitate formation of 
behaviour through control beliefs (Conner and Sparks, 1996). Internal factors 
for example are information, skills, emotions, abilities, and personal capabilities. 
Examples of external factors are opportunities, resources, social and 
organisational barriers and facilitators. 
In a clear attempt to simplify the utilisation of the theory, the developers 
suggested that attitude towards behaviour was equal to the sum of products of 
'behavioural beliefs' and 'outcome evaluations' (Conner and Sparks, 1996; 
Montano and Kasprzyk, 2002; Fig 3.4). For example for a GP to have a positive 
92 
attitude towards prescribing a specific drug for a given patient, she or he should 
positively value the expected change in patient's health and also believe that 
the drug is capable of achieving that change. Because of this theoretical 
reasoning TPB and other theories that utilise the same principle are referred to 
as expectancy-value theories (French and Hankins, 2003). 
FIGURE 3.4. STATISTICAL PRESENTATION OF THE TPB 
Regression models: 
BI = 01 ATT + 
02 SN + 03 PBC 
BEH = 01 BI + 02 PBC 
Sums of products: 
ATT (behavioural belief x outcome evaluation) 
SN (normative belief x motivation to comply) 
PBC 
_7 
(control belief x perceived power) 
BEH: Behaviour; BI: Behavioural intention; ATT: Attitude towards the 
behaviour; SN: Subjective norm; PBC: Perceived behavioural control 
Similarly, subjective norm is the sum of products of normative beliefs and 
motivation to comply with those beliefs; and perceived control is the sum of 
products of control beliefs and their perceived powers (Conner and Sparks, 
1996; Montano and Kasprzyk, 2002; Fig 3.4). For example, the feeling of social 
pressure is the result of the GP believing that her important others (e. g. peers) 
expect her to prescribe in given condition and the GP respects their views. This 
social pressure is again the overall pressure felt from all important others, which 
probably in this case are colleagues (clinical and non-clinical) and patients. A 
negative subjective norm can be observed because of the expectation of an 
untrustworthy or non-respected individual. Theory of planned behaviour 
proposes linear relationships between the model elements. Attitude, subjective 
norm and perceived control all have linear explanatory relationships with 
behavioural intention. In turn, intention and perceived control have linear 
relationship with behaviour. These relationships are best explained by two 
regression models (Fig 3.4). 
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The TPB maintains that attitude and behaviour need to be compatible, if 
attitude is to predict behaviour. This has been called the 'principle of 
compatibility' (Ajzen, 1988; Conner and Sparks, 1996). According to this 
principle, attitude and behaviour have four elements of action, target, context 
and time (Conner and Sparks, 1996; Montano and Kasprzyk, 2002). If attitude 
and behaviour are at the same level with respect to the elements, then the 
correspondence between attitude and behaviour will be the highest (Conner 
and Sparks, 1996). An example of this principle could be presented as a GP 
who prescribes anti-hypertensive medicines according to an evidence-based 
guideline (action), to reduce blood pressure of the patient (target), in his 
practice (context), tomorrow (time). This is only one presentation of a single 
behaviour of the GP. The behaviour could also be divided into separate 
behaviours (e. g. diagnosis, measurement, deciding on drug class, dose of drug, 
dealing with co-morbidities etc). Conner and Sparks (1996, p 134) state that the 
minimum specification of behaviour should include action and time frame. For 
health care providing behaviour of clinicians, specification of time as requested 
by the principle of compatibility may be a challenge. It is very difficult for a 
clinician to predict when they meet a patient that requires an activity that they 
intend to perform, especially in general practice. In theory the principle of 
compatibility is applicable to single behaviours (e. g. teeth brushing, prescribing 
a certain drug for certain condition) as well as general classes of behaviour (e. g. 
oral hygiene, guideline implementation; Conner and Sparks, 1996). 
The main difference between TP13 and theory of reasoned action is in 
inclusion of perceived control into the TPB. The other major difference is the 
way the relationship between behavioural intention and behaviour is devised. 
Reasoned action maintains that intention is the sole predictor of behaviour. 
However, TPB acknowledges that in many circumstances individuals perform 
(or refrain to perform) behaviours despite their intention. This has been 
presented through suggestion of a direct link between perceived control and the 
behaviour (dotted arrow in Fig 3.3). Therefore perceived control has a direct 
effect on behaviour without the mediating effect of behavioural intentions. In 
other words, perceived control moderates the effects of intention on behaviour 
(Baron and Kenny, 1986; Montano and Kasprzyk, 2002). The inclusion of 
perceived control into the model has extended the applicability of the theory 
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beyond easily performed volitional behaviours to those which require skills, 
resources or opportunities, and which are not considered to be within the 
domain of the applicability of theory of reasoned action (Conner and Sparks, 
1996). A further advantage of adding perceived control is that theoretically the 
TPB will be able to take into account the individual's past experience. Previous 
experience of behaviour affects the individual's perceived behavioural control, 
and hence contributes to the formation of intention and behaviour. Thus, the 
TPB can be seen as the more appropriate of the two models with which to study 
provider behaviour since providers' clinical activities are influenced by a wide 
variety of external factors. 
TABLE 3.2. EXAMPLES OF PUBLISHED STUDIES OF HEALTH CARE PROVIDERS USING TPB OR 
THEORY OF REASONED ACTION 
Citation details Method 
Taylor et al, 1994 Expanded 
TRA; Survey 
Millstein, 1996 Longitudinal 
surveys 
Lambert et al, 
1997 
Levin, 1999 
Walker et a[, 2001 
Watson and 
Myers, 2001 
McCarty et al, 
2001 
Topic 
Screening 
mammography 
Offering STD 
prevention advice 
Antibiotics prescribing 
Glove use 
Antibiotic prescribing 
Glove use 
Smoking cessation 
Sample 
85 general internists 
765 doctors 
27 family doctors 
527 nurses and lab 
workers 
126 GPs 
103 nurses 
397 nurses in for 
hospitals 
TRA; survey 
Survey 
Survey 
Survey 
Survey 
Meyer, 2002 Survey Asking for 92 nurse students 
assignments 
In order to utilise the TPB, investigators need to assess the views of a 
sample of respondents using qualitative approaches with the aim of identifying 
salient (or modal) behavioural, normative and control beliefs. Then the salient 
beliefs will be used for development of a theory based questionnaire which is 
then applied to the population under investigation (Conner and Sparks, 1996; 
Montano and Kasprzyk, 2002). Using salient beliefs is based on laboratory 
research on the structure and function of human memory in which only readily 
available elements of memory are used in decision making. The emphasis on 
salient beliefs also stems from earlier works on the relationship between 
attitudes and behaviour, where it is known as the 'specificity hypothesis'. 
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According to this hypothesis, specific attitudes towards the behaviour are more 
likely to predict the behaviour than general attitudes towards it (Raven and 
Rubin, 1983, pp 150-155). The individual is likely to have several beliefs 
towards a given behaviour. Normally only salient beliefs are processed in order 
to make behavioural intention. Using salient beliefs has clear practical 
advantages and is the common approach in TPB studies. Some researchers, 
however, have preferred to use subject-generated beliefs (Agnew, 2000). The 
need for preliminary qualitative interviews and feasibility studies are among 
criticisms of TPB (Rimer, 2002). These can increase the costs of performing 
such research and limit its applications. The other limitation stems from its strict 
restriction to three elements of attitude, subjective norm and perceived control. 
This may result in exclusion of other important psychological variables and limit 
the application of the theory (Rimer, 2002). 
Other cognitive models based on expectancy-value structure have been 
previously applied to prescribing behaviour (Raisch, 1990a; Raisch, 1990b). 
'Drug-choice model'was specifically developed to explain prescribing behaviour 
and maintained that practitioners' prescribing was determined by their belief 
towards the outcome expected from the drug and the value they assigned to it 
(Segal and Helper, 1982). Both TPB and reasoned action have been 
successfully applied to a variety of behaviours including smoking, alcohol 
consumption, food choice, exercise, sexual behaviours, recycling and dieting 
(Ajzen, 1991; Armitage and Conner, 2001; Hardeman et al, 2002). Until fairly 
recently, however, the majority of health related TPB research has been 
conducted to investigate the behaviour of patients or healthy populations, rather 
than health professionals. To date, a small number of studies have examined 
the utility of the TPB in investigating the behaviour of different categories of 
health professionals in a variety of settings (Table 3.2). The theory contributes 
to the understanding of several interventions through its concepts of subjective 
norm and perceived control (Table 2.1 and 3.3). 
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3.2.7. Other relevant theories 
Several other theories are not discussed. One relevant theory is health 
education theory (Green et al, 1980; Moulding et al, 1999). Many aspects of this 
theory are covered in others that this chapter has introduced (Glanz et al, 
2002a). The theory's main message is in its emphasis on the role of active 
involvement of the target population in changing behaviour. The theory supports 
participatory and interactive involvement of physicians in development, 
adaptation and adoption of clinical guidelines (Moulding et al, 1999). Learning 
theories and adult learning theories (Skinner, 1953; Cantillon and Jones, 1999; 
Kaufman, 2003) are also not discussed in detail. Different elements of these 
theories are incorporated in the theories introduced in the chapter, mainly social 
cognitive theory (3.2.5). Anyhow the classical theories of learning still provide 
stimulating messages for behaviour change. Laboratory research suggests that 
first-learned things generalise better over time and place (Bouton, 2000), 
therefore it is easier to introduce a new behaviour by clinical guidelines than 
changing a previously performed behaviour. The theory also suggests that 
lapses towards the old behaviour should be considered as a possibility and to 
be understood (Bouton, 2000). The other groups of theories which are not 
discussed in the chapter are those known as social marketing theories (Kotler 
and Roberto, 1989). The importance of following these techniques for 
guidelines implementation has been highlighted in the literature (Grol, 1997). 
Again many aspects of these approaches are covered in the theories already 
discussed (e. g. the diffusion of innovation). Health belief model (Becker, 1974; 
Rosenstock et al, 1994) is another theory that has been applied to provider 
behaviour (i. e. cancer screening; see Clasen et al, 1994). It is among the most 
popular health psychology theories (Glanz and Maddock, 2000; Glanz et al, 
2002a). However, it shares many characteristics with other social cognition 
theories (e. g. TPB; Davidson, 1998; Quine et al, 2000). More importantly it is 
content specific (see 3.1.3) and application of content specific theories to 
provider behaviour may prove difficult. 
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3.3. Potentials of TPB for the study of GP prescribing 
The selective review of the theories of behaviour change and their applications 
to health care providers demonstrated the intellectual depth that theoretical 
approaches could provide for health services research. Different academic 
disciplines provided opportunities to devise methods for tackling the great deal 
of variation still seen in prescribing and understanding the different reactions 
observed towards clinical guidelines. Using information summarised in this 
chapter, Table 2.1 was expanded to include relevant theories (Table 3.3). This 
attempt, however, did not overcome the main limitation, which was that most 
theories were not tested in empirical research. So the critical mass required for 
the careful application of the theories to provider behaviour was not attained. It 
should be noted that not all theories relevant to each intervention were 
mentioned in the table, for two reasons. First, the theories overlapped 
considerably, for example self-efficacy was part of different psychological 
theories. Hence if the contribution of the theories in understanding of the 
intervention was via this component, then mentioning one theory in the table 
considered sufficient. Second, the table was not meant to be comprehensive, 
but to link theories to interventions. Further detail was included in the text of the 
chapter. Table 3.3 included all the interventions that were identified and 
reported as the result of the overview of systematic review, except two 
interventions for which there were evidence of no effect (i. e. didactic CME and 
substitution model of inter-professional shared care). These were excluded. 
Theories also indirectly contribute to health services research and quality 
improvement and that is by selective use of theories' components in the 
investigations and interventions. Many of these contributions are not fully 
acknowledged and are used only as practically known methods of changing 
behaviour. Despite this, it can be argued that assessing the theories of 
behaviour change in their totality is essential. If the theories are not assessed 
as a whole it is always difficult to relate success or failure of interventions or 
explanatory investigations to the theories. 
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TABLE 3.3. STRATEGIES FOR IMPROVING PRIMARY CARE PRESCRIBING AND THEORIES THAT 
MAY EXPLAIN VARIATION IN THEIR UPTAKE 
Intervention Relevant theories Effect Cost Durability 
Voluntary/ Competence CME (interactive) Adult learning; TPB ++ Medium ? 
Internal oriented 
motivation 
IP education Adult learning ? Medium ? 
Mailed printed Social influence; +/0 Low ? Short 
material TPB 
Mailed national Social influence + Low Medium to 
warnings $ long 
Participatory Social influence; + High Wedium to 
guideline devel. TPB; health long 
education 
IP shared care Health education; +/0 ? High ? 
(cons ult. -liaison) TPB 
Mass media Diffusion of + Low ? Medium 
innovation; TPB; 
social influence 
Performance Audit and TPB; social + Low to ? 
oriented feedback$ influence; stages of medium 
change 
Reminder systems TPB ?+ Low to Short 
medium 
Educational Diffusion of ? ++ Low to Short to long 
outreach innovation; social high 
influence; stages of 
change; TPB 
Voluntary/ Social Peer review Social influence; ? Wediurn ? 
External Influence TPB; Diffusion of to high 
motivation innovation 
Patient mediated Social influence; + Low to ? 
TPB medium 
Local opinion Diffusion of ? Wedium ? 
leaders innovation; to high 
Leadership; TPB 
CQI 1$ Management ? Wediurn ? 
theories to high 
Physical Practice support Management ? ? ? 
support theories; TPB 
Essential drugs 
programmes 
Financial Financial 
Incentives incentives 
Management 
theories 
Economic theories/ 
social influence 
?+ ? 
Low to 
high 
? 
? Short to 
medium 
Non- Reimbursement Economic theories; ? ? 
voluntary and budgetary TPB; social 
policies influence 
Rules, obligations Economic and ? ? ? 
management 
theories; social 
ecology 
Restricted Economic theories; + ? Wediurn to 
formulary social ecology long 
De-registration / Economic theories; ? ? 
reclassification social ecology 
* Adapted from Table 2.1, Grol (1992) and Wensing and Grol (1994). IP: Inter-professional, ++: strong evidence 
suggests positive (intended) effects, +: limited evidence suggests positive (intended) effects, +/0: variable 
effectiveness, ?: no evidence of effect, ? +: no evidence of effect, however less reliable evidence suggests positive 
effects, ? +/-: no evidence of effectt likelihood of positive and negative (intended and unintended) effects, $ it usually 
also has an element of social influence, % it usually incorporates competence oriented approaches, $$ It usually has 
elements of physical support and competence oriented approaches. 
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Theory of planned behaviour provides interesting avenues to explain 
variation in provider behaviour. First, TPB, unlike most other theories presented 
in this chapter, satisfies Kerlinger's strict definition of theory (Table 3.1; see also 
Rimer, 2002). That is to say, the theoretical components of the theory are 
properly codified and the theory suggests methods of assessing the relationship 
between the components. Therefore, it is possible to test TPB in empirical 
research. Second, the theory is a thoughtful elaboration of the behaviours of 
rational actors. Hence, its components contribute to the understanding of 
variation in effectiveness of several interventions to improve prescribing as 
presented in Table 3.3. Third, it has been applied in a few circumstances to 
explain the variation in intention and occasionally the reported behaviour of 
clinicians (Table 3.2). Although the reported applications of the TPB to provider 
behaviour are limited, they demonstrate general support for the theory as a 
potentially useful tool for understanding provider behaviour. Fourth, none of 
previous TPB studies included objective measures of clinician behaviour and 
instead relied on reported behaviour. This limited the reliability and validity of 
the reported goodness-of-fit of the models. It is therefore essential to assess 
TPB using actual behavioural measures before making conclusions. Fifth, the 
theory has never been used before to explain variation in prescribing intentions 
and prescribing outcomes in relation to clinical guidelines. Sixth, there was a 
strong view among some leading health services researchers and health 
psychologists that TPB might provide part of the answer to the understanding of 
provider behaviour. This was particularly encouraging as it was assumed that 
the results of assessing TPB would be of immediate use to the scientific 
community as well as policy-makers. Using all these arguments, it was 
concluded to assess the validity of TPB as a theoretical tool for the 
understanding of GP prescribing in accordance to clinical guidelines. 
Nonetheless, there was no claim that the TPB was the only suitable theory in 
need of being assessed, nor that it was the only theory that might help provider 
behaviour change and quality improvement initiatives. 
The following chapters of the thesis report the findings of the primary 
studies. Chapter 4 reports the findings of the qualitative study of GPs' views on 
implementation of guidelines to improve prescribing. The qualitative study was 
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conducted to achieve two goals: one to gain better understanding of variations 
in implementation of clinical guidelines, and second to identify GPs modal 
beliefs in order to test the TPB. The main results of the formal assessments of 
TPB using methods recommended by its advocates (i. e. questionnaire surveys) 
are reported in Chapter 7. 
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Doctors are men who prescribe 
medicines of which they know little, 
to cure diseases of which they know 
less, in human beings of whom they 
know nothing. 
Voltaire (1694 - 1778) 
Chapter 4. The complexities of changing primary 
care prescribing: a qualitative study 
1. Introduction 
This chapter presents the results of a qualitative study of GPs and primary care 
academics to understand the variations observed in the implementation of 
clinical guidelines' prescribing recommendations. It reports the results of the 
analysis conducted using the framework method. It also gives details of the 
thematic framework developed through the analysis and the insights that the 
study adds to the findings of the previous stage of the project. 
4.1.1. Background 
In the last two decades improving quality of prescribing attracted a lot of 
interests, not least because important fraction of health care resources were 
(and increasingly are) spent on it (Donaldson and Donaldson, 2003). Despite 
the availability of evidence, changes in prescribing are delayed and require 
planning and investments. For example, clear-cut messages for antibiotic 
prescribing are still to be implemented (McEwen et al, 2003) and although there 
are numerous studies on how to improve prescribing, but still all reasons behind 
'nonscientific prescribing' are not known (Kumar et al, 2003). While there was 
evidence that neither demographic and social characteristics (Soumerai and 
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Avorn, 1987) nor organisational culture (Dowswell et al, 2001) predicted 
physician prescribing, few studies tested the theoretical models that 
acknowledged psychological and organisational processes which preceded 
behaviour (Marteau et al, 2002). Focus on GPs' attitudes and personal beliefs 
may provide a better insight of prescribing. The importance of identifying 
underlying personal reasons for nonscientific prescribing is documented in the 
literature. A multi-centre trial studied expressed reasons physicians' 
nonscientific prescribing' and concluded that 'greater attention must be paid to 
physicians'attitudes and motivations concerning suboptimal prescribing if 
programmes are to succeed in replacing these practices with more rational 
clinical decision makincl (Schwartz et al, 1989, p 577). 
4.1.2. What role for qualitative studies? 
Underlying beliefs are better captured through qualitative studies (Comaroff, 
1976). Qualitative studies should play important roles in the assessment of 
health technologies (Black, 1994; Leys, 2003) particularly in general practice 
(Murphy and Mattson, 1992; Jaye, 2002). Interviews could be particularly useful 
in identification of barriers to guideline implementation and in understanding 
how those barriers affect individual physicians (Pathman et al, 1996). Surveys 
then would be very useful in quantifying these qualitative findings in larger scale 
(see Cabana et al, 2001 as an example in asthma care). A few qualitative 
studies have focused on prescribing. A 1996 study of change in prescribing 
found that GPs freely spoke of their prescribing and were ready to offer 
embarrassing observations during the interviews. The study demonstrated that 
interviews were useful tools of studying prescribing in primary care. The study 
identified three models of change in prescribing: accumulation model, challenge 
model and continuity model (Armstrong et al, 1996). Another British study of 
GPs' and consultants' reasons for change in clinical practice found that 
education was important in changing prescribing (Allery et al, 1997). A 
qualitative study of 24 Scottish GPs assessed statins prescribing using semi- 
structured interviews. It concluded that GPs rarely critically appraised trial 
results, but evaluated the results in terms of their social and economic 
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implications (Fairhurst and Huby, 1998). It suggested that compiled sources of 
evidence (e. g. evidence-based guidelines) could play a useful role. It implied 
that GlPs were likely to rely on trustworthiness of the source of the guidelines, 
and that GlPs considered the implications of implementing clinical guidelines. 
Another qualitative study of prescribing, performed on seventeen GlPs, tried to 
identify variables that explained prescribing variance (Carthy et al, 2000) and 
concluded that consultant's prescribing was among those variables. 
Salisbury and colleagues (1998) used qualitative and quantitative 
methods to audit three changes in prescribing (use of warfarin or aspirin for 
atrial fibrillation, angiotensin converting enzyme inhibitors for heart failure and 
substitution of trimethoprim for co-trimoxazole) and concluded there were no 
effects from clinical protocols. They reported positive views of participants 
towards clinical protocols, but found that many did not use them for these key 
changes. They compared practices that used protocols for heart failure 
treatment with those that did not, and found no statistical difference (Salisbury 
et al, 1998). Their conclusion of no effect may not be correct, owing to the 
potential lack of statistical power. Observing conflicting results in terms of 
guidelines implementation, Grol et al performed an observational study to 
identify those attributes of clinical guidelines that influenced implementation 
(Grol et al, 1998). The Dutch study concluded that 'specific attribute of clinical 
practice guidelines determine whether they are used in practidd (ibid, p 86 1). 
There had been further qualitative studies to elicit broad issues such as 
'GPs views on use of guidelines' or 'their attitudes towards evidence-based 
medicine in general' (Langley et al, 1998; Mayer and Piterman, 1999). These 
issues are too broad to be covered in single studies, as the researchers would 
be more likely to get general statements in response. In contrast there had been 
disease (or clinical area) specific studies of guideline impacts on practice. For 
example, a qualitative study of patients suggested that patient willingness to 
take warfarin played a major role in the implementation of atrial fibrillation 
clinical guidelines (Howitt and Armstrong, 1999). Another recent example was 
qualitative study of how to implement hypertension guideline recommendations 
for the elderly patients (Cranney et al, 2001). 
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The overview of systematic reviews (Chapter 2) demonstrated that no 
single intervention or combinations of interventions were successful for clinical 
guidelines implementation across settings or contexts. Therefore it was decided 
to assess the views of GPs about the factors that facilitated or inhibited clinical 
guideline implementation. To ensure capture of important variables of changing 
prescribing in primary care, it was decided to focus on a small set of different 
clinical conditions. This selective approach could provide the opportunity of 
comparing different clinical conditions, clinical guidelines and dissemination 
strategies. The results of qualitative study were also considered important for 
informing the next phase of this PhD project, namely the development of the 
questionnaires to assess the ability of TPB in explaining variation in prescribing. 
4.1.3. Objectives 
The qualitative study was aimed to improve understanding of the findings of the 
previous phase of the project, to be used for the development of appropriate 
research tools for the next phase of the project and to identify key themes for 
the implementation of clinical guideline prescribing recommendations in primary 
care. Specifically the qualitative study objectives were: 
To explore key themes for the implementation of clinical guideline 
prescribing recommendations in primary care 
> To explore GPs' attitudes towards clinical guidelines; and to identify 
salient attitudes and beliefs about prescribing in accordance with 
guidelines to develop TPB survey questionnaires for the next phase of 
the project 
> To explore barriers to and facilitators of implementation, and to explain 
differences in implementation 
To suggest approaches and strategies to improve implementation of 
clinical guideline prescribing recommendations in primary care and to 
improve the understanding of variations observed in the previous phase 
of the project (i. e. the overview of systematic reviews) 
> To identify two appropriate clinical conditions to be used in the next 
phase of the project (i. e. the TPB surveys of GPs) 
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4. Z Methods 
4.2.1. Setting 
The study was conducted in British primary care with emphasis on England. 
Respondents were from two former Primary Care Groups located in North East 
of England as well as individuals from other parts of England, Wales and 
Scotland. 
4.2.2. Participants 
A purposeful sample of 25 participants was interviewed. Twelve participants 
were GPs (one trainee, ten GPs from practices in York and Selby and one GP 
from Scotland). Three were female. The participants worked in partnerships of 
different sizes ranging from two partners (one fulltime and one part-time) to ten 
partners. Another sample of thirteen GPs and academics of primary care from 
other parts of Great Britain were invited to take part in the interviews. These 
interviewees were categorised as academics of primary care. In this group nine 
respondents were practising as GPs as well as their academic appointment, 
one was formerly a GP and three were non-GP academics of primary care. in 
this group two interviewees were from Scotland, two from Wales, one from 
Manchester, one from London and seven from North and East of England. Two 
were female. Amongst the academic group seven held chairs. 
GPs were invited who had interest in or experience of clinical guideline 
implementation, whether or not they agreed with the guidelines. They were 
identified in consultation with a local GP trainer, a University of York health 
services researcher and the interviewees. Academics of primary care were 
invited to ensure a more widespread account of the issue. The criteria for 
choosing this group were extended experience in development, implementation 
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or evaluation of clinical guidelines. The participants were identified in 
consultation with two University of York health services researchers. 
Eighteen GPs were invited of whom twelve were interviewed. Sixteen 
primary care academics were invited of whom thirteen were interviewed. One 
GP declined the interview because his practice was flooded and they were 
involved in sorting out the problem. My vehicle broke down on my way to 
another arranged interview. Attempts for re-arranging it were unsuccessful. 
Another GP agreed to be interviewed and then declined owing to other 
commitments. Others provided no reason for declining. The overall response 
rate was 74%. 
4.2.3. Clinical conditions 
This qualitative study deliberately focused on five clinical conditions for which 
there were evidence-based clinical guidelines and recommendations and 
prescribing was important part of managing the disease. The clinical conditions 
were asthma (in adults and children older than five years), use of statins for 
prevention of coronary heart disease (CHID), epilepsy, menorrhagia and 
depression. The conditions provided a suitable combination of clinical 
guidelines: high awareness with complicated prescribing (asthma), high 
awareness with less complicated prescribing decisions (statins for CHID 
prevention), medium awareness with focus on diagnosis rather than treatment 
(depression) and conditions for which guidelines were not well publicised in 
primary care and GlPs had varying degrees of responsibilities (menorrhagia and 
epilepsy). All those clinical conditions resembled each other in the fact that GPs 
prescribed medicines for their treatment at some stage of the disease. Also for 
all of them there were recognised clinical guidelines with prescribing 
recommendations. 
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4.2.4. Interviews 
The interviews were conducted in late 2000 and early 2001. Twenty-five GPs 
and academics of primary care took part in the interviews, of which, eleven 
were face-to-face (with those living or practising in or around York) and fourteen 
were telephone interviews. Twenty-five in-depth or semi-structured interviews 
(Britten, 1995; Morse and Field, 1996) were conducted lasting 25 to 45 minutes. 
The interviews were planned so that there were minimal chances of disruption 
(Britten, 1995). The three starting interviews were face-to-face and in-depth and 
were conducted with one GP, one GP trainee and one academic with interest in 
guideline implementation and prescribing in primary care. The purpose of these 
exploratory interviews was to provide a better understanding of the context and 
also to provide a suitable set of questions for the semi-structured interviews. 
They were also used to identify five clinical conditions with different 
characteristics to focus on during the semi-structured interviews. 
The author conducted all the interviews following the recommendations 
of Morse and Field (1996) and Ajzen (2002). Therefore the interview questions 
were devised so that they captured salient beliefs of the GPs, which were to be 
used for the development of the TPB survey questionnaires (i. e. next phase of 
the project). The study objectives were stated at the start of each interview. The 
interviewees were consented to tape-record the interviews for the purpose of 
this study with the ethical intention of respecting the confidentiality of the 
interviewees. In semi-structured interviews, about ten open-ended questions 
were asked (Appendix IV). The first two questions were general and asked 
about the respondents' experience of useful and non-useful clinical guidelines. 
The following questions focused on the five clinical conditions (asthma, 
depression, epilepsy, menorrhagia and statins for CHID prevention). The next 
set of questions asked about influential people in clinical guideline 
implementation, and other barriers to and facilitators of implementation. In the 
end, the interviewees were invited to add any extra points or comments. All of 
the interviews were transcribed for the analysis. 
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4.2.5. Thematic framework and qualitative analysis 
For analysis, we followed the 'framework' method (Ritchie and Spencer, 1994; 
Ritchie et al, 2003). This method had two advantages. First, no specialised 
computer software package was required. Here the Microsoft Word software 
package was used, although the job could be done using spreadsheet 
packages as well. Second, the method had been specifically developed for the 
analysis of qualitative data for policy-oriented projects. Health services 
researchers had used the method successfully (e. g. Griffiths et al, 2001). 
Ritchie and Spencer (1994) explained that 'qualitative data analysis is 
essentially about detection, and the tasks of defining, categorising, theorising, 
explaining, exploring and mapping are fundamental to the analyst's role' (p 
176). The framework was found a very useful method to fulfil these tasks. 
The framework has five broad steps. The method consists of 
'familiarisation', 'identifying a thematic framework', 'indexing', 'charting' and 
'mapping and interpretation'. The steps were followed very closely. Ritchie and 
Spencer (1994) recommended that the analysis should start with data 
familiarisation, especially where not all interviews were performed by the person 
responsible for the analysis. This was not a concern in this study, because all 
the interviews as well as transcribing were conducted by one person. 
Nonetheless all the interview tapes were listened to again, and a contact and 
content summary form was developed and filled out for each interview during 
the process (Miles and Huberman, 1994, p 54). The initial thematic framework 
was developed based on the interviews, prior thoughts and literature review 
(Chapters 2 and 3). Theoretical knowledge, mainly the TPB (Ajzen, 1991), was 
exploited for the development of the thematic framework (deductive approach; 
see Pope et al, 2000). Deliberate attempts were made to include identifiable 
variables that corresponded to the main elements of TPB (i. e. attitude towards 
the behaviour, subjective norm and perceived behavioural control) in the 
framework. A preliminary framework was developed and then discussed in a 
series of iterative meetings between the researcher and his advisor. Then the 
thematic framework was checked against the interviews through repeating the 
familiarisation process. The themes were updated in the process of the analysis 
(Pope et al, 2000). The initial framework contained nine themes which were 
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reduced to seven as the analysis developed. The process of refining the themes 
followed a non-strict adoption of grounded theory (Barbour, 2001). Where 
theoretical reasoning and literature were not supported by data, superiority was 
given to the data (inductive approach; see Pope et al, 2000). 
The transcribed text was 'indexed' using the codes relating to the themes 
and sub-themes of the thematic framework. Sections of data were indexed with 
one or more codes (cross indexing) wherever appropriate (Pope et al, 2000). 
For each 'theme' one table was produced in Microsoft Word. Each table row 
was assigned to one interviewee identified with appropriate code. Table 
columns were assigned to the sub-themes. The tables were then attached 
together to produce the analysis 'chart'. The final chart was a large table of 
many cells, in which each cell corresponded to the views expressed by one 
interview coded for one sub-theme. The data extracts were then 'cut and 
pasted' from the indexed transcribed texts to appropriate cells on the chart. The 
chart was then printed on A3-sized papers for the analysis. Therefore it was 
possible to compare the views expressed by one interviewee across different 
themes and sub-themes (by looking across the rows), and to compare the views 
of different interviewees for each theme (by looking across the columns). The 
main transcription files were consulted in the course of the analysis and further 
extracts were added to the chart whenever it was necessary. The chart was 
used to interpret the data by comparing the data extracts for individuals and 
sub-themes. The relationships between the sub-themes and themes were also 
investigated. 
When quoting from the interviews, each interviewee was represented 
with a code. GPs' codes started with the letter'P' and academics of general 
practice codes started with the letter'A'. In this report, curly brackets at the end 
of italic statements refer to the interviewee codes. 
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4.2.6. Ethical considerations 
The study was conducted with careful consideration of ethical issues. The 
participants agreed to take part in the study after receiving letters or emails that 
contained information about the purpose and methods of the study. The time, 
venue and method of the interviews (face-to-face or telephone) were mutually 
agreed upon. The purpose of the interviews and the study objectives were 
reiterated at the beginning of each interview. All the participants consented to 
their interviews to be tape recorded and used for the purpose this study. Tape 
recordings were appropriately coded and stored securely. Transcribed 
information were coded and stored securely. The participants were assured that 
the research reports would not contain any specific details which would allow 
the identification of specific individuals or practices. Local Research Ethics 
Committee approvals were not sought as at the time of data collection 
interviewing health professionals did not require ethics approval. No honorarium 
was offered to the participants. 
ill 
4.3. Findings 
4.3.1. Description of the issues discussed in the interviews 
Clinical guideline influence on GP prescribing was the focus of the interviews. 
However, other behaviours such as diagnosis and (cancer) screening were also 
discussed, although the interviewees were not asked about those. The first 
question asked the interviewees to name any clinical guideline that they 
recalled as useful in improving prescribing. In response, there was a 
widespread recognition that the British Thoracic Society (BTS) asthma 
guidelines were useful (British Thoracic Society, 1993b; British Thoracic Society 
and National Asthma Campaign, 1997a; British Thoracic Society and National 
Asthma Campaign, 1997b). This was followed by guidelines for primary and 
secondary prevention of coronary heart disease. The interviewees referred to 
Sheffield (Hag et al, 1995; Ramsay et al, 1996) or New Zealand (Jackson, 
2000) risk tables, or to the Joint British Recommendations (British Cardiac 
Society et al, 1998; British Cardiac Society et al, 2000). As mentioned in 4.2.3 
asthma, primary and secondary prevention of coronary heart disease, 
depression, epilepsy and menorrhagia were directly covered by the interview 
questions. During the interviews other clinical conditions such as COPD, 
osteoporosis, UTI, influenza, drug addiction, gastroenteritis and diabetes were 
also discussed although there were no specific questions about those diseases. 
4.3.2. Themes, sub-themes and items 
As a result of the analysis seven themes and thirty sub-themes were identified. 
It was aimed to limit the number of themes and sub-themes to prevent 
confusion and increase the coherence of the analysis. The themes and sub- 
themes were important issues for the implementation of clinical guidelines to 
change GPs' prescribing. Seventy-seven items were categorised within the sub- 
themes (Table 4.1). 
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TABLE 4.1. THEMATIC FRAMEWORK FOR QUALITATIVE ANALYSIS OF THE INTERVIEWS: THEMES, 
SUB-THEMES AND ITEMS 
Theme 1: Credibility of content of clinical guideline 
1.1 Evidence 
Evidence-based clinical guideline 
Strong evidence is not available 
1.2. Change 
Reflecting Us normal practice 
Clinical guideline for areas that are changing 
1.3. Flexibility 
Each patient is unique 
Clinical guideline allows flexibility 
Non evidence-based clinical guidelines 
Change in clinical guideline message 
Many patients have more than one problem 
Clinical guideline is inflexible 
Having negative effect on patient-doctor Having positive effect on patient-doctor relationship 
relationship 
Theme 11. Credibility of source of clinical guideline 
11.1. Reputable bodies 
Clinical guideline is from a reputable body 
11.2. Secondary care as reputable body 
Guideline produced by secondary care 
Secondary care do not understand GPs 
11.3. National bodies as credible sources 
NICE and SIGN are influential 
NSFs 
11.4. Pharmaceutical companies 
Drug companies and their representatives 
11.5. Publishing guidelines 
GPs' ideas haven't been represented in it 
It's far from general practice realities 
NICE guidelines are not helpful 
Publishing in respected sources Inclusion in the BNF 
Theme Ill. Presentation of clinical guidelines 
111.1. Simplicity 
Complicated message Simplicity of clinical guideline 
111.2. Systematic presentation 
Stepped approach 
Theme IV. Influential people in implementation 
IVA. Patients 
Patients as facilitators 
Patient compliance (or preference) 
IV. 2. Consultants 
Consultants are positively influential 
Consultants are negatively influential 
IV. 3. GP colleagues 
GP colleagues within practice 
GP colleagues are neutral or negatively influential 
IVA Practice nurses and primary care team 
Practice nurses 
Patients as barriers 
Consultants are neutral 
GP colleagues outside practice 
Primary care team as a whole 
Nurses follow clinical guidelines (implementation Professional boundaries between doctors and 
rely on nurses) nurses (nurse led clinics) 
IV. S. PCOs, pharmacists and prescribing advisers 
PCGs are influential PCGs are neutral 
Pharmacists, prescribing advisers 
IVA Drug companies and reps 
Drug companies and their representatives 
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TABLE 4.1. THEMATIC FRAMEWORK FOR OUALITATIVE ANALYSIS OF THE INTERVIEWS: THEMES, 
SUB-THEMES AND ITEMS 
Theme V: Organisational factors 
V. 1. Practice characteristics 
Dispensing or training status Having clinics 
V. 2. Information technology 
Computerised system (clinical guideline included) Computerised practice 
V. 3. Availability of required resources 
Necessary hardware unavailable to GPs 
VA Time, workload and Information overload 
Lack of time; increased workload 
Having a single national guideline for problem 
V. 5. Cost and expenditure 
Clinical guideline justifies extra costs and prevents 
unreasonable costs 
Information overload 
Increased costs and expenditure 
Theme VI. Disease characteristics 
VII. 1. Treatment is secondary care based 
Treatment is mostly secondary care based 
VI. 2. Difficulty of diagnosis 
Diagnosis is the major problem not treatment 
VI. 3. Rare or 'simple' disease 
Being familiar with clinical guideline message but Non-remembering the clinical guideline 
not the guideline itself 
Theme VII. Dissemination strategy 
V11.1. Planning Implementation 
Receiving clinical guideline through the post is not 
useful 
Implementation programme 
VII. 2. Can Implementation be successful? 
Difficult to relate the achievements to guidelines 
Lack or weakness of implementation programme 
Clinical guideline Is rubbish or useless or not helpful 
Misunderstanding clinical guideline message Clinical guideline changed my practice 
V11.3. When do GPs welcome new guidelines? Perceived need, past experience, and 
knowledge 
Positive experience with clinical guideline Having a perceived need to a clinical guideline 
Clinical guideline increases the knowledge base Perceived as non-useful in first contact 
VII. 4. Ownership - local versus national guideline 
Practice- based (or focally adapted) guideline Being on the guideline development team 
VII. S. Enforced implementation; medico-legal Issues 
Medico-legal issues Audit and clinical governance 
Enforcing clinical guidelines by quality markers and Dissemination perceived insulting or imposing 
indicators 
VII. 6. Supporting implementation and Implementation cost 
Financial incentives and resources No financial Incentive 
_ 
Repeating clini2al guideline message Cost-containing motives for dissemination 
The first three themes referred to the important characteristics of clinical 
guidelines that influenced the implementation of prescribing recommendations. 
The themes were 'credibility of content', 'credibility of source' and 'presentation' 
(Table 4.1). 
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4.3.3. Theme 1: Credibility of content of clinical guideline 
Three characteristics of clinical guidelines were identified that together helped 
G Ps to form their judgement about the credibility of the content of prescribing 
recommendations. Those were: evidence that guideline was based on; 
relationship of guideline to change in practice and change in guideline itself; and 
flexibility of the message and its applicability to a wide range of primary care 
patients. 
I. I. Evidence 
The interviewees strongly insisted on the importance of inclusion of evidence- 
based recommendations in clinical guidelines. In their view, being 'evidence- 
based' was a major characteristic of any acceptable guideline. "You got to have 
trust and faith in the fact that [clinical guidelines] have been correctly 
researched' (P2). One interviewee, referring to the current BTS asthma 
guidelines, said: "they are actually based on evidence of effectiveness from 
things like the Cochrane database and randomised controlled trials. ... they've 
actually gone through the right rigorous process of guideline formulation. So 
that's why I'm happyjust to use them as a blueprinf' (A 11). He also added that 
weak evidence-base resulted in non-adherence to guidelines: "where the 
evidence isn't excellent, it's obviously more difficult to use a guidefine" (Al 1). 
Another interviewee insisted that "I'm not saying I use [CHD prevention 
guideline] as necessarily as they've laid out, because hypercholesterolaemia is 
an area that I think has been poorly researched and we are at the moment 
working on a baseline that has never been established' (P1 0). 
However, not all interviewees defined the best evidence as it was defined 
in classic evidence-based medicine (Sackett et al, 1996). Some types of 
evidence did not seem so reliable to GlPs. In their view, 'evidence' should come 
from trials of primary care patients, including almost all primary care patients, 
with comprehensive characteristics, such as the presence of co-morbidity, older 
patients and different presentations of a disease. One interviewee explained 
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that guidelines had to be "based on good evidence, ... a number of trials, some 
sort of meta-analysis. The other good evidence would be pragmatic trial based 
in primary care. But unfortunately a lot of them aren't. So a lot of people I'm 
dealing with would have been excluded from the explanatory trials. Which 
means that I haven't got any good evidence to support my decision makincf 
(M). They admitted that this sort of evidence was not always available and 
added perhaps that was why the guidelines were not so useful to them. 
"Nobody really devised it up so that you can see the mild and moderate forms of 
depression that we diagnose J. n primary care so often, [to say] which 
[antidepressants] are best for those different conditionsý' (Al 1). "... who's to say 
what percentage of patients should be on beta, -blocker after MI? Because 
nobody trials our patients" (M). In this context, if the G Ps perceived 'evidence' 
as irrelevant or unconvincing, they concluded there was no evidence available. 
Apparently some GPs adopted a passive approach to acquisition of 
knowledge derived from emerging evidence. 'They (GPs) should'become 
aware'of the evidence behind recommendations. In this approach, the 
responsibility of distributing evidence and convincing GPs fell upon 
disseminators, researchers and policy-makers and not the practitioners. "A 
couple of years ago GPs were apparently under scrutiny because they were 
referring too many people for PSA [Prostate Specific Antigen], where now the 
hospital expects to see, well ... yes, do PSAs on everybody. I'm not aware of 
treatment having changed and I'm not aware of the evidence of how to treat CA 
prostate having changed' (P5). This statement could be read in two ways: it 
might mean that 'I am aware that there is no evidence to support the change in 
practice'. On the other hand, it might imply that 'because I am not aware of any 
change in evidence, therefore there has been no change'. 
Regardless of all the emphasis on evidence as a major characteristic of 
an implementable guideline, there were important exceptions. Few referred to 
the BTS asthma guidelines as evidence-based and most considered the BTS 
guidelines as not necessarily based on evidence, at least in their early versions. 
However, the interviewees believed that the BTS asthma guidelines were 
largely adopted in general practice. They mentioned other (poorly defined) 
element as the underlying reason for this success, practicality "the fact that 
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some of [BTS] wasn't evidence-based didnt seem to make a lot of difference. It 
was a practical set of guidelinesý' (Al 3). It seemed that a practical guideline 
could apparently overcome its shortcomings in evidence. Although in the 
literature being 'evidence-based'was defined as the major characteristic of 
clinical guidelines, to practitioner evidence was only one element among others. 
On the other hand supposedly evidence-based asthma guidelines (North of 
England Asthma Guideline Development Group, 1996; Centre for Health 
Services Research, 1996; North of England Evidence Based Guideline 
Development Project, 2001) might have failed to appeal to GPs. "I think if you 
send me a copy of North of England guidelines for GPs, I will be very surprised 
if I read them, I will be very surprised if I refer to them, because I think I'm pretty 
good in asthma care, but it could be possible then to start a sort of cycle or build 
a system around me ... and support me to use the guidelines ... " (A 10). 
For a variety of reasons, GlPs perceived many guidelines as unhelpful or 
useless. Most importantly it was due to the perceived lack of evidence behind a 
guideline. "Am I thinking the guidelines are rubbish? And I do. Quite a lot of 
guidelines that come ... and I do quick reading, I say I 
don't accept that. ... if I 
don't see strong evidence linked' (P5). Failure of clinical guidelines was not due 
to GPs but the guidelines themselves. "There is a common view that the failure 
of guidelines is simply due to a resistance or the stupidity on the part of general 
practitioners, which I think it is very unreasonable. It's mostly because the 
guideline is simply not adequately implementabld' (A4). Evidence-based 
guidelines also could lack 'implementability' and therefore be unhelpful. "Some 
of the North of England guidelines, for example the asthma guideline, again we 
had to turn it to a [name of area] one, because it was unusable. ... it was much 
too difficult to folloW (A5). 
1.2. Change 
Change in guideline recommendations without proper justification worried the 
GPs and evoked scepticism. "I suppose one does become sceptical with some 
of the guidelines, particularly with the asthma one, which has been changed in 
quite large areas. And you then begin to wonder, how long before it changes 
again and for what reasonT He added ". -- And the blood levels [cholesterol] 
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that we are talking about have been reduced and then been reduced again. And 
it worries me. These are probably knee jerk responses rather than anything 
else. ... i don't think we prescribe as many sta tins as other practices do" 
(P 10). 
Change whether because of new evidence or because of improvement in the 
guideline might negatively influence implementation. One example was the 
prevention of CHID: " That [statins] shows another problem. You know everybody 
with ischaemic heart disease must have cholesterol under five, which is 
incredibly tight. And veiy much moving goalpost and God knows how low can it 
get again" (P5). 
Noticeable changes in guideline recommendations negatively affected 
patient-doctor relationship. Patients became sceptical of the quality of care that 
they had received. One interviewee (P5) explained "(change) would be very 
difficult for the patient. What's different today? You need quite a lot of time in 
explaining. I suppose that's why you go down to special clinics; you've got more 
time to explain. " GPs needed more time to educate patients. I think the patients 
would need a lot of education ... we are talking about cholesterols that two or 
three years ago considered normal being abnormal. Changing your advice to 
people. ... Not only changing your advice, but putting them on drugs, drugs that 
could upset the liver. So I think to some extent some of the patients found it 
puzzling and threatening, possibly' (P6). GP 'time' was potentially an important 
factor here. Time is discussed further under organisational factors (4.3.7). 
Despite these G Ps welcomed guidelines because of 'changes' in the 
management of patients. "There tend to be areas where there's change going 
on. People feel they need update on them. Helicobacter would be a classic for 
that. People weren't exactly sure what to do with it. ... Some secondaty care 
advice didn't seem appropriate ... And so they [clinical guidelines] had an 
impact" (A5) 
If the guidelines had reflected the current state of practice and suggested 
minor improvements, they would have found their way much easier into 
practice. "It's the BTS ones. ... Because it's the only one that I know of. ... To 
be honest, that's the way we've treated the asthma for years, anyway. / don't 
think there is anything in it that is any different from how we managed asthma 
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for the last fifteen years. So I suppose that didn't make any changee' (P8). 
Guidelines also helped practitioners to be confident of the care they offered. 
found them useful, because they confirmed what / was doing was the right 
thingf (P10). On the other hand if a guideline had tried to reverse the tide, it 
would have faced more resistance. Clinical guidelines "hopefully ... work with 
the current influence in practice rather than against them. " The interviewees 
gave examples of the guidelines that tried to discourage prescribing of selective 
serotonin reuptake inhibitors (SSRI) or proton-pump inhibitors (PPI), as 
example of guidelines that tried to reverse the tide and failed. 
Ironically, guidelines also failed to be accepted in practice because of the 
opposite characteristic: reflecting normal practice. Many clinical guidelines 
repeated the established facts that GPs already knew. "But / must admit that I 
do find some of the guidelines that are merely repeating something that been 
very well established. ... / do find some of them a little bit, 
just repetitive" (P 10). 
1.3. Flexibility 
Some interviewees argued that clinical guidelines worked over masses of 
people and were not designed for individual patients. Therefore it was 
unreasonable to follow them rigidly. 'You can't be too strict to the guideline. 
Guidelines correlate over masses of people. That is supposed to be beneficial 
for the biggest percentage, but it doesn't necessarily help an individuat (P7). 
"Some of the most confusing guidelines are related to diabetes ... They are 
attempting to say what might be good for thousands of peopld' (M). Research 
evidence was considered as irrelevant in the same way. "It could be quite 
difficult in applying them to individual patients. So whilst they may have validity 
in population level it's often difficult see how that individual patient sitting in my 
consulting room fits in. ... The 4S study had a major effect on us but even then 
we weren't quite sure how it fitted into individual paffen&' (P5). 
The other argument was that patients' needs were different from those 
expressed in the guidelines. Guidelines tended to answer straightforward 
questions. "It came with no surprise. We do not need a guideline to tell us that if 
you have more than one or two risk factors and you have raised cholesterol that 
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you should consider the use of statins. But that does not help you if you have a 
45 year old man in front of you but no risk factors, except that he has a raised 
cholesterol, the guidelines say nothing about hini' (A4). Many patients had co- 
morbidities, making it more difficult to apply guidelines. One interviewee (1311) 
explained "many elderly patients, who the guidelines are particularly for, have 
more than one problem. Pying to deal with the problems that they want to deal 
with and working through my agenda of trying to implement the guidelines is 
difficult and usually the priority in the consultation is the patient's agenda and 
not mind'. While clinical guidelines expected GPs to think in a certain way, 
patients' expectations were different. "If we try too hard with that patient, we will 
end up using probably 20 tablets a day. And in that patient the top priority might 
be the fact that he or she has osteoarthritis which is to have a pain killer. While 
our priority is completely different based on what's we think is good medicine, 
as based on guidefinee'(A4). 
Others argued that doctors were trained to answer patient's needs, not to 
follow strict rules. Doctors needed to be flexible towards patients' requests. "But 
the guidelines can't cope with variation. Black or white. ... They can set a 
measure for cholesterol level, for example 5. That's OK, thanks. For something 
like epilepsy., do you have epilepsy or do not have epilepsy. That's OK [but they 
can't cope with variation in treatments. ]... Anything that we use [a guideline for 
it] has to be easy and straight to follow. ... We are trained to 
look and assess 
people and individual problems for that person and not trained to follow that 
robust? And make the person fif (134). The guidelines were most useful where 
the clinical problem had not much variation. In real life practice many clinical 
conditions were complicated. Unless the guidelines were 'flexible' they would 
not help management of complicated conditions. "/ think if a guideline is very 
rigid, it prevents that sort of flexibility that GPs like ... to be able to work with 
patient rather than just impose on them"(A3). Some guidelines achieved this 
level of flexibility. One interviewee gave an example of a guideline produced by 
GlPs for the treatment of helicobacter pylori: '... and then later GPs'ones came 
along and they are much more pragmatic and sensible for use in primary care. 
And so they had an impact Thinking about that, it's moving from a very strict 
set of guidelines to a looser more general practice friendly one. That's attractive 
for GPsý' (M). "[1U there are a number of different options for you to use in 
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different scenarios [and] it is not completely rigid [then it is useful]' (P9). Despite 
this, one study reported that prescriptive recommendations (such as the NSF 
for coronary heart disease) were more likely to be followed and were preferred 
by GPs over loose recommendations (such as the NSF for mental health) 
(Sheaff et al, 2003). 
4.3.4. Theme 11: Credibility of source of clinical guidelines 
Under this theme the views of the interviewees towards potential sources of 
clinical guidelines for primary care were discussed (other than GPs 
themselves). This section assessed the credibility of different professional 
groups, public and private bodies for development of primary care clinical 
guidelines. 
11.1. Reputable bodies 
The source of guidelines was perceived important. "You got to have trust and 
faith in the fact that [clinical guidelines] ... are from reputable body' (P2). It was 
referred to as one of the reasons for the BTS asthma guidelines' perceived 
success. Because "the British Thoracic Society seeing as authoritative without 
being overly aggressive" (M) and "because the BTS is a reputable 
organisation" (139). The characteristics of 'reputable bodies' identified in the 
interviews could be summarised as widely known, authoritative and often 
national, and those bodies that GPs expected to receive advice or support from 
them. Guidelines from reputable bodies were more likely to be implemented, 
especially when they possessed other characteristics of guideline with credible 
source (see below). 
11.2. Secondary care as reputable body 
Many GPs did not seem to consider hospital clinicians (especially local 
consultants) as reputable sources for clinical guidelines. They considered high 
representation of consultants in guideline committees as a factor that might 
121 
undermine validity. "The [NICE's] ischaernic heart one had two or three GPs [in 
guideline development team] out of 60 or 70 people, which / find deeply 
depressingf(P5). On the other hand, referring to the examples of successful 
guidelines, neither the BTS asthma, nor the Joint British Recommendations 
were originated from primary care. Some interviewees acknowledged this. 
Other interviewees had a long list of reasons to justify why they did not consider 
secondary care as a credible source for useful primary care guidelines: 
Patient-doctor relationship 
Consultants were thought as unaware of the kind of communication that GPs 
maintained with their patients. "A bad example, we were handed a guideline this 
morning by our midwife, who has some trouble connecting with the practice, 
saying 'oh here are the guidelines for HIV screening forpregnant women' ... 
These are not guidelines with any use to us at all. These are guidelines with two 
or three consultants who say what's happening. They haven't got the first clue 
about our communication with our patients. So they are probably not even be 
looked af' (P3). GPs were more related to their patients than consultants, and 
had a less formal relationship with patients. As in this example of HIV 
screening, it might be reasonable for a consultant to produce a guideline 
advising GPs to ask sensitive questions, but it would be more difficult for GPs to 
ask those of pregnant patients. 
Case-mix and working conditions 
GPs had worked in hospitals, while consultants had not been in general 
practice. "Sometimes the hospital clinicians don't properly understand the way 
we work and the guideline that is simple to them theoretically could be very 
difficult in the community... The fact is that all the GPs have worked in the 
hospital themselves, but the opposite isn't true" (P6). It was perceived that 
consultants did not have a clear view of primary care. "/ remember the one a 
couple of years ago about gastroesophaegeal reflux disease. And it was very 
secondary care based. ... when you start reading a guideline like that, its 
advice's based on what's happening in secondary care, you can quickly get 
bored of if' (P1 2). "Guidelines are less likely to be effective if they come from 
the bodies that don't reflect the situation where the GPs working. So specialists' 
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guidelines are sometime ihapprppfiatd'(A2). Also case-mix was different in 
primary care. "I would say that guidelines produced by secondary care 
specialists without input from primary care or public health tend to be pretty 
useless, because secondary care tends not to appreciate the case-mix that GPs 
have to deal with"(M). Consultants saw 'filtered' patients. "The bit that they 
miss out which is the major problem, try to take on board what is actually like in 
primary care, we see unfiltered patients with their own idiosyncratic health 
belfe&' (P5). 
One way route of communication and mutual respect 
Some interviewees thought that there was a one-way route of communication 
between secondary care and general practice. "A lot of hospital departments 
send regular newsletters out and in that they often contain clinical advice. I 
found those quite difficult. ... Each department feels because that they have 
sent a newsletter out we have produced a dialogue, ... / think they are the 
saddest ones that consultant colleagues try hard to communicate and say how 
they see the world... Everybody needs guidelines ... we need to start to 
respect each others'skills and perspectives more ... This apparently comes to 
good practice and if you don't adhere to them then by definition your practice is 
poor" (P5). This feeling could also result because of 'professional boundaries'. 
GlPs did not produce guidelines for consultants, while they received guidelines 
from them. GPs also felt that while consultants tried to improve GP behaviour 
via guidelines, they themselves were in need of improving their behaviour. "I 
think they are even worse in following clinical guidefineg' (P9). 
Workload 
Some secondary care guidelines were perceived as being produced to reduce 
workload in secondary care by transferring it to general practice. 
One stop shops 
One interviewee mentioned that hospital consultants had a ladder system for 
diagnosis. "The consultants basically create a false situation in that they mostly 
work by Irying this and this and if it doesn't work doin something else'- so they 90 
tend to have a ladder system for use of guideline. ... GPs do not work that way. 
123 
... GPs are more like a one-stop shop. ... In fact keep out the consultants. Don't 
let them chair the meetings, only use them as resource" (M). The interviewee 
fell short of saying what GPs did when their patients came back for further 
advice for the same condition. 'Keep out the consultants' was amongst the 
extreme views and was not shared by everyone. 
Restricted pharmacy 
"They have a restricted pharmacy. They can't prescribe everything. And what 
they can prescribe is often dictated by cost. And we know that the hospitals are 
able to negotiate very favourable prices for drugs, which is not available in the 
community when we start prescribing if' (P8). Therefore, a drug which had a 
favourable price for hospital prescribing could evoke unnecessary costs in 
general practice. This situation, however, has now more or less changed. With 
the increasing power of PCTs and also the tendency of hospital Trust and PCTs 
to issue joint formularies, GPs and consultants tend to have similar choices. 
11.3. National bodies as credible sources 
At the time that the qualitative study started NICE was a young organisation and 
had not yet published any 'guidelines', but 'guidance'. The interviewees referred 
to those NICE publications as clinical guidelines. No direct questions were 
asked about NICE or other national bodies in the interviews, but the 
interviewees referred to them frequently. 
National bodies, including NICE and also Scottish Intercollegiate 
Guidelines Network (SIGN) were perceived as credible sources. There were 
some positive comments on the quality of SIGN guidelines. "There are Scottish 
guidelines called SIGN. Because they are on the web, while I don't use them, I 
refer to them quite a lot. And they extremely good and I think they are probably 
an under-used resource in England'(A3). NICE was perceived as a national 
authoritative body, which could ease the problem of multiple sources of 
information. "We get an awful lot of information and it's difficult to pull out what's 
the most important piece. That's why actually the NICE guidelines are in a 
better way of doing it. Because they come from a central recognised [body], 
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whether it's approved by everybody, but it's recognised by everybody, and they 
come in the same format with the blue cover and it's thin ... " (P8). 
There was a sense that some National Service Frameworks (NSFs) and 
NICE guidance had been imposed on general practice without proper 
justification. They saw them as influential sources of change in prescribing. "I 
suspect we will be driven more and more by guidelines that come out of NICE, 
because there is no option but to listen to those whatever you think of them" 
(P5). Interviewees were also unsure about the way the NICE guidance had 
been produced or how the topics were being chosen. They were particularly 
negative towards NICE guidance for Relenza prescribing. "And it's just really 
unrealistic of people at NICE expecting people follow that sort of guidelines 
[Relenza guidancef'(M). One academic GP had a positive view on Relenza 
guidance, as "something that GPs can stick td' (A2). 
11.4. Pharmaceutical companies 
Pharmaceutical industry was not perceived credible for producing clinical 
guidelines. "Examples of useless guidelines are often driven by pharmaceutical 
companies" (P5). Even the industry's contribution to guidelines developed by 
others resulted in scepticism and could jeopardise the credibility of source. 
Some interviewees thought that possible contribution of pharmaceutical 
companies to the production of BTS asthma guidelines damaged their 
credibility. "They are largely funded by Glaxco and there are issues about, you 
know, their emphasis about drug treatment. But that's the world that we live in 
and that's where the trial evidence largely exis&' (Al 2). Drug companies 
produced lots of different guidelines, which were generally perceived as 
unhelpful. This 'mass production' could be a'noise'factor in guideline 
implementation, as they might distract GPs attention from useful and evidence- 
based guidelines. 
11.5. Publishing guidelines 
The most prominent of all respected sources was the British National Formulary 
(BNF). GPs tended to consult the BNF frequently in their practices. They found 
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it helpful that asthma and CHD prevention guidelines were included in the BNF. 
" The fact that [risk tables] are now being printed in the BNF, they are always on 
my desK' (P1 1). "[BTS guidelines] are actually incorporated into the BNF, which 
/ find very useful. ... I think the ones that are sort of really ratified then they 
should all go into the BNP' (A 11) - 
Generally speaking, publication of clinical guidelines in respected 
journals was considered as a source of credibility. Among those respected 
sources, the BMJ was eminent, probably because it was more widely read. "A 
shorter version of [BTS published] by the BMJ ... [we followed it] because it 
comes with the weight of an organisation like the BMJ behind it. And / think the 
BMJ tends to have a good reputation in a sense that it tends to be fairly peer 
reviewed' (A9). There were also references to the Drugs and Therapeutic 
Bulletin, the Lancet and Thorax. "We discussed benzodiazepines in the late 80s 
when the Lancet article came out saying that they are dangerous if [prescribed 
for] more than 10 to 15 daysý' (P3). But when it came to other journals it was 
less clear. Publication in respected sources was not adequate for 
implementation. 'TNorth of England guidelines] were published in the BMJ, [GP] 
sees its article and takes it to his or her practice. And decides after discussion 
with the partners they were going to do something within the practice. [It is not 
enoughj'(P2). 
Although 'Clinical Evidence'(BMJ Publishing Group) was a new 
publication at the time of the interviews, there were positive references to it: 
"Another book that / think is wonderful is the recent BMA publication about 
clinical evidence"(Al 1). Clinical Evidence could be a useful source whenever 
single and short evidence-based message was required. 
4.3.5. Theme III: Presentation of clinical guidelines 
111.1. Simplicity 
"The message has to be simple. If it is overly complicated, people tend to ignore 
if' (M). There was general agreement that all guidelines should be simple to 
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follow. "The guidelines are quite difficult to use. You never find them when you 
want, and when you do find them they are often badly designed and you can't 
actually fit a particular recommendation to a particular patient" (Al 2). Strong 
and simple messages were more likely to be considered. One interviewee 
explained: " ... I'm sorry if you show me a complicated piece of paper it's no use 
to me. I'm a simple man and I need to have simple ideasý'(P5). It might seem a 
bit odd for an outsider to see GPs insisted on the need for simplicity of clinical 
guideline recommendations. The need for simplicity might reveal the complexity 
of the environment in which GPs practiced. Complexity of the message might 
also hinder understanding and hence make the message less persuasive 
(Raven and Rubin, 1983, ppl85-187). GPsemphasis on simplicity might also 
reflect short consultation time, which is often less than ton minutes (Carr-Hill et 
al, 1998). Simplicity of presentation was among the features of NICE 
publications that G Ps welcomed. "[NICE guidance's] come in the same format 
with the blue cover and it's thin. There is an executive summary at the 
beginning and there is evidence for the reasoning. I've been quite impressed by 
the way we all get them and they are available by emails as well' (P8). 
Simplicity was not a simple concept. There was not complete agreement 
on examples. Guidelines seen as simple by some interviewees were considered 
as difficult by others. Many interviewees considered the BTS asthma as simple, 
but two interviewees (P5 and A4) thought otherwise. "[They] are actually quite 
complicated and difficult to follow, and there are couples of drugs in there where 
their position is not really very clear... " (P5). , 
111.2. Systematic presentation 
Asthma treatment recommendations were in stepped approach in the BTS 
guidelines. This systematic presentation was supported by the interviewees. 
The interviewees expressed that the stepped approach helped 'logical thinking'. 
"It does have some influence... where I am and what stage I am. It makes it 
more logical in the process of treating the patien&' (P 10). Guidelines for CHD 
prevention were also thought to have organised presentation: "I think that 
guidelines are good ways of codifying, making explicit evidence around the 
effectiveness of statine' (A 12). 
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The innovative stepped approach in the BTS asthma guidelines was a 
successful strategy to overcome the complexity of asthma classification and 
treatment. Stepped approach could be compared with splitting asthma to a few 
sub-categories within which patients were located in various stages of the 
disease. So instead of having a complicated clinical scenario with a variety of 
treatment options (difficult), there were a few sub-diagnoses with small number 
of alternative treatments for each (simple). Once it was decided where to put 
the patient, choice of treatment was not difficult. This was mentioned as the 
main reason why the BTS asthma guidelines were perceived simple: "The 
structure of them makes them clinically easy to use" (Al 1). There were no 
known studies assessing the effects of 'stepped presentation' of the BTS 
asthma guidelines on their implementation. However, experimental research in 
nursing demonstrated that the way patient information was presented to the 
nurses influenced their behaviour and quality of care they offered to the patients 
(Dowding, 2001). 
4.3.6. Theme IV: Influential people in implementation 
According to the data, different groups of people influenced GPs' intentions and 
plans to follow specific guidelines and their decisions to prescribe medicines. 
These reference groups had positive or negative influences in different 
circumstances. Six main reference groups were identified and discussed under 
this theme: 'patients', 'consultants', 'GP colleagues', 'nurses and other members 
of primary care team', 'primary care organisations, pharmacists and prescribing 
advisers' and 'pharmaceutical companies and their representatives'. 
IVA. Patients 
Patients who did not comply with treatments were perceived as barriers to 
implementation. Different factors were involved, but patients' difficulties in 
understanding clinical recommendations were perceived as major factor. 
"fBarrier to] asthma [guideline implementation] is patient understanding, biggest 
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problem and it takes us time" (P6). "Patients very often struggle to understand 
the [CHDI risk ... an awful lot of patients don't have a sufficient risk to justify the 
primary prevention use of statins. But patients perceive that slightly raised 
cholesterol wants a tablet to deal with that' (P 11). Also some "patients do not 
like taking prophylax&' (Al 2) for asthma or for CHID. "My barrier for prescribing 
statins is that people don't like taking them. ... So I think as a clinician, I'm less 
inclined to prescribe them than the guidelines make me" (Al 1). All these 
resulted in prescribing not in accordance with guidelines. Patients influenced 
G Ps' choice of drug preparation. "Another guideline we got from prescribing 
authority, to switch off onto generic preparations for salbutamol ... and you see 
patient comes back and says I've used it for years and it works better. Maybe it 
is? Maybe there is something in the way that company makes it... " (P7). In 
occasions, adherence to guidelines resulted in patients leaving the practice. 
"We used to use methadone more, until a guideline came out and we 
decreased it ... lots of our drug-addicts left... " (P7). 
The interviewees noted that as patients became more aware of treatment 
options (e. g. for CHD prevention) they asked their GPs to adhere to them: 
"Should I actuallybe taken something? ' (M). Some GPs were positive towards 
this: "I would be very happy for every patient with a chronic disease to have a 
copy of an up-to-date guideline. Patient may say doctor why am / not having 
ACE inhibitor and the doctor would have to explain X(M). Particularly in cases 
of "more obscure conditions, patient take charge of their care in the way that 
obviously encourage us to share that understanding of the guidelind' (P 12). The 
findings implied that improving patient access to guidelines increased patient 
expectations from doctors. It was known that this sort of pressure from patients 
was more likely to be exerted by middle class and educated patients (Horder et 
al, 1986) 
Guidelines influenced relationship between clinicians and patients in 
different directions. Guidelines helped doctors back their decisions and 
convince reluctant patients: "it makes more sense to say. this is recommended 
with some authoritative basis than say this is what I dd' (M). This might be 
another reason why guidelines recommending no change in practise and 
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confirming current prescribing could be beneficial. Guidelines could overcome 
patients' reluctance in complying with treatment. 
IV. 2. Consultants 
Local consultants were generally perceived as influential on prescribing. "I 
actually think that the doctors that GPs refer to, influence their prescribing quite 
a lof' (Al 1). This influence was exerted through letters sent to GlPs and 
educational meetings. "The key player in all these is the consultant. The 
consultants are whom that GP sends patients to for advice and patient comes 
back on prescription... " (Al 2). "And in lunch time meetings and evening 
meetings... without meetings, the guideline wouldn't be useful' (P7). 
Consultants' influence was also dependent on local relationship: "If the GPs 
have a good relationship with the local consultants, then I think they are in a 
fairly very powerful position in implementing guldelinesý' (P2). Some 
interviewees thought that this influence was becoming less prominent: "I think 
their influence is much less now than before" (M). Consultants had limited 
influence when GlPs managed patients independently. "Most of our asthma 
patients are not supervised by the hospital. So I don't think anything from the 
hospital colleaguesý' (138). 
Consultants' influence on prescribing was perceived as not necessarily in 
accordance with clinical guidelines. GPs thought that consultants seldom 
recommended clinical guidelines in their letters. "They very seldom invoke 
guidelines. I think if they did they would be very helpful. Actually that suggests 
to me that specialists don't follow guidelines eitheP (A3). This was echoed in 
others' views: "I think they are even worse in following clinical guidefineg' (139). 
Therefore, consultants could potentially hinder guideline implementation in 
primary care: "as a GP, as an individual it is very hard to resist that drivd' (P5). 
"If you work closely with somebody in secondary care who has a more 
idiosyncratic method of treatment, you may end up prescribing the way they do 
instead of using the guidelineg' (A 11). 
The findings should be viewed in conjunction with what presented under 
the sub-theme 'secondary care as reputable body' (4.3.4). GPs did not support 
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secondary care initiated clinical guidelines, and were less willing to adhere to 
those guidelines. It was also said that GPs felt that consultants did not 
understand primary care. Here it was noted that GPs believed consultants 
influenced their prescribing. These seemingly conflicting positions were very 
important in understanding the dynamics of primary care. Decision makers 
should be interested in the possibility reconciling these two positions to improve 
the quality of care. Would consultants be co-operative in the implementation of 
guidelines that were produced without their input? 
IVA GP colleagues 
GP colleagues within practice were considered influential. The influence was 
variable, and as for consultants was not always in line with guideline 
recommendations. "Partners are really important. ... If your partners prescribe 
differently you might pull the guideline out and say that's actually what this 
guideline says. Unless you have the confidence to do that, you might be more 
inclined to what the practice wanted' (Al 1). G Ps used their in-house meetings 
to reach agreement over specific prescribing approaches or whether to follow a 
guideline. "We have a little clinical meeting every couple of weeks and try both 
[my GP colleague and 1] doing roughly the same thing"(P7). Meetings could 
happen as often as every day (P3), in informal way, or be planned as a formal 
session: "One of the partners did some homework. There was a meeting of all 
clinicians, it was presented and discussed. And then the written version is 
shared around and people have it on their desks" (A3). The meetings reflected 
the reality of modern general practice, where GP partners 'shared' patient care 
responsibilities. "We found that anything is only useful if all three partners 
agree. ... There is no Point at all if I stop prescribing benzodiazepines, unless 
we all do sd' (P3). "We all do mostly the same to be honest. And we do discuss 
it at intervals" (138). In this team approach some GPs assigned the responsibility 
of looking for evidence to one partner. "We nominate one of the partners in the 
group to have a look about question specifically and she is being much more 
aware of the guidelines [for statins]. We work as a practice team on that level 
and we distribute audit and guideline update" (P 12). "... One of partners is 
interested in contraception ... so she keeps us updated therd'(P3). In-house 
meetings did not happen regularly in some practices (A3). 
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GPs found it easier to reach agreement about a clinical guideline in 
smaller partnerships. "Probably the bigger the group are in, the more 
disagreement you'll get. ... Car? you thrash those out or do you accept lowest 
common denominator rubbish" (P5)? Another interviewee who was from a large 
practice did not see in-house colleagues as influential: T You have to find 
someone [influential], I wouldn't think it would be anybody necessarily in the 
practice? ' (P2). Individual G Ps might play dominant roles in their practices: "one 
of partners probably has been a little bit more [influence]' (P 10). 
The influence from GP colleagues outside the practice was fairly limited, 
unless from motivated colleagues. "One of our colleagues in practice nearby 
does quite a lot of research on epilepsy. He often talks about epilepsy' (P6). 
Influence of GPs outside the practice seemed to be occasional: "if we talked to 
our colleagues in other practices and see something complete different we 
missed it, then we like to catch ug' (P3). 
IVA Practice nurses and primary care team 
Practice nurses played important roles in guideline implementation, specifically 
where they were actively involved in patient care and running mini-clinics (e. g. 
asthma, diabetes and CHID). Some GPs found this encouraging: "I think the 
important input that we've found is really from our nursing colleagueS7 (A 13). 
Nurses also provided new evidence and useful information. For example 
when there is a change for diabetes -again WHO criteria changed- or for 
asthma that makes almost immediate impact. Partly because our nurses, who 
share that care with us, bully us if we haven't noticed' (P3). 
The interviewees described nurses as "extremely good in creating 
structured approacli' (A6) and as those who "follow protocols much better than 
doctors do" (A3). "My guess is that the vast majority of prescriptions for [CHD 
prevention] the nurse says to GP / need this. GP doesn't think about it, theyjust 
sign if' (Al 0). For that reason some guidelines specifically targeted practice 
nurses. A13 provided examples of such guidelines for epilepsy care. GPs felt 
132 
confident in transferring some of their responsibilities in chronic disease care to 
nurses. "We trained our nurses to look after our asthma patiente'(Pl 1). 
One interviewee mentioned that potential disagreements between GPs 
and nurses negatively affected guideline implementation. "There are some 
professional boundaries about. Who is going to do what and whether we all 
agree about it... Traditionally the doctors; but nurses seem to get more 
involved in statins, nurses tend to be running the CHD clinics. [On the other 
handj GP might accept the guideline, because he wants to give it to the nurse 
to run the clinic with. But obviously that involves both sides to agreeP (M). 
Other primary care team members were mentioned in three interviews. 
The importance of a team approach was emphasized for successful 
implementation CHD prevention. "[Statins] is a fabulous example of everybody 
in primaty care playing a part and that's the success of the implementation of 
the guidefine" (M). "Statins for example, you've got to ha ve. all the practice on 
board, practice manager doing things and so oti'(A5). District nurses also 
influenced implementation (P1 1). 
The interviewees who perceived nurses as influential in guideline 
implementation considered the influence to be positive. This was different from 
the perceived influence of consultants and GP colleagues, which might or might 
not be in line with guideline recommendations. On the other hand, about two- 
third of the interviewees did not refer to nurses, whether positive or otherwise. 
IV. 5. PCOs, pharmacists and prescribing advisers 
The term Primary care organisation (PCO) was used to refer to Primary Care 
Groups and Trusts in England, Local Health Groups or Boards in Wales and 
Local Health Core Cooperatives in Scotland. 
Interviewees thought that PCOs had limited influence on prescribing. The 
influence was materialised through recommending specific types of medicine 
and discouraging others. "Our local PCG has been issuing guidelines on which 
particular type of drugs to use in asthma" (M). PCO formularies were not 
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thought as essentially helpful. "We have just one copy of that formulary in our 
practice and I don't know if they are going to put in every doctor room and 
expect people to stick to it or not I suspect not. Because / can't imagine a lot of 
doctors say 'Right. You need anti-hypertensive, let me see what my PCG let me 
prescribe " (P 1 ). "A problem with a PCG formulary is tha t lo ts of practices o ver a 
wide area are asked to do lots of things together ... there are difficulties 
involved in trying to get everybody to feel as if they have a part of the formulary 
or any decision making is very difficulf' (P2). 
PCOs' prescribing messages were normally received via their prescribing 
advisers and attached pharmacists. Advisers and pharmacists provided GPs 
with information and guidelines. Some interviewees felt too much information 
was delivered in this way: "a lot of guidelines from prescribing advisers come 
around' (P7). One interviewee mentioned that the PCOs' influence was 
growing: "of much growing influence are the prescribing managers in PCGs and 
the attached pharmacists of the practidesý' (M). "In Wales ... generally we have 
employed a pharmacist who worked with the practice. So someone like that 
think could have an influence" (M). 
One interviewee expressed very negative views on PCOs' role in 
general. "... / don't think that we can honestly say that PCGs have the time to 
influence implementation of the guidelines in any great way at the moment. ... / 
think it's waste of time, mainly because they are under-resourced, and the goals 
of Department of Health are unachievable. We end up subsidising PCGs with 
our good will and time and money trying to implement things that are difficult to 
achieve at the best of times; and with the very limited resources that we have, 
becomes impossible. So I don't think that PCGs are here to stay' (132). 
IV. 6. Drug companies and reps 
Drug companies, mainly through their representatives, were another source of 
influence. "The other influence on prescribing that you have to consider is drug 
representatives. We do have influence from them. And it would be narve for me 
to say they don't. They do influence usý' (P6). Some G Ps did not see drug 
company representatives. There was an effect on GPs who saw 
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representatives. The interviewees perceived that the influence was limited to 
certain areas where it coincided with other factors. Two main examples were 
mentioned. Drug companies' campaign a few years ago to encourage GlPs to 
follow BTS asthma guidelines was one of example. The other more recent 
example was the industry's interest in GPs' adherence to primary prevention 
charts, as they believed it increased drug prescribing and hence their profit. 
"Those charts [of CHD] became very familiar partly because pharmaceutical 
companies started giving free copies of them away' (M). This sort of influence 
was perceived as informative by one interviewee. Another interviewee 
mentioned, "their influence / think increasingly is based on scientific fac&' (M). 
Some GPs thought that representatives had an effect by targeting 
consultants (All) or nurses. "The other key fact was the industry, promoted 
[BTS] heavily, particularly to practice nurses. So you could get free copy of the 
guideline... because they said use more medicationsý' (M). 
4.3.7. Theme V: Organisational factors 
This theme covered organisational factors that facilitated or prohibited 
adherence to guideline prescribing recommendations. Five sub-themes were 
identified in this category (Table 4.1). 
V. 1. Practice characteristics 
There was no reference to dispensing status or previous fund-holding status as 
factors inhibited or facilitated adherence to guidelines. One GP trainer 
considered training status as a positive factor: "we are a training practice; we try 
to keep on top of things" (P 10). 
Special mini-clinics for asthma and CHID prevention helped guideline 
implementation. "We now run special ischaernic heart disease clinics ... so we 
are very hot on statin because of the accumulating evidencd' (P5). M ini-clinics 
helped clinicians (including practice nurses) to focus on the disease and provide 
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a more coherent service to patients. "I mean becoming more formal in our 
dealing with asthma patients using our asthma clinic, and therefore probably 
using more preventives, steroids etc. on a more regular basis than we were 
previously'(PlO). 
V. 2. Information technology 
The interviewees were positive about the usage of information technology for 
guideline implementation; perhaps more as a way of the future. Fruitful IT 
experiences were limited: risk calculation for primary prevention ("on a regular 
basis I use a piece of software on the computer which is a risk calculatof' (A9)), 
searching for a guideline when you need it and some limited use of PRODIGY 
(Prescribing Rationally with Decision support in General Practice) software 
package. They saw computerised systems, which included clinical guidelines, 
as the way forward. "Obviously with things such as PRODIGY being around, 
longer term acceptability of the guidelines will be influenced by whether or not 
they are usable within a computerised environment" (M). The other important 
usage of computers was through using computerised patient records for 
identification and proactive follow up of patients, especially those with chronic or 
rare diseases. 
PRODIGY was perceived as useful software package for guideline 
implementation, mainly for diseases with straightforward diagnoses and limited 
choices of treatment. "I used [PRODIGY] twice today. Once for scabies and 
once for tonsillitis and in both cases the computer guideline offered the 
recommended treatment. In both cases there isn't any choice. ... and the 
computer guideline actually made it easier than think about it myself. ... In more 
complicated cases like hypertension it goes to a rather long branching tree. So 
it takes longer rather than just writing your preferred drug' (A3). The perceived 
inefficiency of the computerised packages for enhancing the implementation of 
guidelines for chronic diseases had also been reported in a randomised trial 
(Hetlevik et al, 2000). GPs sometimes found PRODIGY intrusive during their 
consultation sessions. "... even PRODIGY, I found it quite intrusive to be 
honest. I found it very useful if you got a difficult patient and, I think, after the 
surgery. But actually during consultation do / want prescribing prompts? The 
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answer is yes, but if I have got the time to go through it' (P5). Asa result many 
GPs chose not to follow PRODIGY instructions. 
V. 3. Availability of required resources 
Implementation of some guidelines relied upon specific instruments and 
hardware. The interviewees offered some examples: COPD guidelines 
(spirometer), guidelines for heart failure (echocardiography) and the diagnosis 
of urinary tract infection in children (collection bags). "/ found COPD guideline 
by BTS quite difficult because it requires spirometely, and being realistic, many 
of us don't have spirometers. i'm not sure how relevant they are to routine 
care... " (P6). "In heart failure ... you can make accurate 
diagnosis only by 
echocardidgraphy and many GPs realise that the appropriate treatment is ACE 
inhibitors, but GPs don't always have access to the investigations and there is a 
long waiting list. ... Whether it's the guideline that's 
failing or the implementation 
process itself was handicapped' (M). "Heart failure [guideline] is a wonderful 
guideline, but how do You actually put it into practice if you can't get open 
access to echocardidgraphy'(M). Similar problems happened in the absence 
of human resources. "/ think quite a lot of barriers are organisational. - in order to 
meet the guideline, you might have to have a system of careP (M). 
VA Time, workload and information overload 
There was a genuine belief that general practice was under increasing 
pressure, so that it made it difficult to plan for quality improvement in general 
and guideline implementation in particular. "You know a barrier to all clinicians 
doing things better is that they don't have the tirad' (Al 2). "At the moment we've 
been bombarded with so much change that our practice manager, nobody, can 
manage. So if there are any guidelines to come, that's not a good time for 
them... " (133). "Time is issue. It's impractical to do that, without losing for other 
things. ... I think modem general practice requires you to be proactive, to be 
planning for staff, get involved in staff training, following guidelines... safety of 
work .... They take quite a lot of time. We have a meeting regularly which is 
purely non-clinical thing. ... So that influences my prescribing, because I don't 
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manage to prescribe very much because I'm always at meetings (laughlngy' 
(P5). 
The process of reading, understanding, discussing and utilising 
guidelines and eventually auditing implementation could be time consuming. 
Adding to this, the consultation times were pretty short. "The biggest [barrier] is 
the lack of time to initially study the guidelines and take them in, and then when 
the patients come in the lack of time to work trough the guidelinee' (P1 1). The 
interviewees considered the majority of guidelines as technologies that 
produced extra workload. "Time to read, understand, to design strategies, to do 
audit ... is enormously difficult and the resources that go along with that ... 
workload in general practice is so enormous that to try and remember to think 
about other things is really tough" (M). When there was a sense that following 
a guideline decreased demand on GP time, guidelines were more likely to be 
followed. "In helicobacter, there are some suggestions that guidelines might 
decrease workload from dyspepsia and so on. Whether that was true or not, is 
another matter. But there was a perception that it might reduce demand, so it 
was easier to uptake" (M). 
The step-by-step approach towards treatment (i. e. first treat by the least 
expensive drug - which probably was less potent with more side-effects) 
recommended by many guidelines-was considered a barrier to implementation. 
GPs thought this approach resulted in more patient appointments and pressure 
on one of the most precious items in general practice, i. e. time. "If you look at 
most treatment drug guidelines they actually go down a pattern of try this first 
then do that. And that creates more appointmentsP (M). G Ps' concerns over 
their workload and time constraints were well known. But time did not seem to 
be the crucial point. If there was perceived need for a guideline, then time would 
not be a major barrier. GPs worked 'smarter' (Poplin, 2000), shifted or changed 
priorities to produce necessary time. 
Information overload or simply guideline overload was another matter. 
Many guidelines arrived through the post and were ignored. Some GPs sent 
some guidelines "straight to the bid' (P5). Others tried to keep them, but failed 
to use them: "You can't have a guideline library' (P7). "Having a memorable 
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article in the BMJ ... months ago where a 
GP was photographed beside the pile 
of guidelines that had arrived by post during the previous year and it was about 
4 feet talf'(A2). Given that GPs received many guidelines, it was more difficult 
to choose the suitable ones out of the others. GPs tried to be selective, but 
there were not explicit criteria. "That's the main problem in whole business ... 
we have to select one and ignore the rest unless there seems to be a reason for 
change. ... There are lots of guidelines. 
Protocol for that, guideline for this... 
Information overload, guideline overload'(P4). In some clinical areas the 
number of produced guidelines was high, and it was perceived unreasonable to 
expect GPs to consider new guidelines. "If... yet another antibiotic guideline, 
frankly not even be looked at, because it's been reviewed so many times" (P3). 
The idea of a recognised body taking charge and introducing reliable 
clinical guidelines was appealing to some interviewees. "I really like it if some 
overarching body will pull together the best guidelines, all the ones that have 
been really quite marked and say give that book to GP updated every yeae' 
(Al 1). In this sense, GPs had a positive approach towards the NICE role. 
V. 5. Costs and expenditure 
Especially in the case of statins, drug expenditure was an important issue. GlPs 
saw themselves under scrutiny to prescribe within budgetary limits. "And yet 
[while asked to prescribe statins] GPs are criticised for over spending on drug 
budgeF (P5). " You can't do something like [CHD prevention] without spending 
more money at the end of the day' (P6). G Ps were more likely to follow 
guidelines only for secondary prevention of CHID, and not primary prevention. I, / 
don't think the [guidelines] help. Because we can't afford the use of statins that 
the guidelines suggest... " (M). "I think there is a real concern about the cost of 
statins and how that might influence prescribing budgets and GPs ability to 
prescribe other drugs if they would implement the guidelines as widely as they 
would wish to do. / think the evidence so far is that if people stick to secondary 
prevention then it shouldn't be something that actually expensive" (Al 3). 
The issue of cost was more prominent when guidelines requested 
initiation of new and expensive drugs without removing the need for other 
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treatments. "Biggest barrier there [statins] for implementation is initially drug 
cost. ... It was a new area. Wasn't replacing one drug with another Could argue 
in asthma you are doing it, if you implement the guideline ... reduce the use of 
betaZ'(P6). PCOs were not perceived as supportive of guideline 
implementation. "[PCO] where most of the funds come from says you can't 
afford to use [statins]. So in fact in a way they are counterproductive. They get 
you thinking down statins guidelines, but they don't help you" (M). While many 
saw adherence to CHD guidelines as costly, some considered guidelines as 
means of limiting prescribing costs. "There is a perception that the statins 
guideline is based on making sure that not too much money spent on statinsý' 
(Pi 1). 
Some interviewees argued that if clinical guidelines recommended 
cheaper drugs, that were as effective as their counterparts, it would act as an 
incentive. "If the guideline says a drug is only marginally more effective ... but is 
drama tically cheaper, then / think tha t would influence them as well' (A 11). 
Equally guidelines were welcomed if they justified additional prescribing cost, 
e. g. in case of asthma clinical guidelines. 
4.3.8. Theme VI: Disease characteristics 
This theme focused on items which directly explained the specific effects that 
disease (or clinical condition) characteristics had on implementation. Three sub- 
themes were identified under this category: 'treatment is secondary care based', 
'difficulty of diagnosis' and 'rare or simple disease'. 
VI. I. Treatment is secondary care based 
GPs had limited roles in the management of certain diseases. Treatment of 
some diseases was solely or largely secondary care based. Secondary care 
was the natural initiator of the treatment for other diseases and GPs' role was 
mainly to follow up and deal with adverse events, exacerbations etc. Epilepsy 
was a good example of a disease with these characteristics. Interviewees 
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believed that there was less room for manoeuvre in primary care for adherence 
to guidelines' prescribing recommendations. "GPs initiate epilepsy treatment 
very rarely. Usually secondary care doctors who initiate the treatment and we 
just re-prescribe. ... I as a GP have rarely requested routine monitoring, so 
/ am 
not aware of what the guideline says" (1311). "Since initiation of anticonvulsant 
[for epilepsy] treatment is not a primary care task we ... seek advice from 
specialist on that and we follow their advice" (M). GPs were perceived to have 
important roles in identification of epilepsy patients on multi-drug treatment 
(which was discouraged) using practice data. As an exception, one of the 
interviewees had special interest in epilepsy (using SIGN guideline: Scottish 
Intercollegiate Guidelines Network, 1997a; Scottish Intercollegiate Guidelines 
Network, 1997b) and seemed to have managed to influence GP colleagues 
outside his practice. 
VI. 2. Difficulty of diagnosis 
Where the diagnosis was problematic, clinical guidelines with emphasis on 
treatment (including prescribing) might not make much change. The prime 
example was depression, as one of the interviewees explained: "as a student 
andjunior doctor / had a very clear idea about the difference between 
depression and sadness. / don't think there is a distinction anymord' (P5). 
Some of the concerns that were expressed on NICE's guidance for prescription 
of Relenza, referred to the same problem as they saw influenza as a difficult 
disease to diagnose in first place. 
VI. 3. Rare or 'simple' diseases 
For some clinical conditions a short piece of evidence and recommendation 
might work better than a clinical guideline. Menorrhaegia was referred to as an 
example. While some interviewees were more or less aware of the main 
recommendations of the guidelines, no particular guideline was recognised as 
the source. "/ understand that the evidence is that tranexamic acid is the most 
effective drug and ... And majority of GPs and many many gynaecologists do 
use norefisterone, which is ineffective. So it's not quite a guideline, much more 
being aware of evidence"(M). Some GPs used the guidelines when they 
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encountered a problem. "I think that probably stops GPs prescribing so much 
progestogen. ... I remember itiumps from treatment with things like mefenamic 
acid ... to a more severe treatment, which is less well tolerated in pnmaly care. 
I know what the first step is, so I always use that, if / pass the first step / do 
look back at the guidefine? '(Al 1). For clinical conditions like menorrhagia, short 
compiled evidence could be more useful. Publications like the'Clinical 
Evidence' could provide a proper answer to this need. The other useful 
approach was more active use of IT in practice as accessible source of 
information whenever required. IT was particularly useful when doctors sought 
guidelines for treatment of a rare disease. Also patients could play a role in the 
provision of guidelines for obscure conditions (4.3.6). The effects of disease 
complexity on implementation had theoretical and empirical backing in the 
diffusions of innovation theory (3.2.3). 
4.3.9. Theme VII: Implementation strategies 
V11.1. Planning implementation 
Lack of implementation programmes was regarded as the prime reason for non- 
adherence to guidelines. "/ think probably the weak step in all guidelines is 
implementation. The people think that once they've written the guideline and 
come out with a pretty algorithm, that's it and all they have to do Is post it out, 
and the truth would do the rest' (P5). "They got to be effectively disseminated. 
Generally they are not. They're just posted out" (A7). Lack of implementation 
programme was a barrier regardless of the quality of the guideline. "I don't think 
North of England [asthma] guidelines had much impact in general practice. Few 
people knew theni' (M). "All guidelines can be useless If they are not read or 
used, and there is a problem of fact that we getting better and better making 
wonderfully streamlined very scientific guidelines, but unless they are actually 
read and digested and put into practice, then they all be useless. And / think 
some have ... fallen on stony ground' (M). "You can't do sit down with a copy 
of the guidelines with a covering note saying please do this. / don't think it 
works"(A13). There were many examples of weak implementation strategies: 
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"[depression] is a topic that is a bit of a Cinderella. ... I think it is an example of 
where there is evidence but not a great implementation strategy and a lot of 
variation in practicd' (A6). 
Good dissemination and marketing strategy could prove successful even 
with an acceptable and not necessarily evidence-based guideline. The best 
example was the earlier versions of BTS asthma guidelines. "Because [BTS] is 
the one that was marketed the best, was advertised the best, it was the one that 
used nationally. [Even if not evidence-based] but they are workable documents 
that e vetybody uses. To use a different one, seems a bit [odd]' (133). 
Continuous multi-faceted implementation programmes were thought to be the 
most effective. 'fBTS] had a major impact because of its marketing strategy. 
That was presented in a very simple easy format, widely accessible, widely 
talked about, the use of multi-factor approach towards implementing the 
recommendations... " (M). 
V11.2. Can implementation be successful? 
Thinking "that the guidelines on their own would make a difference is probably 
naYvd'(Al2). Even when the change in prescribing was as guideline 
recommended, it was not clear whether the change was due to the guideline, 
because "guidelines are only part of this" (P2). Interviewees gave a few 
examples of change in their prescribing coinciding with clinical guidelines while 
they were not sure what factors were the main causes of change: "/ suppose / 
tend to use aspirin in people with ischaemic heart disease ... but can I link it to 
the guideflneT (P8). "I think one of the problems is how to define 
implementation of the guidelines. I suspect that over time, for example, general 
practice prescribing of anti-asthmatics has moved more closely to BTS 
guideline. But I'd find it very hard to say with any sort of scientific certainty that 
the BTS guidelines did that. ... they may over time actually influence the 
practice, but it's hard to have a cause and effects relationship, unless within 
scientific setting of a research study"(Al 0). "1 only believe trials, there is so 
much confounding out there. I mean, I give you an example, look what 
happened to statins prescribing. I don't believe for a moment that statins 
prescribing has gone up because of the Joint British guidelines on management 
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of coronaty heart disease, although if you look at the graph in a time series way, 
... it is really begins going up in 1999 when those guidelines came out. But / 
think one has to be veiy careful before one can say a specific guideline has 
actually made the difference" (A 12). 
Some interviewees thought that they had altered their prescribing as a 
result of guideline recommendations: "definitely with asthma I'm moved toward 
preventative treatmenf'(P6). Generally speaking the views of non-academic 
GPs were more positive towards the influence of clinical guidelines on 
prescribing, while academics tended to be less confident of guidelines as the 
cause of change in prescribing. 
There were specific cases where guideline effect was prominent. NICE's 
guidance on Relenza was one example, as it was a relatively new line of 
treatment. Before the guidance was released, many GPs were reluctant to use 
Relenza on the recommended scale and with its release the drug was 
prescribed more. Therefore, interpreting the cause of change could be context 
dependent. For menorrhagia the guidelines were not actively implemented and 
were unlikely to have caused notable changes in practice. For statins, although 
the guidelines were actively disseminated, perhaps accumulative evidence and 
different sources of message had caused most of the effects. 
In some cases GPs were aware of guideline but not familiar with the 
message. More commonly they were familiar with the guidelines' message 
without remembering the source, specifically where there were many different 
guidelines for a condition, or where there had not been massive implementation 
strategies. This could hinder the implementation of guideline updates. 
Guidelines could play another role in implementation. They might help 
'change' to stay longer in practice. They could provide a milestone for reference 
and implementation. Respected and well-known guidelines (e. g. the BTS 
asthma) transferred new evidence, through update versions, much more easily 
into practice. 
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Guideline implementation could go wrong in different directions, for 
example, when the message or dissemination approach were prone to 
misunderstanding. It might cause firm beliefs against the wishes of 
implementers and the content of recommendations. These beliefs could be 
more resistant to change. One interviewee reported that some GPs used CHD 
primary prevention risk tables for patients who fell within secondary prevention 
category. A previous study reported similar phenomenon (Fairhurst and Huby, 
1998). When studying cost-effectiveness of clinical guidelines, these are among 
the adverse events that should be measured and taken into account. 
V11.3. When do GPs welcome new guidelines? Perceived need, past 
experience and knowledge 
GPs were positive towards change coming through guidelines as it helped them 
to perform better in their professional responsibilities. In this sense they were 
receptive towards guidelines. "We as professionals want to know we are doing 
our best for our patients ... " (P2). Guidelines were more effective when G Ps 
had perceived need for advice for treating a disease, or when they were aware 
of potential shortcoming in the care they provided. "Somebody who seeks 
guidelines is much more likely to implement them than if guidelines imposed' 
(P2). This 'need effect' could be the result of another phenomenon. As noted 
because of information overload GPs ignored many guidelines and chose only 
those that considered helpful (4.3.7). When there was a need, GPs were less 
likely to ignore a source of evidence-based advice even if it came through the 
post. "/ was ready for [BTS asthma guideline]. By the time they came out I was 
desperate to read them" (P5). "/ look at the ones that / have been really looking 
foe' (P 12). 
Targeting clinical areas where quality of care was lower than expected 
could result in dramatic achievements and boost general practice morale. One 
interviewee (A13) reported 90 percent change (improvement) in prescribing 
when they introduced a guideline for the use of sublingual analgesics. He 
believed this success was due to good communication with GPs and GPs 
readiness for adopting the guideline. "Why do you introduce guidelines and 
usually we produced a guideline to resolve a problem. And if that problem have 
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been recognised by the GPs they have usually been co-operating with the 
guideline that we produced' (Al 3). To complete this discussion, it should be 
noted that perceived need was not a pre-requisite for every implementation. As 
for the example of NICE guidance on Relenza, while there was no particular 
perceived need in primary care, the guidance was to some degree adopted. 
GPs were 'selective' in using guidelines. They did not read every 
guideline they received. Many guidelines were thrown away after a quick look. "/ 
usually have a look at [clinical guidelines] and if / don't think they're gonna to be 
useful i [throw] them in the bih" (Al 1). If a guideline was read once and 
perceived as non-helpful, more effort would be required to convince GPs to 
read it again. We called this the 'first contact' effect. Clinical guidelines should 
be presented and disseminated in a way that they attracted G Ps' attention. 
There was theoretical and experimental support for the importance of the first 
contact. In social psychology it had been referred to as 'primacy effect' (Raven 
and Rubin, 1983, pp 90-91). 
Guidelines were also used as a source of up-to-date 'knowledge'. GPs' 
information-see king could be exploited for guideline implementation. "There is a 
lot of pressure to prescribe statins and I think we need to be sure we know what 
we are doing and how we are doing X(138). Generally clinical guidelines were 
perceived as useful in improving the knowledge base and providing information 
to practitioners. "Guidelines have helped me to improve my knowledge base 
from time to timd'(A4). This guideline-derived knowledge could then be used 
for changing behaviour, but also in many cases to 'confirm' the current good 
clinical practice: "I must admit I only use them if I'm finding difficulty in the 
managing of particular patient. And wouldprobably use them tojust confirm" 
(P10). Many GPs defined this approach towards guidelines as'using'them, but 
not all had the same terminology: "While I don't use [SIGN guidelines], I refer to 
them quite a lot. And they are extremely good' (A3). The importance of 
understanding the meaning behind terminology was noted before when 
discussing 'evidence' (4.3.3). This represented another example. 
146 
VIIA Ownership - local versus national guidelines 
Interviewees expected the publication of national guidelines to overcome the 
problem of conflicting messages and "too many separate groups producing 
guideflnee' (P1 0). They defined national guidelines as those produced either by 
a national authoritative body (e. g. NICE) or a body who had achieved nationally 
recognised status (e. g. BTS). "For example the BTS [asthma] guidelines are 
national guidelines, everyone's doing the same thing, and I think people quite 
like thaf' (Pl 1). 
Local ownership could increase the perceived credibility of a guideline 
and hence improve implementation. The interviewees argued that local 
ownership (through producing local versions of national guidelines or 
membership of guideline development groups) had an important facilitating 
effect on adherence. "A meeting within a practice developing their own 
guidelines, perhaps based on national guidelines, and / think the key word is 
ownership. / think if doctors ... have ... some ownership of the decision making 
process, then they are much more likely to be successful' (P2). "An in-house 
protocol probably got the greatest credibility of all. I don't use external 
guidefinee'(A3). " The biggest barrier, I think is not being locally owned' (M). 
The process of local adaptation might also improve the chance of in- 
depth understanding of guideline recommendations as well as the underlying 
justifications for the recommendations. "Ostepporosis guidelines we produced in 
[name of city], they certainly were useful, because we actually worked them up 
togetheras GPs7(M). The same might be achieved where GPs were members 
of guideline development groups. "Because everybody participated in creating 
them, eveiybody is participating in the using of them. It is a key factor. It's not 
the government telling us what we should be doing' (M). "I had contact with 
North of England guideline for non-steroidal anti-inflammatory drug for 
osteoarthritis. So [/] tend to use paracetamol or paracetamol-based analgesics 
first. ... Because I was a member of the working party for that guidefine" (P8). 
Obviously not all GPs could be members of guideline development groups and 
not even all of them could contribute to local adaptation. The sense of 
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ownership could be to some extent achieved if guidelines were produced so 
that GPs views were clearly represented in the process. 
VII. 5. Enforced implementation; medico-legal issues 
Quality markers or indicators were considered as means of enforcing 
implementation of guidelines. Where used, they could be effective in behaviour 
change. "[NICE Relenza guidance] I don't quite know how did they come to that 
decision but it's difficult not to pay attention to them because they are going to 
be national markers of what we were up to... "(P5). Some perceived 
governmental targets (such as those in NSFs) as imposed. Those 
recommendations were seen as things that they'had to'follow. "We are ftying 
to get National Service Framework for heart disease implemented. ... You've 
got to do it. If you don't you can't get your money or your quality markers. ... It's 
a stick, isn't it? That means you have to do that guideline, whether it's right or 
wrong"(P7). 
GPs thought some of these markers were not justified and were not 
based on evidence. V ourperformances are being measured by a certain 
percentage of ourpatients being on beta-blockers after MI, who's to say what 
percentage of patients should be on beta-blocker after MR Because nobody on 
trials is of our patients. They've done trials on highly selective groups of peopld' 
(A9). The negative feelings of GPs towards guidelines without their contribution 
were briefly encountered, while discussing previous sub-themes (4.3.4). GPs 
saw it insulting if people who had no responsibility for 'doing the job' produced 
guidelines for G Ps. "To me - to be honest - that's quite insulting because the 
people who actually are not doing the work and not involved with it, draw the 
guideline and I don't see how this expert body can expect it to be implemented' 
(P5). Seeking GP support for the targets would ease their achievement. "Try to 
persuade people that actually this is OK to follow. It is by us, for us, not 
dropped upon usý' (M). Although 'imposed' guidelines achieved some results, 
especially in short term, they might have negative consequences (Lewin, 1951). 
'Imposing' should not be the first option. Enforcement might reduce morale in 
general practice and should be limited to the vital areas and to the topics where 
other interventions proved ineffective. 
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Audit (and feedback) in general was perceived as a facilitating factor. 
Two reasons were expressed. First, GPs became aware of their performance 
as a result of audit and tried to improve it: "our primary care development plan 
... requires us to audit ... and it showed that we weren't doing very well with 
cholesterol. ... ... that was the biggest factor [in improving the service], the fact 
that we did an audiF (136). Second, as comparative practice data were 
distributed among their colleagues, they themselves tried to keep up. "And 
that's a bit of peer competition / suppose. In a silly way, you don't want to fail in 
front of your peers ... it is a system that works: audit and then threats that those 
figures are going to be published or circulated' (P6). Another study argued that 
this competition effects as a result of audit tended to have limited effects (Sheaff 
et al, 2003). 
A further use of clinical guidelines could be in defining minimum 
standards of care and trying to achieve those minimum standards by clinical 
governance. One interviewee explained this approach in more details. "They 
are not called guidelines anymore. They're called minimum standards. We've 
actually moved on from guidelines towards clinical governance. ... You are not 
trying to get local ownership of them, you say 'right, can we deliver this? 'Rather 
than rewriting them for the practice, you actually say 'well, we can't find our 
hysterectomy patients, because we don't have a computer. ' So you then [go] to 
PCG and say/ need a computer... " (M). 
Medico-legal consequences of adhering to or ignoring a guideline could 
also act as enforcement. Some interviewees referred to this, mainly as an 
action that authorities might take if GPs did not follow guidelines. They did not 
sense strong pressure from potential medico-legal consequences instigated by 
health authorities. The other potential medico-legal liability was that as patients 
became aware of the guidelines, they could sue their Us if they did not follow 
the guidelines. Again there was no widespread concern about it and no 
experience or observation was reported. 
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VII. 6. Supporting implementation and implementation cost 
Persistent and repeated distribution of guideline messages was an important 
implementation facilitator. Again they used BTS asthma guideline as example. 
"... probably the number of times that I'm exposed to it. So for example the BTS 
guidelines, they hit you over and over agairt' (Al 1) . "Repetition is another thing. 
If it's the first time that they've heard of the guideline, they are liable to ignore it. 
BTS was quite example of that. Because you got it from everybody you talked 
to about asthma. Reps talked about it' (M). Hearing the guideline message 
repeatedly could have a facilitating effect, if those different sources provide non- 
conflicting messages. "That's also something very important. The same 
message is presented in different ways, but they are not conflicting messagee' 
(M). 
The idea of financial incentives and rewards for practices that improved 
the quality of their prescribing had some support. "The rewards can be in terms 
of chronic management paymen&' (M). But some thought there were not 
enough financial incentives to follow guidelines. "/ need to be able to give you 
an incentive to change your habits from neproxen to ibuproten and there aren't 
any. There are no real incentives. Often there is talk that financial incentives are 
useful, but there aren't really financial incentives available in order to do this" 
(P2). PCOs'financial resources were perceived to be insufficient. Sometimes 
not all extra costs incurred from guideline implementation were met. An 
example was prescribing costs of statins if guidelines implemented: "[PCO] get 
you thinking about statins guidelines, but they don't help you" (M). 
GPs did not welcome cost-containing messages in clinical guidelines, 
especially if they could not clearly see the justifications. They needed to be 
convinced that guideline objectives were explicit and justified. "I think clinical 
guidelines are very useful provided they are logical ... provided we can see the 
logic behind them. / think we tend to be suspicious that there is an alternative 
motive in producing guidelines which basically is to restrict amount of money 
spent on prescribing which may or may not be justified' (P8). 
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There were times when the cheapest treatment option (with equal 
effectiveness) was not the best option from GP point of view. Minor side-effects, 
extra appointments required, number of times the drug should be taken by 
patients were among factors that contributed to shaping GP view towards 
guidelines recommendations. "I think it's easy for a pharmacist to say prescribe 
four tablets a day, but it's easier for GP to say no you can just have one tablet a 
day which is minocin. And I think we are less worried about costs when we are 
dealing with teenagers with acne, four tablets versus one, there is no 
comparison" (A4). This had a message for planning of cost-effectiveness 
studies. Far too often small but important costs to patients and GPs (e. g. time, 
convenience) were ignored in the studies. One interviewee provided another 
illustrative example of this issue: "ourpractice guidelines [for depression] are 
about 3-4 years old now and I'm pretty sure aren't being followed at all. ... The 
guidelines in depression tended to say start with tricyclics, now most of the 
people we see with depression, are working and also driving a car. And ... 
tricyclics ... cause drowsiness"(A9). 
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4.4. Discussion 
4.4.1. Limitations and strengths 
In recent years several qualitative studies of prescribing in British primary care 
have been published. The studies focused on different issues and problems 
such as change in prescribing (Armstrong et al, 1996; Allery et al, 1997), 
prescribing of new drugs (Prosser et al, 2003; Jacoby et al, 2003), patient- 
doctor relationship (Britten and Ukoumunne, 1997; Britten et al, 2000), variation 
in cost and prescribing (Carthy et al, 2000), implementing clinical guidelines 
(Freeman and Sweeney, 2001), implementing hypertension guidelines 
(Cranney et al, 2001), use of statins (Fairhurst and Huby, 1998), secondary 
prevention of CHID (Summerskill and Pope, 2002), effectiveness of 
computerised clinical guidelines systems (Rousseau et al, 2003), antibiotic 
prescribing (Kumar et al, 2003) and antithrombotic treatment for atrial fibrillation 
(Howitt and Armstrong, 1999). Some studies included groups outside primary 
care teams such as consultants (Allery et al, 1997) or patients (Britten et al, 
2000). The qualitative study reported here was different from previous studies in 
two aspects. First, it had a unique sampling approach as it included GPs as well 
as academics of primary care. Second, the study asked about the views of the 
participants about implementing prescribing recommendations of clinical 
guidelines for five clinical topics; asthma, statins for prevention of CHID, 
menorrhagia, epilepsy and depression were directly covered in the interviews. 
The topics ensured variation in terms of complexity of the disease, availability of 
clinical guidelines, GP role in prescribing and the importance of prescribing in 
management of the problem (4.2.3). 
The study had important limitations. The analysis, as well as data 
collection and transcription, was conducted by single researcher. This might 
have increased the subjectivity of the findings (Mays and Pope, 1995). To 
reduce this limitation, different sections of the results were presented in in- 
house and external seminars, advisory meetings and national and international 
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conferences (e. g. Rashidian and Russell, 2002a and 2002b). Based on the 
feedbacks received, the analyses were re-che6ked to ensure the findings were 
supported by the data and that alternative interpretations were also reported. 
The findings were also backed up with verbatim quotes from the interviews to 
help the readers examining the validity of the findings (Greenhalgh and Taylor, 
1997). Quality of data was not audited by others. Errors might have happened 
while transcribing the data. Attempts were made to reduce the likelihood of 
errors. The tapes were listened to twice before transcribing and were 
transcribed with care. The validity of the findings could have been improved by 
feeding back the results of the analysis to the interviewees ('respondent 
validation', Mays and Pope, 2000; or'member checking', Giacomini et al, 2000). 
This was not conducted because the first full-draft of the analysis suitable for 
feedback was prepared about one year after the interviews. It was perceived 
that the respondents were likely to have forgotten the content of the interviews 
and also might have modified their views. The delay in preparation of the full- 
draft happened because of the time required for the transcription and analysis 
of qualitative data, as well as the time that the researcher had to spend on 
preparation of the next stages of the project. 
Some qualitative studies used random sampling (Dowswell et al, 2001; 
Harrison et al, 2003). Objective sampling approaches provide the chance of 
identifying trends and generalisable phenomena which may be missed in 
purposively sampled studies. Some random sampled studies were conducted 
alongside RCTs, comparing different trial arms (Harrison et al, 2003). That 
approach increased participation rate, which could otherwise be a threat to 
random-sampled qualitative studies. 
The inclusion of two different groups of interviewees (GPs and 
academics of primary care) into the study improved the comprehensiveness of 
the study (Mays and Pope, 2000). It also enabled the researcher to look for 
systematic differences between the two groups. The differences In the views of 
the interviewees were highlighted when discussing different themes. Discordant 
views were more prominent when discussing particular examples (e. g. whether 
the BTS asthma guidelines were evidence-based or simple or whether the NICE 
Relenza guidance was useful). There was more congruence on the content and 
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general meaning of the themes. There were also extreme views, e. g. one 
academic of primary care (M) thought that consultants should be kept out of 
any guidelines developed for primary care. The discordant views were not along 
the lines of the two different groups of interviewees (i. e. practitioners versus 
academics). The exception was on whether the guidelines resulted in change in 
behaviour (4.3.9). Generally there was more support among the non-academic 
GPs for the view that some guidelines caused changes in practice, while 
academics tended to be more doubtful of the cause of observed changes. Apart 
from the above example, discordant views reported under different themes were 
dispersed between the two groups. For example, in case of NICE Relenza 
guidance, one academic of primary care perceived it as something unrealistic 
(A9) and another one considered it as "something that GPs can stick to" (A2). 
Obtaining views of other important groups such as practice nurses, 
consultants and practice managers might have increased the 
comprehensiveness of the study, but these were beyond the stated objectives. 
The sampling approach and the inclusion of academic practitioners might have 
caused biases (selection bias) in the results, as the main criteria were to invite 
those with active experience of guideline implementation. Therefore positive 
views towards guidelines might have been over represented. Despite these 
concerns, many negative comments and views towards clinical guidelines and 
their use were received from the interviewees, which were perhaps the outcome 
of their experiences. Focus on specific clinical conditions might have reduced 
the generalisability of the findings to other clinical conditions. This was, 
however, intended and provided the chance to obtain more detailed views about 
the target issues. 
The framework method helped structuring the process of qualitative 
analysis and hence making it more objective. It also enabled explicit 
incorporation of a priori theoretical and empirical reasoning into the analysis 
(Pope et al, 2000). The purposive method of sampling and focus on guidelines 
for specific clinical conditions helped this study to go further in exploring GPs' 
views. The study identified and reiterated many factors that hindered or 
facilitated implementation of guidelines to change prescribing in primary care. 
More importantly it mapped and defined the inter-relationships between these 
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factors. It reinforced findings of some previous studies, challenged others and 
raised new questions. The findings were confined to the merits and limitations 
of qualitative studies (Murphy et al, 1998). The study strongly supported the 
theoretical standing that 'despite their specificity, clarity, and credibility, 
guidelines are unlikely to produce significant change in clinical practices without 
carefully designed and executed programmes to achieve their implementation' 
(Mittman et al, 1992, p 421). 
4.4.2. Evidence, usefulness and relevance 
Subsection 4.3.3 reported the participants believed guidelines should be based 
on evidence as an essential feature. The thematic framework suggested that 
evidence base, flexibility and change formed the credibility of content of a 
guideline, acknowledging the limitation of research evidence in convincing GPs 
to implement a guideline. In a well conducted descriptive study, Grol et al 
identified a few attributes of guideline recommendations that influenced 
implementation (Grol et al, 1998). Among those were (positively worded) 
recommendations being 'non controversial and compatible with current 
practice', 'precise and specific' and 'not demanding change of routines'. Being 
evidence-based was another important attribute, but its weight was equal to 'not 
having consequences on management'. This analysis supported Grol et al's 
finding in two directions. First, the evidence base of guidelines had limited role 
in enhancing implementation. Second, perceived relationship between guideline 
and change in practice was important in implementation. 
In this study, participants had different views on what constituted the best 
evidence to base their practice on. This raised the question of whether it was 
possible to propose a new level of evidence for general practice, while it still 
remained methodologically credible. Green (2000) encountered the same 
phenomenon while studying road safety issues through interviews with a mixed 
sample, which included managers, health promotion staff, road safety officers 
and police officers. She saw although they all agreed that decisions should be 
based on evidence, they did not agree on the nature of evidence (Green, 2000). 
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She offered two themes to explain the differences: that evidence was 'situated 
within specific agendas' and that it was 'constructed through professional 
practice'. This qualitative study supported the first theme. GPs found evidence 
less useful if its agenda was different from their agenda. The second theme, 
construction of evidence through professional practice, did not explain the 
variations observed in the data. Within the sample of interviewees it was 
unlikely to relate differences in views to different professional practices or their 
access to different sources of information (e. g. publications). 
The presence of variation in understanding of 'evidence' raised some 
questions. Was evidence-based medicine becoming a term that people used for 
different purposes and different meanings ('agendas')? To what extent research 
evidence was important for implementation of guidelines' prescribing 
recommendations (i. e. could it be quantified)? Wood et al (1998) concluded that 
'evidence was important, but not that important', adding, 'one requires precision 
in talking about evidencd (pl 735). This statement was very similar to what 
found in this study. The term 'evidence' could play the role of a jargon and could 
support opposing positions. Also it might or might not apply to specific 
phenomena depending on one's choice and viewpoint: a small trial might be 
seen as credible evidence to some GPs and as irrelevant and non-helpful piece 
of research to others. Similarly others argued that successful implementation 
was not based on the rigor of the evidence, but on three variables: the 
evidence, the context, and facilitation of implementation process (Kitson et al, 
1998). Wood et al (1998) went even further and argued: 
there are simply (re)constructions of evidence able to support almost any 
position. ... The nature of evidence is ambivalent. It is constructed into debates and controversies, which are often equally supportive of 
opposing viewooin&'(pp 1735 and 1737). 
Although Wood et al might be able to provide 'evidence' (i. e. examples) for the 
above claim, it did not seem to be accurate. There were many examples where 
evidence overwhelmingly supported a specific clinical practice over the 
competing alternatives; and some were presented in the findings. 
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Other interesting terms were 'relevance' and 'usefulness'. Some GPs 
found the 'evidence' as irrelevant to their individual patient condition or simply 
useless. This was also noted in previous studies: 'the quality of evidence upon 
which guidelines are based is frequently criticised, on the grounds that most 
trials are hospital based... and always exclude a proportion of patients' 
(Dowswell et al, 2001, p 121; see also Schwartz et al, 1989 and Cranney et al, 
2001). Therefore, 
unless academics can leam to understand the clinician's definition of 
evidence and effectiveness, they cannot hope to have a major impact on 
the latter group's prescribing practices (Schwartz et al, 1989, p 581). 
GPs uncertainty in what was the best evidence to base a 
recommendation on resembled the difficulties the methodologists face in 
grading clinical guideline recommendations. The traditional approach was to 
assign the highest grade to the recommendation if they were based on 
evidence from good quality meta-analyses or RCTs. This traditional wisdom 
was challenged and some argued that grading of recommendation was not just 
about the evidence base of recommendation (GRADE Working Group, 2004). 
The new approach suggested consideration of a few other factors as well as 
quality of evidence: 'balance of benefits and costs', 'balance of benefits and 
harms', 'strength of recommendation' and its 'relative importance'. The 
qualitative study supported inclusion of other factors when grading evidence. 
The problem would now be that recommendations might become more 
subjective and potentially prone to new criticisms. 
Interviewees referred to flexibility as a factor that could accommodate 
both research evidence and real practice together. Some researchers adopted 
the same position (Graham et al, 2000b). They challenged the assumption that 
variations in care processes and outcomes reflected poor practice in primary 
care. Studying the validity of heart failure guideline for primary care, they 
offered their 'conundrum' as: 'clinical guidelines must be both clinically 
applicable to individual patients and whole populatj . ons'(p 953). However, this 
might not be an easy task to achieve and probably 'a bridge too far. Again the 
definition itself required more clarification and boundaries were not precise. In 
order to cover that level of comprehensiveness in guidelines, exhaustive and 
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detailed documents would be required. The resulting guideline would perhaps 
be more complicated than what many GPs expected to see, as discussed in 
details under 'simplicity' (4.3.5). 
Change in guidelines featured as an important factor that could result in 
reducing the credibility of content of a clinical guideline. Change in guidelines 
(for example through updating) negatively affected implementation through 
impeding clinicians' progress through the learning curves (Maisonneuve and 
Tiiu, 1999), although this was probably more relevant to complicated 
procedures than to prescribing. 
4.4.3. Guidelines and practice improvement 
Answering the question of whether guidelines changed prescribing was not the 
objective of the qualitative study. This was better done through systematic 
reviews of trial evidence (e. g. look at Grimshaw and Russell, 1993; Grimshaw et 
al, 1995; Grimshaw et al, 2004; also see Chapter 2) or qualitative evidence (e. g. 
see Ferlie et A 2001). In particular, guidelines alone had limited impact on 
behaviour change. Allery et al (1997) studied why G Ps changed their clinical 
practices (including prescribing) and found a small role for guidelines. However, 
closer look at the way Allery et al analysed their data raised some questions 
over the approach they used for categorisation of reasons for change. It 
seemed that guidelines might have contributed through other factors that Allery 
et al identified. GPs used guidelines for a variety of purposes including for 
improving communication with patients. Similar to this analysis, others found 
that 'the GPs appeared to be more interested in using evidence to reassure 
patients and answer any queries they may have, than change their practice 
based on if (Mayer and Piterman, 1999, p 631). 
Armstrong et al (1996) found that implementation was dependent on the 
experience of GPs using drugs on their patients. They identified three models of 
change in prescribing: accumulation model, challenge model and continuity 
model. The findings reported in this chapter were in line with accumulation 
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model (e. g. statins) and continuity model (e. g. asthma). Armstrong et al did not 
observe much change in GlPs prescribing, regardless of many potential sources 
of encouragement for changing prescribing. 
Several studies and reports tried to highlight attributes of good clinical 
guideline (Field and Lohr, 1990; Cluzeau et al, 1999a; Cluzeau et al, 1999b; 
Grilli et al, 2000; Graham et al, 2000a; The AGREE collaboration, 2001; The 
AGREE collaboration, 2003). Earlier papers did not include the issues relevant 
to application and implementation of guidelines among the attributes. This was 
rectified when an international tool for guideline appraisal was developed (The 
AGREE collaboration, 2003). One domain of the appraisal tool was called 
'application' and covered three items of 'cost implications', 'organisational 
implications' and 'audit criteria' (The AGREE collaboration, 2001). The major 
limitation of the appraisal tool was that it was more concerned with the process 
of guideline development than it was with the content (or quality) of clinical 
guidelines. However, an empirical study suggested that the tool related with 
some aspects of credible content of clinical guidelines (Iran! et al, 2003). 
The Institute of Medicine (Field and Lohr, 1990) identified eight attributes 
of 'good practice guidelines'. Those attributes were validity, reliability and 
reproducibility, clinical applicability, clinical flexibility, clarity, multidisciplinary 
process, scheduled review and documentation (ibid, p 59). Almost all of these 
attributes were highlighted by the participants in the qualitative study, with the 
exception of scheduled review. Reliability and reproducibility were also indirectly 
mentioned. The study, however, implied that not all attributes were given the 
same weight in GP view. Some GlPs gave further weight to attributes that others 
saw as less essential. The findings also suggested the addition of one further 
attribute to the list. Guidelines should be clear in their stand against current 
practice and also the potential changes they propose. The now attribute might 
help clinicians to obtain better understanding of why the particular guideline was 
considered as required, which was far too often unclear to clinicians. It would 
also help clinicians and managers to plan resources, the time required for 
implementation and the actions to be undertaken in response to the guideline. 
We called this attribute 'planning for change'. 
159 
The other, rather important finding of this qualitative study was that even 
if all attributes of 'good clinical guideline'were present, guidelines' success in 
improving quality of care required more conditions to be met. The findings 
suggested that the attributes of good clinical guideline might be more attractive 
to methodologists and developers of clinical guidelines than they were to 
clinicians. In reality clinicians were not equipped with reliable tools and 
methodological knowledge to test the 'validity' or'reliability and reproducibility' 
of clinical guidelines. Instead, as the findings of the qualitative study suggested, 
clinicians tended to use credibility of source of guideline and 'respected others' 
recommendations as proxy for those attributes. The AGREE instrument could 
overcome the problem, at least in part (The AGREE collaboration, 2003), and 
therefore it might be useful asset for clinicians and other members of primary 
care teams. The AGREE instrument was used in two recently conducted 
workshops in London (Rashidian, 2004a) and Cambridge (Rashidian, 2004c) in 
which the participants appraised clinical guidelines that they had different levels 
of familiarity with. Although none of the participants had any previous 
experience with the instrument, they were able to perform the task. It is yet to 
establish the validity of judgements made using AGREE, but as mentioned 
previously at least one study suggested that guidelines which obtained higher 
score with AGREE seemed to be of higher content validity (Irani et al, 2003). 
4.4.4. Credibility of source 
It has been argued that credibility of source of a guideline, or the messenger 
who is transferring it, are important elements in guidelines' adoption by 
practitioners (Raisch, 1990a; Rogers, 1995b). The qualitative study provided 
further evidence for the importance of credibility of source. In terms of 
messengers for transferring of guideline, Rogers thought that physicians 
considered 'near-peers' as more trustworthy than others (Rogers, 1995b). The 
analysis suggested that GPs generally considered other GPs as trustworthy, but 
this was not always the case for hospital consultants. Like other studies 
consultants were viewed as valuable sources of advice and support (Carthy et 
al, 2000), but it depended on context, and negative views were expressed at the 
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same time. Others studies suggested that credibility of evidence or source of 
evidence was related to professionalism (Bradley, 1992). This could explain 
somehow the negative views of GPs towards guidelines that were produced or 
promoted by consultants for GP use. Development of clinical guidelines for GPs 
by hospital consultants is still common practice in the UK (Bowens et al, 2001). 
Sometimes consultants spend as little as one hour on developing guideline for 
GPs (Bowens et al, 2001). The interviewees strongly believed that GPs should 
be directly involved in the development or local adaptation of clinical guidelines 
for primary care. 
Rogers (1995) viewed diffusion of innovation as a social process, so that 
physicians sought 'information from peers, usually those who have previously 
adopted the innovation of interest'(p 326). With this in mind, it was easier to 
understand why consultants were not always 'near-peers'. Consultants did not 
work in the same setting as GPs and therefore did not adopt the innovation in 
the way that GPs did. As Greer (1995) put it, appreciation of contextuality was 
wisdom: 'the many factors that impinge not on theory but on practice' (p 328). 
The study suggested GPs were frustrated not only because of the 
number of guidelines they received (Hibble et al, 1998), but also because of the 
perceived lack of relevance and quality of many of those guidelines. The 
participants felt that some secondary based guidelines did not relate well with 
their primary care practice. Evidence suggested that many guidelines suffered 
from poor quality regardless of who produced them (Shaneyfelt et al, 1999). A 
careful review of 431 guidelines from specialty societies suggested that very 
few met all criteria of good guidelines (Grilli et al, 2000). 
The BNF had been shown as a credible source of evidence (Salisbury et 
a[, 1998; Carthy et al, 2000). The study supported the inclusion of clinical 
guidelines in the Formulary to improve their credibility and implementation. 
Apart from BNF, there was limited support that for publications in other sources 
as an implementation tool. This reflected the findings of two previous studies 
(Timpka et al, 1989; Armstrong et al, 1996). 
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4.4.5. Patient pressure 
When studying the reasons for 'non scientific prescribing', Schwartz and 
colleagues (11989) found out that 46% of physicians expressed 'patient demand' 
as the underlying factor. A further 24% mentioned that they used non-effective 
drugs because of 'placebo effect', implying it was the preferred drug for the 
patient (Schwartz et al, 1989). The qualitative study did not imply that patient 
preference were the main factor of non evidence-based prescribing (4-3.6). 
There could be two reasons for this difference. First, the qualitative study was 
different in approach and main questions from Schwartz et al study. They had 
identified physicians that prescribed certain drugs more than recommended and 
then had asked them why they did so. Second and probably more important 
difference was because of setting. Physicians participating in Schwartz et al 
(1989) expressed that they considered patient expectations because of the 
predominantly fee-for-service nature of health services in the US (at the time), 
which was different from the NHS: 'many feared that ... a failure to 
accommodate patients in prescribing could mean loss of business and 
reputation' (Schwartz et a[, 1989, p 579). The fee-for-service market might also 
explain why 1975 study in Iran concluded that inappropriate antibiotic 
prescribing was due to patient pressure (Amidi et al, 1975). Nonetheless, the 
finding that patient expectation was not the main underlying factor of non- 
evidence-based prescribing was in line with what being reported in previous 
reviews (Horder et al, 1986). 
Other studies in Australia (Cockburn and Pit, 1997) and England (Britten 
and Ukoumunne, 1997; Britten et al, 2000) identified that patients were more 
likely to receive prescription if GPs perceived that the patients expected it. 
These studies were performed in non fee-for-service health systems, and still 
GPs were likely to prescribe according to perceived patient pressure. A recently 
published study of the importance of patient pressure in British primary care had 
interesting findings (Little et al, 2004). They measured patients' expectations 
before the visits and doctors' perceptions at the end of the visits. They found 
that the perceived patient pressure was independent predictor of prescribing, 
even when perceived medical need was controlled for (Little et al, 2004). The 
impact of (real) patient expectation was less prominent and inconclusive. Little 
162 
et al study was supportive of the TPB notion of subjective norm (Ajzen, 1991). 
The theory asserted that social pressure affected intention and subsequently 
behaviour if it was 'perceived' by the individual, whether or not it reflected the 
actual social pressure. 
A UK study of factors associated with costs and variation in prescribing 
interviewed seventeen GlPs in Avon and reported excessive and unrealistic 
requests for prescribing from patients as underlying reasons for low quality 
prescribing (Carthy et al, 2000). There were differences between Carthy et al's 
and the qualitative study presented here. First, Carthy et al assessed antibiotic 
prescribing, where GPs are urged to prescribe less. The present study focused 
on prescribing for predefined clinical areas in which guidelines were generally 
urging for more proactive prescribing of specific products. Second, in the 
present study, widely-known clinical guidelines for asthma treatment and CHID 
prevention could have helped GPs in better communication with patients and in 
convincing them. Also in light what reported by Little et al (2004) it was likely 
that the perceived pressure for low quality prescribing (Carthy et al) might not 
have reflected patients' real expectations. 
4.4.6. Local initiatives and national priorities 
The interviewees generally supported in-house and local adaptation of national 
guidelines. Local initiatives, especially at practice level, might explain some of 
variation in quality of care received by patients (Griffiths et al, 2001) and were 
more likely to succeed in implementation (Fairhurst and Huby, 1998). Social 
influence theory advocated use of participatory guideline development to 
increase ownership and implementation (Mittman et al, 1992). The issue of 
locally developed guidelines was discussed in Chapter 2 (2.3.6 and Table 2.1) 
and in 4.3.9. A systematic review of clinical guideline implementation 
programmes in primary care reported a success rate of four out of nine for local 
guidelines, and one out four for national clinical guidelines (Worrall et al, 1997). 
Despite that a review of rigorous interventions for guideline implementation 
identified four studies, of which only two studies found participatory guidelines 
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effective (Grimshaw et al, 1995). The overview of systematic review concluded 
that participatory guideline development was unlikely to be cost-effective 
(2.3.6). Local adaptation, however, could be used for setting standards of care 
and local targets (4.3.9) and might facilitate 'translation of evidence': 
It follows, therefore, that research is rarely, if ever, self-evident to the 
practitioner, but varies according to the context within which it is 
received. ... In promoting an 
innovation orpiece, of research evidence we 
are not dealing with the uncomplicated dissemination of findings to a 
largely passive and receptive audience -a simple problem of "putting 
theory into practice" in the hackneyed sense of the phrase - but with the 
question of reconnecting research with its supplementaly other- practice. 
The key point here is how evidence is translated within the assumptive 
world of practitioners (Wood et al, 1998, p 1734). 
Despite benefits of local initiatives, national priorities should be taken into 
account. Making priorities based on local consideration might result in 
unnecessary focus on areas that were already in satisfactory status (Haines 
and Jones, 1994). In recent years in England, national priorities often emerged 
through NSFs and more specifically via guidance and guidelines issued by the 
NICE. Credible and evidence-based performance indicators might improve 
implementation of NSF recommendations and NICE guidelines and give 
authority to monitor change (Wilkinson et al, 2000). However, it might be the 
case that most changes happen in data recording. Also the quality gap might 
increase as practices with better infra structure and quality of service would 
respond more rapidly to the initiatives (Wilkinson et al, 2000) and get rewarded. 
The analysis of the interviews implied that enforcing guideline implementation 
could be successful in limited instances, could be short lived, and might hinder 
long term success of implementation programmes. According to the field theory 
(Lewin, 1951) increasing deriving forces without addressing resisting forces 
leads to increased tension without much achievement. Approaches that includ 
imposing guidelines might'force, practitioners to develop avoidance strategies, 
but not change actual prescribing intentione (Raisch, 1990b, p 540). 
Although financial, managerial and other pressures might be necessary 
to change behaviour in special circumstances, they should not be used as a 
routine. The study and previous research indicated that practitioners interpreted 
these pressures or objectives with suspicion (Mayer and Piterman, 1999). Also 
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the findings supported previous studies that physicians did not welcome cost- 
containment motives for change in prescribing (Raisch, 1990b). The 
respondents to a survey of 1549 physicians in the USA found it unacceptable 
and ethically incorrect if payers enforced guidelines. This was especially true 
when the guidelines included cost containment motives (Sulmasy et al, 2000). 
Cost containment motives should be explicitly defined in the guidelines (Mayer 
and Piterman, 1999), especially as it was not uncommon for guidelines to aim 
for reducing costs (O'Brien et al, 2000). 
4.4.7. Practice nurses, prescribing advisers and reps 
Some interviewees considered practice nurses as more active in guideline 
implementation than GPs- Other studies of practice nurses in the UK had found 
that nurses were generally welcoming towards clinical guidelines (Harrison et al, 
2002; Puffer and Rashidian, 2004) and encouraged GPs to be likewise 
(Cranney et al, 2001). The participants also found nurses positively influential 
on their implementation of clinical guidelines. Also the participants had positive 
views on the effects of nurse-run mini-clinics on guideline implementation. Four- 
year follow-up of an RCT demonstrated that CHID prevention clinics were linked 
to improved quality of patient care, potential life saving and fewer cardiac 
arrests (Murchie et al, 2003). 
The study suggested that prescribing advisers had only limited roles in 
implementation of guidelines, similar to another British study (Salisbury et al, 
1998). This was despite the theoretical support (Mittman et al, 1992) and 
empirical evidence for positive effects of educational outreach visits on 
prescribing (see 2.3.8). However more recent studies found the effectiveness of 
educational outreach variable (2.4.1). Two recent British trials indicated that the 
effects of prescribing advisers were likely to be minimal and limited to certain 
conditions (Watson et al, 2001; Freemantle et al, 2002). These findings and the 
interviewees responses might be explained by social influence theory, which 
implied that educational outreach visits were likely to be more successful when 
advisers were known and respected by target GPs (Mittman et al, 1992). 
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Interviewees acknowledged the role of drug company reps in the 
implementation of BTS asthma guidelines and less prominently in the diffusion 
of CHID risk estimation charts. It was suggested that this sort of influence 
tended to be indirect (Rogers, 1995b). A British RCT failed to demonstrate any 
effects from drug company reps' visits (Freemantle et al, 2000). Similar to the 
views expressed by the interviewees, previous research demonstrated that 
many members of guideline development groups had relationship with drug 
industry (Choudhry et al, 2002). The participants found this a threat to the 
validity of clinical guidelines. 
4.4.8. Information technology; medico-legal issues 
Previous research concluded that computerised systems may not be that 
effective in improving implementation of guidelines for a chronic disease like 
diabetes (Hetlevik et al, 2000), mental health care (Lewis et al, 1996) or even 
lipid lowering prescribing (Hobbs et al, 1996). The benefits of computerised 
systems tend to be limited to certain areas of care including screening and 
prevention (see 2.3.10). At the time that this study was conducted there were 
limited research on the effectiveness of computerised clinical guidelines (e. g. 
PRODIGY) in improving quality of care in British primary care. A recent cluster 
randomised trial and a follow up qualitative study concluded that the 
computerised system was unsuccessful in improving implementation of clinical 
guidelines for asthma and angina (Eccles et al, 2002; Rousseau et al, 2003). 
These studies supported the finding that incorporation of clinical guidelines for 
complicated clinical conditions (e. g. hypertension, asthma) into software 
packages would have a limited impact on implementation. 
Respondents did not perceive that guidelines were causing them more 
susceptible to medico-legal claims. This was in line with what predicted in a 
previous systematic review of evidence (NHS Centre for Reviews and 
Dissemination, 1994). They referred to the Bolam test as a basis for 
identification of clinical negligence cases in court (Jones, 2000). The Bolam test 
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used the criteria of common professional practice rather than whether the 
practice was based on evidence. Based on this test professional non-adherence 
to a guideline was negligent only if it was shown that the guideline was so 
widely used and accepted by the professional community that no reasonable 
skilled professional failed to comply with the recommendations (NHS Centre for 
Reviews and Dissemination, 1994). The Bolarn test has been challenged in 
more recent court rulings (Jones, 2000; Samanta and Samanta, 2003). Despite 
this the interviewees did not perceive medico-legal issues a major source of 
discontent for guidelines. 
4.4.9. Thematic framework, TPB and the taxonomy of 
interventions 
The qualitative study findings were used to update the taxonomy of 
interventions presented in Tables 2.1 and 3.3. A further column was added to 
the original table to present whether GPs perceived the intervention as 
'effective', with 'limited effect' or 'not effective'; or whether there was no mention 
of the intervention in the interviews ('not stated'). One intervention (essential 
drugs programmes) was specific to developing countries context and therefore 
was noted as 'not applicable' (Table 4.2). 'Not stated' category might imply that 
the intervention had limited application for changing prescribing behaviour, it 
was not effective or it was not widely experienced in the UK. It was assumed 
that interventions with no evidence of effect and 'not stated' in the interviews 
were unlikely to be important assets for behaviour change. There were 
important agreements between the findings of the systematic review and the 
qualitative study. This might reflect the sampling of the qualitative study and that 
the respondent might have been informed of the literature. There were also 
important disagreements. For some intervention with no evidence of effect, the 
qualitative study provided support. This could be informative since not all 
interventions could be assessed in experimental or quasi-experimental studies. 
The comparisons were summarised in Table 4.3. 
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TABLE 4.2. SAGE TAXONOMY OF INTERVENTIONS, VERSION 11. STRATEGIES FOR IMPROVING 
PRIMARY CARE PRESCRIBING: EFFECTIVENESS EVIDENCE PLUS THE OUALITATIVE STUDY 
FINDINGS 
Opinions of the 
Evidence from the overview of systematic reviews Interviewees 
Intervention Relevant Effect Cost Durability 
theories 
Competence CME Adult learning; ++ Medium ? Not stated 
oriented (interactive) TPB 
IP education Adult learning ? Medium ? Not stated 
Mailed printed Social influence; +/0 Low ? Short Not effective 
material TPB 
Mailed national Social influence + Low Medium to Not stated 
warnings $ long 
Participatory Social influence, + High ? Medium to Effective 
guideline devel. TPB; health long 
education 
IP shared care Health +/0 ? High ? Effective 
(consult-liaison) education; TPB context specific 
Mass media Diffusion; TPB; + Low ? Medium Not stated 
social influence 
Performanc e Audit and TPB; social + Low to 7 Effective 
oriented feedback$ influence; stages medium 
ofchange 
Reminder TPB 7+ Low to Short Limited effect 
systems medium 
Educational Diffusion; social ? ++ Low to high Short to long Limited effect 
outreach influence; stages context specific 
of change; TPB 
Social Peer review Social influence; ? Wedium to ? Effective 
influence TPB; Diffusion high 
Patient mediated Social influence; + Low to ? Effective 
TPB medium 
Local opinion Diffusion; ? Wedium to ? Stated once 
leaders Leadership; TPB high effective 
Cal $$ Management ? Wedium to ? Not stated 
theories high 
Physical Practice support Management ? ? ? Eff ective 
support theories; TPB 
Essential drugs Management ?+ ? ? N/A 
programmes `6 theories i 
Financial Financial Economic; social ? +/- Low to high ? Short to Limited effect 
incentives incentives influence medium 
Non- Reimbursement Economic ? +/- ? ? Limited effect 
voluntary and budgetary theories; TPB 
policies 
Rules, Economic and ? ? ? Effective 
obligations management; 
social ecology 
Restricted Economic; social + ? Wedium to Eff ective 
formulary ecology long 
De-registration / Economic; social ? +/- ? ? Not stated 
reclassification ecology I 
IP: Inter-professional, ++: strong evidence suggests positive (intended) effects, +: limited evidence suggests positive 
(intended) effects, +/0: variable effectiveness, ?: no evidence of effect, ? +: no evidence of effect, however less 
reliable evidence suggests positive effects, ? +/-: no evidence of effect/ likelihood of positive and negative (intended 
and unintended) effects, $ it usually also has an element of social Influence, % it usually Incorporates competence 
oriented approaches, $$ it usually has elements of physical support and competence oriented approaches. 
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TABLE 4.3. COMPARISON OF THE FINDINGS OF THE OVERVIEW OF SYSTEMATIC REVIEWS AND THE 
QUALITATIVE STUDY ABOUT THE EFFECTIVENESS OF DIFFERENT INTERVENTIONS 
Intervention Evidence of effect Perceived effectiveness 
(extracted GP opinions) 
Congruent findings 
Participatory guideline + Effective 
development 
Audit and feedback + Eff ective 
Patient mediated + Effective 
Restricted formularies + Effective 
Reminder systems ?+ Limited effect 
IP shared care +/0 Effective / context specific 
Incompatible findings 
Educational outreach ? ++ Limited effect 
Mailed printed material +/0 Not effective 
Interventions with no evidence of effect that were perceived effective 
Peer review ? Effective 
Local opinion leaders ? Effective 
Practice support ? Effective 
Rules, obligations ? Effective 
Interventions with no evidence of effect and not stated In the Interviews 
IP education ? Not stated 
Cal ? Not stated 
++: strong evidence suggests positive (intended) effects, +: limited evidence suggests positive (intended) effects, +/0: 
variable effectiveness, ?: no evidence of effect, ? +: no evidence of effect, however less reliable evidence suggests 
positive effects, ? +/-: no evidence of eff ectl likelihood of positive and negative (intended and unintended) effects 
Identification of the qualitative themes was an evolving process and 
matured during the process of the analysis, in line with the framework 
methodology (Ritchie and Spencer, 1994). The thematic framework started with 
nine main themes and reduced to seven (Table 4.1). For example analysis 
revealed that all of the sub-themes of 'practitioner related attitudes' were 
somehow relevant to the other main themes, hence this theme was dropped 
from the final framework. The themes also were not completely exclusive and 
there were degrees of overlaps. For example, there were difficulties in 
categorising the items relevant to patient-doctor interaction under the main 
themes. In the end, it was decided to split the items between two different 
themes of 'credibility of content of clinical guideline' under 'flexibility' and 
'influential people in implementation' under 'patients'. A similar situation 
happened when dealing with items explaining the role of secondary care 
professionals in implementation of guidelines in primary care. In this case, the 
items were split between 'credibility of source of clinical guideline' and 
'influential people in implementation'. The other example was 'publishing clinical 
guidelines in respected source' as a sub-theme. Although it could have been 
discussed under 'dissemination strategy', it was decided to put it under 
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'credibility of source of clinical guideline'. It was argued that guidelines were 
usually published by the developers, while other dissemination activities were 
normally performed without the developers' involvement or their knowledge. On 
the other hand, the sub-theme of 'ownership' was categorised under 
'dissemination strategies'. Although local ownership of guideline improved 
credibility, it was usually undertaken as part of the dissemination process. 
TA13LE 4.4. SIMPLIFIED THEMATIC FRAMEWORK. FACTORS THAT MAY EXPLAIN VARIATION IN 
EFFECTIVENESS OF INTERVENTIONS TO IMPROVE PRIMARY CARE PRESCRIBING 
Theme 1: Credibility of content of clinical guideline 
Evidence-based Flexible 
Reflect change in practice/ Avoid change in recommendations 
Theme 11. Credibility of source of clinical guideline 
National professional bodies e. g. BTS Secondary care (not reputable) 
(reputable) 
National governmental bodies e. g. NICE Pharmaceutical companies (not reputable) 
(reputable) 
Published guidelines In respected sources (e. g. BNF, Clinical Evidence, BMJ, Lancet) 
Theme 111. Presentation of clinical guidelines 
Simple Systematic presentation 
Theme IV. Influential people In Implementation 
Patients (barriers and facilitators) Practice nurses and primary care team (usually 
facilitators) 
Consultants (barriers and facilitators) PCOs, pharmacists and prescribing advisers 
(limited effects) 
GP colleagues (barriers and facilitators) Drug companies and reps (barriers and 
facilitators) 
Theme V: Organisational factors 
Practice characteristics (mini-clinics) 
Information technology (effective In limited 
circumstances) 
Availability of required resources 
Time, workload and Information overload 
Cost and expenditure 
Theme VI. Disease characteristics (where guidelines for GPs could be less effective) 
Treatment Is secondary care based Rare or'simple' disease 
Difficulty of diagnosis 
Theme VII. Dissemination strategy 
Planning Implementation Ownership - local versus national guideline 
Perceived need, experience and knowledge Enforced Implementation 
Supporting Implementation and Implementation Medico-legal Issues 
cost 
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Simplified version of the thematic framework was presented in Table 4.4. 
The sub-themes were re-worded to ease the understanding. Short explanations 
(in brackets) were added to the sub-themes to demonstrate how the sub- 
themes might influence implementation. The simplified thematic framework was 
incorporated in a secondary analysis of the data focusing on the relationships 
between different themes. The results of this secondary analysis were used to 
develop a simple model for implementing prescribing recommendations within 
guidelines in primary care. The model is presented in Chapter 5. 
The thematic framework was developed following deductive (extracting 
sub-themes and items from theories and literature) and inductive (using data to 
develop the framework) approaches. Theory of planned behaviour was the main 
theory used for the development of the thematic framework. At superficial level, 
the final framework (Tables 4.1 and 4.2) might have little resemblance to the 
TPB and its constructs (3.2.6 and Fig 3.3). However the framework substantially 
benefited from the TPB. Among the main themes, Theme IV (influential people) 
was derived directly from the TPB's notion of 'subjective norm'; and the 
corresponding sub-themes reflected important groups that formed the salient 
normative beliefs of the interviewees. Other themes were also closely correlated 
with TPB constructs. Themes I and 11 (credibility of content and source) affected 
GPs'attitudes towards implementing guidelines. Themes III (presentation), V 
(organisational factors) and VII (implementation strategies) were more closely 
related to the TPB concept of 'perceived behavioural control'. Sub-themes 
identified as 'organisational factors' directly influenced guideline 
implementation, resembling the direct link between perceived controls and 
behaviour in TPB. The correlations between the themes and TPB construct 
were not exclusive. For example, 'credibility of source' could also affect 
'subjective norms'. Only theme VI ('disease characteristics') did not seem to 
correlate with TPB constructs. 'Disease characteristics' was developed mainly 
as a 'screening' theme (5.3.1). The sub-themes could be used for identifying 
circumstance for which clinical guidelines for GPs might not be very effective. 
The results of the qualitative study were used for the next stages of the 
project. Among five clinical conditions directly assessed in the study, only two 
conditions (asthma and statins for CHID prevention) had widely known clinical 
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guidelines and hence were suitable for use in the surveys. The qualitative study 
was also used for the identification of salient beliefs of GPs about implementing 
prescribing recommendations of clinical guidelines for asthma and CHID 
prevention. These beliefs were incorporated into the TPB questionnaires. 
Theory of planned behaviour was then directly assessed. The results are 
presented in Chapter 7. 
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McFarlane's law: 'when conflicting theories co-exist, 
any point on which they all agree is the one most likely 
to be wrong. 
McFarlane, 1984, p 253 
Chapter 5. SAGE model for implementing clinical 
guidelines in Primary Care Organisations in the 
NHS 
5.1. Introduction 
5.1.1. Background 
Many (Grimshaw and Russell, 1993) have advocated the use of clinical 
guidelines to diffuse evidence-based practice. However more recent reviews 
(e. g. Oxman et al 1995; Davis and Taylor-Vaisey 1997; Bero et al 1998; NHS 
Centre for Reviews and Dissemination 1999) have shown that changing 
professional behaviour is difficult. Nevertheless some interventions are more 
successful than others (Wensing et al, 1998). 
Against this background clinical governance was introduced (Department 
of Health, 1998). Since then the role of PCOs has been expanded to include 
quality improvement (Department of Health, 2001c). In this role they can exploit 
national targets (e. g. from National Service Frameworks - NSFs), guidelines 
and guidance (e. g. from the National Institute for Clinical Excellence - NICE) 
and quality reports (e. g. from the Commission for Health Improvement). 
Nevertheless it is difficult for PCOs to improve quality of care through 
proactive implementation of guidelines. Given their limited resources and the 
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increasing cost of prescribing, extra costs are not welcome. However PCOs 
have some advantages. First they have more power to influence prescribing 
initiated in secondary care. Secondly, because PCOs scrutinise prescribing 
costs, GPs may be more willing to adopt evidence that reduces costs. 
5.1.2. Existing models for implementing guidelines & changing 
prescribing behaviour 
Understanding and synthesising the evidence on modifying physicians' 
behaviour is difficult. Stocking (1985) was one of the first to study the diffusion 
of innovation in British health care. Greer (1988) and Phelps (2000) saw the 
problem as one of information diffusion and others as one of research utilisation 
(Logan and Graham, 1998). Others focused on specific physician behaviours 
like prescribing (Raisch 1990a & 1990b) and preventive care (Walsh and 
McPhee, 1992) or on specific underlying factors (Robertson et al, 1996). 
Implementing evidence-based practice and clinical guidelines is the focus of 
other publications (Rogers, 1995b; Grol, 1997; Kitson et al, 1998; Thorsen and 
Makela, 1999). These and others have proposed frameworks for implementing 
evidence-based practice (Stocking, 1985; Greer, 1988; Logan and Graham, 
1998; Baker et al, 1999; Ashford et al, 1999; Phelps, 2000). 
Previously systematic reviews have been used to generate an 
educational taxonomy of guideline implementation (Lomas and Haynes, 1988; 
Grimshaw and Russell, 1994; Wensing and Grol, 1994; Le Grand et al, 1999). 
Similarly the overview of systematic reviews was exploited to update taxonomy 
of interventions for prescribing behaviour in primary care (Table 2.1). Here the 
results of the secondary analysis of the qualitative data are used to generate a 
model of guideline implementation focusing on a single behaviour (prescribing) 
in a specified setting (primary care). 
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5.1.3. Theories of behaviour change 
Grol (1997) recognised the importance of studying psychological theories of 
guideline implementation. Among theories for explaining behaviour in health 
professionals, social cognition approaches were focused on because these 
have more potential to explain guideline implementation (Bandura, 1986; Ajzen, 
1991; Conner and Sparks, 1996). Among those, the TPB asserts that 
'individuals make behavioural decisions based upon consideration of available 
information' (Conner and Sparks, 1996). Consistent with this Mittman et al 
(1992) described social influences on guideline implementation. The TPB 
argues that'subjective norms'are among main predictors of intentions, and 
'perceived behavioural controls' mediate other external influences on intentions 
and behaviour. Other factors that were considered in developing the model 
included credibility of evidence source (see 4.3.4.; also Filed and Lohr, 1990), 
marketing strategies (Rogers, 1995b) and organisational factors (Berwick, 
1996). Coercion may also explain variations in practice (Grol, 1997). 
5.2. Methods 
This is a model of guideline implementation for PCOs across Britain. Though it 
is based on theories of behaviour change, technical terms typical of the 
behavioural sciences are excluded from it. Rather than make it exhaustive, it 
also excludes esoteric elements with less practical relevance. 
The qualitative study comprised 25 semi-structured, in-depth interviews 
with GPs and primary care academics (Chapter 4). They were conducted in late 
2000 and early 2001. Data was analysed using the framework method (Ritchie 
and Spencer, 1994; Ritchie et al, 2003). In principle the model was based on 
these interviews. To make the resulting model of guideline implementation for 
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prescribing in primary care more comprehensive, also the results of the 
overview were consulted. 
5.3. The model - findings and synthesis of the model 
This model of guideline implementation comprised six steps, successively 
addressing: condition characteristics; guideline characteristics; influential 
people; organisational factors; implementation strategies; and adherence 
monitoring. The steps closely followed the themes identified from the primary 
analysis of qualitative data (Table 4.2). The differences were that Themes 1-3 
(credibility of content, credibility of source, and presentation) were grouped 
under'guideline characteristics' here, and the final step 'adherence monitoring' 
was extracted from 'implementation strategies' theme (Figure 5.1). 
5.3.1. Choosing the condition 
The model asked three main questions about the condition: 
Does secondary care have a major influence on treatment for this 
condition? If so then successful implementation will need close 
collaboration with secondary care. 
2 Why is prescribing for this condition difficult? Is it because diagnosis is 
also difficult? If so then successful implementation will need to address 
this issue, possibly through close collaboration with secondary care. 
3 Prevalence - is the condition rare? If so then successful implementation 
needs effective reminders to GPs, perhaps through patients or 
computerised guidelines. 
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FIGURE 5.1. SAGE MODEL OF GUIDELINE IMPLEMENTATION FOR PRESCRIBING IN PRIMARY CARE 
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5.3.2. Choosing the clinical guideline 
The model asked four main questions about the guideline: 
Are the guideline sources (both developer and disseminator) credible? 
In particular many GPs have objections to guidelines from secondary 
care. They believe hospital doctors differ in their case-mix, workload and 
relationships with patients, and are therefore unfamiliar with primary 
care. For guidelines to cross these professional boundaries needs 
publication in a respected source, or local review and adaptation to 
primary care or, best of all, both. 
2 Is the guideline content credible? Though GlPs value evidence-based 
guidelines in principle, they often find that evidence unsatisfactory or 
irrelevant in practice. They may even see evidence as reliable, but 
irrelevant to their patients. Again local adaptation may be helpful. 
3 Is the guideline message consistent with accepted wisdom? GPs find 
sudden changes in these messages threatening to both their trust in the 
evidence and their relationship with patients. So it is essential to justify 
any change of message. It is especially difficult to reverse trends in 
prescribing practice. 
4 Is the presentation of the guideline as clear and simple as possible, 
consistent with accuracy? Simplicity is not a simple concept (4.3.5). 
Some GPs find a given guideline simple while others perceive it as 
difficult to understand or follow. First contact with a guideline is especially 
important. It must overcome GPs' universal experience of guidelines that 
were neither credible nor consistent. 
5.3.3. Identifying people who influence the target prescribing 
behaviour 
GlPs within a practice generally affect each others' behaviour. The effect in 
larger practices can be substantial, especially when principals divide 
responsibilities. To ensure that one engages all opinion leaders it is prudent to 
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involve more than one practitioner per practice in implementation, but its 
benefits should be compared with extra costs involved. Other potentially 
influential people include practice nurses and other members of the primary 
care team, especially those involved in the care of patients covered by the 
guideline. 
Outside the practice but within the locality, secondary care is a major 
source of influence on prescribing. It is especially important to attract local 
consultants' support for targeted guidelines when their existing influence is not 
entirely consistent with guideline recommendations. Nurse practitioners and 
clinical nurse specialists can also be influential. Though the influence of PCO 
prescribing advisers (and pharmacists) is still limited, their role in 
implementation is likely to increase as PCOs settle down. 
Patients also influence GPs' prescribing behaviour. So targeting patients, 
especially those with rare diseases or major health care needs, can encourage 
GPs to adhere to guidelines. This can also help to maintain the patient-doctor 
relationship in the face of changes in guideline recommendations. 
National bodies are also influential. Respondents admitted that NSFs 
and guidance from NICE both influence their prescribing. The main reasons 
given were the credibility of the sources and the authority conveyed by their 
publications. Pharmaceutical company representatives can also encourage or 
discourage adherence to prescribing guidelines. They have direct influence on 
GPs and indirect influence through consultants and nurses. Their role can be 
beneficial where the guideline recommends a new drug or more of an old drug. 
5.3.4. Identifying relevant organisational factors 
Respondents argued that the current state of primary care had direct effects on 
implementation and indirect effects on other elements in the model. Workload in 
general practice was a major issue. There was a strong belief that GPs and 
primary care teams were under increasing pressure, mainly because of 
continuous change in clinical practice and management. 
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The process of assimilating, implementing and auditing guidelines 
consumes yet more time. Furthermore the stepwise approach of most 
guidelines for drug treatment results in more appointments. Thus most GPs 
perceived guidelines as sources of extra workload. Fortunately GPs change 
their priorities to create more time for essentials. For example 'mini-clinics' have 
proved helpful in providing extra time and staff for targeted activities, and could 
help in implementing guidelines. 
The cost of drugs is also important. PCOs need to be especially vigilant 
when advocating guidelines that recommend expensive new drugs without 
reducing the need for old treatments. For example the perceived cost of statins 
delayed their adoption until the true cost became clear. Respondents generally 
regarded computerised patient databases as essential in chronic disease 
management. Though there was more suspicion of computerised guidelines, 
many regarded them as useful for rare diseases or conditions with limited 
choices of treatment. They also observed that prescribing recommendations 
could be difficult to follow if access to technology were difficult, for example to 
echocardiography for heart failure. 
5.3.5. Planning implementation strategies 
PCOs should plan their strategies for implementing prescribing guidelines using 
the best available evidence. Many high quality evidence-based guidelines have 
failed through poor implementation, while some mediocre guidelines have 
achieved success through careful implementation strategies (Grimshaw & 
Russell, 1993). Therefore it is recommended that PCOs estimate the level of 
support needed with care. While underestimating the needs of practices will 
prevent successful implementation, overestimation will take resources from 
other guidelines. 
Most of the respondents perceive central guidelines from NICE and 
central targets in NSFs as influential, but not yet coercive. The analysis implied 
that it was important to avoid negative feelings whenever possible. The long- 
term effects of quality improvement programmes depend on the genuine 
support of those responsible for their delivery. Once GPs perceive influence as 
coercion, adherence to guidelines may fall. As a strategy, therefore, one should 
confine the enforcement of guidelines to crucial issues when other approaches 
have proved ineffective. Even then clear messages supported by appropriate 
quality indicators are essential. 
The participants agreed that the main aim of prescribing guidelines is to 
improve patient care. They did not accept cost containment as the sole 
justification for guidelines. When alternative treatments differ in cost but not 
effectiveness, therefore, PCOs should inform GPs accordingly. They should 
specify the benefits of using the more cost-effective drug in releasing resources 
for other patients, preferably with examples. Financial incentives for adherence 
to guidelines were likely to be effective, and merit serious consideration. 
When there is a national validated prescribing guideline for their chosen 
condition, PCOs should choose it and avoid weaker alternatives. Local versions 
of national guidelines can address local concerns, and increase both GPs' 
sense of ownership and their understanding of the underlying evidence. In 
particular PCOs can profitably encourage practices to develop protocols for 
adhering to national guidelines. 
5.3.6. Monitoring adherence to guidelines 
Quality indicators in the form of adherence measures play an important part in 
achieving clinical effectiveness. Their role is to identify, not only poor practice, 
but also outstanding improvement. Even where there is no financial reward, 
recognition of achievement can be fulfilling. Many practices are not aware of 
their strengths and adherence measures can reveal them. In short PCOs should 
set minimum standards of care using guidelines as yardsticks, support their 
practices to achieve them, and publicise success stories both locally and 
nationally. 
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5.4. Discussion 
5.4.1. Taking account of GPs attitudes 
Six key steps were described for PCOs and practices to consider in 
implementing guidelines - condition and guideline characteristics, influential 
people, organisational factors, and implementation and monitoring strategies. 
Underlying theories (Conner and Sparks, 1996) and the findings identified that 
practitioners' attitudes played an important role. GlPs'attitudes and beliefs can 
moderate the influences of other factors on the effectiveness of prescribing 
guidelines. While those attitudes often reflect the reality of clinical practice, they 
can also reflect personal bias (Raisch, 1990b). Either way the attitudes of GPs 
and other primary care workers deserve careful attention. 
5.4.2. How to use the model 
The model views clinical guidelines as comprehensive tools conveying evidence 
to improve prescribing. The model strongly implied that PCOs should not use 
their limited resources to develop their own guidelines. Instead they should 
choose the best available guideline, preferably national, certainly validated. The 
membership of 'guideline teams' responsible for local adaptation, dissemination 
and implementation is important. They may include a wide range of 
stakeholders including GPs, practice and community nurses, practice 
managers, local consultants, community pharmacists, and clinical effectiveness 
officers. Team development takes time but may bring further benefits. 
Guideline teams should tackle implementation as a continuous 
systematic cycle of quality improvement rather than a single task (Berwick, 
1992; Russell and Wilson, 1992; Russell et al, 1993; Donabedian, 2003). The 
effectiveness of quality improvement cycles is yet to be established in critical 
appraisal (2.3.13), but their use seems logical and while there are not many 
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effective alternatives can be helpful. Some respondents recognised that clinical 
governance provided a useful framework for this process. Thus the co-operation 
and support of colleagues over time is essential. While the role of guideline 
characteristics and credibility receives a lot of emphasis, the findings of primary 
analysis (4.4.2) and other literature confirmed that this was only one of many 
influences on adherence (Freeman and Sweeney, 2001). Though the model 
gives weight to organisational factors, guideline teams should bypass those that 
are not alterable (Raisch, 1990a). They should also recognise that it is not cost- 
effective to address every shortfall in clinical behaviour (Mason et al, 2001). 
5.4.3. Areas for further research 
The continuing systematic review of clinical guidelines by the Cochrane 
Effective Practice and Organisation of Care Review Group (2002) has identified 
research into many elements of the model. However the contribution of other 
elements in the model needs more research. These include the contribution of 
practice nurses to GPs' prescribing behaviour. There is also a need to test 
empirically the ability of the theories of behaviour change summarised in this 
paper to explain the uptake of guidelines. In particular national sample surveys 
of GPs are used to validate the TPB (Ajzen, 1991) in this field (Chapters 6 and 
7). 
5.4.4. Summary 
Changing prescribing behaviour in primary care is a difficult task to which 
clinical guidelines can contribute. The model provided a framework and guide 
for PCOs keen to improve quality through guidelines. Successful 
implementation depends on careful planning and consideration of the elements 
of the model. The model can also identify barriers that hinder adherence to 
guidelines. It may help to explain why clinical guidelines vary in their uptake. 
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The most important maxim for data analysis to heed, 
and one which statisticians have shunned, is this: far 
better an approximate answer to the right question, 
which is often vague, than an exact answer to the 
wrong question, which can always be made precise. 
Tukey, 1962, pp 13-14 
Chapter 6: Sampling and sample size for the TPB 
and SAGE surveys 
1. Introduction 
In this chapter the sampling framework and sample size of the SAGE surveys 
are being discussed. It starts with the methods which are applied and tested for 
the purpose of defining a TPB survey sample size, and it follows towards 
specific sample size calculations for the two randomised multi-stage surveys 
planned for this study. The surveys' results are presented in Chapter 7. This 
sample size calculation work was first carried out in October 2001 prior to the 
main SAGE surveys. Its results were used in sampling and sample size 
calculation for the surveys and were presented in the International Society for 
Technology Assessment in Health Care (ISTAHC), Berlin (Rashidian et al, 
2002). The chapter was updated in September 2003 to include new literature 
and to prepare it for publication. To our knowledge this is the first systematic 
attempt to determine sample size for TP13 studies. 
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6.1.1. Sample size calculations in the TPB studies 
Regression analyses are the main recommended analyses for the TPB (Ajzen, 
1991; Conner and Sparks, 1996). Until recently most of the literature suggested 
simple rules-of-thumb for sample size in regression analyses (e. g. Altman, 
1991, p 349). These rules-of-thumb usually take one of three forms: a minimum 
constant value; a minimum ratio of subjects to explanatory variables; or both 
combined (Green, 1991). There is a wide range of alternatives within these 
rules. The minimum ratio of subjects to explanatory variables, for example, 
varies from ten (Altman, 1991) or fifteen subjects per variable (Stevens, 1996) 
to forty subjects per variable in stepwise regression (Pallant, 2001). The danger 
of using simple rules-of-thumb is that the investigator ignores 'the idiosyncratic 
characteristics of research studies' (Green, 1991, p 501). In recent years 
investigators have been more inclined to perform sophisticated analyses to 
ensure their proposed sample sizes conform to the required power. Also 
methodological papers are published on power in regression analysis (Green, 
1991; Hsieh et al, 1998). Comparing power analysis with simple rules Green 
(199 1) concluded 'researchers who use rules-of-thumb rather than power 
analysis are trading simplicity of use for accuracy and specificity of response' (p 
508). 
In planning the surveys, published papers from studies of the application 
of the TPB and theory of reasoned action to health professionals' performance 
were reviewed. Out of ten papers, five reported how they estimated the required 
sample sizes (Table 6.1). Three papers referred to simple rules to justify their 
intended sample size (Levin, 1999; Meyer, 2002; Puffer and Rashidian, 2004). 
The fourth paper, a theory of reasoned action study (Lambert et al, 1997), used 
Cohen's (1988) power table and concluded a sample of only 19 would suffice. 
Finally, a recent randomised trial, used a computer software package for 
sample size calculation (Bonetti et al, 2003). A further review of ten different 
TPB studies (eleven papers) revealed a similar phenomenon (Anderson et al, 
1998; Jemmott et al, 1998; Cox et al, 1998; Abraham et al, 1999; Sheeran et al, 
1999; Conner and Mcmillan, 1999; Terry et al, 1999; Armitage and Conner, 
1999a; Armitage and Conner, 1999b; Conner et al, 2000; Conner et al, 2001). 
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Only one of those papers reported its methods of sample size calculation 
(Jemmott et al, 1998). There is a wide range of sample sizes in those studies. 
As the minimum, a theory of reasoned action study was based on a sample of 
only 27 (Lambert et al, 1997) and a TPB study included 765 professionals 
(Millstein, 1996). 
TABLE 6.1. SAMPLE SIZES IN TPB AND THEORY OF REASONED ACTION STUDIES OF HEALTH 
CARE PROFESSIONAL BEHAVIOURS. 
Citation details Method 
Taylor et al, 1994 
Millstein, 1996 
Lambert et al, 
1997 
Levin, 1999 
Expanded 
TRA; Survey 
Longitudinal 
surveys 
TRA; survey 
Survey 
Walker et al, 2001 Survey 
Watson and Survey 
Myers, 2001 
McCarty et al, Survey 
2001 
Meyer, 2002 Survey 
Topic 
Screening 
mammography 
Offering STD 
prevention advice 
Antibiotics 
prescribing 
Glove use 
Antibiotic 
prescribing 
Glove use 
Smoking 
cessation 
Asking for 
assignments 
Sample 
85 general 
internists 
765 doctors 
27 family 
doctors 
527 nurses and 
lab workers 
126 GPs 
103 nurses 
397 nurses in 
for hospitals 
92 nurse 
students 
Power 
calculation 
method 
reported? 
No 
No 
Cohen's 
power table 
rule of thumb 
for SEM 
No 
No 
No 
N>=50+8m 
Puffer and Survey Offering smoking 48 nurses simple rule of 
Rashidian, 2004 cessation advice thumb 
Bonetti et al, 2003 RCT Third molar 99 dentists GPower 
management software 
package 
TRA: the theory of reasoned action ; SEM: structural equation modelling; ST D: sexually 
transmitted diseases 
Sample size calculation cannot guarantee that a study would have 
sufficient power (Vickers, 2003); however, where there is no power calculation it 
is more likely to waste resources in over-sampled or under-powered research. 
Given the wide range of observed sample sizes, a careful examination of power 
for TBP studies was considered useful for the SAGE surveys and beneficial to 
future research investigations. Before the exercise, two loose limits for the 
sample size were set: the sample should not be smaller than fifty 
(approximately fifteen cases per variable, Stevens, 1996). Upper limit was 
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considered as 600 (or two hundred per independent variable) as a larger 
sample could cause serious resource implications for the surveys. 
6.1.2. Introducing TPB regression models 
Two sets of linear regression models form the main analyses of a TPB study 
(Ajzen, 1991; Conner and Sparks, 1996). Model A is intended to explain the 
variance in behavioural intention (131). In this model, attitudes (ATT), subjective 
norms (SN) and perceived behavioural controls (PBC) are the explanatory 
variables. 
(Model A) Y -`ýA +, 8IX1 +fl2X2 +fl3X3+ e 
or 
BI =, 80 + fl, x ATT + fl2xSN+fl3x PBC 
The second set of models (Model B) is intended to explain the variance in target 
behaviour (BEH). In this multiple regression BI and PBC are the explanatory 
variables. 
(Model B) Y: -rO +rIX1 +r2X2 +e 
or 
BEH=ro +r, xBl+r2x PBC 
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6. Z Methods 
In all the following analyses 5% chance of Type I error was accepted, and 
power to detect differences between alternative hypotheses was set at 80% as 
recommended for research in behavioural science (Cohen, 1988). 
6.2.1. Green (1991) and Cohen (1988) approach: the ý. method 
Green (199 1) introduced a two-step approach for sample size calculation called 
the X method. It is derived from previous work of Cohen (1988, pp 444-5). The 
method has clear advantages over other simple rules. It closely follows the 
power analysis approach and is capable of taking effect size into account; 
something that is missing in other simple rules. Green (1991) compared the 
output of the method with Cohen's power table and found that the results were 
very close, especially when there were limited numbers of explanatory variables 
in the regression models. 
The X method has some limitations. It is based on Cohen's (1998, pp 
448-55) power tables that may be different from other power tables. It also 
assumes that all explanatory variables are included in the model at the same 
time, precluding stepwise regression analysis. This, however, is not a serious 
limitation for two reasons: many have recommended against the use of 
stepwise analysis (Miles and Sheviin, 2001; Cohen et al, 2003); and theory 
based analyses such as TPB studies should include all the variables into the 
regression model at the same time. The third limitation is the need for careful 
estimation of the effect sizes from prior research before the start of sample size 
calculation. This limitation equally applies to other methods as they too require 
some measure estimation from previous studies. 
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The measure of effect size in multiple linear regression is p2 (squared 
multiple correlation coefficient), estimated by R2. In order to facilitate the ease of 
computation, R2 is frequently converted to f 2: 
(1) Effect size index: f2= 
R2 (Cohen, 1988, p 410) 
1-R 
In the, % method the null hypothesis Ho: p2= 0 is tested against the alternative of 
HI: p2 =R2. Sample size (N) is a function of X and f 2: 
(11) XI f2, where X=6.4 + 1.65m - 0.05& 
m is the number of explanatory variables in the regression model. Sample size 
estimated by this riiethod will be close to what can be obtained from power 
tables (Green, 1991). 
6.2.2. Hsieh et al (1998) approach: the VIF method 
For the sake of simplicity the method introduced by Hsieh et al (11998) was 
called the Variance Inflation Factor (VIF) method. As the first step in this 
method the sample size is calculated for a simple regression model. As the 
second step the sample size is adjusted for multiple regression using the 
estimated value of VIF (Miles and Shevlin, 2001). As the aim is to calculate the 
sample size for models A and B (6.1.2. ), simple regression models A' (e. g. 
BI =, 80 +, 81 x SN) and 13' (e. g. BEH = ro + r, x BI) are introduced to correspond 
with models A and B respectively. In model A' explanatory variable can be ATT, 
SN or PBC depending on which one is the main focus of the research. Likewise 
in Model 13', BI or PBC can be used as the explanatory variable. 
For the simple regression models (e. g. A') the hypothesis HO: p=0 is 
tested against the alternative HI: p=r, where r is the expected correlation 
coefficient between explanatory and outcome variables. As the models are 
linear, this is equivalent to testing Ho: 81 =0 against fl, =, 8'1, where fl, is the 
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slope coefficient (Hsieh et al, 1998). This hypothesis tests the proposed 
formulae to calculate sample size (first step): 
(111) N 
(ZI-a/2 
+ Zl-#Y 
+3 where C Y2 
1+r 
C2 
109(1-r 
As (x = 0.05 and 0=0.8, hence 
(Zl-a/2 
+ Zl-, 6) 
2= (1.96 + 0.848) 2=7.885 
The second step is to adjust N' to correspond with the multiple 
regression models (A or B) for which we want to calculate the sample size. In 
the second step, the null hypothesis Ho: [A, A, fl3] = [0, & fl3] is tested against 
the alternative of [, 8'1, A, A] (Hsieh et al, 1998). To estimate the required 
sample size (N) for these models, an estimate of VIF and P2123 is required. P2123, 
or tolerance, is the proportion of variance in one explanatory variable being 
explained by other explanatory variables in a multiple regression (V). The 
required sample size is: 
(IV) N=N'fxVIF=i --- here VIF 
1 
and 
1 p12 
ý2 ,w j- I 
'023 23 
(V) 
22 
-2r12 r13 r23 
'02 
r, 2 
+ rig 
123 2 1- r23 
Formula (V) presented in here applies to a regression model with three 
explanatory variables (Model A). The formula should be adjusted for the number 
of variables in regression model. The correlation value between the outcome 
and explanatory variables (r in formula 111) is required for the estimation of N'. 
The estimation Of P2123 is possible if the zero-order correlations between 
explanatory variables in models A and B are available, which in turn will be 
used for sample size calculation (IV). The assumptions and formulae presented 
here can easily be modified to apply to other regression models with different 
number of explanatory variables. 
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6.2.3. Estimating the sample size 
The likely values required for the SAGE surveys' sample size calculation were 
estimated using the reported values in published studies. Seven TPB studies of 
health professionals' report at least some of the values required for sample size 
calculation using the X and VIF methods (Millstein, 1996; Levin, 1999; Walker et 
al, 2001; Watson and Myers, 2001; McCarty et al, 2001; Meyer, 2002; Puffer 
and Rashidian, 2004). Zero-order correlations between the TPB variables and 
R2 values were extracted from studies wherever reported (Table 6.2). Then 
sample sizes for different models were estimated using the two methods and 
the results were compared to identify the appropriate method for sample size 
calculation. To calculate the sample size for the surveys, the median values of 
the reported estimates in previous studies were extracted and the appropriate 
method was used to calculate the basic sample size. 
6.2.4. Sampling frame, design effect and stratification factor 
An additional issue in studies of health professionals is that the data are likely to 
be clustered. This means that the independence assumption is violated, and 
thus the power of the study is reduced. GPs who work closely together (for 
example in multi-partner practices or within PCOs) are likely to think and 
behave more similarly to one another than other GPs. For example they may 
have more similar prescribing patterns. Therefore the variation in prescribing of 
GlPs working within a PCO is likely to be less than the variation observed 
between GlPs working in different PCOs. Intra-cluster coefficient (ICC) is a 
statistical measure used to capture the cluster effect. In its simplest form, it can 
be represented as ratio of between-cluster variation to total variation (Campbell 
et al, 2001 b): ICC = where a' is between-cluster variance and or' is 2bW .2+ b Ob N 
within cluster variance. Bigger values of ICC represent further losses in power. 
Clustering reduces effective sample size. Because of clustering effect, a 
larger sample size would be required to achieve the same power that could 
have been obtained if data were not clustered. The ratio of the total number of 
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subjects required using cluster randomisation to the number required using 
individual randomisation is known as the design effect (e. g. see Kerry and 
Bland, 1998). The design effect (DE) in a cluster randomised study equals to 
DE =1+ (n -1) x ICC (Campbell et al, 2000b), where n is the number of 
cases sampled per cluster. This is accurate when cluster size is constant for all 
clusters and there is no stratification. Estimation of ICC is an important step in 
estimation of design effect. In this study ICC was estimated from published work 
while considering the nature of variability in prescribing for asthma and of 
statins. Ideally previous studies used for estimating ICC should have had similar 
outcome measures and have been conducted in similar setting. Given there 
were no studies with these characteristics sensitivity analysis was performed to 
establish the effects of different values of ICC on the sample size and on the 
optimal number of sampled GPs per PCO. A range of possible stratification 
variables were considered to reduce the design effect resulting from the 
clustered nature of primary care and to reduce random error (Moser and Kalton, 
1993; Ukoumunne et al, 1999a; Ukoumunne et al, 1999b). 
Figure 6.1 is a schematic presentation of the sampling frame and the 
randomisation process for the surveys. Further details are presented in the next 
Chapter (7.2.2). 
FIGURE 6.1. SAGE MULTI-STAGE SAMPLING SCHEME 
Strategic Health Authority 
I Stratification: 
Primary Care Organisation 
- Three strata using the 
Jarman UPA score 
Randomisation: 
General practice 
Simple random sample of -17 
PCOs per strata 
<- Simple random sample of 
, /-/- 
ýTll() 
practices per PCO 
-Simple random sample of 
one GP per practice 
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6.3. Findings 
6.3.1. Sample size by the X method 
Sample size was calculated using the reported R2 values (Table 6.2. ). The 
resulting sample sizes ranged from four to 41 for Model A (prediction of 
intention) and from five to ten for Model C (prediction of behaviour). These 
sample sizes were smaller than the minimum samples suggested by most rules- 
of-thumb. Small sample sizes were the outcomes of large reported R2 values of 
up to 0.74 in previous TPB studies (Table 6.2). 
6.3.2. Sample size by the VIF method 
This method requires the estimated values of zero-order correlations for sample 
size calculation. Many papers do not report the zero-order correlation values 
between explanatory variables. In this study, sample size calculation with this 
method provided a wide range of values and larger than what achieved through 
the X method (Table 6.2). For Model A, it ranged from 36 to 4024, resulting from 
correlation coefficients of 0.56 and 0.06 between subjective norm and intention 
respectively. For Model B, sample sizes ranged from 18 to 92. 
Using the VIF method, wherever the correlation between the target 
explanatory variable and the dependent variable is large and zero-order 
correlations between the explanatory variables are small, the resulting sample 
size will be very small. On the other hand a small correlation between the target 
explanatory variable and the dependent variable, with large correlations 
between the explanatory variables will result in very large sample sizes. 
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6.3.3. SAGE surveys' basic sample sizes 
The analyses demonstrated that within the range of likely values reported in 
TPB studies, the VIF was more sensitive to variation in parameters' estimates 
than the X method (Table 6.2). The VIF was chosen as the method of choice for 
two reasons. First, TPB studies tended to report high goodness-of-fit values. 
Therefore, sample size calculation methods that used the goodness-of-fit of the 
model would result in sample sizes estimates that were too small for stable 
regression analyses. Second, the X method ignored the peculiarities of potential 
collinearities between the TPB explanatory variables. It also ignored variations 
in the correlations between the explanatory variables and the independent 
variables. Therefore, sample sizes estimated by the X method might be too 
small for identification of important contributions made by individual variables 
into the model. One might argue that in TPB studies the contribution of 
individual explanatory variables in the models is more informative than the 
general goodness-of-fit of the models. 
Thus the VIF method was used for the SAGE surveys sample size 
calculation. To calculate the surveys' sample sizes, the median values of the 
reported coefficients in previous studies summarised in Table 6.2 were used 
(Table 6.3). The only exception was the correlation between intention and 
behaviour, where the median value of 0.4 from previous studies was not used. 
Instead the sample size was calculated in a way to have power of detecting a 
correlation coefficient of 0.25 between intention and behaviour. This was due to 
the reported correlation coefficients were from two studies that measured 'self- 
reported' behaviour at the same time of measuring intention resulting in 
artificially high reported coefficients and R2 values (Levin, 1999; Watson and 
Myers, 2001). The sample sizes were estimated to be 114 for Model A, and 148 
for Model B, if simple random sampling was used (Table 6.3). 
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TABLE 6.3. SAGE SAMPLE SIZE, BEFORE INCORPORATION OF THE DESIGN EFFECT 
Model A 
Correlations SN and 131 SN and ATT SN and PBC ATT and PBC 
0.3 0.5 0.2 0.4 
Sample size 114 
Model C 
Correlations 131 and BEH BI and PBC 
0.25 0.4 
Sample size 148 
6.3.4. ICC and design effect 
The outcome variables of interest in here are GPs' prescribing for asthma and 
of statins, both process variables (Campbell et al, 2000b). The variables should 
be adjusted for case-mix and demographic variations, before being entered in 
the analysis. Many other patient and practitioner variables also affect 
prescribing. Doctors working in one locality may prescribe more similarly than 
those who work in different areas, hence increasing ICC. If prescribing data is 
collected using GP records, then it is a process variable which heavily relies on 
clinician and practice characteristics. It is also influenced somehow by patients, 
as patients' characteristics influence prescribing patterns. On the other hand 
prescribing data obtained from dispensing sources or pharmacies is a process 
variable that becomes more correlated with patients' compliance and 
characteristics. Dispensing data may be different from what can be obtained 
from general practices, as some patients may decide not to take their 
prescriptions to the dispenser. This suggests prescribing data from pharmacies 
has the potential of more variability within clusters than it is the case for process 
variables. Prescribing data to be used for the analysis of the surveys was 
obtained through access to the Prescribing Analyses and CosT (PACT) data 
(Majeed et al, 1997). 
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Campbell et al (2000b) estimated that ICCs for process variables were in 
range of 0.05-0.15. They suggested using ICC value of 0.1 for process 
variables where there was no reliable estimate. ICCs tend to decrease in bigger 
clusters (Ukoumunne et al, 1999a). In the SAGE surveys, GPs were clustered 
within PCOs. The arguments put forward in the previous paragraph and the size 
of the clusters suggested that the true value of ICC for the SAGE surveys was 
probably smaller than 0.1. There were no published ICCs measures for the 
process variables to be used in the surveys (i. e. prescribing for asthma and of 
statins). To decide the likely value of the ICCs within the range of 0.05-0.1 it 
was decided to look for the ICCs for similar patient outcomes. Ukoumunne et al 
(1999, pp 74-75) reported ICCs of 0.0096 for'taking medication for asthma', 
0.0000 for'having steroid inhaler, 0.0061 for'having asthma not on inhaled 
beta-2 agonists'and 0.0011 for'having asthma not on inhaled steroids'frorn 
two different British studies in primary care. Although these variables were 
patient outcomes clustered within practices, they were the closest variables to 
asthma prescribing with reported ICCs that were identified in the literature. 
These small values implied that ICCs for different measures of asthma 
prescribing might be close to the minimum value suggested by Campbell et al 
(2000b). 
ICC for statins may be slightly higher than asthma. The qualitative study 
(Chapter 4) suggested that statins prescribing was more sensitive to prescribing 
costs and budget limitations. Also local initiatives might have greater influence 
on statins prescribing especially for primary prevention of coronary heart 
disease (Rashidian and Russell, 2003). More similarities were observed 
between the interviewees in their intention to prescribe preventive drugs for 
asthma and to follow the recommendations of the guidelines and more 
variability in their views towards statins guidelines. 
Thus it seemed that an ICC of 0.1 to be unnecessarily large for the 
SAGE surveys and a value closer to 0.05 was more representative of the true 
ICC. Although the ICC values for asthma and statins prescribing were not 
necessarily the same, using a single value for both eased the sampling 
procedures and the surveys' handling. With all of these considerations, a value 
of 0.07 for ICC seemed reasonable. Sensitivity analysis of the effects of 
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different ICC values and cluster sizes were performed for both sample sizes of 
114 (Table 6.4) and 148 (Table 6.5). The tables' format was derived f rom 
Ukoumunne et al (1 999a). With an ICC of 0.07 and 10 GPs per cluster, the 
required sample size for Model B was 242. 
TABLE 6.4. SENSITIVITY ANALYSIS FOR THE EFFECTS OF ICC AND CLUSTER SIZE ON DESIGN 
EFFECT AND SAMPLE SIZE, IF THE SIMPLE RANDOM SAMPLE SIZE IS 114 
Estimated Number sampled per cluster Number sampled per cluster 
ICC n=10 n= 20 
Design GPs Clusters Design GPs Clusters 
effect required required effect required required 
0.00 1.00 114 12 1.00 114 6 
0.01 1.09 125 13 1.19 136 7 
0.03 1.27 145 15 1.57 179 9 
0.05 1.45 166 17 1.95 223 12 
0.07 1.63 186 19 2.33 266 14 
0.10 1.9 217 22 2.9 331 17 
TABLE 6.5. SENSITIVITY ANALYSIS FOR THE EFFECTS OF ICC AND CLUSTER SIZE ON DESIGN 
EFFECT AND SAMPLE SIZE, IF THE SIMPLE RANDOM SAMPLE SIZE IS 148 
Estimated Number sampled per cluster Number sampled per cluster 
ICC n=10 n= 20 
Design GPs Clusters Design GPs Clusters 
effect required required effect required required 
0.00 1.00 148 15 1.00 148 8 
0.01 1.09 162 17 1.19 177 9 
0.03 1.27 188 19 1.57 233 12 
0.05 1.45 215 22 1.95 289 15 
0.07 1.63 242 25 2.33 345 18 
0.10 1.9 282 29 2.9 430 22 
6.3.5. Stratification factor 
Stratification reduces the design effect and randomisation errors (Moser and 
Kalton, 1993; Robson, 1993; Ukoumunne et al, 1999a). The measures of the 
target behaviour (dependent variables) are the most appropriate variables for 
stratification. The target behaviours in here were prescribing for asthma and 
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statins as documented in PACT data. Neither of these outcome measures were 
available prior to the surveys. Therefore a range of other variables were 
considered for stratification. The Jarman Underprivileged Area score (Jarman 
score) was used for stratification (Jarman, 1983). 
6.3.6. Response rate and the final sample size 
Response rates to surveys including surveys of GPs varies considerably (Asch 
et al, 1997; Olatunbosun et al, 1998; Di lorio et al, 2000; McColl et al, 2001). By 
employing different approaches for increasing the response rate (including 
individually signed covering letters, information sheets, good quality prints, 
reminder letters, business reply envelopes etc (McColl et al, 2001; Edwards et 
al, 2002)) a response rate of 50% or higher deemed attainable. Considering a 
response rate of 50%, final proposed sample size for each survey equalled 484 
(242/0.50; Figure 6.2). 
FIGURE 6.2. ESTIMATED SAMPLE SIZE FOR MODEL B 
Simple random sampling, using VIF method 148 
(a = 0.05; power = 80%) 
Design Effect = 1.63 242 
(ICC = 0.07; 10 G Ps per cluster) 
50% response rate 484 
BEH =, 80 +, 81 x BI +, 82x PBC 
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6.4. Discussion 
6.4.1. Method of choice for sample size calculation 
The findings in Table 6.2 suggested the X method had limited application for 
TPB sample size when it was based on actual goodness-of-fit (R 2) values 
derived from papers, rather than values suggested by Cohen (1988). Green 
(1991) provided evidence for the advantage of the X method over other less 
sophisticated rules (e. g. N> 50 + 8m) when generic values were used for 
models' goodness-of-fit. Within the TPB literature the regression models' 
goodness-of-fit tended to be large (Table 6.2). All the reported goodness-of-fit 
values were larger than 0.2 with a median of 0.48. Hence the estimated sample 
sizes ranged from (as low as) four to 41 (Table 6.2). These sample sizes were 
less than minimum samples suggested by most rules-of-thumb. In this context it 
was concluded that the X method had no advantage over simple rules-of-thumb 
and could be misleading (also see 6.3.3). An example of erroneous judgments 
that followed the use of the, % method was seen in Lambert et al (1997) study 
when they concluded a sample of 19 would suffice. 
The VIF method was responsive to the requirements of TPB studies. For 
Model A, the power calculation was based on the least powerful predictor of 
intention, subjective norm. This way the study would detect significant 
contributions of all explanatory variables in variation in intention. For Model B, 
the power calculation was based on the best predictor of behaviour, intention 
because a small correlation coefficient between prescribing and predictors was 
possible. The sample size calculations resulted in larger sample sizes for Model 
A than for Model B (Table 6.2). The opposite was expected because the TPB 
variables were more powerful in explaining the variance in intention than in 
behaviour. Smaller sample sizes for Model B in here were merely the result of 
the limitation of information available. Table 6.2 demonstrated that only three 
TPB studies attempted to measure behaviour as well as intention (Millstein, 
1996; Levin, 1999; Watson and Myers, 2001). Of those, only two papers 
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provided values required for the VIF method (Levin, 1999; Watson and Myers, 
2001). In both studies behaviour was self-reported and measured at the time of 
measuring intentions. It is known that simultaneous measurement of intention 
and behaviour is flawed (Conner and Sparks, 1996) and erroneously inflates the 
effects size. Thus larger sample sizes are required for the TPB studies where 
variation in the behaviour is explained. 
6.4.2. Estimating ICC 
We could have used other approaches for the estimation of ICC. Some 
investigators use routine data (Eldridge et al, 2001). Use of routine data can 
lead to more accurate estimates of ICC, but it requires access to data sources 
and can be time consuming. This would have been the preferred option, given 
there were no previous reports of the ICCs for the study outcomes in the 
literature. Unfortunately the study did not have access to the routine data 
required for the calculation of the ICCs. 
There are concerns about the reliability of ICC estimates from previous 
studies. Difference in outcome measures and settings limits the general isability. 
Also ICC measurement is dependent on the estimation methods and hence 
subject to variability (Muller and Buttner, 1994; Campbell, 2000). It can also be 
manipulated by the choice of independent variable (Campbell, 2000). 
Nonetheless, obtaining ICCs from previous studies is the most widely used and 
a practical approach. Others tried to assign confidence intervals to the 
estimates (Ukoumunne, 2002). The outcomes of this work were not 
encouraging as the confidence intervals were very wide. 
6.4.3. Choice of stratification factor 
Although the Jarman score was used for stratification in the surveys, there were 
other variables that could have been used for this purpose. One potential 
approach was to use the presence of specific clinics for asthma and coronary 
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heart diseases in practices as a proxy of quality of care and stratify according to 
it. Data availability was the advantage of this approach. However, this factor 
could not effectively discriminate between practices. The majority of general 
practices provided coronary heart disease prevention special clinics and more 
than 90% of the general practices provided special clinics for the treatment of 
asthma (Baker and Hann, 2001). 
Larger practices have more enhanced infra-structures and capacities 
including support from nurse practitioners than solo or smaller practices. It was 
possible to stratify based on the number of whole time equivalent GPs in 
practices and consider the variable as a proxy to the quality of care; because 
infra-structure and primary care professionals contributed to variation in the 
quality of care provided by GPs (incl. statins and asthma prescribing). Some 
recent studies challenged this hypothesis. One paper suggested single-handed 
practitioner did not necessarily provide lower quality of care (Hippisley-Cox et 
al, 2001). A large scale national survey in England concluded that although 
practice size was related with quality of care, this was not a simple relationship 
and different types of practices had different advantages (Campbell et al, 
2001 a). An RCT of educational outreach visits to improve prescribing for four 
clinical conditions concluded that single-handed practices were more likely to 
improve their compliance with evidence-based clinical guidelines than multi- 
partner practices (Freemantle et al, 2002). Another study reported that PCGs 
with bigger proportion of single-handed practices did not necessarily had lower 
provision of some services, including asthma clinics (Baker and Hann, 2001). A 
further study of statins prescribing concluded that the number of partners in 
practice and practice characteristics (fund-holding and training statuses) had no 
significant relationship with statins prescribing (Packham et al, 1999). The 
average list size per whole time equivalent GP at practitioner, practice or PCO 
level could also be of some value for stratification. There might be a correlation 
between the workload and the quality of prescribing. In this case list size should 
have been adjusted for sex ratio and age of the patients. 
There were justifications for the use of socioeconomic variables as the 
stratification factor. Socioeconomic status of the patients might influence the 
quality of care offered to the patients. For example it was argued that practices 
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with a greater proportion of middle-class or younger patients were more likely to 
improve than others (Jefferys and Sachs, 1983; Horder et al, 1986). Deprivation 
scores were shown to be significantly correlated with all cause cardiovascular 
disease mortality and hence were valid measures of need (Smith et al, 1998b). 
Several deprivations scores are used for the identification of area 
socioeconomic status. The Jarman score, like some others, is based on census 
data. It is originally developed as the measure of GP workload (Jarman, 1983; 
Jarman, 1984). It is known that census based scores may have limited validity 
in representing actual values (Scrivener and Lloyd, 1995). They may also be out 
of date, depending on the timing of the application in comparison to the census 
year. Despite all, the Jarman score has shown useful applications in different 
settings as a socioeconomic variable. It has been validated as a measure of 
health care need (Foreman et al, 2003) including for asthma and statins 
prescribing (Packharn et al, 1999; Salamzadeh et al, 2003). It is widely used in 
a wide range of different studies as a proxy for (health care) need and or 
deprivation. 
The Jarman score possesses some basic advantages that improve its 
validity as a stratifying factor in the SAGE surveys. The score combines a series 
of demographic characteristics (e. g. elderly living alone, children under five in 
the area), socioeconomic circumstances (unemployment and social class V) 
and also the proportion of people from ethnic minorities (Jarman, 1983; Baker 
and Hann, 2001). Those characteristics may influence the need for care 
(asthma and coronary heart disease) and also the dompliance with the offered 
care. A UK study measured the rate of parents' reported wheezing symptoms in 
children. It concluded that lower social class correlates with higher frequency of 
persistent wheezing in children (Duran-Tauleria and Rona, 1999). Having ethnic 
minorities among the indicators is another advantage of the Jarman score. 
There is some evidence that ethnic minorities receive lower quality of care 
including for asthma care (Griffiths et al, 2001), although ethnic background 
may not be directly related to the number of first asthma admissions to hospitals 
(Griffiths et al, 1997). A significant relationship between the Jarman score and 
prescribing for asthma, as obtained from PACT, was explored in a study of GPs 
in Bradford (Salamzadeh et al, 2001). They also reported a higher level of 
readmission to hospital in asthma patients from high Jarman score areas 
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(Salamzadeh et al, 2003). This study was different from Griffiths et al (1997) as 
it focused on readmission rate instead of first admissions, which are more linked 
to individual patient circumstances. Despite these, Baker and Hann (2001) 
found an inconsistent relationship between the Jarman score and the provision 
of asthma care in practices in different areas of the UK. Another study observed 
no significant relationship between the Jarman score and some process 
measures of asthma care (Campbell et al, 2001 a). However, prescribing was 
the outcome measure in neither of the two latter studies. 
Another widely used deprivation score is the Townsend score. It 
comprises four variables which basically represent the socioeconomic status of 
households: unemployment, car or home ownership and overcrowding 
(Townsend, 1987). This combination of items may explain the lack of 
relationship between this score and prescribing for asthma reported from PACT 
(Salamzedeh et al, 2001). On the other hand a relatively coherent relationship is 
observed between higher Townsend score in the area and higher prevalence of 
reported persistent wheezing in children (Duran-Tauleria and Rona, 1999). 
There are also important relationships between some deprivation scores 
and statins prescribing. One study reported a significant negative relationship 
between the level of deprivation (measured by the Townsend or Jarman scores) 
and statins prescribing (Packham et al, 1999). Higher utilisation of 
cardiovascular treatments in low income families, compared with the social 
classes of I and 11, is reported in the literature (Lloyd et al, 1995b). The 
phenomenon may be due to higher prevalence of the disease. Both the 
Townsend and Jarman scores identify low income families and they are highly 
correlated (Pearson r=0.89 reported in Lloyd et al, 1995b). 
Use of census based data for stratification of general practices is prone 
to some biases. These data are reported according to the postal code. If the GP 
practice postcode is used, the problem is that patients registered with the 
practice may live in addresses with different postcodes and hence deprivation 
scores. If the scores are used at the PCO level, this problem will be less 
prominent but then stratification will be limited to the PCO level. A better 
solution is to measure the practice score through the collation of the postcodes 
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of all the patients' on the practice list (a weighted average). This is previously 
used as a measure of need to construct the prescribing allocation formula at 
PCG level (Rice et al, 2000). The basic unit of analysis in the Rice at al (2000) 
study was practice but the data can be aggregated to PCO level if their 
constituent practices are known (personal communication with N Rice, Sep 
2001). Nonetheless, access to the collated deprivations scores was not granted 
to this study. As a result and given the observed relationships between the 
Jarman score with statins and asthma prescribing, this score was used as the 
stratifying factor at the PCO level. 
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6.5. Conclusions 
If theoretical implications are to be tested, for example the mediating role of 
intention between attitudes and behaviour, then the study should be powered 
for that purpose. A review of the theory of reasoned action studies concluded 
many studies were powerful enough to test the goodness-of-fit (132) of the 
model, but not so to test the mediating effects of intentions between attitudes 
and behaviour (Bagozzi et al, 1989). The study supported their finding. It could 
be argued that if the approach presented in this paper was followed, there 
should be enough power to test the models' specific elements. 
The relationships of interest within the regression models of the SAGE 
surveys are between subjective norm and intention (Model A), and between 
intention and behaviour (Model B). Given a generally weak relationship between 
subjective norm and intention the proposed sample size will be large enough to 
reject the null hypothesis of no correlation between either attitude and intention 
or behavioural control and intention (Armitage and Conner, 2001). However, as 
the correlations between behavioural control and behaviour are usually smaller 
than those between intention and behaviour, the study is likely to be 
underpowered for the weaker elements in Model B. For both models, the 
proposed sample size is indeed large enough to test the significance of the 
models as a whole. 
To our knowledge this was the first comprehensive attempt to establish a 
suitable method for sample size calculation for a TPB study. Most of the 
published studies of the TPB had ignored the issue of sample size. Two 
methods of sample size calculation for regression analysis were compared. The 
findings suggested that the VIF method was the most appropriate approach, 
especially when the contribution of specific explanatory variables in the model 
was sought. 
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When we cannot measure, our knowledge is meagre 
and imperfect. 
Lord Kelvin, British scientist 
Even when we can measure, our knowledge is meagre 
and imperfect. 
Jacob Viner, American economist; quoted from Fuchs, 
2000, pl 42. 
Chapter 7. Attitudes, beliefs and prescribing for 
asthma and of statins: national surveys of GPs 
1. Introduction 
This chapter reports the results of two surveys of GlPs beliefs, attitudes, 
prescribing intentions and prescribing outcomes. The two surveys were used to 
assess the ability of the TPB in capturing observed variations in GP prescribing 
intention and prescribing behaviour. The analyses present the limitations and 
merits of TPB in this setting. The results of the surveys are then compared with 
the findings of the previous stages of the project. 
The results of the qualitative study (Chapter 4) were used to identify 
suitable clinical and prescribing topics for the assessment of TPB. Secondary 
prevention of CHD and management of asthma were chosen according to two 
criteria. First, clinical conditions should have had at least one nationally known 
clinical guideline in order to be able to assess GPs intentions to adhere to the 
recommendations. Both CHID prevention and treatment of asthma had 
nationally known clinical guidelines. Second, the drug therapies used for those 
clinical conditions should have limited applications for the treatment of other 
diseases. Both statins and inhaled corticosteroids had limited applications for 
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diseases other than CHID or asthma. The latter criterion was required as PACT 
data was not linked to individual patient characteristics or diagnoses. 
7.1.1. Theory of planned behaviour (TPB) -a summary 
Chapter 3 provided more detailed presentation of TPB (3.2.6). Here TPB is 
briefly reviewed. TPB (Ajzen, 1991) is a social cognition theory (Conner and 
Sparks, 1996), extended from the theory of reasoned action (Ajzen and 
Fishbein, 1980) to provide a theoretical basis for explaining volitional behaviour. 
The theory assumes individuals are rational actors who carefully process 
information before making behavioural decisions. The information processing 
may change underlying beliefs and through them behaviour. 
Theory of planned behaviour suggests that behavioural intention 
(intention) is determined by attitude towards the behaviour (attitude), perceived 
social or peer pressure (subjective norm) and perceived behavioural control 
(perceived control) (Figure 7.1). The term 'attitude towards behaviour' is to 
prevent confusing different attitudes with one another (Montano and Kasprzyk, 
2002). For example a GP's attitude towards asthma can be different from his 
attitude towards prescribing a drug to treat asthma. The subjective norm is to 
explain the effects of perceived expectation of important others on the person's 
behaviour. A GP may perceive pressure from respected colleagues to prescribe 
for a given condition, and hence be more inclined to prescribe. An effect in the 
opposite direction may result from perceived pressure from someone 
considered untrustworthy or not-respected. Perceived behavioural control is the 
person's perception of his ability to perform the behaviour. According to the 
theory, internal and external factors might inhibit or facilitate behaviour through 
control beliefs (Conner and Sparks, 1996). Examples of internal factors are 
information, skills, emotions, and personal capabilities. Examples of external 
factors are opportunities, resources, and social and organisational barriers and 
facilitators. Theory of planned behaviour acknowledges that in many 
circumstances individuals perform (or refrain from performing) behaviours 
despite their intention. This is reflected in the model through a link between 
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perceived behavioural control and behaviour (Figure 7.1). Theoretically the TPB 
is capable of taking into account the person's past behaviour. Past experiences 
affect the person's perceived control and contributes to the formation of 
intention and behaviour. 
FIGURE 7.1. THEORY OF PLANNED BEHAVIOUR (TPB) 
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BEH: Behaviour; BI: Behavioural intention; ATT: Attitude towards behaviour, 
SN: Subiective norm: PBC: Perceived behavioural control 
The theory proposes linear relationships between model elements. 
Attitude, subjective norm and perceived behavioural control all explain intention. 
In turn, intention and perceived behavioural control predict behaviour. These 
relationships are presented by two regression models (A and B) in Figure 7.1 
(Ajzen, 1991; Conner and Sparks, 1996). Theory of planned behaviour has 
shown a good ability in prediction of intended behaviour. The general idea is 
that the professional behaviour of health care professionals is mostly 
intentional. If it is true, the TPB could explain some of the variation in their 
behaviour. In particular TPB might be able to reveal some of the important 
barriers to and facilitators of evidence-based behaviour. For successful change 
of behaviour, careful attention to attitudes is one of the important factors 
(Oxman and Flottorp, 2001). Attitudes of physicians toward guidelines have 
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been studied before (e. g. Olatunbosun et al, 1998). The advantage of TPB is in 
its consideration of subjective norms and perceived controls. 
7.1.2. What is PACT data? What are prescribing units? 
Prescribing analyses and cost (PACT) counts all GP prescriptions that have 
been dispensed by community pharmacies (i. e. not secondary care based), 
dispensing practices or appliance contractors (Majeed et al, 1997). The PACT 
'catalogue' includes quantity and number of items prescribed and their costs. It 
is difficult to assess the quality and relevance of the prescribing activities 
reported in PACT as the data are not linked to patients or diagnoses. PACT is 
widely used as a health services research tool (for example see Hobbs et al, 
1996; Majeed et al, 1997; Griffiths et al, 1997; Watson et al, 2001; Jones et al, 
2001; Watkins et al, 2003). 
General practice demography influences GP prescribing patterns 
(Majeed et al, 1997). For example a university health centre is likely to have 
lower prescribing rates for statins on average since many registered patients 
are young adults. Prescribing units are therefore developed to weight age and 
gender to reflect for prescribing variation caused by demographic differences. 
Prescribing units reflect approximate prescribing needs of the population served 
by a practice and are based on studies of datasets linked to patients (Majeed et 
al, 1997). The simplest forms of prescribing units are those based on the 
number of patients registered with a practice, with higher weights given to 
elderly patients. A more sophisticated prescribing unit takes into account age 
and gender as well as other factors (Lloyd et al, 1997). This latter prescribing 
unit (known as ASTRO-PUs) is applicable across diseases as general indicator 
of prescribing need, hence may have limited validity when specific diseases or 
classes of drugs are assessed. Specific therapeutic group age-sex related 
prescribing units (STAR-PUs) take into account disease and treatment category 
and are calculated for different sections of the BNF (Lloyd et al, 1995a). 
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7.1.3. What are inhaled corticosterolds for? 
Inhaled short-acting P2-agonist bronchodilators (e. g. salbutamol) are the first 
line of treatment for mild asthma. Previous studies suggested that about half of 
asthmatic patients were being treated using inhaled short-acting P2-agonist 
bronchodilators only (Walsh et al, 1999). Chronic and frequent use of these 
products is not recommended and their use should be limited to control of 
exacerbation of asthmatic signs and symptoms (British Thoracic Society and 
National Asthma Campaign, 1997a; Scottish Intercollegiate Guidelines Network, 
1998; Eccles et al, 2001 b); although this advice may not be followed for an 
important proportion of patients (Warner, 1995; Walsh et al, 1999). Inhaled 
corticosteroids are used as the second line of treatment. The main indication for 
the use of inhaled corticosteroids is for the management of asthma in patients 
not controlled by, or requiring frequent use of, short-acting P2-agonist 
bronchodilators (British Thoracic Society and National Asthma Campaign, 
1997a; Prescribing Support Unit, 2002). Inhaled corticosteroids used for 
prophylactic treatment of asthma are of three main types: beclomethasone 
dipropionate, budesonide and fluticasone propionate (British Medical 
Association and Royal Pharmaceutical Society of Great Britain, 2001). There 
are some differences between these. The most commonly used and cheapest 
product is beclomethasone. Budesonide has a similar efficacy to 
beclomethasone (Boe et al, 1989), but lower systemic absorption makes it more 
useful for patients requiring higher doses of steroids. Fluticasone is twice as 
potent as beclomethasone (Barnes et al, 1993) and also more expensive 
(Prescribing Support Unit, 2002). Fluticasone is more likely to be consultant 
initiated than the others (Anon., 2002). There are also combination preparations 
including inhaled corticosteroids and short- or long-acting P2-agonist 
bronchodilators. Examples of these are beclomethasone & salbutamol, 
budesonide & formeterol and fluticasone & salmeterol. The combination 
products are generally more expensive than single products, but easier to 
administer to patients. These medicines are administered by different devices, 
in different dosages, and as generic or non-generic preparations affecting both 
their efficacy and cost. For patients requiring large quantities of corticosteroids, 
addition of long-acting P2-agonist bronchodilators (e. g. formoterol or salmeterol) 
is recommended. These drugs are prescribed as separate formulae or in 
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combination with corticosteroids. It should be noted that these medicines do not 
replace corticosterolds, but are prescribed as addition to them to reduce the 
need for corticosteroids (British Thoracic Society and National Asthma 
Campaign, 1997a). Other groups of drugs including those of theophylline family 
are also used for treatment of asthma. P2-agonist bronchodilators and 
theophyllines are used for other indications including chronic obstructive 
pulmonary disease (COPID). The use of inhaled corticosteroid is almost 
exclusively limited to asthma (Prescribing Support Unit, 2002). As there is no 
strong evidence suggesting clinical superiority of one drug over the others 
among inhaled corticosteroids, short-acting bronchodilators; or long-acting 
bronchodilators, it is recommended that the prescribing of the cheapest drug in 
each category should be considered (Eccles et al, 2001 b). 
7.1.4. What are statins for? 
Administration of statins for secondary prevention of CHID reduces mortality and 
coronary artery events. A large survey of general practices in England in 1997- 
1998 revealed that still many patients were not receiving the quality of care 
expected for them for the secondary prevention of coronary heart diseases 
(Brady et al, 2001). They revealed that in all areas of secondary prevention 
there were 'ample opportunities' for improvement. Hype rcho leste rolae m ia was 
less well managed than hypertension with many patients not receiving statins 
that they required (Brady et al, 2001). Currently only 35% of patients who 
require statins are receiving them (Malik, 2004). 
Statins are 3-hydroxy-3-methylglutaryl coenzyme-A (HMGCoA) 
reductase inhibitors, and generally result in reduction in low-density lipoprotein 
cholesterol (LDL) and total cholesterol levels. They have been proved effective 
for secondary and primary prevention of CHD in several RCTs (Caro et al, 
1997; West of Scotland Coronary Prevention Study Group, 1998; Tonkin et al, 
2000; Schwartz et al, 2001; Sever et al, 2003). Four types of statins were in use 
in the UK at the time of the study: atrovastatin, pravastatin, simvastatin and 
fluvastatin. A fifth type (cerivastatin) had been withdrawn from the British market 
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owing to its side-effects. The most commonly used statins are simvastatin and 
pravastatin. Atrovastatin has the added advantage of being effective for 
'combined hype rlipidaem ia' (i. e. high blood levels of cholesterol and triglyceride 
together; British Medical Association and Royal Pharmaceutical Society of 
Great Britain, 2001). Fluvastatin is the least potent and atrovastatin is the most 
potent statin (Jones et al, 1998; Prescribing Support Unit, 2002). The main 
indications for the use of statins are primary and secondary prevention of the 
CHID and also control of hype rcholesterolaemia. 
7.1.5. Objectives 
The surveys aimed to assess the ability of TPB to explain and predict GPs' 
prescribing in accordance with clinical guidelines. The aim was pursued through 
the following objectives. 
> To explore the ability of TPB to explain GPs' intentions to adhere to 
national guidelines on prescribing statins 
> To explore the ability of TPB to explain GPs' intentions to adhere to 
national guidelines on prescribing for asthma 
To explore the ability of TPB to explain and predict GPs' prescribing of 
statins 
> To explore the ability of TPB to explain and predict GPs' prescribing for 
asthma 
> To explore practice and demographic variables that can explain GPs' 
prescribing of statins and for asthma 
To explore optimal scaling strategies for internal reliability and analytical 
qualities of TPB measures in the context of GP prescribing 
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7.2. Methods 
7.2.1. Setting, participants and data collection 
Two stratified random samples of GPs across England were surveyed. Pilot 
surveys were conducted in 2001. The first mailings of the main surveys were 
sent out towards the end of January 2002. Two reminders followed the main 
surveys at intervals of approximately twenty days. The last filled in 
questionnaires were received in early April 2002. All the mailings included the 
questionnaire (Appendices VII-1 or VII-2), pre-paid reply envelope, individually 
addressed and hand-signed covering letter (Appendix VII-4) and information 
sheet (Appendix VII-3). 
GP addresses in England were obtained from the NHS Executive in 2001 
after they carefully examined the research plan and objectives. Later an 
identical database including GP addresses was obtained from the National PCT 
Database, after the British Medical Association viewed the research summary 
plan and granted permission. The National PCT Database kindly negotiated 
access to this database. This second database was required since it included a 
further identifier code permitting linkage between general practices and the 
General Medical Services (GMS) Statistics databases. 
Participating GPs were asked to consent for us to access their statins 
and asthma prescribing data from PACT. Access to the PACT data for statins 
and asthma was negotiated with the Prescription Pricing Authority (PPA). 
Copies of signed consent forms were sent to the PPA. The original consent 
forms were not transferred since they were part of the confidential 
questionnaires. The PPA carefully assessed the consent forms and signatures 
and granted access to the PACT data for bronchodilators (BNF Sections 3.1), 
inhaled corticosteroids (BNF Section 3.2) and statins (BNF Section 2.12). PACT 
data were provided on paper (PACT 'catalogue'), comprising several pages of 
detailed prescribing information for each GP. Data were entered into computer 
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for analysis. Prescribing activity indicators were developed using the PACT data 
for the period April-June 2002. 
7.2.2. Sampling and sample size 
Sample size calculations indicated that 242 respondents were required for each 
survey (Chapter 6). Assuming 50% response rate and allowing for inaccuracies 
in the sampling frame, for each survey 510 GPs were sampled. The effective 
sample size was smaller owing to out-dated addresses or GlPs on long term 
leave. It was known that about 2% of GP addresses in the GIVIS Statistics were 
inaccurate (Baker and Hann, 2001). 
FIGURE 7.2. SAGE MULTI-STAGE SAMPLING SCHEME 
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The participants were identified using multi-stage stratified random 
sampling. Primary care trusts and primary care groups (PCOs) were stratified 
using Jarman scores. The Jarman scores were obtained from the National PCT 
Database, located at the University of Manchester (accessed October 2001). 
The PCOs were divided into three strata with equal number of PCOs; strata 1 
(-36 < mean Jarman score < -9.8); strata 2 (-9.8 < mean Jarman score < +5); 
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and strata 3 (5 < mean Jarman score < 65). Then seventeen random PCOs 
were identified from each stratum. Ten GPs were randomly sampled from each 
PCO for each survey. If there were twenty or more practices in the PCO, only 
one GP was randomly sampled from each practice (Figure 7.2). Otherwise, 
more than one GP was randomly sampled from the required number of 
practices. In total ten practices (from five PCOs) received three questionnaires, 
170 practices received two questionnaires (one asthma and one statins 
questionnaires) and the rest of the sampled practices (650) received only one 
questionnaire. 
7.2.3. Regional pilot studies 
Two separate 'regional' pilot surveys were conducted in Selby and York PCT to 
assess the sampling approach and response rate, and most importantly test the 
questionnaires. The results were also used to assess different analytical 
approaches for the TPB measures. 
Eighty-one GPs were sent the 8-page asthma questionnaire. The packs 
sent to the GPs also included hand-signed covering letter, summary research 
plan and pre-paid reply envelope. At least eight GPs did not receive the letters 
owing to having moved from the practice or sick leave. Fifteen GPs responded 
to the first questionnaire and another thirteen to the reminder. The raw 
response rate after one reminder was 35% (28 out of 81) and the effective 
response rate was 38% (28 out 73 which is 81 less 8). All but two respondents 
agreed for us to obtain and analyse their PACT data by signing the consent 
forms. 
A separate group of eighty-two GlPs were sent the 8-page statins 
questionnaire. As with the asthma questionnaire, the packs also included 
signed covering letter, summary research plan and pre-paid reply envelope. At 
least five GlPs did not receive the letters owing to having moved from the 
practice or sick leave. Sixteen GPs responded to the first questionnaire and 
another four responded to the reminder. The raw response rate after one 
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reminder was 24% (20 out of 82) and the effective response rate was 26% (20 
out of 78). All but two respondents agreed for us to obtain and analyse their 
PACT data by signing the consent forms. There was no significant difference 
between the response rates of the two surveys (p=O. 15). 
7.2.4. Questionnaires 
The questionnaires were developed following the guidelines provided (Conner 
and Sparks, 1996; Ajzen, 2002b). The process of questionnaire development is 
important part of conducting TPB surveys. In psychology this process is 
generally referred to as 'operational isation' of the theory. 'Operationalisation' 
has been defined as the process of applying an abstract theory to a specific 
population, activity or setting (Resnicow et al, 2002). 
Two separate questionnaires were developed for statins prescribing 
('statins questionnaire', Appendix VII-1) and prescribing for the treatment of 
asthma ('asthma questionnaire', Appendix VII-2). As recommended (Conner 
and Sparks, 1996; Ajzen, 2002b), semi-structured interviews were used to elicit 
salient beliefs of GPs about outcomes, barriers to and facilitators of adhering to 
clinical guidelines for asthma drug treatment and for using statins (Chapter 4). 
An earlier version of the qualitative study's thematic framework (Table 4.1) was 
used for the identification of salient beliefs. All 'items' included in the framework 
were re-arranged under three main TPB themes of 'attitudes', 'subjective norms' 
and 'perceived controls'. Then specific analytical 'chartswere developed for 
each of the TPB themes. In each chart, the columns corresponded to the 
thematic items and the rows corresponded to the interviewees. The interviews 
were already transcribed and indexed for the main qualitative analysis. Indexed 
verbatim quotes from the transcribed interviews were copied and pasted into 
the charts. The charts were then analysed for identification of the salient beliefs 
for inclusion into the pilot questionnaires. Identification of salient beliefs followed 
a simple content analysis approach. Belief items were considered salient if 
more interviewees had reported the belief items, and the belief was perceived to 
be strong. Salient belief items were included in the pilot questionnaires. 
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Development of the final questionnaires then followed statistical 'item reduction' 
strategies using the results of the regional pilots (see 7.2.7). The TPB predictor 
measures (i. e. attitude, subjective norm and perceived control), behavioural 
intention and reported past behaviour were made compatible in terms of action, 
target, contexts and time, according to the 'principle of compatibility' (Ajzen, 
1988; Conner and Sparks, 1996). Hence in all items the behaviour was defined 
as 'following clinical guidelines prescribing recommendation, in the practice over 
the following three months'. As recommended, the questionnaires incorporated 
multiple measures for each variable to increase measurement reliability 
(Bagozzi et al, 1989; Conner and Sparks, 1996). The preliminary questionnaires 
were assessed in terms of face validity and readability by a GP, a health 
psychologist with experience of TPB questionnaires and three health services 
researchers (Streiner and Norman, 2003). Then the questionnaires were 
formally piloted on two separate groups of GPs working in Selby and York PCT. 
The asthma and statins questionnaires were randomly assigned to the GPs, 
stratified by practice. The regional pilots' results were used to reduce the 
number of questions included in the final version of the questionnaire (7.3.1). 
Statistical techniques were used for item reduction (7.2.7). 
The formats of the questionnaires used in the main surveys were as 
follows. Non-TPB items included two questions on self-identity, asking whether 
the GlPs considered themselves as evidence-based, or patient-centred 
practitioners. Each questionnaire also had a series of demographic questions. 
The asthma and statins questionnaires included 46 and 47 TPB items 
respectively. TPB items were measured on 7-point bipolar or unipolar scales 
(Montano and Kasprzyk, 2002). 
Dependent TPB variable 
Behavioural intention. Three measures of intention were used in the 
questionnaires. Each item assessed one of the three main aspects of intentions: 
intention (or volition), desire and expectation (Conner and Sparks, 1996). 
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Independent TPB variables 
Pastbehavidur. Two questions asked whether GPs' past prescribing (in the 
preceding three months) of statins and drugs for asthma were in line with 
clinical guidelines recommendations. 
Attitude. This was measured both directly and indirectly. Six items were used for 
direct measurement of attitude using the semantic differential scaling approach 
(Oppenheim, 1996; pp 236-239). The items included the good-bad scale to 
capture general attitude, scales with 'instrumental' qualities (e. g. valuable- 
worthless) and scales with 'experimental' (e. g. appropriate-inappropriate) 
qualities (Ajzen, 2002b). To measure indirect attitudes, five salient perceived 
outcomes (beliefs) of adhering to secondary prevention of CHID and asthma 
clinical guidelines prescribing recommendations were identified from the 
qualitative interviews. For each outcome two questions were asked: the 
strengths of the GPs' belief that the outcome might occur as a result of 
prescribing (belief strength'); and their evaluation of how good or bad it was if 
the outcome happened ('outcome evaluation'). The belief strength sub-items 
were assessed using unlikely-likely scales and outcome evaluations sub-items 
were assessed by extremely bad-extremely good scales. The responses to the 
two questions were multiplied and the mean of the sums of products of five 
multiplications constituted the final score for belief based (indirect) measure of 
attitude (Ajzen, 1991). 
Subjective norm. Subjective norm captured perceived social norm or pressure 
for performing or not performing prescribing. Subjective norm was measured 
directly using two items with 'injunctive' quality. 'Injunctive' quality referred to the 
perceived view of the respondent that whether others expected or approved his 
or her behaviour (Ajzen, 2002b). In here the GPs' perceived view that whether 
important others expected or approved his or her prescribing in accordance with 
guideline recommendations was sought. Indirect subjective norm was also 
measured. It was based on normative beliefs. The beliefs were howimportant 
others' (salient referents) thought about prescribing according to the clinical 
guideline. The 'important others' (i. e. practice nurse, GP colleague, local 
hospital consultant and PCO prescribing adviser) were identified from the 
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interviews. Normative beliefs about 'important others' were assessed using two 
sets of sub-items. First set of sub-items measured the perceived views of the 
important others (e. g. practice nurse) about prescribing in accordance with 
guideline. These sub-items were called as normative 'belief powee. They were 
assessed using I should-I should not scales. Second set of sub-items asked 
about the respondent motivation to comply with the perceived view of 'important 
others' (e. g. practice nurse). They were measured using 'not at all-very much' 
scales. The 'belief power' and 'motivation to comply' sub-items were then 
multiplied to obtain the normative belief score corresponding with each 
'important other. For example if a GP perceived that his practice nurse 
colleague strongly expected him to prescribe statins for secondary prevention of 
CHID, and the GP also respected the view of the practice nurse colleague, he 
would have had positive normative belief. Similar questions were asked for all 
'important others'. The mean of the normative beliefs' scores yielded the indirect 
subjective norm measure (Ajzen, 1991). 
Perceived behavioural control (perceived control). Perceived control was 
intended to capture the respondents' confidence in performing the behaviour. 
As with previous independent variables it was measured by direct and indirect 
variables. Directly measured perceived control was captured using three items. 
The items were designed to be able to capture self-efficacy of GPs in 
performing prescribing (i. e. the level of perceived difficulty in adhering to the 
guideline prescribing recommendations) and whether they perceived they had 
control (Ajzen, 2002b) over prescribing (i. e. other factors did not prevent them in 
doing so). Indirect perceived control was measured based on six salient control 
beliefs. For each control belief the respondents were asked to respond to a 
'belief strength' sub-item and a'perceived power' sub-item. Different scales 
were used for the assessment of belief strength, but most used strongly 
disagree-strongly agree scales. For example they were asked how strongly they 
agreed that the BTS asthma guidelines' recommendations were based on 
evidence. Then the GPs were asked whether they perceived the control belief 
as a powerful source of influence on their behaviour ('perceived power'). For 
example they were asked to rate how easy it was to prescribe as guideline 
recommended if the guideline was evidence-based. These sub-items were 
assessed by scales such as difficult-easy. The score for indirect perceived 
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control was the mean of sum of products of control belief strengths and their 
perceived powers (Ajzen, 1991). 
7.2.5. Prescribing outcome indicators 
Source of prescribing data 
PACT was the source of prescribing data used in the study. STAR-PU was 
considered as the most appropriate prescribing unit for these analyses as 
different gender specific age groups were weighted according to the specific 
therapeutic groups (i. e. BNF sections; Lloyd et al, 1995a). For example the 
weighting for males between 5 and 14 years for bronchodilators (BNF section 
3.1) was 3.2, while for the same gender-age group the weighting for inhaled 
corticosteroids (BNF section 3.2) was 4.8 (Prescribing Support Unit, 2002). The 
PACT data used in this study focused on GPs rather than practices, because 
obtaining practice PACT data required the consent of the senior partners or all 
partners worked in the practices. On the other hand 'practice' demographic 
distribution was obtained from GMS Statistics. Therefore, STAR-PUs were 
calculated for the practices' list sizes, and then were divided by the number of 
whole time equivalent GPs (obtained from questionnaires) working in each 
practice. For each of asthma and statins surveys two primary prescribing 
outcomes were defined: 'effective delivery' and 'efficiency' indicators of 
prescribing. It was known that PACT based indicators were more accurate for 
efficiency measures than they were for quality measures (Majeed et al, 1997). 
Defined Daily Dose, Adequate Daily Quantity and Net Ingredient Cost 
Prescribing outcomes could be based on Defined Daily Doses (DDD; WHO 
Collaborating Centre for Drug Statistics Methodology, 1999). DDD is 'the 
assumed average maintenance dose per day for a drug used on its main 
indication in adults'. DIDID is not the recommended dose and in some cases may 
not be a real dose. It is rather a unit of measurement. DIDID values as calculated 
by the WHO are based on the international experience. The advantage of using 
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DDD values rather than actual drugs prescribed is that it enables one to 
compare prescribing practices of similar drugs that are part of one Anatomical 
Therapeutic Chemical group (WHO Collaborating Centre for Drug Statistics 
Methodology, 1999). Since there are differences between the prescribing 
routines in the UK and the international values used for the calculation of DDDs, 
a separate set of values are calculated to reflect UK prescribing routines. There 
are also medicinal products in use in the UK for which there are no DDDs (e. g. 
topical drugs or some combination asthma inhaler drugs). Hence the 
Prescribing Support Unit funded by the Department of Health has defined 
Adequate Daily Quantities (ADQs) for use in the UK. Like DDD, ADQ is not a 
recommended dose but an 'analytical unit produced in order to compare more 
accurately the prescribing activity of primary care practitioners. 
TABLE 7.1. DDD AND ADQ VALUES FOR STATINS AND INHALED CORTICOSTEROIDS 
BNF (generic) name Other names Administration 
route 
DDD ADQ Unit 
Statins 
Atrovastatin Lipitor Oral 10 10 Mg 
Cerivastatin (withdrawn) Lipobay Oral 200 100 Mcg 
Fluvastatin Lescol Oral 40 30 Mg 
Pravastatin Upostat Oral 20 15 Mg 
Sirnvastatin Zocor Oral 15 15 Mg 
Inhaled corticosterold 
Beclornethasone & Ventide Inhaled aerosol 2 Puffs 
salbutarnol 50mcg/1 00mcg 
Beclornethasone & Ventide Inhaled powder 4 Rotacaps 
salbutarnol 100mcg/200mcg 
Beclornethasone & Ventide Inhaled powder 4 Rotacaps 
salbutarnol 200mcg/400mcg 
Beclomethasone Inhaled 0.8 0.4 Mg 
aerosol/powder 
Beclomethasone CFC free Inhaled aerosol 0.2 Mg 
Budesonide Inhaled 1.5 1.5 Mg 
suspension 
Budesonide Inhaled 0.8 0.4 Mg 
aerosol/powder 
Budesonide & formeterol Symbicort Inhaled 2 Puffs 
aerosol/powder 
Fluticasone propionate Inhaled 0.6 0.2 Mg 
aerosollpowder 
Fluticasone propionate Inhaled 2 Mg 
suspension 
Fluticasone & salmeterol Serefide Inhaled 2 Puffs 
aerosol/powder 
Table extracted from Prescribing Support Unit, 2002, pp 31 and 35. 
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Both ADQ and DDID values were considered for the analysis of data in 
this study (Table 7.1). DDD values were used for statins. Statins DDDs 
represented equipotent doses of statins (Prescribing Support Unit, 2002). The 
DDD values for statins were obtained from the two latest PSU reports 
(Prescribing Support Unit, 2000; Prescribing Support Unit, 2002). The PSU 
updated some statins ADQs in a note published on 13 August 2004. The 
updated values were generally higher than the previous ones (e. g. ADO for 
simvastatin increased from 15mg to 20mg). Statins ADQs were not used in this 
study since they did not reflect equipotent doses of statins but the current 
practice in the UK (Prescribing Support Unit, 2002). ADQs were used for 
inhaled corticosteroids. There were no DDDs available for some inhaled 
steroids. As inhaled corticosteroids'ADQs generally represented the equipotent 
doses of these drugs, they were useful for the analyses (Prescribing Support 
Unit, 2002). 
Prescribing costs were calculated using net ingredient cost (NIC). NIC is 
cost of a medicine before any discounts or exemptions and it excludes any 
dispensing costs or fees. It also excludes any adjustment for income which may 
apply to prescription charges paid to the dispenser or to whether the patient has 
purchased a pre-payment certificate (National PCT Database, 2004). 
Statins; indicators 
Statins DDDs per lipid lowering STAR-PU was suggested as 'effective delivery' 
indicator of prescribing in primary care (Department of Health, 2001 b). The 
Department of Health (2001) also suggested three further effective delivery 
indicators of statins prescribing: 'number and percentage of patients discharged 
from hospital with a diagnosis of acute myocardial infarction prescribed statins', 
'proportion of patients with a CHD risk greater than 30% over 10 years with a 
current prescription for treatment with statins' and 'proportion of patients with 
coronary artery disease prescribed a statin within the last 12 months'. None of 
these further indicators were obtainable from PACT data. For this study two 
statins prescribing outcomes were used. The effective delivery outcome was 
defined as statins DDDs per lipid lowering STAR-PU (Prescribing Support Unit, 
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2002) as weighted by the number of whole time equivalent GPs working in the 
practice. This outcome was simply called 'statins DIDID per weighted STAR-PU'. 
The efficiency outcome was defined as statins cost per statins DIDID and called 
as such. 
Asthma indicators 
Prescribing for asthma takes a variety of forms and preparations are prescribed 
in different quantities, administration forms and combinations. There are many 
generic and non-generic alternatives for the drugs. Different measures are used 
as effective delivery indicators for asthma prescribing. The Department of 
Health suggested 'proportion of patients with a diagnosis of asthma and a 
prescription for inhaled bronchodilators, who also received a prescription for 
inhaled corticosteroids within the last year' as the indicator of effective delivery 
of asthma care (Department of Health, 2001 b). A similar indicator was defined 
based on long acting P2-agonists. Neither indicator could be obtained from 
PACT data. 
Traditionally, a commonly used effective delivery indicator of asthma 
prescribing in the literature was the ratio of prophylactic prescribing (i. e. inhaled 
corticosteroids) to inhaled bronchodilators (Audit Commission, 1994; Majeed et 
al, 1997). The assumption was that bigger ratios reflected better prescribing. 
The Audit Commission (1994) suggested that 'those GPs who prescribe these 
preventive drugs less than one quarter as often as they prescribe 
bronchodilators' needed to be scrutinised for their prescribing. This arbitrary 
threshold of 'a quarterwas a reflection of practice patterns at the time, rather 
than being based on evidence. Later studies suggested that the mean ratio as 
measured in DDD had increased from 0.49 to 0.73 (Majeed et al, 1999). The 
increase happened in about 6 years (1992-1998) and reflected faster increase 
in inhaled corticosteroid prescribing (Majeed et al, 1999; Premaratne et al, 
1999). These ratios could be measured in terms of the ratio of prescribed 
DDDs, the ratio of NICs or the ratio of the number of dispensed items. 
Dispensed item was defined as one preparation on the prescription (Majeed et 
al, 1997). A prospective study of prescribing from 1993-1996 in West Midland 
assessed the validity of the ratio of DDDs (Frischer et al, 1999). They used 
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prescribing data from the General Practice Research Database (GPRD) and 
concluded that the ratio explained up to 37% of variation in asthma admission 
rates. It should be noted that data from the GPRD were linked to individual 
patients and their diagnoses. The prophylactic to bronchodilator ratio as 
measured from PACT data had been used successfully in previous studies in 
terms of NIC, number of prescribed items and DDDs (Feder et al, 1995; Griffiths 
et al, 1996; Griffiths et al, 1997; Aveyard, 1997). Use of number of dispensed 
items was not a valid measure of prescribing (Bogle and Harris, 1994) as it was 
dependant on the GPs' routines of managing their repeat prescription orders. 
For example G Ps who renewed patients' repeat prescriptions every month 
prescribed twice the number of items as GPs who renewed repeat prescriptions 
bimonthly; even if both prescribed exactly the same medicine and of the same 
quantities. Also others had failed to find any relationship between quality of 
asthma care and the number of prescribed items (Jones et al, 1995). 
The prophylactic to bronchodilator ratio was more valid if the ratio was 
measured in DDDs (Shelley et al, 1996; Majeed et al, 1997). However, one 
study concluded that the PACT based ratio of inhaled corticosteroids to 
bronchodilators in DDDs at health authority and general practice levels did not 
correspond with the admission rates for asthma (Shelley et al, 1996). Later the 
same group of researchers compared the asthma symptoms of patients from 
two general practices that differed in their corticosteroid to bronchodilator ratio. 
They concluded that the ratio was a valid indicator of quality (i. e. bigger ratio 
was indicative of less asthmatic symptoms in patients) if the difference was big 
enough (0.24 versus 1.53 in their study; Shelley et al, 2000). 
The prophylactic to bronchodilator indicator however did not reflect 
recent developments in treatment of asthma and innovations in drug 
manufacturing and packaging. As noted before long-acting P2-agonist 
bronchodilators were indicated for prophylactic treatment. Also more and more 
combination therapies of corticosteroids plus long- or short-acting P2-agonists 
were manufactured and prescribed. All these combined preparations were 
categorised in BNF Section 3.2 with inhaled corticosteroids. It should also be 
noted that the STAR-PUs for inhaled bronchodilators differed with STAR-PUs 
for inhaled corticosterolds (Prescribing Support Unit, 2002). These might 
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explain why the ratio was not listed among the Department of Health 
recommended indicators. The Department of Health (2001) instead proposed 
using inhaled corticosteroids' DDDs per STAR-PU as indication of prescribing 
practice in accordance with BTS asthma guidelines' recommendations. It also 
proposed using inhaled corticosteroid NIC per DDD as 'efficiency' indicator of 
asthma care in primary care (Department of Health, 2001 b). Likewise the 
National PCT Database used inhaled corticosteroids per corresponding STAR- 
PU as the effective delivery indicator of asthma treatment and cost per DDD 
indicator as the measure of efficiency. Simpler approaches had also been tried 
for the identification of better asthma services. One survey of general practices 
suggested that practices with better management of asthma were likely to have 
higher respiratory drug costs (including inhaled corticosteroid costs) as 
measured from PACT data (Jones et al, 1995). 
In this study inhaled corticosteroid ADQs (Table 7.1) per weighted STAR- 
PU was used as the effective delivery measure of asthma prescribing. And 
inhaled corticosteroid cost per ADO was used as the efficiency measure of 
asthma prescribing. Apart from the two primary prescribing outcome indicators, 
one further indicator of effective delivery was used as the secondary outcome 
(Griffiths et al, 1996; Griffiths et al, 1997): the ratio of inhaled corticosteroid 
costs (BNF Section 3.2) to inhaled P2-agonists costs (BNF Section 3.1.1). 
7.2.6. Non-response analysis 
GMS Statistics were used for non-response analysis. GIVIS Statistics provides 
data about GPs, their practices and partnerships, services and patients. It is 
collected twice per year and is available through National PCT (formerly PCG/T) 
Database, National Primary Care Research and Development Centre, 
University of Manchester for research use. The GIVIS Statistics as presented in 
the National PCT Database are linked to the practices and not to the GPs. 
Although it was possible to link GPs with practices using an identifier code, it 
was not possible to link the sampled GPs with GIVIS Statistics directly. This was 
attributable to the surveys' sampling approach in which more than one GP was 
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sampled from some practices. The problem was overcome by separating those 
'extra' GPs per practice from the rest and linking different files separately with 
the GMS Statistics data. Then the resulting files were merged back together 
and used for non-response analysis. T-tests and chi-squared tests were used 
for univariate non-response analysis. Multivariate analysis of non-response was 
performed using logistic regression. Linking and merging of files were 
performed using different computer software packages Microsoft Excel, 
Microsoft Access and SPSS at different stages. All the analyses were 
performed by the S PSS software package Version 10. 
7.2.7. Analysis 
Combining regional pilots and mains surveys 
For the final analyses data from regional pilots and main surveys were 
combined. This was to increase analytical power and was conducted after 
careful examination of potential differences between the two samples. To 
achieve this, individual questions within the main surveys were matched with 
their corresponding questions in the regional pilots. Responses to the pilot 
questions were re-ordered if necessary to ensure they matched the main survey 
questions (e. g. if an item was scaled as 'definitely-definitely not'for the main 
survey and on the reverse scale for the pilot, the responses to the latter were 
re-ordered). Regional pilots' questions that had not been used in the main 
survey questionnaires were excluded from the final analyses. 
Item ordering, missing values and scaling 
All the items were ordered so that lower scores represented 'negative' 
responses towards the behaviour (e. g. 'definitely not' or'strongly disagree'). 
Missing items were replaced by the mean of other items in the scale. In the first 
instance, attitude, subjective norm and perceived control items were treated 
bipolarly (-3 to 3), and intention and reported past behaviour items were treated 
unipolarly (1 to 7). The corresponding scales'scores were calculated by 
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summing the items' scores and dividing the total by the number of items in the 
scale. The indirect measures of attitude, subjective norm and perceived control 
were constructed as the means of sums of products of corresponding belief 
based items (Ajzen, 1991; see Table 7.2). 
TABLE 7.2: CONSTRUCTION AND SCALING OF INDIRECT TPB MEASURES 
TPB measure Construct Scaling approach 
unipolar - bipolar Indirect attitude (behavioural I (belief strengthx outcome beliefs) evaluation) 
Indirect subjective norm Z (belief strength x motivation 
(normative beliefs) to comply) 
Indirect perceived behavioural I (belief strength x perceived 
control (control beliefs) power) 
bipolar - unipolar 
bipolar - unipolar 
Item reduction 
The results of the regional pilots were used to reduce the lengths of the 
questionnaires. Two analytical approaches were used for item reduction: the 
internal consistency approach or Likert scaling (Oppenheim, 1996, pp 195-200) 
and factor analysis (ibid, pp 166-171,200). For the internal consistency 
approach Cronbach's a values for the scale were calculated. Then Cronbach's 
a was calculated for the scale if each item was deleted. If the deletion of an item 
from the scale resulted in an increase in the internal consistency of the scale 
(i. e. bigger Cronbach's a) then the item was a candidate for removal from the 
scale. Principal component analysis was used for identification of factors in the 
scales. Correlation matrices were inspected for the presence of coefficients of 
higher than 0.3. A scale considered factorable if the Kaiser-Meyer-Oklin value 
exceeded 0.6 and the Barlett's Test of Sphericity reached the statistical 
significance (Pallant, 2001). These statistical tests assessed the factorability of 
the scale. If the tests were successful, a minimum number of factors that 
explained majority of variance in the scale were kept in the analysis. Then the 
factors were subjected to rotation (Streiner and Norman, 2003). Rotation helped 
the items to load only on one factor; and also helped all the items on each factor 
to have the same sign (negative or positive). For directly measured 
components, attention was also paid to the endorsement rate in response to 
individual items (Streiner and Norman, 2003). If there was high endorsement in 
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response to an item (i. e. most responses were limited to one option), then the 
item was dropped from the final questionnaire or re-worded. 
Other univarlate analyses 
Internal reliability of direct or indirect TPB, variables (7.2.4) was assessed by 
measuring Cronbach's a (Bland and Altman, 1997). Pearson's correlation 
coefficients were calculated to examine univariate correlations between 
variables. T-tests were used for comparison of mean values between regional 
pilot and main surveys respondents, and between subgroups. 
Regression analysis 
Multivariate analyses were conducted using ordinary least square regression 
(Tabachnick and Fidell, 2001). These analyses were used to explain the 
variation in prescribing intentions and prescribing indicators (behaviour). Rests 
in linear regression are robust and moderate departures from the analysis 
assumptions generally have little effects on the validity of null hypothesis tests 
(Cohen et al, 2003). Nonetheless following approaches were used to assess the 
analysis assumptions. Multi-collinearity was assessed by observing the 
variance inflation factor for each independent variable. Variance inflation factors 
of less than two with collinearity diagnostics of within recommended ranges 
(e. g. 'condition index' < 15) were representative of the absence of multi- 
collinearity. 'Casewise' diagnostics function was employed for the identification 
of outliers with residuals outside three standard deviations. Heteroscedasticity 
was assessed by observing the normality of the error term using histograms of 
standardised residuals, normal P-P (expected cumulative probability versus 
observed cumulative probability) plots and scatter plots of regression 
'Studentised deleted residuals' against standardised predicted values (Cohen et 
al, 2003). Cook's distance value was plotted against 'centred leverage value' for 
the identification of cases with strong influence on the regression model. 
Stepwise regression was not used (Miles and Shevlin, 2001). 
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Development of regression models 
TPB regression models to explain variation in intention were developed as 
recommended by Ajzen (1991,2002). For theoretical reasons all independent 
variables were included in the models at the same time. Non-significant 
variables were kept in the models unless they caused multi-collinearity. 
Several variables were considered for inclusion in the regression models 
of prescribing indicators. These variables included TPB measures (i. e. attitude, 
subjective norm, perceived control and intention), TPB belief-based items and 
demographic variables. Apart from the TPB measures, there were no a priori 
strong reasoning to suggest which TBP belief items and demographic variables 
should be expected in the models. Also the sample size was small for reliable 
stepwise regression analysis in which statistical procedures could be used for 
the identification of important explanatory variables. Sample sizes in the 
magnitude of several hundred were required for such analyses. Therefore it was 
important to follow procedures to prevent 'over-fitting' models, avoid multi- 
collinearity and reduce the chances of losing important observations due to lack 
of power. Univariate analyses were performed to assess correlations between 
TPB belief measures and self-identity variables with prescribing indicators. 
Variables with univariate p-values of equal to or less than 0.2 were included in 
linear regression models to explain variation in prescribing outcomes. This 
arbitrary higher level of Typed error was considered to reduce chances of 
important Type-11 errors due to lack of power and theoretical understanding. At 
the next stage univariate analyses assessed relationships between practice and 
demographic variables and prescribing outcomes. Eligible variables were then 
included into the models following above criteria. Variables remained within the 
models if p-values for their corresponding regression coefficients were equal to 
or smaller than 0.2. 
Transformation 
Statistical transformation of data was avoided to prevent difficulty for the 
interpretation of the findings. Highly skewed variables or variables with similar 
values for many respondents (consultation length, practice deprivation score, 
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number of WTE GPs in practice) were transformed (square root or logarithm) or 
replaced with binary variables (based on median). 
All the analyses were performed by the SPSS software package Version 10. 
7.2.8. Ethical considerations 
The study was conducted with careful consideration of ethical issues. Consent 
forms were included on the first page of the questionnaires and the participants 
were asked to tick relevant boxes and sign the form. The signature was 
required by the PPA to grant access to the GPs' prescribing data. Each 
questionnaire or reminder sent included hand-signed covering letter (example in 
Appendix VII-4), one page summary protocol and pre-paid return envelope. 
Questionnaires sent for the main surveys were also accompanied with 
'questions and answers' page (Appendices VII-3). The returned questionnaires 
were appropriately coded to permit identification of the respondents (for PACT 
data and demographic information) and also to send reminder letters. The data 
from questionnaires was transferred to the computer. The questionnaires were 
stored securely. All the data received was dealt with confidentially. The 
participants were assured that the research reports would not contain any 
specific details which would allow identification of specific GPs or practices. The 
names and addresses of the GPs were obtained from the Primary Care 
Research Centre, University of Manchester after they sought the approval of the 
BMA on our behalf. For this purpose summary research plan was provided and 
it was understood that the addresses would not be used for other purposes. 
Local Research Ethics Committee approvals were not sought as at the time of 
data collection surveying health professionals did not require ethics approval. 
All respondents were told that they would be included in a lottery and the winner 
would receive a digital camera as a token of gratitude. After the surveys were 
accomplished the lottery was conducted in the presence of Prof Gillespie, Dean, 
Hull-York Medical School and as a result a digital camera was awarded to the 
winner. All the respondents were sent letters informing them of the result of the 
lottery. 
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Z3. Findings 
7.3.1. Item reduction 
The regional pilots' questionnaires were long and included several items for 
each TPB component, e. g. six separate items measured the respondents' 
intention. Internal reliability analysis and principal component analysis were 
applied to the regional pilots' results for item reduction. Despite small sample 
sizes behavioural beliefs and normative beliefs were factorable but control 
beliefs were not. The statistical analyses were complemented with interpretive 
judgements. This was to ensure the resulting questionnaire included important 
belief based items extracted from the interviews and covered different 
theoretical structures suggested by Ajzen (2002) for the directly measured 
components of the TPB (i. e. intention, attitude, subjective norm and perceived 
control). For example out of six intention items used in pilot questionnaire, three 
were kept for the main surveys. The retained intention items covered three 
theoretical aspects of intention: 'intention', 'desire' and 'expectation' (Conner 
and Sparks, 1996). The pilot respondents' comments on individual items were 
also taken into account. 
As a result of item reduction the numbers of behavioural beliefs in 
asthma and statins questionnaires were reduced from seven in the regional 
pilots to five in the main surveys. Similarly the normative beliefs were reduced 
from five to four. There were ten control beliefs in asthma and eleven in statins 
pilot questionnaires. These were reduced to six control beliefs in the asthma 
main survey and to seven beliefs in the statins main survey. Item reduction also 
reduced the number of intention items from six to three, attitude items from 
twelve to six, subjective norm items from four to two and perceived control items 
from five to three in each questionnaire. In the regional pilot questionnaires 
there were five self-identity items (e. g. 'I see myself as an evidence-based 
practitioner'). Two self-identity items were kept in each of the main surveys 
(Appendices VII-1 and VII-2). 
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7.3.2. Optimal scaling of belief based items 
The results of the regional pilot surveys were used to determine the optimal 
scaling approach for the belief based TPB items. The items used in the 
questionnaires were 7-point scales. The items were worded unipolarly (e. g. 
'unlikely - likely', scored from 1 to 7) or bipolarly (e. g. 'bad - good', scored from 
-3 to +3). For the direct TPB measures (i. e. attitude, subjective norm and 
perceived control) it would make no difference in the statistical analysis whether 
the items were treated as bi-polar or otherwise, because numerical 
transformation of a unipolar scale to a bipolar scale just required subtracting by 
4 which was a simple linear transformation. 
Unlike direct variables, scaling of belief based variables could affect the 
results of statistical analyses. This was because the beliefs' composite scores 
were calculated by multiplying two related sub-items. For example each indirect 
attitude measure was calculated by multiplying the two components of the 
behavioural belief which were the belief strength and the outcome evaluation 
(Behavioural beliefs = Z'behavioural belief strength' x 'outcome evaluation'). 
Because of this multiplication, the scaling approach affected the outcome. 
Suppose both belief strength and outcome evaluations were scaled bipolarly. If 
the respondent chose the lowest value for both items (i. e. -3), then the product 
was a large positive value (-3 x -3 = 9) suggesting the underlying belief had 
important positive contribution to the formation of attitude. If the items were 
treated unipolarly then the lowest value for each item was '1' and the product 
was also 1 (1 x1= 1), suggesting the underlying belief had minimal contribution 
to the attitude. And if one item was scaled unipolarly and the other itein 
bipolarly, the product suggested negative contribution (1 x -3 = -3) in the 
attitude. These comparisons suggested that scaling of the items for indirect 
measures had important effects on the relationships between the TPB 
components. Unfortunately there was no a prior! to decide the optimal scaling 
method for indirect measure items (Ajzen, 2002b). The choice of scaling 
approach should be based on the way the items were interpreted by the 
respondents (semantic scaling), which was in turn difficult to establish as 
different respondents interpreted the items differently. The other alternative was 
to test statistically different scaling approaches and choose the one that 
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provided the highest correlation values between the indirect and direct 
measures of the TPB components (Ajzen, 2002b). The results of the regional 
pilots were used to assess the optimal scaling method for the analysis of the 
main surveys. As the asthma regional pilot received higher response rate, 
primarily its results were used for establishing the optimal scaling approach 
unless the analyses were inconclusive. 
Behavioural belief items 
Conner and Spark (1996) suggested that for indirect attitude items the optimal 
scaling method was when both belief strength and outcome evaluation items 
were treated bipolarly. As mentioned before, Ajzen (2002) suggested there was 
no a priori method of establishing the optimal scaling method, but argued that 
for indirect attitude it was reasonable to treat belief strength as unipolar and the 
outcome evaluation as bipolar. His approach was in line with wording of the 
items in the survey questionnaires. The effects of different scaling approaches 
to the measurement of the indirect attitude component were assessed. 
a. Unipolar - Unipolar scaling. All the behavioural belief items were 
constructed based on unipolar scaling of both belief strength and its outcome 
evaluation. The resulting items possessed acceptable internal reliability 
(Cronbach's a=0.85). The single variable of indirect attitude measurement was 
produced by adding the products. There was significant correlation of 0.55 
between this variable and overall direct attitude variable. 
b. Bipolar - Unipolar scaling. All the behavioural belief items were 
constructed based on bipolar scaling of belief strength items and unipolar 
scaling of outcome evaluation items (Cronbach's a=0.81). The products were 
added up to produce the indirect attitude measure. There was significant 
correlation of 0.44 between this variable and overall direct attitude variable. 
c. Bipolar - Bipolar scaling (recommended by Conner and Spark, 1996). All 
the behavioural belief items were constructed based on bipolar treatment of 
belief strength and outcome evaluation items (Cronbach's a=0.78). The 
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correlation between the resulting indirect attitude measure and direct attitude 
measure was 0.47 and it was significant. 
d. Unipolar - Bipolar scaling (recommended by Ajzen, 2002). The resulting 
scale produced the highest internal reliability measure (Cronbach's a=0.87). 
The indirect attitude measure also possessed the highest correlation coefficient 
with the direct measures of the attitude (r=0.63). 
All the correlation values reported in options (a to d) above were with the 
direct attitude scale used in the regional pilots. The pilot attitude scale was 
constructed of 12 items. After item reduction procedures (see 7.3.1) only six of 
the items were kept for the final questionnaires. If the pilot's direct attitude scale 
was constructed by these six remaining items only, then scales according to b 
and c above were no longer significantly correlated with the direct attitude. The 
unipolar - bipolar construct (V) retained a significant correlation coefficient of 
0.57. These analyses supported unipolar scaling of belief strengths items and 
bipolar scaling of outcome evaluation item suggested by Ajzen (2002). This was 
also consistent with the wording of the items in the questionnaire. 
Normative belief items 
Conner and Spark (1996) suggested normative belief strength items should be 
scaled as bipolar and motivation to comply items as unipolar. This scaling 
approach fitted with the wording of the items used in the questionnaires and 
was followed for the analysis. The resulting items were internally consistent 
(Cronbach's a=0.77). 
Control belief items 
There were no recommendations on the best way of scaling the control belief 
items. Conner and Sparks (11996) suggested that future studies should focus on 
this. The results of the asthma and statins regional pilots were used to identify 
the optimal scaling approaches for control belief items (indirect perceived 
control). The results were inconclusive, perhaps because of the inherent 
difficulty of justifying the scaling approach for control belief items and the small 
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number of subjects responding to the pilots. Unlike behavioural belief items, it 
was not possible to conclude an optimal scaling approach for control belief 
items. Therefore, the results of the statins main survey were used to establish 
the optimal scaling approach for the analyses. The control belief strength items 
were scaled bipolarly for interpretive reasons. The perceived power items were 
scaled bipolarly and unipolarly in turn to identify the scaling approach that 
yielded the highest internal reliability. The reliability of a further approach was 
also assessed in which indirect perceived control measures were based on 
belief strength items only. Bipolar-unipolar scaling approach resulted in a scale 
with higher reliability (Cronbach's a=0.48) and higher correlation (r=0.35) with 
perceived control (direct measure). 
7.3.3. Response rate, response pattern and non-response 
analysis 
Despite efforts to boost response rate, the surveys achieved low 
response rates of 27% (135 out 500 which is 510 less 10) to the statins survey 
and 19% (94 out of 495 which is 510 less 15) to the asthma survey (Figure 7.3). 
FIGURE 7.3. RESPONSE PATTERN TO THE STATINS SURVEY 
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The response rate to the asthma survey was significantly lower than the 
response rate to the statins survey (chi-squared=9.5; p=0.002). These response 
rates were lower than that achieved in the regional pilots with longer 
questionnaires, low quality prints and one reminder. 
TABLE 7.3. UNIVARIATE ANALYSIS OF NON-RESPONSE 
Responders* Non-responders P value 
Two surveys combined 
List size in 2000 6673(4219) 6409(4112) 0.40 
List size 6699(4241) 6590(4065) 0.73 
List size per practicing GP 1877(556) 1962(585) 0.05 
Rural patients 751(1476) 659(1375) 0.39 
Patients for whom drug was dispensed 524(1279) 409(1171) 0.23 
Total number of GPs in practice 3.8(2.3) 3.5(2.2) 0.17 
Proxy measure of need 2.0(3.2) 2.3(3.4) 0.15 
Having training status $ 86(38%) 198(26%) 0.001 
Having dispensing status $ 48(21%) 134(18%) 0.27 
Being single-handed $ 43(19%) 189(25%) 0.05 
All qualified in the UK $ 148(65%) 433(58%) 0.06 
Statins 
List size in 2000 6756(4442) 6232(4077) 0.21 
List size 6827(4483) 6423(4028) 0.34 
List size per practicing GP 1893(538) 1981 (609) 0.14 
Rural patients 822(1669) 627(1330) 0.23 
Patients for whom drug was dispensed 627(1464) 363(1095) 0.06 
Total number of GPs in practice 3.8(2.3) 3.4(2.2) 0.12 
Proxy measure of need 2.1 (3.7) 2.3(3.3) 0.44 
Having training status $ 53(39%) 83(24%) 0.001 
Having dispensing status $ 30(22%) 55(16%) 0.08 
Being single-handed $ 25(19%) 95(27%) 0.05 
All qualified in the UK $ 83(62%) 201(57%) 0.36 
Asthma 
List size in 2000 6654(3898) 6567(4143) 0.98 
List size 6513(3878) 6737(4097) 0.63 
List size per practicing GP 1855(584) 1945(562) 0.17 
Rural patients 649(1145) 688(1415) 0.81 
Patients for whom drug was dispensed 376(941) 450(1235) 0.59 
Total number of GPs in practice 3.7(2.2) 3.6(2.2) 0.66 
Proxy measure of need 1.81 (2.4) 2.3(3.6) 0.09 
Having training status $ 33(35%) 115(29%) 0.23 
Having dispensing status $ 18(19%) 79(20%) 0.93 
Being single-handed $ 18(19%) 94(24%) 0.37 
All qualified in the UK $ 65(69%) 232(58%) 0.05 
* All values are means (SID) unless marked with $ where the valu es are numbers (%'). 
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The responding GPs were not different from non-respondents in terms of 
the average number of patients registered with the practices (list size), practice 
proxy measure of need based on the Jarman score (Baker and Hann, 2001), 
total number of GPs working in the practices, number of rural patients 
registered with the practices, list size per practising GP in the practice, 
dispensing status and whether all the GPs in the practice were qualified in the 
UK (Table 7.3). The only clear difference observed at this stage was in the 
training status of the practices, which was predictive of higher response rate, 
especially to the statins survey. Marginally significant trends suggested GPs 
with larger list sizes, single-handed GPs and those practising among colleagues 
not qualified in the UK were less likely to respond to the surveys. Such findings 
might have been caused by multiple significance tests (Perneger, 1998). No 
adjustment was performed at this stage (Bland and Altman, 1995), but the 
findings were re-evaluated in multivariate analyses. The exclusion of GPs with 
practice list sizes of less than 500 (n=8) did not significantly change the results. 
Multivariate analysis was performed using logistic regression. Combining 
the two surveys concluded that the training status of the practice (odds 
ratio=1.7; 95% CI=1.3-2.4; p<0.001) and the statins survey (odds ratio=1.7; 
95% CI=1.2-2.3; p<0.001) were the only individual variables that contributed to 
higher response rates. For the statins survey, GPs within training practices were 
more likely to respond (odds ratio=2.1; 95% CI=1.4-3.2; p<0.001). For the 
asthma survey, GlPs working in practices in which all the practitioners were 
qualified in the UK were more likely to respond (odds ratio=1.7; 95% CI=1.0-2.7; 
p=0.04). 
Of those responding to the statins main survey 31 % were female while 
the corresponding value for asthma survey was 44% (p=0.05). GIVIS Statistics 
provided the gender distribution of GPs in the practices, but no data about the 
gender of individual practitioners. Hence it was not possible to compare the 
gender profile of respondents with no n- respondents. The difference was 
examined for single-handed GPs only (236 in total). There were no significant 
differences between the gender profile of single-handed GPs who responded to 
the questionnaires and those who did not. 
238 
The response rate from GPs working in practices in which all GPs were 
qualified in the UK (regardless of their ethnic origins) was higher than others. 
59% of the sampled GPs were working in such practices, but 65% of the 
responding GPs were from them (p=0.06) (Table 7.3). These proportions were 
not evenly distributed between the two surveys as 69% of asthma respondents 
were from these practices (versus 58%; p=0.05), while the corresponding value 
for statins survey was 62% (versus 57%; p=0.36). This difference was partly 
due to the lower response rate of the GPs working in practices with non-UK 
qualified colleagues to the asthma survey. Further analyses were performed 
comparing GPs responding to the first mailing with the GPs that responded to 
first or second reminders. The two groups were compared for all the variables in 
Table 7.3. There were no differences between the two groups except for'all 
qualified in the UK'variable (Table 7.4). The GPs who responded to the first 
mailing were more likely to be working in practices in which all the GPs were 
qualified in the UK (73%). In contrast only 55% of the GPs who responded to 
the two reminders were working in practices in which all the GPs were qualified 
in the UK (p=0.006). Within survey analyses revealed interesting phenomena: 
the difference between respondents to the first mailing and respondents to the 
reminders was not significant for the asthma survey (74% versus 64%; p=0.28), 
but the difference was significant for the statins survey (72% versus 49%; 
p=0.008). 
TABLE 7.4. NON-RESPONSE ANALYSIS: RESPONSE TO THE FIRST MAILING AND REMINDERS AND 
ITS RELATIONSHIP WITH THE COUNTRY OF QUALIFICATION 
Asthma Statins 
First mailing Reminders First mailing Reminders 
All qualified in 37(74%) 28(64%) 
the UK 
Not all qualified 13 (26%) 16(36%) 
In the UK 
Total 50(100%) 44(100%) 
53(72%) 
21(28%) 
74(100%) 
30(49%) 
31(51%) 
61(100%) 
p value 0.28 0.008 
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7.3.4. Demographic characteristics of GPs participating in the 
statins survey 
In total 155 responded to the statins questionnaire, including twenty at the pilot 
stage of the study. The GPs had a mean age of 46 years. Years since 
graduation from medical school was calculated by subtracting the GPs' 
graduation year from 2001. On average they were 22 years from graduation. All 
but two GPs were principals. Eighteen (12%) GPs were single-handed; and 45 
(29%) worked in practices with one or two GPs. Forty-four GPs were female, 39 
GPs worked in dispensing practices and 52 GPs worked in practices with 
training status. Forty-five per cent of GPs reported that their practice formerly 
had fund-holding status. The GPs reported an average consultation time of 9 
minutes. 
TABLE 7.5. STATINS SURVEY PARTICIPANTS' DEMOGRAPHIC CHARACTERISTICS 
Total Regional pilot Main 
Age (range) 46(29-65) 44(29-54) 47(30-65) 
Years since graduation (range) 22(5-42) 18(5-30) 23(7-42) 
Female (%) 44(28) 2(10) 42(31) 
Dispensing practice 39(25) 10(53) 29(22) 
Training practice (%) 53(34) 8(40) 44(33) 
Former fund-holding status (%) 70(45) 6(30) 64(48) 
Computerised (%) 138(89) 19(95) 119(89) 
Consultation time (range) 9(5-13) 9.5(8-10) 9(5-13) 
Senior partner in practice (%) 71(47) 14(70) 57(44) 
WTE GPs working In practice 3.9 5.4 3.7 
There were no significant differences between the GPs in the regional 
pilot and the main survey in terms of age and years since graduation from 
medical school. Consultation time for pilot GPs was on average (half a minute) 
longer than other GPs. The difference was of little importance, but it reached 
statistical significance. GPs in the regional pilot were more likely to be male 
(p=0.05), to work in dispensing (p=0.004) or larger (p=0.003) practices and to 
be senior partners in their practices (p=0.03; Table 7.5). 
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7.3.5. Intention to prescribe statins 
Data from 155 questionnaires were analysed. The respondents expressed 
positive intentions to pursue guidelines' prescribing advice (three items; scale 
range: bl to 7; mean=6.1; Cronbach's a=0.69). They also reported they had 
followed guidelines' advice for secondary prevention of CHID for more than half 
of their patients (two items; scale range: 1 to 7; mean=5.8; Cronbach's a=0.56). 
There were no significant differences between the regional pilot and the main 
survey respondents in terms of their intentions or reported prior prescribing. 
TABLE 7.6. REGRESSION MODELS FOR EXPLAINING THE VARIATION IN STATINS' PRESCRIBING 
INTENTION 
Dependent variable P coefficient (CI) p-value Model's F- Model's R 
for P value (p-value) squared 
Model 1 (direct variables) 31.6 (<0.001) 0.41 
Attitude 0.48 (0.29 to 0.67) <0.001 
Subjective norm 0.13 (-0.01 to 0.27) 0.07 
Perceived control 0.15 (0.04 to 0.27) 0.01 
Model 2 (direct variables, 26.1 (<0.001) 0.44 
past behaviour) 
Attitude 0.43 (0.24 to 0.62) <0.001 
Subjective norm 0.12 (-0.02 to 0.26) 0.09 
Perceived control 0.12 (0.00 to 0.23) 0.05 
Past behaviour 0.20 (0.04 to 0.36) 0.02 
Model 3 (indirect 25.0 (<0.001) 0.35 
variables) 
Indirect attitude 0.10 (0.05 to 0.13) <0.001 
Indirect subjective norm 0.02 (-0.02 to 0.05) 0.35 
Indirect perceived control 0.06 (0.01 to 0.11) 0.02 
Model 4 (all TPB 31.1 (<0.001) 0.48 
variables, past behaviour) 
Indirect attitude 0.07 (0.03 to 0.11) <0.001 
Attitude 0.25 (0.05 to 0.45) 0.02 
Indirect perceived control 0.04 (0.002 to 0.08) 0.04 
Past behaviour 0.32 (0.17 to 0.48) <0.001 
GPs reported very positive attitudes towards following statins prescribing 
recommendations for secondary prevention of CHID (six items; scale range: -3 
to 3; mean=2.1; Cronbach's a=0.87) and perceived positive social norms (two 
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items; scale range: -3 to 3; mean=1.9; Cronbach's a=0.89). Their perceived 
ability to overcome barriers was lower (three items; scale range: -3 to 3; 
mean=1.1; Cronbach's a=0.58). Among the perceived control items, the mean 
response to the item assessing the 'controllability' of prescribing (whether GPs 
perceived it was under their control and not dependent on other circumstances) 
was 0.6. On the other hand they perceived the behaviour as less difficult in 
terms of decision making and performing ('self-efficacy'; mean=1.4). 
Direct measures of attitude, subjective norm and perceived control 
explained up to 41 % of the variance in prescribing intentions. The addition of 
prior reported behaviour increased this to 44% (Models 1 and 2 in Table 7.6). 
Among TPB measures, attitude was the most powerful explanatory variable for 
intention followed by perceived control. Self-identity measures did not improve 
the regression model. 
Attitude, subjective norm and perceived control were also indirectly 
measured using belief based items (Table 7.7). All indirectly measured 
variables were positively correlated with the direct measures and the 
correlations coefficients varied from moderate (0.35) to large (0.65) (Cohen, 
1988). The indirect TPB measures were included in separate regression 
analyses to explain the variation in intention. Indirect measures of attitude, 
subjective norm and perceived control explained 35% of the variation in 
intention. Like direct measures, the regression coefficients for indirect measures 
of attitude and perceived control reached statistical significant while the 
coefficient for indirect subjective norm did not. The addition of reported past 
behaviour to Model 3 increased the explained portion of variation in intention to 
44% (F=26.3, p<0.001). Then a separate model was devised including all direct 
and indirect TPB variables. Variables with large p-values that were suspected of 
causing multi-collinearity were excluded. The resulting model explained 41 % of 
variation in intention (F=31.9, p<0.001). Then the reported past behaviour was 
added to the model (Model 4; R-squared=0.48). None of subjective norm 
variables contributed to this final model (Table 7.6). Individual normative belief 
items were also assessed for their potential contribution to Model 4, but failed to 
improve. Self-identity measures did not improve the models. No other 
demographic or practice variable contributed to the model. 
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TABLE 7.7. INDIRECT BELIEF BASED MEASURES OF THE TP13, AND THE MODAL 13ELIEF ITEMS 
USED IN THE STATINS SURVEY AND THE MEAN RESPONSES TO THEM 
Correlation with Internal Mean (SD) 
corresponding reliability: (scales' range: 
direct measure: Cronbach a -21 to 21) Pearson r (p value) 
Indirect attitude 0.52 (<0.001) 0.72 12.4(4.7) 
Indirect subjective norm 0.65 (<0.001) 0.80 10.7(5.4) 
Indirect perceived control 0.35 (<0.001) 0.48 7.4(3.8) 
Belief items 
Behavloural beliefs (range: 1 to 7) 
ff / (GP) prescribe statins for secondaly prevention of CHD as recommended 
in clinical guidelines ... 
1. Patients will be healthier 5.5(1.5) 
2.1 receive 'quality markers' 4.7(l. 8) 
3. Standard of care will not be judged negligent 4.8(1.7) 
4. It prevents harm to patients 5.2(1.6) 
5. It provides better quality of care for patients 5.6(1.5) 
Normative beliefs (range: -3 to 3) 
... thinks I shouldIshould not prescribe statins for... 
1. Practice nurse 1.9(1.2) 
2. GP colleague 1.9(1.0) 
3. Local hospital consultant 2.3(1.0) 
4. PCO prescribing adviser 2.2(1.1) 
Control beliefs (range: -3 to 3) 
1. Clinical guidelines for secondary prevention of CHD are evidence-based 1.9(1.2) 
(facilitator) 
2. Statins prescribing recommendations in guidelines have substantially 0.5(1.5) 
changed 
3.1 am under time pressure to care for CHD patients 1.3(1.9) 
4. The inclusion guidelines for secondary prevention of CHID in the BNF is 2.3(1.0) 
appropriate (facilitator) 
5. NSF for heart disease advocates statins prescribing for secondary 2.1 (1.3) 
prevention of CHID (facilitator) 
6. Prescribing statins as recommended could exhaust practice budget 1.5(l. 7) 
Self Identity 
1.1 am an evidence-based practitioner 5.2(1.5) 
2.1 am a patient-centred practitioner 6.1 (1.1) 
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7.3.6. Statins prescribing 
Primary prevention 
GPs were asked to report their practice of statins prescribing for primary 
prevention of CHID. Only three GPs (2%) mentioned they did not prescribe 
statins for primary prevention. Twenty-eight GlPs (18%) had no explicit criteria, 
14 GPs (9%) prescribed for those with a minimum CHID risk of 15% over the 
next ten years, 44 GlPs (29%) prescribed for patients with a CHID risk of 15-30% 
and 65 GlPs (42%) prescribed for patients with a CHID risk of more than 30% 
over the next ten years. There was no identifiable pattern of difference between 
these groups in terms of their prescribing as measured by statins DIDD per 
weighted STAR-PU (ANOVA test, between group degrees of freedom=3, F=1.3, 
p=0.28). 
Effective delivery indicator: statins DDD per weighted STAR-PU 
Data for this outcome was available for 128 GPs. Statins DDD per weighted 
STAR-PU ranged from 0.09 to 1.39 (median=0.61; mean=0.66; SD=0.31). 
Higher values were assumed to correspond with more effective CHD prevention 
practice (Department of Health, 2001 b). There was no significant difference 
between the regional pilot and the main survey respondents (W. 1; mean 
difference=0.10; p=0.27). 
Model 1 in Table 7.8 reported the results of regression analysis using 
TPB measures as predictors. None of the direct or indirect TBP variables 
significantly contributed to the regression model. Following the criteria explained 
in 7.2.7, self-identity and TPB belief based variables were included in the 
analysis. The variables explained 14% of variance in the outcome. Regression 
coefficients for only one behavioural belief and one self-identity variable were 
significant. This suggested those who viewed themselves as evidence-based 
practitioners and those perceived that following guidelines recommendations for 
statins prescribing resulted in 'quality markers' had prescribed more statins 
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DIDID per weighted STAR-PU. No other TPB variable met the pre-defined 
criteria to be included in the model. 
TABLE 7.8. REGRESSION MODELS FOR EXPLAINING VARIATION IN STATINS PRESCRIBING - 
EFFECTIVE DELIVERY INDICATOR 
Dependent variable 
Model 1 (TPB variables) 
Behavioural belief 2: 
quality markers 
Self identity 1: evidence- 
based practitioner 
Behavioural belief 5: 
quality of patient care 
Control belief 4: inclusion 
in the BNF 
Normative belief 4: PCO 
adviser 
Model 2 
Practice deprivation score 
Female GP 
Years since graduation 
Control belief 4: Inclusion 
In the BNF 
Behavioural belief 2: 
quality markers 
Interest In CHD 
B coeff iclent (CI) p for P 
0.008 (0.001 to 
0.016) 
0.042 (0.002 to 
0.081) 
-0.009 (-0.018 to 
0.000) 
-0.007 (-0.015 to 
0.000) 
-0.006 (-0.014 to 
0.003) 
0.23 (0.14 to 0.32) 
-0.20 (-0.31 to 
-0.097) 
0.008 (0.002 to 
0.014) 
-0.006(-0.013 to 
0.000) 
0.005 (0.000 to 
0.011) 
0.06 (-0.03 to 0.16) 
0.028 
0.040 
0.056 
0.064 
0.18 
<0.001 
<0.001 
0.008 
0.066 
0.068 
0.19 
Model's F (p) Model's R 
squared 
3.4(0.007) 0.14 
11.1 (<0.001) 0.39 
Variables excluded from Model 2 because univarlate p>0.2 
Training status Asthma clinic CHD clinic 
Cornputerised practice Previously fund-holding 
Variables excluded from Model 2 after Initial Inclusion (because p for regression coefficient > 0.2) 
Consultation length Dispensing status Senior partner 
All partners graduated in the UK Number of WTE GPs In practice 
Then a second regression model was devised to assess the variance in 
effective delivery indicator. All variables from Model 1 (Table 7.8) plus 
demographic and practice variables were eligible for inclusion if they had a 
univariate p-value of smaller than 0.2 against the indicator and p-value 
remained less than 0.2 in multi-variate analysis (Table 7.8). Consultation time 
and practice deprivation scores were transformed to binary variable as they 
were skewed. The number of WTE GlPs in practice was analysed as both binary 
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and continuous variables. 'Years since graduation' was used in preference to 
age. Model 2 of Table 7.8 represented the results of the final regression model 
after exclusion of ineligible variables. The model explained 39% of variation in 
the prescribing indicator. Given that there were no individual patient 
characteristics in the model, this was acceptable. The model suggested that 
GPs working in practices with higher deprivation (binary variable based on 
median) and GPs with more years in practice had prescribed more statins per 
prescribing unit. On the other hand female GPs had prescribed less statins as 
measured by the indicator. Sensitivity analysis was performed by testing the 
model on the respondents to the main survey only (excluding regional pilot). 
The results were similar to those reported in Table 7.8. 
Efficiency indicator: statins cost per DDD 
This indicator was meant to reflect cost conscious prescribing by GPs, in which 
GPs chose statins that were cheaper per statins DDD. Costs were for net 
ingredients measured in pounds sterling. Higher values for this outcome 
reflected less efficient prescribing. The data were normally distributed (range: 
0.40 to 0.83, median=0.62, mean=0.62, SD=0.08). Three cases were excluded 
from the analysis as outliers. There was no significant difference between the 
regional pilots and the main survey respondents for this outcome (t=1.1, mean 
difference=0.02, p=0.28). 
In the first regression model, the TPB variables with correlations smaller 
than 0.2 were included (Model 1). Indirect subjective norm and indirect control 
belief explained 4% of variance in efficiency indicator. This suggested that the 
GPs feeling under more social pressure from their'important others'were likely 
to prescribe less efficiently. In reverse those perceiving higher levels of self- 
efficacy and control over barriers were spending less per statins DIDID. The 
observed effects from both beliefs were small (Table 7.9). Then the control and 
normative belief variables with correlation coefficient p-values of less than 0.2 
were added to the model (four belief based variables). 
In presence of belief items, the indirect variables were no longer 
significant contributors and were excluded because of large p-values (Model 2). 
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Model 2 explained 12% of variance in the outcome. It suggested GPs 
perceiving pressure from PCO advisers for prescribing statins were less likely to 
prescribe efficiently. On the other hand GPs believing more strongly in NSF 
support for statins prescribing for secondary prevention were likely to prescribe 
cheaper statins (Table 7.9). 
TABLE 7.9. REGRESSION MODELS FOR EXPLAINING VARIATION IN STATINS PRESCRI13ING - 
EFFICIENCY INDICATOR 
Dependent variable 
Model 1 (TPB variables) 
Indirect perceived control 
Indirect subjective norm 
Model 2 (TPB belief 
based variables) 
Normative belief 4: PCO 
adviser 
Control belief 5: NSF 
advocates statins 
prescribing 
Control belief 3: time 
pressure 
Model 3 (all variables) 
Normative belief 4: PCO 
adviser 
Senior partner 
Control belief 5: NSF 
advocates statins 
prescribing 
Number of WTE GPs In 
practice 
Interest In CHD 
CHD clinic 
Control belief 3: time 
pressure 
p coefficient (CI) p for P Model's F 
(P) 
2.7(0.07) 
-0.004 (-0.008 to 0.000) 0.048 
0.003 (0.000 to 0.005) 0.048 
0.003 (0.001 to 0.005) 0.003 
-0.002 (-0.004to -0.001) 0.006 
-0.002 (-0.005 to 0.001) 0.11 
0.003 (0.002 to 0.005) <0.001 
0.036 (0.011 to 0.060) 0.004 
-0.002 (-0.004 to - 0.008 
0.001) 
0.007 (0.002 to 0.012) 0.010 
-0.028 (-0.052to . 0.003) 0.027 
-0.028 (-0.050 to 0.000) 0.048 
-0.003 (-0.006 to 0.000) 0.051 
5.3(0.002) 
6.4 (<0.001) 
Model's R 
squared 
0.04 
0.12 
0.29 
Variables excluded from Model 3 because univariate p>0.2 
Number of WTE GPs in practice Asthma clinic Age 
Computerised practice Previously fund-holding Practice deprivation score 
All partners graduated in the UK Gender Dispensing status 
Consultation length 
Variables excluded from Model 3 after Initial Inclusion (because p for regression coefficient > 0.2) 
Practice list size Training status Years since graduation 
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Model 3 was developed by addition of demographic and practice 
characteristics to Model 2. Unlike the results observed for the effective delivery 
outcome, the TPB measures retained their contribution to the outcome in the 
presence of demographic and practice characteristics. Model 3 explained 29% 
of variance in the efficiency outcome. Apart from belief based items (all three 
significant), working in a larger practice (more GP colleagues) and being the 
senior partner in practice were both linked to more costly statins prescribing. In 
contrast, GPs who mentioned they provided CHD clinics in their practices and 
those with interest in CHID were more efficient prescribers (Table 7.9). 
7.3.7. Demographic characteristics of GPs participating in the 
asthma survey 
Total number of respondents to the asthma survey was 122 of whom 28 GPs 
participated in the regional pilot. All but one GP were principals in their 
practices. All but ten GPs were working in computerised practices, with fifty per 
cent reporting asthma clinical guidelines on their computer systems. Other 
practice characteristics were reported in Table 7.10. 
TABLE 7.10. ASTHMA SURVEY PARTICIPANTS' DEMOGRAPHIC CHARACTERISTICS 
Total Regional pilot Main 
Age (range) 46(29-69) 45(35-66) 46(29-69) 
Years since graduation (range) 21(6-43) 22(11-43) 21(6-41) 
Female (%) 51 (42) 11(41) 40(44) 
Dispensing practice 33(27) 16(59) 17(19) 
Training practice (%) 36(30) 9(33) 27(30) 
Former fund-holding status 45(37) 5(19) 40(45) 
Computerised (%) 107(88) 27(100) 80(89) 
Consultation time (range) 9.6(5-15) 9.8(7-10) 9.5(5-15) 
Senior partner In practice 55(45) 18(67) 37(43) 
The respondents' mean age was 46. On average, 21 years had passed 
since their graduation from medical school. Forty-two per cent of the 
respondents were female. Forty-five per cent of GPs reported that their practice 
formerly had fund-holding status. There were no significant differences between 
the GPs in pilot and main surveys in terms of age, gender, years since 
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graduation from medical school and consultation time. GPs in the pilot were 
more likely to be working in dispensing practices (p<0.001), in formerly fund- 
holding practices (p=0.01) and to be senior partners (p=0.03) in their practices 
(Table 7.10). 
7.3.8. Intention to prescribe medicines for asthma 
In total 122 GPs responded to the asthma questionnaire. GPs intended to follow 
clinical guidelines' prescribing recommendations for the treatment of asthma 
(three items; scale range: 1 to 7; mean=5.5; Cronbach's a=0.58). The exclusion 
of the third intention item from the scale increased internal reliability coefficient 
to 0.79, but did not improve the regression model or the significance of 
regression coefficients. Hence the original scale of three items was used for the 
analyses. GPs also reported that they had followed guidelines advice when 
prescribing for asthmatic patients within the past three months for more than 
half of their patients (two items; scale range: 1 to 7; mean=5.4; Cronbach's 
a=0.54). There were no significant differences between the regional pilot and 
the main survey respondents in terms of their intentions or reported prior 
prescribing. 
Three direct TPB measures assessed GPs' perceived controls, attitudes 
and subjective norms. GPs perceived themselves to be able to overcome 
barriers to evidence-based prescribing for asthma (three items; scale range: -3 
to 3; mean=1.5; Cronbach's a=0.78). GPs were equally confident of their self- 
efficacy and control over factors that hindered this. Less than 10% of the 
respondents did not perceive themselves to have control over barriers (mean 
response of less than 0). GPs had positive attitudes towards following clinical 
guidelines' prescribing recommendations (six items; scale range: -3 to 3; 
mean=2.1; Cronbach's a=0.90) and perceived that the social norm was to 
prescribe in that manner (two items; scale range: -3 to 3; mean=2.0; Cronbach's 
a=0.63). 
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Up to 43% of variance in prescribing intentions was explained by direct 
TPB measures. Perceived control was the sole predictor variable with 
significant regression coefficient. The addition of prior reported behaviour did 
not significantly improve the model as the regression coefficient for prior 
behaviour was non-significant (Models 1&2 in Table 7.11). Self-identity 
measures did not improve the models. 
TABLE 7.11. REGRESSION MODELS FOR EXPLAINING THE VARIATION IN INTENTIONS TO 
PRESCRIBE FOR ASTHMA TREATMENT AS RECOMMENDED BY CLINICAL GUIDELINES 
Dependent variable coefficient (Cl) p value Model's F Model's R 
for value (p value) square 
Model 1 (direct variables) 26.5 (<0.001) 0.43 
Perceived control 0.44 (0.26 to 0.62) <0.001 
Attitude 0.20 (-0.03 to 0.42) 0.09 
Subjective norm 0.19 (-0.05 to 0.43) 0.11 
Model 2 (direct variables, 20.9 (<0.001) 0.44 
past behaviour) 
Perceived control 0.40 (0.22 to 0.58) <0.001 
Subjective norm 0.18 (-0.06 to 0.41) 0.15 
Attitude 0.13 (-0.10 to 0.37) 0.27 
Past behaviour 0.15 (-0.03 to 0.32) 0.10 
Model 3 (indirect 34.9 (<0.001) 0.40 
variables, past behaviour)) 
Indirect subjective norm 0.10 (0.07 to 0.13) <0-001 
Past behaviour 0.21 (0.04 to 0.37) 0.02 
Model 4 (all TPB 46.1 (<0.001) 0.47 
measures) 
Indirect subjective norm 0.07 (0.04 to 0.11) <0.001 
Perceived control 0.44 (0.25 to 0.62) <0.001 
Attitude, subjective norm and perceived control were also indirectly 
measured using modal belief based items (Table 7.12). Indirectly measured 
attitude and subjective norm were positively correlated with their direct 
measures (r=0.45 and 0.76 respectively). Six modal control beliefs were used 
for the assessment of indirect perceived control. Three belief items (control 
belief items 2,3 and 5 in Table 7.12) were not correlated with the direct 
measure, while others had statistically significant correlations (r from 0.22 to 
0.44). The inclusion of items 2,3 and 5 in the indirect perceived control belief 
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resulted in slight reduction in the reliability of the scale (Table 7.12). There was 
statistically significant correlation (r=0.29) between two control belief items of 
'evidence base' and 'hearing about the guideline' (control belief items 1 and 6). 
TABLE 7.12. INDIRECT BELIEF BASED MEASURES OF THE TPB, AND THE MODAL BELIEF ITEMS 
USED IN THE ASTHMA SURVEY AND THE MEAN RESPONSES TO THEM 
Correlation with Internal Mean (SD) 
corresponding reliability: (scales' range: 
direct measure: Cronbach a -21 to 21) Pearson r (p value) 
Indirect attitude 0.45 (<0.001) 0.73 12.4(4.1) 
Indirect subjective norm 0.76 (<0.001) 0.88 10.1 (6.1) 
Indirect perceived control 0.33 (<0.001) 0.32 4.4(3.6) 
Indirect perceived control (3- 0.42 (<0.001) 0.39 4.6(6.0) 
beliefs) * 
Belief items 
Behavioural beliefs (range: 1 to 7) 
If I (GP) prescribe for treatment of asthma as recommended in clinical 
guidelines ... 
1. Patients will be healthier 
2.1 receive 'quality markers' 
3. Standard of care will not be judged negligent 
4. It prevents harm to patients 
5. It provides better quality of care for patients 
Normative beliefs (range: -3 to 3) 
... thinks I shouldIshould not prescribe for asthma as recommended... 
1. Practice nurse 
2. GP colleague 
3. Local hospital consultant 
4. PCO prescribing adviser 
Control beliefs (range: -3 to 3) 
1. BTS guidelines for asthma are evidence-based (facilitator) 
2. BTS asthma guidelines have substantially changed their recommendations 
3.1 am under time pressure to care for asthmatic patients 
4. BTS asthma guidelines are not flexible * 
5. The inclusion BTS guidelines for asthma in the BNF is appropriate 
(facilitator) 
6.1 constantly hear about the BTS asthma guidelines (facilitator) 
Self Identity 
5.5(l. 3) 
3.7(l. 8) 
4.1(1.7) 
5.3(l. 5) 
5.7(l. 3) 
2.0(1.0) 
1.7(l. 1) 
2.0(1.2) 
2.1(1.1) 
1.4(l. 5) 
0.2(l. 4) 
1.2(l. 8) 
0.6(l. 6) 
2.3(l. 2) 
0.3(l. 6) 
1.1 am an evidence-based practitioner 5.1 (1.4) 
2.1 am a patient-centred practitioner 5.7(1.4) 
* Control beliefs that contributed to the 'Indirect perceived control (3-bellefs)' variable. 
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The indirect measures were included in separate regression analyses to 
explain variation in the TPB. Indirect perceived control had no significant 
contribution to variation in intention. This remained unchanged even when the 
measure was based on three beliefs 2,3, and 5 discussed above. Indirect 
measure of attitude too had no contribution to the model. Unlike what reported 
for statins surveys, indirect subjective norms were the only significant 
contributors to the model. The analysis suggested significant multi-collinearity 
between indirect subjective norm and indirect attitude. The exclusion of indirect 
attitude slightly reduced R-squared and changed no other parameter. A model 
based on indirect subjective norm and reported past behaviour accounted for 
40% of variation in intention (Model 3, Table 7.11). All TPB variables were 
eligible for inclusion in Model 4, but only two significantly contributed to it. The 
model including direct perceived control and indirect subjective norm explained 
47%; and inclusion of past behaviour in the model did not significantly change 
the parameters (Model 4, Table 7.11). 
Given that indirect measures of perceived control and attitude had no 
contribution to the models, individual belief items were included to identify 
control and behavioural beliefs that were linked to intention. One control belief 
item (control belief 2) was the only one that significantly improved Model 4 (R- 
squared change=0.03, F change=6.1, p=0.02). It suggested that those who 
agreed more strongly with 'BTS guidelines had changed their 
recommendations' had weaker intentions to follow those recommendations 
(regression coefficient=-0.031, p=0.015). Self-identity measures did not improve 
the models. 
7.3.9. Prescribing for asthma 
Effective delivery indicator: Inhaled corticosterold ADQ per weighted 
STAR-PU 
Data for 96 GPs was available for the calculation of this indicator. Inhaled 
corticosteroid ADO per STAR-PU ranged from 0.13 to 2.43 (median=0.91, 
mean=0.82, SD=0.49). GPs with higher values for this indicator assumed to 
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have followed the BTS asthma guidelines' recommendations more closely 
(Department of Health, 2001 b). There was no significant difference between the 
regional pilot and main survey respondents for this indicator (mean 
difference=0.23, W. 7, p=0.09). 
TABLE 7.13. REGRESSION MODELS FOR EXPLAINING THE VARIATION IN EFFECTIVE DELIVERY 
INDICATORS OF PRESCRIBING FOR ASTHMA 
Dependent variable coefficient (Cl) p for Model's F (p) Model's R 
squared 
A) Inhaled corticosterold DDD per weighted STAR-PU 
Model 1 (all variables) 4.4(0.003) 0.18 
Computerlsed practice 0.44 (0.09 to 0.80) 0.02 
Years since graduation 0.01 (0.002 to 0.03) 0.02 
Asthma clinic -0.23 (-0.43 to - 0.03 
0.03) 
Dispensing status 0.17 (-0.04 to 0.38) 0.11 
Variables excluded from Model I because univarlate p>0.2 
Senior partner Training status Consultation length 
Number of WTE GPs working in Practice deprivation score Age 
practice 
All partners graduated In the UK Practice list size Interest In asthma 
Variables excluded from Model I after Initial Inclusion (because p for regression coefficient > 0-2) 
Previous fund-holding status Gender 
B) Ratio of prophylactic cost to bronchodilator cost 
Model 2 (all variables) 8.3(0.005) 0.09 
Control belief 2: BTS -0.03 0.005 
asthma guidelines have 
substantially changed their 
recommendations 
Variables excluded from Model 2 because unIvariate p>0.2 
Asthma clinic Previous fund-holding status Dispensing status 
Training status Consultation length Gender 
Senior partner Practice list size Age 
Years since graduation Number of WTE GPs In practice 
Variables excluded from Model 2 after Initial Inclusion (because p for regression coefficient > 0.2) 
Practice deprivation score Computerised practice Interest In asthma 
All partners graduated In the UK 
No direct or indirect TPB variable significantly contributed to the 
regression model. Following the criteria explained in 7.2.7, only one behavioural 
belief and one control belief measure met the statistical criteria for inclusion in 
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the regression models. However, these three variables had no significant 
contribution to variation in the outcome indicator. The indicator was transformed 
to its square root yielding a distribution close to normal (range: 0.36 to 1.56; 
median=0.91; mean=0.92, SD=0.25). Procedures followed for the non- 
transformed variable were repeated. No significant univariate or multivariate 
relationships between the TPB measures and the square root of effective 
delivery indicator were observed. Therefore Model 1 was devised using 
demographic and practice characteristics only (Table 7.13). The included 
variables explained 20% of variation in inhaled corticosteroid DDD per weighted 
STAR-PU. The model suggested that more experienced GPs and those who 
worked in computerised practices were more likely to offer better quality of 
asthma prescribing. On the other hand the presence of asthma clinics was 
correlated with less inhaled corticosteroid DDDs per weighted prescribing unit. 
As the analyses identified no relationship between the TPB measures 
and the primary effective delivery outcome, they were repeated using the 
secondary outcome. The prophylactic cost to bronchodilator cost ratio was the 
planned secondary effective delivery outcome (range: 0.6 to 4.2; median=1.8; 
mean=1.8; SD=0.67). It was assumed that GPs with bigger ratios had better 
quality of asthma prescribing. Three TBP variables met the criteria for inclusion 
into the regression model: indirect attitude, behavioural belief 5 ('better quality 
of care) and control belief 2 ('guidelines have substantially changed their 
recommendations'). Only control belief 2 remained in the final model (Table 
7.13). Model 2 explained 9% of variation in secondary outcome and suggested 
that GPs who believed more strongly in'BTS asthma guidelines have 
substantially changed their recommendation' had smaller prophylactic to 
bronchodilator cost ratios. The addition of demographic and practice 
characteristics variables (including those significant in Model 1) did not improve 
this model. 
Efficiency indicator: Inhaled corticosterold cost per ADQ 
The indicator was meant to capture efficient use of resources for asthma 
prescribing. Evidence suggested that it was appropriate to use the cheapest 
available inhaled corticosteroid when prescribing for asthma (Eccles et al, 
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2001 b). Costs (NIC) were expressed in pounds sterling. ADQs for different 
preparations were presented in Table 7.1. The distribution of data for this 
outcome was close to normal (range: 0.11 to 0.75; median=0.32; mean=0.29; 
SD=O. 12). 
TABLE 7.14. REGRESSION MODELS FOR EXPLAINING THE VARIATION IN EFFICIENCY INDICATOR 
OF PRESCRIBING FOR ASTHMA 
Dependent variable coefficient (Cl) p-value Model's F Model's R 
for value (p value) square 
Model I (TPE3 variables) 6.0 (<0.001) 0.22 
Behavioural belief 1: -0.007 (-0.01 to - 0.005 
patients'will be healthier 0.002) 
Control belief 6: hearing 0.003 (0.001 to 0.01 
about BTS asthma 0.006) 
guidelines 
Normative belief 4: PCO 0.004 (0.001 to 0.02 
prescribing adviser 0.008) 
Control belief 3: under 0.004 (-0.001 to 0.10 
time pressure 0.009) 
Model 2 (all variables) 5.5 (<0.001) 0.34 
Behavioural belief 1: -0.007 (-0.01 to - 0.007 
patients'will be healthier 0.002) 
Asthma clinic 0.07 (0.02 to 0.12) 0.009 
Practice deprivation score 0.05 (0.005 to 0.01) 0.03 
(two categories) 
Normative belief 4: PCO 0.004 (0.00 to 0.03 
prescribing adviser 0.008) 
Control belief 6: hearing 0.003 (0.00 to 0.04 
about BTS asthma 0.006) 
guidelines 
Computerised practice -0.08 (-0.17 to 0.07 
0.01) 
Variables excluded from Model 2 because univarlate p>0.2 
Consultation length Age Years since graduation 
Training status Fund-holding status Dispensing status 
Gender Senior partner In practice 
Variables excluded from Model 2 after Initial Inclusion (because p for regression coefficient > 0.2) 
Number of WTE G Ps in practice All partners graduated In the UK Interest In asthma 
Practice list size 
At the first stage the TPB direct and indirect variables were assessed for 
their contribution to explaining variation in efficiency outcome. Indirect and 
direct subjective norms as well as indirect perceived control met the criteria for 
inclusion in the model, but the model did not reach statistical significance. Also 
255 
self-identity measures were not related to the efficiency outcome. At the next 
stage belief based TPB variables were considered. Six variables met the 
minimum criteria, but two (normative beliefs 2 and 3) were excluded from the 
model because of minimal contribution and presence of multi-collinearity. Model 
1 explained 22% of variation in efficiency outcome (Table 7.14). The model 
suggested GPs believing more strongly that adhering to BTS asthma guidelines 
improves patients' health were likely to be more efficient prescribers. In contrast 
those GPs who believed more strongly that they constantly hear about asthma 
guidelines and those who perceived more strongly that PCO prescribing 
advisers expected them to follow the BTS guideline were likely to be less 
efficient prescribers (Table 7.14). 
Model 2 was developed by addition of demographic and practice 
variables to Model 1. All belief based variables that were significantly related to 
the efficiency outcome in Model 1 kept their statistical significance in the latter 
model. Model 2 explained 34% of variance in efficiency outcome. It suggested 
that as well as the conclusions of Model 1, the presence of asthma clinics in 
practices and high deprivation scores (binary variable based on median score) 
were associated with less efficient prescribing. As the observed association with 
binary deprivation scores disappeared when the linear variable (i. e. square root 
of original score) was used in the model, it should be treated with caution. 
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Z4. Discussion 
This study was probably the first TPB study of GPs' adherence to clinical 
guidelines and probably the first TPB study that considered both prescribing 
behavioural intentions as well as GPs' actual prescribing practice. Similar to the 
findings of previous studies of health professionals (Table 6.2), the TPB proved 
to be a powerful model for explaining variation in behavioural intention. Up to 
47% of variation in reported intentions to follow clinical guidelines' prescribing 
recommendations were explained in different models (Tables 7.6 and 7.11). 
TPB elements also demonstrated some ability to explain variation in prescribing 
outcomes. Belief based TPB variables explained up to 14% of variation in 
statins prescribing indicators and 22% of variation in asthma prescribing 
indicators (Tables 7.8,7.9,7.13 and 7.14). These latter explanatory powers 
were achieved, however, through significant deviations from standard methods 
of analysis TPB items as suggested by Ajzen and others. 
7.4.1. Statins prescribing 
The study demonstrated that attitude and perceived controls were the main 
explanatory variables for variation in statins prescribing intentions (Table 7.6). 
According to this finding, subjective norms were not important elements in GPs' 
decision making processes when prescribing statins for secondary prevention of 
CHID. This might have happened because statins prescribing might be more 
correlated with the GPs beliefs in strength of evidence of effectiveness and 
organisational and monetary barriers rather than expectations of colleagues and 
other professionals. It might also be the result of poor performance of the 
composite scoring approach for subjective norm measurement. 
Similar pattern was observed in the analysis of the effective delivery of 
statins prescribing. No normative belief was related to the outcome, while one 
behavioural belief (the likelihood of getting quality markers) was linked to the 
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outcome. A further behavioural belief and one control belief also approached 
statistical significance (Model 1, Table 7.8). The observed effects of 'getting 
quality marker' belief were small (small coefficients). There might be different 
explanations for the finding. It might be the result of statistical artefact or it might 
not reflect GPs true feelings and beliefs. If the responses were valid 
representation of GlPs beliefs, then the findings suggested that when GPs 
perceived statins prescribing as likely to result in 'quality markers', they were 
more likely to follow it. In contrast, other beliefs did not show such effects. 
Unlike intention and the effective delivery outcome, subjective norms had 
significant contribution to efficient prescribing outcome. Different beliefs 
explained 12% of variation in efficient prescribing. Those GPs who perceived 
more pressure from PCO advisers for statins prescribing were likely to prescribe 
less efficiently (Table 7.9). The other interesting finding here was that belief 
based TPB variables were able to contribute significantly to the model in 
presence of demographic and organisational factors. Analysis of the efficiency 
indicator yielded other interesting findings. Senior partners and those working in 
larger practices were more likely to spend more on statins DDDs. In reverse 
having CHD clinic or interest in CHD were linked to less costly prescribing 
(Model 3). More efficient prescribing because of CHD prevention clinics was an 
addition to their previously shown positive effects on quality of care and death 
rate in experimental studies (Murchie et al, 2003). Higher reported perceived 
control was correlated with more efficient prescribing (Model 1). Among the 
control beliefs the NSF was significantly correlated with the outcome. 
Interestingly, control belief 6 (statins prescribing may exhaust practice's 
prescribing budget) was not correlated with the outcome. Among all the 
variables contributing to Model 3 (Table 7.9), belief items, interest in CHD and 
clinics were changeable without major revisions in the structure of primary care. 
Further studies were required to estimate how much cost was involved in 
changing beliefs and interests. 
The analyses suggested practices with higher deprivation scores had 
higher values of the effective delivery indicator (Model 2, Table 7.8). This was 
different from previous literature on lower quality of care offered to socially 
deprived patients (see Chapter 6). One explanation might be that among 
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patients younger than 60, socially deprived patients who were exempt from 
prescribing charges might have more incentive to continue their treatment 
course with statins than those that were marginally better off but found the 
continuing costs a disincentive. Some limitations should be noted here before 
making any conclusion. First the variable used in the mode was binary (using 
the median), because the original variable was positively skewed with many 
practices having a score of zero. Therefore the finding did not suggest dose 
response pattern. Second higher prescribing might be the result of higher needs 
of the patients (i. e. CHID; see Smith et al, 1998b). Third, the data did not 
demonstrate whether it was the deprived patients who were receiving these 
statins or other patients registered with those practices (i. e. ecological fallacy; 
see Morgenstern, 1995). Answering these queries with PACT data was not 
possible and required further research including patient data. The analysis 
however did not indicate that people living in socially deprived areas were 
receiving lower quality care. 
7.4.2. Prescribing for asthma 
Indirect subjective norms and direct perceived control variables were able to 
explain 47% of variation in intentions to prescribe in accordance with the BTS 
asthma guidelines (7.11). The absence of any significant contribution from 
attitudes was unexpected as attitudes were generally the most powerful 
predictors of intentions in TPB studies (Lambert et al, 1997; Levin, 1999; Walker 
et al, 2001; Watson and Myers, 2001; Puffer and Rashidian, 2004). TPB 
variables had no contribution to the primary effective delivery outcome of 
prescribing for asthma (corticosteroid DIDD per weighted STAR-PU). It was not 
possible to ascertain whether this showed genuine lack of relationship between 
psychological constructs of the TPB and the outcome, or difficulties in 
measuring a valid indicator of asthma prescribing from PACT data (7.2.5). 
A significant relationship was observed between one control belief and 
secondary effective delivery outcome (corticosteroid cost to P-agonist cost ratio) 
(Table 7.13). The analysis suggested those GPs that felt more strongly that 
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'BTS asthma guidelines recommendations have substantially changed'were 
likely to prescribe less in accordance with the guidelines' recommendations. 
This was the only variable with significant contribution to the model. This finding 
was consistent with the qualitative study (Chapter 4) which suggested the 
notion of change was an important factor for guideline implementation, and with 
the analysis of asthma prescribing intentions (7.3.8). This control belief did not 
feature in the models explaining efficiency indicator (Table 7.14). The belief and 
its potential effect on prescribing might be a response to some of the changes in 
the BTS asthma guidelines recommendations through the years (British 
Thoracic Society, 1993a; British Thoracic Society and National Asthma 
Campaign, 1997a; British Thoracic Society and Scottish Intercollegiate 
Guidelines Network, 2003). However, again it was difficult to establish whether 
this association was due to statistical artefact or genuine relationship between 
the belief and the outcome. It would be interesting to know what level of change 
in recommendations could cause enough discontent in GPs to hamper guideline 
implementation. Such studies might be difficult with real life scenarios, as there 
were a lot of confounding factors. It might be possible, however, to conduct a 
study using guideline simulations and record the reaction of GPs to the change 
in recommendations. This might help the development and implementation of 
clinical guidelines in future. On the other hand, asthma care in British primary 
care was often offered by practice nurses under GP supervision. Therefore, 
changes in recommendations might not affect Us in terms of time spent on 
patient education or losing face in front of patients (e. g. because GPs changed 
their recommendations). Similar explanation might also apply to CHD 
preventive care. The qualitative study (Chapter 4) suggested that statins were 
usually prescribed by Us while they were consulting patients, while asthma 
prescribing happened as a result of assessments conducted by practice nurses. 
Model 1 in Table 7.13 suggested having 'asthma clinic' in practice was 
correlated with lower quality of asthma prescribing. This finding was puzzling, 
since case studies demonstrated that asthma clinics were linked to many 
aspects of better asthma care (Dickinson et al, 1998). Also clinical guidelines 
emphasised the importance of providing asthma clinics in general practice 
(Scottish Intercollegiate Guidelines Network, 1998). On the other hand a 
randomised trial of using specialist nurses to support practice nurses in asthma 
260 
care failed to improve patient outcomes (Premaratne et al, 1999). An 
explanation for the survey's finding could be that asthma clinics had improved 
the management of patients in a way that short-acting P2-agonist bronchodilator 
treatment was adequate for bigger proportion of patients. As a result, less 
amount of inhaled corticosteroid were prescribed per weighted STAR-PU. 
Similar to the analysis of efficiency indicator of statins prescribing, TPB 
belief based variables were powerful predictors of variation in the efficiency 
outcome of asthma prescribing (Table 7.14). Three behavioural beliefs 
explained up to 22% of variation in the outcome and retained their significant 
contribution to the model in presence of demographic and practice variables 
(Table 7.14). Again, as for the statins efficiency outcome, perceiving more 
pressure from PCO prescribing advisers was linked to less efficient prescribing 
for asthma. Also the analysis suggested that GPs who heard more about the 
BTS asthma guideline were less likely to prescribe efficiently. Among all 
demographic and practice characteristics, three had significant contributions to 
the model. Computerised practices were likely to prescribe more efficiently, 
while those with asthma clinics or higher deprivation scores seemed to be less 
efficient in their prescribing of inhaled corticosteroids (Table 7.14). It was known 
that asthma clinics might result in increase in asthma treatment costs 
(Dickinson et al, 1998), but there should be no reason for it to reduce the 
efficiency in choice of inhaled corticosteroids. A previous study suggested there 
could be interaction effect between practice deprivation and the corticosteroid to 
bronchodilator ratio (Shelley et al, 1996), in which in more deprived areas, the 
ratio was less 'preventive' of asthmatic admission to hospital. In other words 
higher ratios did not reflect themselves in reduction in admission rates. This 
might also be the result of higher levels of need in deprived areas (Salamzadeh 
et al, 2003). The caveats discussed in the previous section on statins, apply 
here as well. 
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7.4.3. Self identity, expressed interest and practice 
characteristics 
Self identity measures did not contribute to models intended to explain variation 
in prescribing intention. Interestingly, GPs who perceived themselves as 
evidence-based practitioners were likely to prescribe more statins per weighted 
prescribing unit (Table 7.8). This observed effect turned non-significant in 
presence of demographic and practice characteristics. No other contribution to 
multi-variate models was observed from the evidence-based practitioner self- 
perception or the patient-centred practitioner self-perception. 
Expressed interest in CHID was correlated with more efficient statins 
prescribing (Table 7.8) but not more effective prescribing (7.9). The analyses 
did not identify any links between expressed interest in asthma and prescribing 
outcomes. This was different from other studies (Jones, 1992), which concluded 
that interest in asthma reduced prescribing costs. Campbell et al (2001 a) 
concluded that the training status of the practice was not a significant predictor 
of quality of care. Training status did not feature in any of the multivariate 
models of prescribing outcome indicators. No practice or service characteristic 
was linked in multivariate analysis with the effective delivery indicator of statins 
prescribing. Only having CHID clinic was correlated with efficient prescribing of 
statins (Table 7.9). Computerised practices presented themselves as effective 
prescribers for asthma (Table 7.13). Rather surprisingly, GPs who reported 
having asthma clinics prescribed less efficiently and less effectively as 
measured by the indicators (7.4.2; also Tables 7.13 and 7.14). 
Previous studies identified strong relationships between practice booking 
intervals and the quality of chronic disease management. One large survey 
concluded that the scores for quality of care for asthma were 67% higher in 
practices with 10-minute booking intervals for routine consultations than in 
practices with 5-minute intervals (Campbell et al, 2001 a). The quality scores 
were calculated using a set of criteria including prescribing. No such 
relationship was identified in the surveys' analyses. This might be due to the 
lack of statistical power to capture these potential differences in the surveys. 
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Only one GP in the statins survey and one in the asthma survey reported 5- 
minute booking intervals. 
7.4.4. Valid measurement of prescribing 
TPB assumes that behaviours were under volitional control, and therefore 
attitude towards behaviour, and not attitude towards target, predicted 
behavioural intention and behaviour (Montano and Kasprzyk, 2002). The 
difference between these two types of attitudes was discussed in Chapter 3 
(3.2.6). It is common to assume physicians' behaviour as volitional and the 
result of careful decision making. Clinical preferences and choices of physicians 
were referred to as 'individual clinical policies' implying deliberate decision 
making (Lomas and Haynes, 1988). However, variations in physicians' 
behaviour might not be volitional in all circumstances. The review of the impact 
of computerised reminder systems demonstrates well that some variations were 
due to errors of omission (Soumerai et al, 1989). A long term study 
demonstrated that as soon as computerised reminders were stopped the rate of 
antibiotic prescribing for streptococcal pharyngitis returned to lower pre- 
intervention levels (Barnett et al, 1978). In that study all participating physicians 
had agreed to take part in the reminder system and considered antibiotic 
prescribing for streptococcal pharyngitis as clinically important topic. Variation in 
prescribing might be down to simple (or complicated) organisational variables 
despite individual physicians' clinical policy. In theory, TP13 was capable of 
capturing these variations under the perceived control concept. Suppose a 
physician was asked about his or her perceived ability to prescribe appropriate 
antibiotics for all cases of streptococcal pharyngitis requiring the treatment. It 
could be assumed that when the reminder system was not in place, the 
physician would express less ability to perform the behaviour. In reality, this 
assumption depended on the physician being aware they had omitted some 
cases that required the treatment. Unless the physician was aware of the 
omission, the TPB's perceived control concept might not capture the variation. 
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Prescribing outcomes might not be accurate reflections of GP intention 
and activity, rather the effects of other clinicians' behaviour. Practice nurses 
were actively involved in the management of chronic diseases and their 
preferences could affect GP prescribing. Nurses usually had the authority to 
decrease or increase the dosage of prescribed treatments, although they 
consulted the GPs for the initiation of new medicines (Dickinson et al, 1998). A 
proactive practice manager who pursued the identification of patients requiring 
secondary prevention or those with asthmatic symptoms might contribute to 
higher levels of prescribing, without direct effects on the beliefs of the GPs. GPs 
in partnership practices might sign the repeat prescription orders for patients 
under the care of their GP colleagues, without being directly involved in decision 
making for the care of the patient. Also some medicines assessed in this study 
could be consultant initiated. For example, if the local consultant prescribed 
expensive products such as fluticasone propionate more frequently, the GP 
prescribing might appear less efficient as a result. Or if a local hospital was 
proactive in ensuring all coronary artery patients were discharged on statins this 
would improve the performance of local GPs without necessarily affecting their 
views or beliefs. 
Habits and routines contribute to clinician behaviour. GP prescribing for 
certain conditions might be due to routines more than to decisions. An analytical 
study of GPs' cognitive processes while prescribing (antibiotics) for UTI or 
stomach complaints concluded that up to forty per cent of prescribing decisions 
were due to habits (Denig et al, 2002). They also concluded that habits resulted 
in optimal or suboptimal prescribing for patients. If that was the case, then 
attitude towards behaviour were less influential in affecting the behaviour. 
Despite Denig et al (2002), the term 'routine'was deliberately used in here 
instead of 'habit' to acknowledge that prescribing required information 
processing. Behaviours such as prescribing (for given conditions) that were not 
completely volitional, but were not as automatic as habits, better to be referred 
to as routines (Norman and Conner, 1996). The spontaneous processing model 
accounted for behaviours which were not mediated by decisions following 
careful considerations. This model suggested that in these circumstances, 
attitude towards objector target might explain behaviour better that attitude 
towards behaviour. The model argued that attitude towards object could be 
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activated in response to certain cues and lead to change in behaviour (Norman 
and Conner, 1996). The model also suggested that deliberate consideration of 
behaviour happened more in novel conditions, or for now problems, than in 
familiar conditions (Norman and Conner, 1996). The implications of this 
argument for guideline implementation was that careful and volitional 
assessment of patients followed by deliberate implementation of guideline 
recommendations was more likely to happen for new patients or diseases, or 
new presentations of chronically ill patients. GPs might prescribe many drugs 
because of routines (similar patients, protocols) or previous decisions (repeat 
prescription in chronic diseases). It might also imply that changing prescribing 
for treatment of chronic diseases or common diseases (with chance of seeing 
many seemingly similar patients) were more difficult than for other diseases. 
It was important to distinguish behavioural attempts from actual 
behavioural performance. For example GP might intend to prescribe statins for 
secondary prevention of CHID in accordance with the guideline. The doctor 
offers the prescription to the patient. The patient may refuse to take the 
medicine in two ways. He or she may refuse to accept and as a result the GP 
decides to offer an alternative medicine, non-medicinal treatment or none for 
the time being. Second, the patient may receive the prescription, but decides 
not to go to the pharmacy and take the medicine. In both of these scenarios, 
there has been a behavioural attempt, but no behavioural activity. The outcome 
measure in the study is only capable of capturing actual behaviour outcomes 
through drug dispensing information (PACT data). Note that the second 
scenario is not, even in theory, captured by the perceived control element of 
TPB. The positive behaviour of the GP has not resulted in prescribing because 
of the patient's decision. The GP has no control over the patient's decision and 
may not become aware of it. This is another limitation of studying clinicians' 
behaviour. In the context of the TPB, both behavioural attempts and actual 
performances form what called behavioural achievement (Ajzen, 1991). 
However, behavioural attempts are very difficult to measure in prescribing 
context. Also, for example, if the patient who is supposedly on the treatment 
does not take the drug regularly, it will affect its need for the medicine and 
therefore the amount dispensed through repeat prescription. All these scenarios 
suggested that future TPB studies would do better if considered doctors' 
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prescriptions as the outcome rather than dispensed medicine. Future studies 
should also focus on new patients or new prescriptions and attempt to separate 
repeat prescriptions. 
It has been argued that patient variables such as culture, economic and 
social circumstances and patients' perception of the outcome were more 
important variables of variation in the provision of health care than doctors' 
recommendation (Greer et al, 2002). Crude social variables did not capture this 
variation. The study did not measure patient characteristics. Indeed it was 
difficult to measure these in valid and reliable ways. Nevertheless this might 
have contributed as one of the factors that resulted in incomplete capture of 
variance in prescribing indicators. 
7.4.5. Specific recommendations versus guideline as a whole 
The surveys assessed only some of the messages provided by the clinical 
guidelines. Clinical guidelines very often give non-prescribing advice as well as 
prescribing advice. The surveys focused on specific prescribing issues. 
Therefore the totality of the guidelines' advice was not considered. Focused 
approach is common in guideline implementation studies. Two investigators 
systematically reviewed several clinical guidelines and non-interventional and 
interventional studies of guideline implementation (Chrischilles and Gondek, 
1997). Among twenty-four non-interventional studies they found only one study 
that considered all the prescribing advice offered in the studied guideline. They 
concluded that the majority of guidelines did not provide detailed advice about 
drug regimen issues that were required for the evaluation of prescribing. 
Similarly, another systematic review identified only one study that'looked at a 
broader range of quality of care issues, including inappropriate choice of 
therapy, under-dosage and over-dosage, scheduling, drug-drug interactions, 
therapeutic duplication, allergies and the omission of necessary drug therapies' 
(Anderson and Lexchin, 1996). This might be because of difficulties in 
measuring appropriate outcomes. On the other hand it might be due to the 
limited information provided in many clinical guidelines. Very often there is not 
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enough evidence to support detailed recommendations. Even if the guidelines 
provided detailed advice, it would be difficult to link recommendations to 
measurable outcomes. A review of nineteen primary care clinical guidelines 
concluded that it was not possible to link most of the guidelines' 
recommendations to measurable outcomes (Balas et al, 1994). 
TPB has stronger theoretical footing when applied to behaviour rather 
than consequent outcome and to single behaviour rather than multiple 
behaviours (Bagozzi et al, 1989; Conner and Sparks, 1996). These issues 
impose limitations on studies using TPB to examine adherence to guidelines. 
Adherence to guideline involves multiple behaviours. It might include correct 
diagnosis and diagnostic investigations, proper consultation with the patients, 
drug and non-drug prescriptions, management of adverse events and follow-up. 
Thus the goal of adherence is achieved only if most or all of those behaviours 
are performed. To assess the feasibility of the TPB in explaining variation in 
guideline implementation required focus on limited areas of guideline 
recommendations. It is possible, at least in theory, to capture all 
recommendations made by guidelines, but it would require questionnaires of 
several pages long that would reduce the chances of getting meaningful 
responses from participating GPs. 
7.4.6. Study design and data sources 
Prospective designs are appropriate for TPB studies. Behavioural intention and 
its determinants are measured at one point of time and behaviour at a later 
stage (Conner and Sparks, 1996; Montano and Kasprzyk, 2002). Simultaneous 
measurement of behaviour with other elements of the model (cross-sectional 
design) is not recommended and might provide poor and unreliable measures 
of past behaviour (Montano and Kasprzyk, 2002). The analysis of the surveys' 
prescribing outcomes was essentially prospective. The responses to the 
questionnaires were collected in early 2002, while the prescribing data was for 
April to June 2002. Another important feature of the design was the attempt to 
capture documented behaviour from PACT data instead of relying on reported 
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behaviour, which was common in TPB studies. Self reported behaviour has 
higher correlation with attitudes and intentions and might be subject biases 
(Armitage and Conner, 1999b; Armitage and Conner, 2001). 
The primary outcome measures used in the surveys were calculated 
from PACT data. PACT was not linked to patient records; hence it was not 
possible to assess the appropriateness of prescribing for individual patients. 
Using PACT data, the investigator was incapable of establishing whether those 
patients who required drug therapy based on their diagnosis were given the 
drug appropriately, and whether those who should not have received a drug 
were given it. Prescribing units captured only part of these variations. GP lists 
were inflated by about six per cent (National PCT Database, 2004), because 
movements (of young adults), emigrations and deaths are not quickly updated. 
Therefore the practice demographic data and hence the STAR-PUs might not 
reflect the truth. It was not possible to establish the level of inflation for different 
practices. This was likely to introduce error into the analyses of effective 
delivery outcomes and reduce the significance of regression coefficients. 
The arguments in favour of or against the use of different prescribing 
indicators were presented in the methods section (7.2.5). In addition, a 
consensus development study assessed the validity of prescribing outcomes 
(Campbell et al, 2000c). The study used Delphi method (Adler and Ziglio, 1996) 
to identify valid prescribing indicators of quality and efficiency of prescribing 
based on PACT data. Out of 41 indicators that were assessed for both quality 
and efficiency, only 12 (out of 41 x2=82) were considered valid by participants. 
The 'valid' indicators did not include indicators of prescribing for asthma or of 
statins. However, an indicator for asthma measuring cost per DDD of inhaled 
corticosteroids scored reasonably well for efficiency (7 out of 9). Another 
asthma indicator, ratio of inhaled corticosteroids DDD to inhaled corticosteroids 
STAR-PU scored 6 out of 9 as a quality indicator. An indicator'items of lipid 
lowering drugs per patients aged 45-75' also scored 6. The only statins 
prescribing indicator considered in the study was 'no of items for statins per 
1000 patients'. This indicator understandably scored low for both prescribing 
quality and efficiency. 
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The study design could have been improved by recruiting GPs from 
practice linked to databases such as General Practice Research Database 
(GPRD), Doctors Independent Network (DIN) or MediPlus database 
(Lawrenson et al, 1999; Hansell et al, 1999). The advantages of using these 
resources were that GPs prescribing data were linked to individual patients and 
their recorded diagnosis (see Appendix VIII). Hence it would have been 
possible to reduce variation in prescribing outcomes occurred because of 
different sources of inaccuracy. The main disadvantage of the GPRD database 
was that it might not be representative of the GP population. However, if high 
response rate was achievable from the GPs linked to this database, the 
disadvantage might be ignored. It was not possible to use GPRD or similar 
resources because it required financial resources that were not available to this 
PhD study. 
7.4.7. Response rate, questionnaire design, optimal scaling and 
TPB analysis 
In recent years the response rate of health professionals (in particular GPs) to 
research surveys has been failing (Kaner et al, 1998; Barclay et al, 2002). Low 
response rates may threaten the validity of the findings of surveys. The detailed 
non-response analysis identified differences between the respondents and non- 
respondents, but most did not reach statistical significance (Table 7.3). There 
was significant difference between the two surveys, as more GlPs responded to 
the statins surveys. Apart from this the only other clear difference between the 
two groups was the higher response rate from training practices. This was 
statistically significant in overall analysis and for the statins survey but not the 
asthma survey. If the lack of significant relationship between the training status 
of the practice and responding to the asthma survey was not statistical artefact 
it might suggest that GP trainers no longer found asthma an interesting topic. 
The response rate from those GPs who were working in practices in which all 
GlPs were qualified in the UK (regardless of their ethnic origins) was higher than 
others. 59% of the sampled GlPs were working in such practices, but 65% of the 
responding GPs were from them (p=0.06; Table 7.3). 
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Despite strenuous efforts the response rates were poor. The efforts 
included two reminders, reducing the number of questions in the main surveys, 
better quality print for the questionnaires, pre-paid reply envelopes, individually 
addressed and hand-signed covering letters every time, changing covering 
letter content for the first and second reminders and the provision of a lottery for 
respondents. A factor that might have contributed to low response rate was the 
request for access to the GPs' PACT data. Anecdotal feedback from 
respondents suggested that some found asking for access to PACT data a 
reason for not returning the questionnaire. The other potentially important factor 
was the length of the questionnaires. Shorter questionnaire might have led to a 
better response rate. Shortening the questionnaires should be done without 
excluding important elements of the TPB. In the light of that, it might be possible 
to reduce the number of items in direct attitude and intention scales. This, 
however, would not shorten the questionnaire dramatically. Most of the 
questionnaire items were belief based and the findings strongly supported their 
inclusion in TPB studies. Therefore, questionnaire length would remain the 
limiting factor for TPB studies of health professionals. Another solution for 
reducing the number of items in the questionnaire was to drop value statements 
from belief based items. This could shorten the questionnaire substantially. In a 
recently published study of primary care physicians, the investigators dropped 
value items; instead they multiplied positive beliefs by an average positive value 
and multiplied negative beliefs by an average negative value (Montano and 
Kasprzyk, 2002). They did this to shorten the questionnaire. Shortening the 
questionnaires in this way has theoretical drawbacks, as one expects different 
beliefs to elicit different values from different physicians. The validity of solutions 
like this also depends on finding solutions to the more serious limitation of TPB 
studies, namely the inability of the theory to suggest optimal scaling approach 
for the questionnaire items (7.3.2). 
It was recently suggested that the analysis of composite scales as 
suggested by Ajzen and others introduced biases in the findings and made 
interpretation difficult (French and Hankins, 2003). They considered this to be a 
problem of modelling the interaction between expectancy and value items, 
rather than the theory. One proposed solution was to put expectancy and value 
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items in the regression model and then add composite measure (i. e. interaction) 
to see how much more of the attitude's variance was explained by the 
interaction. But the authors argued this was not psychologically sound (Hankins 
et al, 2000; French and Hankins, 2003). Future studies might use statistical 
optimisation to identify the best scaling approach and composition strategy for 
the analysis of the TPB items (Box and Cox, 1964). Such optimisation should 
be based on datasets of a few different studies of health professionals, ideally 
all with prospective measures of outcome behaviour 
Previous studies proposed that subjective norm was the weakest 
explanatory variable of intention (Godin and Kok, 1996; Armitage and Conner, 
2001). Hence the power calculation for the surveys was based on the 
relationship between subjective norm and intention (Chapter 6). The results of 
the surveys did not support that assumption. Subjective norms performed as 
well as other elements of the TPB in the models. More importantly, one 
normative belief remained significant contributor to variation of the outcome for 
both statins and asthma surveys. This might be the result of careful attention to 
the measurement of subjective norm and normative beliefs in the surveys 
(Armitage and Conner, 2001). Careful attention was given to the optimal scaling 
of TPB indirect measures. Many previous studies shunned this important 
consideration (e. g. Walker et al, 2001). 
It was argued that to test a theory, it was not always suitable to conduct 
empirical research (Smedslund, 2000). Smedslund proposed that the distinction 
between a priori positions and empirical questions were not always 
acknowledged in psychological research. He argued that for a priori positions 
'rational evaluation' was the way of testing the position and not empirical 
research. This could have important implications for the way the TPB was 
evaluated. Because of similarities in item wording it seemed plausible to expect 
high correlation between the items, e. g. between intention and reported past 
behaviour, or between attitude and intention. Some of the relationships 
observed in the analysis of the TPB were logical. Davidson (1998) documented 
similar criticisms over the transtheoretical model - that high internal reliabilities 
observed in empirical studies were the mere results of similarities between the 
meanings of the items (semantic overlap). Where there was semantic overlap 
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between scale items, the psychometric characteristics of the scale could be 
misleading (Davidson, 1998). Also good internal reliability estimates might have 
happened because of the way items were presented. Likewise, if items had 
similar meanings, they would share specific variance and common factor 
variance. Similarity of item wordings for proximal constructs of the model could 
have resulted in good psychometric capabilities only because of inter-item 
semantic overlaps. Nonetheless there were elements in the TPB that warranted 
empirical testing. Among those were the relative strengths of different elements 
of the theory in explaining variation in intention. The criticism applied most to 
explaining variation in intention using direct TPB variables. The criticism might 
not apply to the models that explained intention by indirect measures or the 
models that explained actual behaviour (e. g. prescribing). The TPB belief based 
constructs performed reasonably well in the surveys' models where intention 
was the predicted variable, as well as in the models with prescribing as 
predicted variable; however in the latter group the belief based items were used 
as individual items. 
Measurement of reported past behaviour in the surveys followed Ajzen's 
and others' recommendations. This was not ideal, especially as the format of 
reported behaviour question became similar to the format of the intention 
question (Armitage and Conner, 2001). An alternative approach would have 
been to use written case simulations or vignettes and ask the GPs to report 
their behaviour in response to the vignette. Ideally, minimum of two case 
simulations should have been used to capture different aspects of past 
behaviour. However, addition of even one vignette could have resulted in 
significantly longer questionnaire. It should be noted that in the analysis of the 
surveys, the reported past behaviour was used only in complementary analyses 
and it did not contribute to the variation in the prescribing indicators. 
Inclusion of social desirability questionnaire might have increased the 
validity of the findings (Crowne and Marlowe, 1960). Following clinical 
guidelines' recommendations for secondary prevention of CHID and treatment of 
asthma were 'socially desirable' behaviours. Hence the respondents might have 
unintentionally ('social desirability') or intentionally ('faking good') expressed 
themselves more positive towards the behaviours; than they really were 
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(Streiner and Norman, 2003). However, inclusion of further questions in the 
questionnaire was not feasible. The questionnaires were already long enough to 
discourage some GPs from responding. Longer questionnaires might have 
resulted in lower response rates. Also previous studies suggested that social 
desirability had minimal impact on TPB models (Armitage and Conner, 1999a). 
Another approach would have been to ask about different set of 
behavioural beliefs in the questionnaires. The actual behavioural beliefs were 
targeted towards the ultimate outcomes of evidence-based prescribing for 
patient outcome and improved quality of life. Alternatively, these items could 
have targeted immediate behavioural outcomes, e. g. reducing number of 
asthmatic attacks, re-admissions, blood cholesterol level, risk of cardiac events 
or even number of visits to the practice. Using these items might have resulted 
in bigger correlation coefficients between beliefs and intention or prescribing 
indicators. On the other hand this approach might have reduced the correlations 
as these specific outcomes might not necessarily correlate with the goal of 
achieving better quality of care for patients. Also specific questions might not 
necessarily correlate with the totality of following clinical guideline 
recommendations, as they might relate to individual patients or to specific ways 
of prescribing. These might alter from time to time even for individual patients. 
Nonetheless specific outcomes did not demonstrate themselves in the 
qualitative interviews as salient beliefs for GPs when they thought of 
implementing guidelines. 
Future studies might also assess the TPB in the context of diseases with 
more controversies surrounding their management. These studies could 
contrast different beliefs against each other. For example, GPs might have 
strong behavioural beliefs in support of a guideline, but have negative normative 
beliefs since their colleagues disapprove of the recommendation. 
7.4.8. Can the TPB improve understanding of GP prescribing? 
The TPB surveys targeted prescribing for two specific conditions. Therefore, the 
results were not included into the taxonomy of interventions presented in Table 
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4.2. In order to use TPI3 surveys to explain variations observed in the 
effectiveness of interventions, TPB studies should be conducted along-side 
experimental studies. The surveys' results demonstrated that control beliefs 
(whether GPs perceived themselves to be able to undertake the behaviour) and 
normative beliefs (whether GlPs perceived important others approved or 
expected the behaviour) were at least as important as behavioural beliefs 
(whether the behaviour resulted in suitable outcomes) in behaviour formation. 
This has important implications for clinical guidelines development and 
implementation. Although the methods of developing valid guidelines have 
improved in recent years, less is known on how to incorporate the views of 
target practitioners into the guidelines. Recent studies demonstrated the role 
that physicians' beliefs played in their behaviour, including their prescribing. A 
nested observational study of 800 patients in five British general practices 
concluded that perceived medical needs of patients was the main predictor of 
GP prescribing (Little et al, 2004). They also observed that doctors were more 
likely to prescribe in response to patients' pressure if they perceived the 
pressure. By interviewing patients as well, they found that GPs' perceived 
pressure was independent of real expectations of the patients. 
The theory performed well in explaining variation in GPs stated intentions 
to adhere to guidelines prescribing outcomes. This was similar to previous 
studies of health professionals (Table 6.2) and health behaviour in general 
(Ajzen, 1991; Conner and Sparks, 1996; Armitage and Conner, 2001). Although 
the observed ability of the direct variables (attitude, subjective norm and 
perceived control) in explaining variation in intention could be explained in part 
by semantic overlap (7.4.7), the indirect variables had high correlations with the 
intention, and in that sense the TPB seemed internally valid. 
Attempts were made to identify optimal scaling approaches for belief 
based items for the calculation of expectancy-value composite scores. When 
this was possible (behavioural beliefs), different scaling approaches did not 
make a lot of difference to the outcome of the analysis and it was possible to 
identify a relevant scaling approach. For control beliefs, the study was not able 
to suggest any optimal scaling approach. It should be noted that although it was 
possible to support empirically previously suggested scaling approach for 
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behavioural beliefs (Ajzen, 2002b) and there was agreement on how to scale 
normative beliefs (Conner and Sparks, 1996; Ajzen, 2002b), these did not 
tackle the main problem of 'sums of products' calculations and scaling, which 
was the difficulty of establishing the location of the natural zero on the scales 
(French and Hankins, 2003). Further methodological studies were required to 
investigate the options available (7.4.7). Future works should consider the 
potential for variable scaling of items within beliefs as well as between beliefs 
and also expectancy statements. 
TPB elements explained parts of variation in prescribing indicators. The 
consistency of the findings for one normative belief (PCO prescribing advisers) 
for both statins and asthma survey supported the basic assertion of the TPB 
that beliefs influenced the outcome. However, there was no significant 
relationship between intention and prescribing indicators. The TPB suggested 
that the behaviour was distal to the formation of beliefs; and beliefs influenced 
behaviour through the intention. The TPB also suggested perceived controls 
moderated the effects of intention on behaviour. Control beliefs as well as 
behavioural beliefs inconsistently featured in models explaining variation in 
prescribing indicators. Therefore, it was not possible to claim the findings 
supported the direct effects of control beliefs on behaviour, because other 
groups of beliefs showed similar capabilities. Nonetheless, the findings were 
against the theory of reasoned action assertion that behaviours were conducted 
through the formation of behavioural intentions. The existence of direct links 
between different beliefs and prescribing indicators opened the issue of another 
difficulty in testing the TPB. In reality there are certain degrees of overlaps and 
correlations between different beliefs (Ajzen, 1991). For example normative 
beliefs (e. g. GP's perceived belief that colleagues expected him or her to follow 
guideline's recommendations) could be linked to behavioural and control 
beliefs. The GP's colleagues could affect his or her behavioural beliefs (e. g. 
whether guideline recommendations resulted in improved patient health) and 
his or her control beliefs (e. g. whether following guideline recommendation 
resulted in waste of practice resources). Therefore although it was sensible to 
look for identification of beliefs in each category, they were not mutually 
exclusive. 
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The contribution of beliefs in explaining variations in prescribing 
outcomes was encouraging and improved the understanding of GP prescribing. 
The stability of these findings was not assessed as required larger sample 
sizes. Also there were differences in the explanatory contributions of different 
beliefs to the asthma and statins models. This could have been caused 
because of instability in the models. However, it should be noted that these 
were correlational models. When two regression models have different 
explanatory variables and there are correlations between the explanatory 
variables included in the models, differences in explanatory variables might not 
be because of instability but because of those correlations (Russell and 
Gregson, 1981). There were also differences in the models prescribing 
outcomes. Different outcome variables (for asthma and statins) could be 
explained by different explanatory variables. Another difference between the 
outcome measures was that the efficient prescribing indicators were more valid 
than the effective delivery indicators. The differences might have also been 
caused by non-response bias, so that the respondents to the asthma survey 
were different from the respondents to the statins survey. 
The analysis of prescribing indicators suggested that beliefs (e. g. 
normative beliefs) were better predictors of behaviour than the composite 
scores for their corresponding higher level construct (e. g. indirect subjective 
norm). The finding that some beliefs but not others significantly contributed to 
the models was not against one of the underlying principles of the TPB, namely 
that intentions and behaviours were based on salient beliefs. But it again 
questioned the usefulness and reliability of composite scoring approaches 
recommended by the TPB. 
The findings suggested that the TPB helped understanding of GPs 
prescribing behaviour and their intentions to implement a clinical guideline. TPB 
also featured well in the design and analysis of the qualitative study (Chapter 4). 
TPB models should be tested in future alongside RCTs where prospective 
collection of valid outcomes could minimise the caveats and help to assess the 
theory in controlled situation. It will also help to test the assumption of causality 
in the TPB (i. e. change in beliefs ultimately results in behaviour change). 
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We live in an age of mass loquacity. We are all writing 
it or at any rate talking it: the memoir, the apologia, the 
cy, the cri de coeur. Nothing, for now, can compete 
with experience-so unans werably authentic, and so 
liberally and democratically dispensed. Experience is 
the only thing we share equally, and everyone senses 
this. 
Martin Amis, All from experience, (Amis, 2000). Quoted 
from the BMJ 323,162 
Knowing is not enough, we must apply; willing is not 
enough, we must do 
Goethe 
Chapter 8. Conclusions and implications 
B. 1. As a prologue: revisiting the complexities 
Provider (including physician) behaviour change can be analogised to a maze. 
Change or improvement, as targets, are achieved when one gets through the 
maze and reaches to the anticipated exit. However, each policy-maker or 
practitioner knows only part of the way through this maze. It is difficult to avoid 
all the dead-ends or predict the time required to go through the maze. A 
graphical image from the world of arts might resemble the difficulties of 
behaviour change. In the film "a chump at Oxford (1940)" played by two 
acclaimed comedians Stan Laurel and Oliver Hardy, they were lost in a maze at 
the University of Oxford. A student played the role of a ghost that offered them 
handkerchiefs or cigars by his 'ghost hands' and also played tricks. The 'ghost 
hands' are invisible barriers or facilitators for behaviour change initiatives. It is 
extremely difficult, perhaps impossible, to devise in detail a success plan for 
behaviour change that can be reliably applied to different settings and different 
occasions. There are players ('other factors') in provider behaviour maze that 
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are either unknown or have been ignored. These players can have detrimental 
effects on the outcome of the intervention. 
The other problem is that 'provider behaviour maze' has several exits, 
not all favourable. That is to say the success is not always known. For many 
interventions, the available evidence at any given time does not provide 
unchallenged authority for the policy-maker or researcher to say confidently 
what outcomes can be expected if the intervention is to be implemented. This is 
truer for external motivation interventions (e. g. financial incentives) or non- 
voluntary interventions (e. g. rules and obligations) (Table 4.2). Given that no 
single theoretical perspective (Chapter 3) or empirical initiative (Chapters 2 and 
4) is powerful enough to devise all the processes, barriers of progress or routes 
to success, then it is essential to acknowledge the complexity of provider 
behaviour and 'proceed with care' (Black, 200 1). 
Although this thesis was focused on evidence-based practice, it 
acknowledged that 'there is more to primary care than the use of evidence- 
based interventions' (McColl et al, 1998, p 1355). GP capabilities are not limited 
to the understanding of and the willingness to practise based on the best 
available evidence. GPs require equipping themselves with consultation skills, 
team playing skills, practice business management skills, effective 
communication (with local authorities, colleagues and community) and ways of 
promoting access to primary care (McColl et al, 1998). Some argue that GPs 
'take care of individuals in a society, irrespective of the patient's type of disease 
or other personal and social characteristics ... ' (Olesen, 2000, p355). 
Very often clinical guidelines aim to reduce variation in clinical practice. 
Not all variation in practice is bad. Variation can be due to valid reasons, 
including individual patients' needs (Ashford et al, 1999) as well as ambiguity of 
the best available evidence in demonstrating any advantage for one clinical 
practice over the other (Burgers and van Everdingen, 2004; Rashidian, 2004d). 
Hence it is acknowledged that 'not all change is necessarily good and if general 
practitioners resist changing their behaviour this may be for valid reasons' 
(Horder et al, 1986, p 520). 
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8.2. Principal findings 
The thesis was developed based on the findings of three linked studies using 
different methodologies and focus points in order to enhance the understanding 
of clinical guideline implementation in primary care. The first study was the 
overview of systematic reviews (Chapter 2) supported by the selective review of 
theories and models of behaviour change (Chapter 3). The second study was 
the qualitative study (Chapters 4 and 5). It was designed and analysed with the 
help of theoretical insights from theory of planned behaviour (TPB) and the 
findings of the reviews. Then the qualitative study contributed to the planning of 
the third study, which consisted of two TPB surveys of GPs (Chapters 6 and 7). 
The surveys directly assessed the merits of TPB for understanding GP 
prescribing. 
The overview of systematic reviews aimed to identify the effective 
methods of improving primary care prescribing. Thirty-three systematic reviews 
were included. The study developed an updated taxonomy of behaviour change 
interventions for primary care prescribing. It also demonstrated the evidence or 
lack of evidence for the effectiveness of twenty-three interventions identified 
from the literature (Table 2.1). The overview observed that all the studies using 
interactive educational activities (2.3.3) had resulted in positive changes in 
prescribing. The only other intervention that came close to this was educational 
outreach visits (2.3.8). However, the effectiveness of this intervention was 
challenged by more recent evidence not included in the systematic reviews 
(2.4.1). At the other end of the spectrum, there was 'evidence of no effect'for 
didactic educational activities (2.3.3) and the substitution model of inter- 
professional shared care (2.3.7). Evidence for other interventions was mixed, 
while many had not been assessed in rigorous studies (no evidence of effect). 
The overview resulted in important observations. There were several 
occasions in which the systematic reviewers inaccurately or selectively 
reported, or unsafely interpreted the results of primary studies. The variation in 
quality of systematic reviews was known from previous overviews, but this was 
the first time the inaccuracies were discussed in detail (2.4.2). The overview 
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also demonstrated that the infamous dichotomy depicting multi-faceted 
interventions of behaviour change as effective and simple single interventions 
such as 'mailed printed educational materials' as ineffective was short-sighted 
(see 2.3.4 and 2.3.16). The findings advocated that the reports of multi-faceted 
interventions should include the details of the interventions and their intensity. 
Otherwise, generic messages indicating that multi-faceted interventions were 
more effective might result in inefficient use of meagre health care resources; 
especially as some multi-faceted interventions were not more effective than 
single interventions (2.3.16). On the other hand some interventions with small 
effects were cost-effective in improving quality of care (2.3.4; see also Mason et 
al, 2001). The overview also found a few robust studies originated from low and 
middle-income countries. This was a welcome improvement over what Bero et 
al observed in 1998. The wider contribution of investigators from around the 
globe was complementary and increased the understanding of the interventions 
as well as the diversity of the messages. Still, there were many countries with 
no studies included in the systematic reviews. 
The selective review of theories and models of behaviour change 
summarised several important theories of behaviour change. It helped 
identifying theoretical insights that different academic disciplines offered to 
provider behaviour change (Chapter 3). The review of theories put TPB in the 
context, especially as TPB shared some of its concepts with other theories. The 
review also summarised the theoretical justifications for different interventions. 
A selection of theories that were likely to explain variations observed in the 
effectiveness of different interventions was listed in the taxonomy of 
interventions (Table 3.3). The observed effectiveness or lack of effectiveness of 
some interventions was partially explained by the theories. For example 
theoretical reasoning had envisaged the ineffectiveness of didactic educational 
activities and the effectiveness of interactive education. This success was 
probably due to the fact that educational interventions were in use for several 
decades and the theories had progressed alongside the development of the 
interventions. More often, the theories justified certain interventions, while there 
was not enough evidence to support or reject the theories' claims. Clear 
examples of such interventions were 'local opinion leaders', 'peer review', 'inter- 
professional education', 'continuous quality improvement', 'practice support' and 
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'rules and obligations' (Table 3.3). The systematic reviews included little 
evidence for the effectiveness of interventions based on certain theories, e. g. 
management theories. Also interventions with indirect theoretical backing 
resulted in mixed outcomes including unwanted consequences. For example 
financial incentives resulted in significant reduction in repeat prescription rates 
(Krasnik et al, 1990). Overt deviations like this were exceptional. In that sense, 
provider behaviour change did not seem very different from clinical care, where 
not all treatments devised based on p hys io-patho logical arguments were later 
supported by evidence. 
The qualitative study identified seven important themes and thirty sub- 
themes for implementing clinical guidelines for primary care prescribing (Tables 
4.1 and 4.4). The themes were 'credibility of content', 'credibility of source', 
'presentation', 'influential people', 'organisational factors', 'disease 
characteristics' and 'dissemination strategy'. The study highlighted some 
important concepts. One was the importance of understanding what GPs meant 
by the term 'evidence'. 'Evidence'was not necessarily referring to the quality 
and validity of the study that the recommendation was based on. Rather GPs 
considered a set of different criteria when referred to evidence. Similarly the 
participants challenged another common element in evidence-based guidelines: 
'change' in recommendations. The qualitative study also contributed to the 
further development of the taxonomy (Table 4.2). The findings of the qualitative 
study were compared with the findings of the overview of systematic reviews 
(Table 4.3). The findings were congruent in several occasions. More 
interestingly, the interviews supported the use of four interventions for which no 
evidence of effect on prescribing was found. These were 'peer review', 'local 
opinion leaders', 'practice support' and 'rules and obligations'. In that sense the 
qualitative study complemented the overview of systematic reviews. Two 
interventions with no evidence of effect on prescribing remained as such after 
the qualitative study: 'inter-professional education' and 'continuous quality 
improvement'. 
The qualitative data were analysed again noting the higher level 
concepts of guideline implementation (Chapter 5). This analysis was used for 
the development of a simple model for implementing prescribing 
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recommendations in primary care. It comprised six steps: 'choose the 
condition', 'choose the guideline', 'identify influential people', 'identify 
organisational factors', 'plan and adopt the implementation strategy' and 
'monitor the adherence'. The model provided a framework for planning the 
implementation of guidelines and recognising barriers that hindered adherence 
to guidelines. 
The final phase of the project consisted of two surveys aiming to explore 
the ability of TPB to explain and predict GPs' adherence to guidelines. The 
qualitative study and the regional pilots were used to develop the 
questionnaires. Two stratified random samples of GPs in England were 
surveyed. Prescribing data was obtained from PACT. Data were collected from 
a total of 155 GPs for the statins survey. GPs responding to the statins survey 
were more likely to be working in practices with training status and probably 
less likely to be single-handed. Direct and indirect measures of attitude 
(behavioural beliefs) and indirect perceived controls (control beliefs), but not 
subjective norms (normative beliefs, peer pressure) were predictors of variation 
in prescribing intentions. TPB items explained up to 14% of variation in effective 
delivery outcome (Table 7.8). The main predictors were one behavioural belief 
item ('quality marker') and one self-identity item ('evidence-based practitioner'). 
Addition of practice and demographic variables increased the goodness-of-f it of 
the model to 39%. None of TPB measures were significant contributors to this 
latter model, however one control belief (Inclusion in the BNF) and one 
behavioural belief ('quality marker') approached significance. TPB items also 
explained up to 12% of variance in efficient statins prescribing indicator. A 
normative belief ('PCO advisers') and a control belief ('NSF advocates statins 
prescribing') were significant contributors to the model (Table 7.9). 
122 GPs responded to the asthma surveys. The non-response analysis 
suggested that probably the only difference between responders and non- 
responders was in that the responders were more likely to be working in 
practices in which all partners graduated in the UK regardless of their ethnic 
origins. The variance in prescribing intentions was explained by subjective 
norms and perceived controls, and surprisingly attitudes had no contribution to 
the models. No TPB variable had any role in models for the effective delivery 
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primary outcome measure. On the other hand, a control belief ('BTS changed 
their recommendations') explained 9% of the variance in the secondary 
outcome (corticosteroid to bronchodilator ratio; Table 7.13). Three belief based 
items explained 22% of the variance in efficiency outcome (Table 7.14). They 
were 'patients will be healthier' (behavioural belief), 'hearing about asthma 
guidelines' (control belief) and 'PCO advisers' (normative belief). 
The surveys generally supported the ability of the TPB for improving the 
understanding of GlPs' behavioural, control and normative beliefs and their 
intentions. On the other hand, the surveys demonstrated the limits of the theory 
in identifying how different beliefs affected prescribing. The contributions of 
beliefs in observed variations in the prescribing outcomes were not mediated 
through the intentions, despite the TPB. This might have been caused by 
limitations of measuring intentions, measuring prescribing outcomes or both 
(7.4.4; 7.4.6 and 7.4.7). In both of the surveys perceived pressure from PCO 
advisers was correlated with less efficient prescribing (7.3.6 and 7.3.9). TPB 
advocates suggested that in studies with prospective designs (i. e. where 
behaviour was measured after beliefs and intentions), contribution of TPB 
variables in explaining variation of behaviour was causal (Ajzen, 199 1; Conner 
and Sparks, 1996). Since the surveys employed prospective designs, then it 
might be concluded that PCO advisers caused less efficient prescribing. 
Despite Ajzen and others, the direction of cause and effect was not known. 
Although data was collected longitudinally, it did not prove cause and effect 
relationship (Grimes and Schulz, 2002). Alternatively, there might have been 
reverse causal relationship. It could be that GlPs who prescribed statins and 
inhaled corticosteroids less efficiently were under more pressure from PCO 
advisers. The exact nature of relationship between these variables can be 
established in long term cohorts or interventional studies. The finding, however, 
was in line with the results of the overview and the qualitative study and 
questioned the effectiveness of educational outreach visit interventions. 
The thesis also resulted in some methodological advances for the design 
of TPB surveys. Chapter 6 reported the findings of sample size calculations. 
This was the first known systematic attempt to determine sample size for TPB 
surveys. The sample size calculations were based on two different approaches: 
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the X method (reported values of regression model good ness-of-f it) and the VIF 
method (variance inflation factor; zero-order correlations). The VIF was the 
suitable method. The methods used in Chapter 6 could be employed with 
adjustments in other settings and for other regression models. 
8.3. Strengths and weaknesses of the study 
Data from the overview of systematic reviews was analysed using narrative 
synthesis. Due care was given to ensure the analysis was performed 
objectively. Since only one investigator analysed the data, the possibility of bias 
in the analysis could not be ruled out. The overview was limited to published 
systematic reviews; therefore more recent evidence on behaviour change might 
have been missed. Also limitations in quality assessment approaches might 
have resulted in loss of understanding. The overview of systematic reviews had 
the advantage of not limiting itself to the text of systematic reviews, but also 
consulting primary studies where appropriate. This improved the understanding 
of the literature and increased the validity of the findings. First, several 
systematic reviews had included primary studies that did not answer the 
overview's questions or did not meet its inclusion criteria. So consulting primary 
studies was useful to ensure'pears and apples'were not mixed. Second, many 
primary studies were included in more than one systematic review. Third, there 
were discrepancies in the reviews' conclusions and it was useful to identify the 
sources of the discrepancies. 
Because of the focused approach, the overview included smaller number 
of systematic reviews than overviews published prior to it (Grimshaw et al, 
2001). Focused approach might have resulted in omission of interventions with 
potentially useful implications for primary care prescribing. It was argued that 
the advantages of focused approach were further than the disadvantages, 
mainly as it prohibited the dilution of evidence owing to diverse behaviours and 
settings. Some previously published overviews of systematic reviews, including 
those focusing on primary care, did not follow systematic approaches (Conroy 
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and Shannon, 1995; Cantillon and Jones, 1999; Smith, 2000). Therefore the 
overview reported in this thesis was probably the first overview of systematic 
reviews in primary care that followed explicit methodology. 
Purposive sampling was the biggest threat to the validity of the 
qualitative findings. It might have caused selection bias and limited the 
generalisability of the findings. On the other hand the inclusion of academics of 
primary care in the sample was advantageous in enhancing the depth of the 
study. The study was also limited in the fact that a single researcher analysed 
the data. The data also was not subjected to respondent validation. Framework 
analysis was a powerful analytical approach that helped exploit the collected 
data. The secondary analysis of the findings took this one step further and was 
used to suggest a simple model of guideline implementation for prescribing in 
primary care. The qualitative study was also different from previous studies in 
its focus on clinical guidelines for five clinical topics. It ensured variation in 
complexity of the disease, availability of clinical guidelines, GP role in 
prescribing and the importance of prescribing in management of the problem 
(4.2.3). 
Despite the inherent subjectivity of methods used for the analysis of 
qualitative data, the validity of some of the qualitative study findings were 
established in studies published recently. For example the analysis suggested 
that computerised clinical guideline systems had limited use for the 
management of complicated clinical problems (e. g. hypertension or asthma) 
and were more appropriate for diseases with limited options (e. g. statins for 
CHID prevention, antibiotics for tonsillitis). Similarly a recent RCT concluded that 
computerised systems were not effective means of improving quality of care for 
management of asthma and angina in primary care (Eccles et al, 2002; 
Rousseau et al, 2003). 
The main threats to the validity of the surveys were poor response rates. 
This was despite extensive attempts to boost the rates. Detailed non-response 
analysis revealed few differences between the responders and non-responders. 
Non-response analysis helped to understand the limits of generalisability of the 
findings. Despite the analyses one might argue that responders were different 
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from non-responders in the fact they were willing to contribute a few minutes of 
their time to a research study. 'Altruistic' tendencies of GPs might be correlated 
with the service they provided (Le Grand, 2003). Non-response is a challenge to 
studies in primary care, especially TPB studies as they require long 
questionnaires. Another limitation of the surveys was due to the limited validity 
of prescribing outcomes. The validity of PACT data in terms of the 
appropriateness and adequacy of prescribing for individual patients was limited. 
Prescribing units captured some of the variation caused by case-mix 
differences, but this was done at practice level and not for individual patients. 
This could have been improved by accessing data that linked patients with 
prescribing. Efficiency indicators were more valid than effective delivery 
indicators of prescribing. Interestingly, TPB items had more explanatory powers 
in models of prescribing efficiency. The regional pilots helped improving the 
surveys' tools and contributed to the objective choice of optimal scaling 
approaches for the analyses. The uncertainties in optimal scaling of TPB items 
were hardly addressed in previous studies of health care providers. Explicit 
sample size calculations added to the available literature on TPB. 
Previous TPB studies of health professionals did not followed the 
methods used in the surveys. The surveys were designed prospectively and 
were not limited to measuring behavioural intentions (e. g. Walker et al, 2001; 
Puffer and Rashidian, 2004) or self-reported behaviours; only (e. g. Millstein, 
1996; Levin, 1999; Watson and Myers, 2001). The surveys were the first known 
TPB studies of GP adherence to clinical guidelines. Prior to the surveys, there 
was only one TPI3 study of GP prescribing, focusing on intentions and not 
prescribing (Walker et al, 2001). Another study tested the theory of reasoned 
action in explaining variation in physician prescribing, but was grossly 
underpowered (Lambert et al, 1997). Both studies were concerned with 
antibiotic prescribing. Walker et al (2001) achieved higher response rate than 
the asthma and statins surveys. Its investigators chose not to include some TPB 
elements in their questionnaire (i. e. direct subjective norms). Also the major 
difference between that study and the surveys was that Walker et al did not 
request any access to GP prescribing data. 
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The development of the questionnaires was not based on a brief set of 
interviews, a common approach in TPB studies. Rather the questions were 
developed using the qualitative study. The framework analysis of qualitative 
data also developed themes for clinical guideline implementation in primary 
care and some were supported by the TPB surveys. For example the qualitative 
study suggested that change in clinical guidelines might hinder implementation 
of evidence base recommendations. The analysis of the secondary asthma 
prescribing outcome concluded that a control belief that 'BTS asthma guidelines 
had substantially changed their recommendations' was significantly correlated 
with less effective prescribing. The qualitative analysis also supported the TPB 
assertion that beliefs had important roles in the formation of intentions and 
behaviours. 
The choice of clinical conditions for the qualitative study and in particular 
for the surveys was deliberate and objective. Although the choices were made 
for technical considerations, CHID prevention and management of asthma were 
important public health issues with high burden of disease and cost to the 
society and individuals. The findings of the study could contribute to better care 
for imperative conditions with potentials for reducing unnecessary costs. 
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8.4. What does it mean? The study implications 
8.4.1. The implications for future research 
As noted before, optimal scaling methods for the TPB studies were not 
established. Analyses performed for the surveys should contribute to the 
establishment of optimal scaling approaches for the theory. Future studies 
might consider statistical optimisation approaches (Box and Cox, 1964). They 
should consider uncertainties on the natural position of zero on the scales, and 
ideally provide room for variation of the zero point on both expectancy and 
value items of belief based measures (French and Hankins, 2003). 
The TPB studies were helpful in identifying important beliefs and the 
values assigned to those beliefs. TPB tools and questionnaires however were 
not sensitive enough to identify delicate differences between groups of 
responders. GPs might approach clinical guideline recommendations 
selectively. Hence, it is useful to know which guideline recommendations are 
implemented by what group of practitioners. Then it will be useful to know the 
characteristics (e. g. beliefs) of GPs that implement or do not implement certain 
recommendations. In marketing research, this separation of the target 
population into subgroups is known as 'segmentation' (Maibach et al, 2002). 
Sophisticated choice modelling ('conjoint analysis') methods are developed to 
identify and understand the existence of segments and subgroups (Ryan, 1999; 
Ryan and Farrar, 2000; Gustafsson et al, 2003). Identification of the subgroups 
can help devising different interventions specific to the needs of different 
subgroups. Choice modelling may use discrete choice, rating or scaling 
questions and may or may not incorporate vignettes (case scenarios). Choice 
modelling approaches are previously used in TPB studies but mainly as a 
measurement approach for the expectancy-value elements of the theory 
(Jonas, 1993). Choice modelling is also recommended as a technical solution to 
the problem of scaling the belief based items (French and Hankins, 2003). The 
suggestion proposed here differs from previous studies as it aims to use choice 
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modelling for the identification of subgroups within the target population and not 
just as technical remedy to statistical problems. 
Despite limitations, significant proportions of prescribing outcomes were 
explained by TPB variables. This can be improved by objective measurement of 
prescribing outcomes in future studies. Difficulties in the measurement of 
volitional prescribing by GPs suggest that future research should test the theory 
by measuring prescribing for new diagnoses or prescriptions and should 
exclude repeat prescriptions (7.4.4). Conducting TPB studies alongside RCTs 
can improve the quality of data for testing TPB. It will also help identifying 
reasons for adopting or not adopting interventions. 
Choice modelling might help enhancing the findings of the thesis in other 
ways. The qualitative study and the asthma survey suggested that change in 
guideline recommendations might negatively affect implementation. On the 
other hand, changes are inevitable. It will be useful to quantify the adverse 
effects of changes in recommendations on adherence rate, as it can inform 
guideline development as well as guideline implementation processes. 
Quantification of change effects on implementation does require experimental 
research designs, for example by changing guidelines' recommendations in 
different ways, implementing them in different geographical areas and then 
evaluating the implementation. These experimental studies will be very difficult 
in practice and may face political, professional and ethical resistance. Choice 
modelling can be used to assess the effects of hypothetical clinical guideline 
recommendations on stated implementation intentions. 
Efforts should be made to increase the understanding of the validity of 
behavioural theories using empirical research. Throughout the period that this 
thesis was undertaken, the Medical Research Council funded an investigatory 
study assessing the validity of a few psychological theories for provider 
behaviour change. Empirical investigations should be expanded to the theories 
developed by other disciplines (Chapter 3). 
It seems that the effect sizes of behaviour changes interventions are 
declining. Although previous behaviour change improvement studies were likely 
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to achieve significant improvements (North of England Study of Standards and 
Performance in General Practice, 1992a; North of England Study of Standards 
and Performance in General Practice, 1992b), more recent trials tend to 
achieve limited success (Freemantle et al, 2002; Wright et al, 2003). Theory- 
based approaches can help understanding why. TPB can be used for devising 
behaviour change interventions (Ajzen, 2002a), yet the effectiveness of TPB 
interventions for changing provider behaviour is not known (Hardeman et al, 
2002). A postal TPB intervention successfully changed molar tooth extraction 
intentions in the intervention group of dentists (Bonetti et al, 2003). The findings 
of the asthma and statins surveys and of this trial indicate that TPB has 
potential for contribution to active implementation of provider behaviour change 
strategies. This needs to be investigated in carefully designed RCTs. For that 
reason, a protocol for a randomised trial assessing the potentials of TPB based 
educational intervention was prepared (Appendix VIII). As well as the 
effectiveness trial, the proposed study included a cost-effectiveness analysis 
(Drummond et al, 1997; Coyle et al, 1998). This would be important, in 
particular if the potential effect sizes were small. Even small changes in 
prescribing might have important effects on health care costs as well as patient 
outcomes (Jamtvedt et al, 2003). 
8.4.2. The implications for guideline implementation in middle- 
income countries 
Before discussing the implications of the findings for middle-income countries, a 
few issues should be noted. The nature of prescribing problems in developing 
countries is somehow different from what is usually observed in the UK. In 
many countries poly-pharmacy or multi-drug use is a challenge to the system. 
Studies have shown that the average number of drugs per prescription is 
between 2.4 to ten, while if prescribing is conducted rationally, the average 
number of drugs per prescription should be less than two (Le Grand et al, 1999, 
Dinarvand and Nikzad, 2000, Hafeez et al, 2004). A random survey study of 55 
pharmacies in Tehran observed that about 40% of patients who were served by 
daily pharmacies and 80% of those served by 24-hour service pharmacies were 
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not aware of the recommended dosages of the prescribed items. This was 
complicated further by the fact that the average time the pharmacists spent with 
each patient was only 35 seconds (Dinarvand and Nikzad, 2000). Another 
frequently cited prescribing challenge is the overuse of injections. For example 
studies demonstrated that 15-60% of people attending health care facilities in 
different developing countries received at least one injection (Hadiyono et al, 
1996, Dinarvand and Nikzad, 2000, Hafeez et al, 2004). Also it was reported 
that 40-50% of prescriptions contained antibiotics (Dinarvand and Nikzad, 2000; 
Hafeez et al, 2004). The private sector is a major provider in many of these 
countries, especially of primary care, and is very much unregulated. The scarce 
evidence available from developing countries is usually from the public sector 
(Le Grand et al, 1999). All these factors suggest that clinical guideline 
implementation and quality improvement in developing countries should 
probably have a different focus than organisations such as NICE. 
The results of the studies of prescribing in the UK, therefore, are not 
easily generalised to middle-income developing countries. The main 
implications of the qualitative study and the surveys are that they provide a 
model for evaluation that can be applied elsewhere. Although the focus of 
behaviour change may be different in developing countries - for example use of 
statins may be a future concern - it is likely that the systems will face problems 
similar to those reported in the qualitative study if they target use of e. g. aspirin 
for CHID prevention or effective management of diabetes and hypertension. The 
thematic framework and qualitative model can be useful, as they illustrate the 
importance of different factors that may affect guideline implementation. TPB is 
likely to be beneficial in explaining variation in the uptake of guidelines or in 
prescribing. 
The results of the overview of systematic reviews reported positive 
findings from interventions conducted in developing countries. The included 
studies reported evidence from developing countries that suggested the trials of 
interactive educational interventions and educational outreach visits achieved 
significant improvements in provider behaviour (2.3.3 and 2.3.8). In order to 
understand the gene ralisability of the overview findings, other common 
characteristics of health systems in developing countries should be noted. The 
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cost effectiveness of the interventions to change physician behaviour in low and 
middle-income countries can be different from high-income countries. For 
example in high-income countries an intervention like educational outreach is 
costly, because of high personnel costs (in comparison to other services and 
materials). As many high-income countries have a shortage of qualified nurses 
and doctors, opportunity costs are even higher. In comparison, staff cost in 
developing countries are relatively lower than drugs or instruments. Therefore 
interventions that require a lot of staff time may turn out cheaper than those that 
require other services and material. For example an RCT of improving 
prescribing for diarrhoea in Indonesia found educational outreach were much 
cheaper than seminars; i. e. less than a quarter ($0.77 versus $3.30 per 
participant; Santoso et al, 1996). In some middle-income developing countries, 
there are more qualified health professionals than the system requires 
(Malekzadeh et al, 2001; Shadpour, 2003). Therefore investment of resources 
on effective interventions that require active involvement of health care 
providers (i. e. labour intensive interventions) is potentially rewarding. 
8.4.3. The implications for guideline implementation in the UK 
Several findings of the thesis had direct implications for guideline 
implementation in the UK. 
Interventions based on management theories (e. g. continuous quality 
improvement and practice support) had weak evidence base (Table 2.1). This 
might be due to the discipline's culture (e. g. tendency for not using experimental 
designs) or due to the difficulties of subjecting these interventions to 
experimental designs. Practice support, e. g. by developing mini-clinics, was 
perceived effective in the qualitative study, but not in the surveys. The surveys 
provided mixed messages. They found GPs who reported having CHD clinics 
prescribed statins more efficiently. On the other hand, GPs who reported having 
asthma clinics provided less efficient prescribing and potentially of lower quality. 
The caveats of these findings were discussed in Chapter 7. However, the clear 
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message is that rigorous assessment of the effectiveness of interventions 
based on management theories is warranted. 
Interactive continuous medical education should be encouraged and 
replace didactic CIVIE. There was evidence of effect for the former, and 
evidence of no effect for the latter. The only caveat in here is that the evidence 
of effect for interactive CIVIE was partly originated from developing countries, 
hence it might be setting sensitive. It is also likely to be costly, especially in the 
UK, so its cost-effectiveness should be assessed. CIVIE programmes were 
barely mentioned in the interviews. The overview also pointed out that 
interventions based on financial incentives were likely to have unwanted 
outcomes. Although selective use of financial incentives might be advocated, as 
noted in the qualitative study, its blanket use should be avoided (Rashidian et 
al, 2005). 
Do the findings discourage the usage of educational outreach visits? This 
question is difficult to answer. Throughout the period when this thesis was 
undertaken, evidence about the effectiveness of educational outreach visits has 
been growing. It is no longer possible to say that educational outreach visits are 
effective in changing prescribing, since more recent trials provide a mixed 
picture. Moreover, the qualitative study participants had mixed feelings towards 
the role of prescribing advisers in primary care. Efficiency indicators' analyses 
for the asthma and statins surveys suggested GlPs who perceived more strongly 
that PCO prescribing advisers expected them to follow clinical guidelines, were 
more likely to prescribe less efficiently. This did not provide evidence of causal 
effect (see 8.2); nonetheless, the findings of the surveys as well as the 
qualitative study and the overview of systematic reviews complemented each 
other in highlighting uncertainties. Therefore, in answer to the question, one 
might argue that policy-makers should proceed with caution. They should limit 
the amount of resources spent on different forms of educational outreach visits; 
use the intervention for selected areas of care depending on local and national 
priorities, and further evaluate the intervention. 
The findings of the qualitative analyses provided simple criteria for 
identification of conditions for which prescribing guidelines might not be 
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warranted (choose the condition'; 5.3.1 and Fig 5.1). With the current level of 
enthusiasm for guideline development, such findings should be helpful. The 
qualitative analysis also noted the importance of 'first contact' (i. e. if GPs 
perceived a guideline as useless, it would more difficult to gain their confidence 
back; 4.3.9). Hence, the qualitative study supported the care that NICE gives to 
refining guidelines' recommendations before publication. In NICE, this process 
is called 'consultation' phase. Obviously, it should be noted that consultations 
might also negatively result in deviating recommendations away from evidence; 
however, they are great opportunities to ensure guidelines would not fail in 'first 
contact'. 
The qualitative study indicated that inclusion of guidelines in the BNF 
improved implementation. Also the NSFs' recommendations were likely to affect 
prescribing. Both these findings were supported in the statins survey. BNF is 
potentially an under-used source for guideline implementation. It is therefore 
recommended that BNF should refer to more guidelines when discussing 
prescribing alternatives, especially to guidelines for the care of chronic 
diseases. 
The notion of change in clinical guideline recommendations was 
highlighted both in the qualitative study and the asthma survey. Some 
interviewees did not welcome change in guidelines recommendations, in 
particular if they were not convinced why change in recommendations was 
required (4.3.3). Similarly, the GPs who agreed more strongly with the 
statement: 'BTS asthma guidelines had substantially changed their 
recommendations', had potentially lower quality of prescribing for asthma 
(7.3.9). Given evidence-based clinical guidelines are expected to be updated in 
pre-specified intervals (Shekelle et a[, 2001), further investigation of the effects 
of change in recommendations on implementation is warranted. The immediate 
implication, however, is that updating guidelines should not be seen as mere 
updating of evidence-based recommendations. Rather, guideline developers 
should clearly justify the changes made in their recommendations and 
effectively communicate the change with providers. 
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The very first section of the chapter revisited the complexity of changing 
prescribing behaviour. Despite the complexities, all interested parties want to 
see improvements in quality of care. It is sad that evidence based messages 
are not implemented despite all the good wills and efforts. One of the 
interviewees said: 'we as professionals want to know we are doing our best for 
our patients'. Can this thesis be of any help? Emerson once said 'sometimes a 
scream is better than a thesis' (Persaud, 2000). Patients may use occasional 
sscreams' to get the care they expect. The thesis may not eliminate the need for 
occasional screams - by patients or others - but might contribute to reducing 
the need for it. Simple interventions can be cost-effective ways of implementing 
guidelines and should not be ruled-out. GPs views and beliefs should not be 
ignored. Understanding GPs' beliefs may improve the understanding of their 
prescribing and enhance the effectiveness of interventions to improve care. 
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Appendices 
Appendix 11-1. Search strategy for identifying 
systematic reviews of provider behaviour change in 
Medline database* 
1 exp *education, continuing/ 
2 (education$ adj2 (program$ or intervention? or meeting? or session? or 
strateg$ or workshop? or visit? )). tw. 
3 *pamphlets/ 
4 (behavio? r$ adj2 intervention? ). tw. 
5 (leaflet? or booklet? or poster or posters). tw. 
6 ((written or printed or oral) adj information). tw. 
7 (information$ adj2 campaign? ). tw. 
8 (education$ adjl (method? or material? )). tw. 
9 outreach. tw. 
10 ((opinion or education$ or influential) adjl leader? ). tw. 
11 facilitator?. tw. 
12 academic detailing. tw. 
13 consensus conference?. tw. 
14 practice guideline?. tw. 
15 (guideline? adj2 (introduc$ or issu$ or impact or effect? or disseminat$ or 
distribut$)). tw. 
16 ((effect? or impact or evaluat$ or introduc$ or compar$) adj2 training 
program$). tw. 
17 *reminder systems/ 
18 reminder?. tw. 
19 (recall adj2 system$). tw. 
20 (prompter? or prompting). tw. 
21 algorith?. tw. 
22 *feedback/ or feedback. tw. 
23 , (feedback adjl (loop? or control? or regula$ or mechanism? or inhib$ or 
system? or circuit? or sensory or visual or audit$)). tw. 
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24 22 not 23 
25 chart review$. tw. 
26 ((effect? or impact or records or chart? ) adj2 audit)-tw. 
27 *patient education/ 
28 marketing. tw. 
29 ((effect? or impact or evaluat? or introduc$ or compara$) adj2 (prevent$ 
program$ or screening program$)). tw. 
30 ((introduc$ or impact or effect? or implement$ or computer$) adj2 
protocol? ). tw. 
31 (computer$ adj2 (dosage or dosing or diagnosis or therapy or 
decision? )). tw. 
32 *physician s practice patterns/ 
33 (meta-analysis or review literature). sh. 
34 meta-analy$. tw. 
35 metaanal$. tw. 
36 (systematic$ adj4 (review$ or overview$)ý. tw. 
37 meta-analysis-pt. 
38 review. pt. 
39 case report/ 
40 letter. pt. 
41 historical article. pt. 
42 review of reported cases. pt. 
43 review, multicase. pt. 
44 review. ti. 
45 review literature. pt. 
46 33 or 34 or 35 or 36 or 37 or 38 or 44 or 45 
47 39 or 40 or 41 or 42 or 43 
48 46 not 47 
49 animal/ 
50 human/ 
51 49 not (49 and 50) 
52 48 not 51 
53 or/1 -21,24-32 
54 52 and 53 
* Source: Grimshaw et al, 2001. 
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Appendix 11-3. Discarded papers from overview of 
systematic reviews of interventions to improve 
prescribing in primary care 
(ascending in publication order*) 
Reference Focus of the review Reason for discarding / further 
Information 
(Haynes et al, Continuing medical education The review has been updated in 
1984) (Lomas and Haynes, 1988; Davis et 
a[, 1992; Davis et al, 1995; Davis et 
al, 1999) 
(Sourneral and Improving prescribing in Focusing on prescribing in 
Avorn, 1984) hospital setting secondary care. 
(Horder et al, Changing GPs'behaviour Not a systematic review. 
1986) 
(Haynes and Quality improvement using The review has been updated in 
Walker, 1987) computers (Lomas and Haynes, 1988; 
Johnston et al, 1994) 
(Schroeder, 1987) Interventions to reduce medical It is a non-systematic review of 
costs by changing physicians' evidence. 
behaviour 
(Beaudry, 1989) Continuing medical education No focus on prescribing. The review 
does not provide the reference list 
of the included studies. 
(Gurwitz et al, Improving prescribing in nursing Focusing on prescribing In nursing 
1990) homes homes. 
(Raisch, 1990a) Changing physicians' It has been updated in (Pippalla et 
prescribing al, 1995) 
(Raisch, 1990b) Changing physicians' It has been updated In (Pippalla et 
prescribing al, 1995) 
(Lomas, 1991) Effects of consensus Prescribing not discussed. It 
recommendations concludes Dutch studies show more 
success than North American 
studies. 
(Waddell, 1991) Continuing education Focus on nursing practice 
(Davis et al, 1992) Continuing medical education The review Includes several 
interventions other than CME. It has 
been updated In many later 
reviews, Including (Davis et al, 
1995). 
(Grol, 1992) Implementing guidelines In This Is not a systematic review of 
general practice primary literature 
(Long and Improving purchaser and Not a systematic review. 
Sheldon, 1992) provider decisions 
328 
Reference Focus of the review Reason for discarding / further 
Information 
(Axt-Adam et al, Changing physicians' behaviour No prescribing. Lab test ordering 
1993) 
(Buntinx et all, Feedback and reminder in No prescribing. Preventive and 
1993) ambulatory care diagnostic behaviour 
(Greco and Changing physicians' behaviour Non-systematic review of evidence. 
Eisenberg, 1993) Not methods are presented. 
(Grimshaw and Clinical guideline It has been updated In (NHS Centre 
Russell, 1993) implementation for Reviews and Dissemination, 
1994) and (Grimshaw et al, 1995) 
(Kreling and Mott, Cost effectiveness of DUR No study met the reviewers' 
1993) programmes inclusion criteria 
(Ackermann and Physician's adherence to No prescribing. Breast cancer 
Cheal, 1994) guidelines screening. Surveys were included. 
(Austin et al, Effectiveness of physicians' No prescribing. Preventive care 
1994) reminders 
(Gyorkos et all, Effectiveness of immunisation No prescribing. Immunisation 
1994) delivery methods programmes 
(Haines and Evidence implementation Not a systematic review 
Jones, 1994) 
(Johnston et al, Improving quality of care by It has been updated in (Hunt et al, 
1994) computer-based CDSS 1998) 
(Silagy et al, 1994) Effectiveness of health No prescribing. Smoking cessation 
professionals training interventions. 
(Conroy and Clinical guideline Not a systematic review. More like 
Shannon, 1995) implementation in primary care an overview of SRs. Very little on 
prescribing. 
(Davis et al, 1995) Continuing medical education The review covers Interventions 
other than formal CME. It has been 
updated in several later systematic 
reviews. 
(Mandelblatt and Changing physicians' behaviour No prescribing. Breast cancer 
Kanetsky, 1995) screening 
(Oxman et al, Interventions to improve The systematic review has been 
1995) professional practice updated In a few systematic review 
(including EPOC systematic 
reviews) published after It. 
(Sullivan and Effects of computers on primary The review has been updated In 
Mitchell, 1995) care consultation (Mitchell and Sullivan, 2001) 
(Bloor and Controlling pharmaceutical Not a systematic review 
Freemantle, 1996) expenditure through changing 
physician behaviour 
(Bloor et al, 1996) Controlling pharmaceutical Not a systematic review 
expenditure (regulating 
industry) 
(Freemantle, 1996) Effective interventions for Not a systematic review 
329 
Reference Focus of the review Reason for discarding /further 
Information 
decision making 
(Freemantle and Controlling pharmaceutical Not a systematic review 
Bloor, 1996) expenditure through targeting 
patients 
(Kerwick and Changing physicians' behaviour A non-systematic review. Focus on 
Jones, 1996) in primary care psychiatry. 
(Shea et al, 1996) Improving preventive care in No focus on prescribing. 
ambulatory setting 
(Snell and Buck, Improving cancer screening No focus on prescribing. 
1996) 
(Davis and Taylor- Clinical guideline Not focused on specific physicians' 
Valsey, 1997) implementation behaviours (e. g. prescribing) or 
settings (e. g. primary care) 
(Hanson et A Improving care at the end of life Very specific target group 
1997) 
(Howard and Evidence implementation Not a systematic review. Prevention 
Duncan, 1997) of atrial fibrillation 
(HuIscher et al, Improving preventive care in No focus on prescribing. Last 
1997) primary care updated in 1996. Possibly linked to 
(HuIscher, 1998) 
(Worrall et al, Clinical guideline No focus on prescribing 
1997) implementation in primary care 
(Bero et al, 1998) Evidence implementation Not a systematic review of primary 
research. It is an overview of 
systematic reviews. It has been 
updated in (NHS Centre for 
Reviews and Dissemination, 1999) 
(Dowle, 1998) Clinical guideline Not a systematic review of 
implementation in the UK published evidence. It focuses on 
what research initiatives are 
happening in the UK. 
(Freemantle et al, Methodology of evidence No prescribing 
1998) implementation studies 
(Garner et al, Evidence implementation in Not a systematic review 
1998) developing countries 
(Grimshaw, 1998) Improving out-patient referrals No focus on prescribing 
(Huischer, 1998) Preventive care in general This study was not assessed 
practice because of access. Possibly linked 
to (Hulscher et al, 1997) 
(Smith et A Continuing medical education in Not a systematic review of primary 
1998a) primary care studies. It reports the results of two 
systematic reviews already Included 
in the overview. 
(Solomon et al, Improving use of diagnostic No focus on prescribing 
1998) procedures 
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Reference Focus of the review Reason for discarding/ further 
Information 
(Thomas et al, Clinical guideline Not on physician behaviour. Focus 
1998) implementation on professions allied to medicine 
(Cabana et al, Clinical guideline No focus on prescribing. Broad 
1999) implementation inclusion criteria 
(Cantillon and Continuing medical education in it is an overview of systematic 
Jones, 1999) general practice reviews and other studies. 
(Davis et al, 1999) Continuing medical education No discussion of prescribing. An 
update of (Davis et al, 1995). It has 
been updated In (Thomson O'Brien 
et al, 2001) 
(Durieux et al, Continuing medical education Not addressing general practice. In 
1999) French 
(Freudensteln and Continuing medical education in No focus on prescribing. No 
Howe, 1999) primary care discussion or conclusion about it in 
the paper. Only in table of included 
studies, prescribing has been 
mentioned. There is no data 
synthesis for prescribing 
(Gosden et al, Impacts of salary payments on The review has been updated in 
1999) physician behaviour (Gosden et al, 2000) 
(Greenhalgh and Changing physicians' behaviour No focus on prescribing. Review of 
Meadows, 1999) use of patient based measures of 
health 
(NHS Centre for Evidence implementation Not a systematic review of primary 
Reviews and research. It is an overview of 
Dissemination, systematic reviews. It is an update 
1999) of (Bero et al, 1998) 
(Pagliarl and Clinical guideline No focus on prescribing. Barriers 
Kahan, 1999) implementation and attitudes. 
(Shiffman et al, Computer-based guideline No data synthesis in prescribing or 
1999) implementation primary care. Very superficial 
coverage of prescribing In the table 
of included studies. 
(Thomas et al, Clinical guideline Not on physician behaviour. Focus 
1999) implementation on professions allied to medicine 
(Balas et al, 2000) Physicians' prompting No focus on prescribing. Focuses 
on preventive care. 
(Durieux et al, Clinical guideline It is an overview of systematic 
2000) implementation reviews. The first author wrote to 
me that It does not address GPs' 
behaviour specifically. In French 
(Grol and Jones, Evidence implementation Not a systematic review. 
2000) 
(Johnston et al, Barriers and facilitators for audit No focus on prescribing. Studies of 
2000) physiclans'and non-physicians' 
providers are Included. Research 
methods other than those accepted 
by the EPOC are Included. 
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Reference Focus of the review Reason for discarding / further 
Information 
(Lancaster et al, Improving smoking cessation in Focused on smoking cessation 
2000) primary care advice and brief consultations. Last 
updated In 2000. 
(Ockene and Provider education for clinical Not a systematic review. The 
Zapka, 2000) guideline implementation methods are not presented. 
(Smith, 2000) Changing physicians' behaviour Not a systematic review. It Is an 
overview of systematic reviews. 
(Thomson O'Brien Audit and feedback versus Withdrawn from the Cochrane 
et all, 2000) alternative interventions Library as it is now covered by 
(Jamtvedt et al, 2003). Only one 
prescribing paper included in the 
review, which was on interns in 
secondary care setting. 
(Grimshaw et al, Changing physicians' behaviour It is an overview of systematic 
2001) reviews. 
(Stone et al, 2002) Improving adult immunisation No focus on prescribing. 
and cancer screening in 
ambulatory care 
332 
Appendix IV. Semi-structured interviews" plan 
a) Surnmarlsing statement about the project and the purpose of the 
interviews by the interviewer. 
b) Clarifying that the interview will be tape-recorded (consent to record) 
c) Questions: (use questions as a guide only) 
1) Thinking of clinical guidelines in primary care, can you tell me of examples 
where the guidelines were useful in drug prescription of general 
practitioners? 
a. Probe: asking for specific guidelines 
b. Why do you think the guidelines were useful? 
2) Thinking of clinical guidelines in primary care, can you tell me of examples 
where the guidelines were not useful in drug prescription of general 
practitioners? 
a. Probe: asking for specific guidelines 
b. Why do you think the guidelines were not useful? 
The next set of questions asks about your opinions on clinical guidelines 
that have been developed for specific clinical conditions. 
3) Asthma: Among clinical guidelines for the treatment of asthma in adult 
patients, which guidelines are more likely to be followed in general practice? 
a. Why do you think some guidelines were adopted In general practice rather than 
others? How those guidelines Influenced prescribing for asthma? 
4) Statins: How do you think of the advantages of clinical guidelines for the 
use of statins? What are the possible results of adherence to guidelines for 
the use of statins? 
333 
5) Depression: Are you familiar with any guideline for the treatment of 
depression in primary care? Is it likely to be followed in general practice? 
Why? 
6) Epilepsy: Are there any clinical guidelines that you use in the treatment of 
epilepsy? Why? 
7) Menorrhagia: Which guidelines, if any, do you use in the treatment of 
menorrhagia? What influences has it made on your prescribing patterns? 
8) Who else might influence GPs' adherence to any of the guidelines, which 
have been mentioned in the interview so far? 
a. Probe: does it differ for different guidelines? 
9) Barriers: What are the barriers of the clinical guidelines' implementation in 
your practice? 
a. The guidelines can mentioned specifically again, if 
necessary 
10) Facilitators: What do you think are the factors that encourage you to use 
those clinical guidelines in every-day practice? 
11) Is there anything else I should have asked you? 
334 
ST COPY 
AVAILA L 
Variable print quality 
THE UNIVERSITY 4ýj*k 
I Department of Health Sciences 
National Survey of General Practitioners 
Perceptions and Practice of Statin Prescribing 
WE SHALL KEEP ALL RESPONSES STRICTLY CONFIDENTIAL 
We want to analyse your responses in the context of your prescribing practice. We 
should therefore be most grateful for permission to use your Prescribing And CoST 
[PACT) data on asthma and statin prescribing for one year from last quarter. Please 
sign here if you are willing to give access to those data solely for this research. 
1. Do you permit us to access PACT data on your personal prescribing for asthma and 
of statins? Yes r-1 No r-1 
2. Are You the senior partner in the practice? Yes r-1 No F71 
3. If yes, do you permit us to access PACT data for your practice? Yes F-1 No 0 
Signature ....................................................... 
Date ...................... 
Please fill in the questionnaire even if you do not wish us to access your PACT data. 
We shall include all returned questionnaires in a lottery. 
The winner will receive a d*ItAd camera early next year. 
I ; I. ABOUT YOU AND YOUR PRACTICE 1, ýIease tick whichever applies or write the answer where applicable 
1. Age: ..... 2. Sex: FDM 
Fý 3. Year of graduation from medical school? 
4. Are you: 5. Practice status: a. Dispensing EJ 
Principal in practice Yes No (please tick all that apply) b. Previously fund-holding 1: 1 
Salaried GP (PMS contract) Yes No c. Training EJ Other (specify) 
....................... d. Computerised El 
6. How many general practitioners work in the practice? Full-time ...... Part-time 
7. What is the average length of a routine consultation (booking interval) in your practice? ...... minutes 
8. Do you have special clinics for: a. Asthma F-1 b. CHD prevention El 
9. If computerised, do you have any guidelines for statins prescribing on your computer'? 
a. No b. Yes - primary prevention F71 c. Yes - secondary prevention El 
10. Do you have a special interest in CHD prevention? a. No r-] b. Yes r-I 
11. Do you prescribe statins for your patients for primary prevention of CHD? a. No E-1 
b. For those at minimum CHD risk of 15% over the next ten years F-I c. Those at minimum risk of 15-30% F-] 
d. For those at minimum risk of over 30% EI e. Yes, but no explicit risk criterion M 
12. Which version of the Joint British Recommendations guidelines do you use in your practice for secondary 
prevention? a. None r-I b. I don't know c--------- (specify the publication year) 
13. When was the last time that you read or consulted clinical guidelines for CHID prevention? 
a. Never E] b. less than a month ago [-I c. one to three months ago 
d. 3 to 6 month ago [: ] e. 6 to 12 months ago E] f. more than 12 months ago 
14. Please estimate the number of the patients on your practice list who are eligible for statins for secondary 
prevention of CHID? a. I don't know E] b--------- (number of patients) 
Please read questions carefully and tick or draw a circle on whichever applies 
n All 
1. Over the past three months, for 
what proportion of your patients 
eligible for statins for secondary 
prevention did you prescribe in 
accordance with the clinical 
guidelines? 
ý-N P%11 ILMLICUILO 
LI Almost all patients 
LI More than half the patients 
LI About half the patients 
IJ Fewer than half the patients 
LJ Very few patients 
rI.. - ý-. i mo pauenis 
2. Please estimate how often in the past three months you prescribed statins in your practice in accordance 
with the clinical guideline recommendations for secondary prevention? 
Never 1234567 All patients 
3.1 intend to follow the clinical guideline recommendations on prescribing statins for secondary prevention 
over the next three months. 
Definitely 1234567 Definitely not 
4. How likely is it that you will prescribe statins for secondary prevention of CHID in accordance with the 
clinical guideline recommendations over the next three months? 
Very likely 1234567 Very unlikely 
5.1 want to prescribe statins for my patients in accordance with the CHID guideline recommendations for 
secondary prevention over the next three months. 
Certainly not 1234567 Certainly 
6. For me to prescribe statins fo. secondary prevention in accordance with the clinical guideline 
recommendations over the next three months will be 
Good 1 2 3 4 5 6 7 Bad 
Useless 1 2 3 4 5 6 7 Useful 
Safe 1 2 3 4 5 6 7 Dangerous 
Appropriate 1 2 3 4 5 6 7 Inappropriate 
Worthless 1 2 3 4 5 6 7 Valuable 
Unhelpful 1 2 3 4 5 6 7 Helpful 
7. If I prescribe statins for secondary prevention in accordance with the clinical guidelines over the next three 
months, my patients will be healthier 
Unlikely 1234567 Likely 
Better health for my patients would be 
Extremely bad 1234567 Extremely good 
8. If I don't prescribe statins for secondary prevention in accordance with the clinical guidelines over the next 
three months, I won't get my "quality markers" 
Likely 1234567 Unlikely 
Getting "quality markers" would be 
Extremely good 1234567 Extremely bad 
9. If I don't follow the guideline recommendations on prescribing statins for secondary prevention over the 
next three months, the standard of care I provide to my patients might be judged to be negligent. 
Likely 1234567 Unlikely 
Being judged negligent would be 
Extremely bad 1234567 Extremely good 
2 
10. Following statin prescribing recommendations in the secondary prevention guidelines over the next three 
months will prevent harm to my patients. 
Unlikely 1234567 Likely 
Preventing harm to patients would be 
Extremely bad 1234567 Extremely good 
11. Following the secondary prevention guideline recommendations on prescribing statins over the next three 
months will provide a better quality of care for my patients. 
Likely 1234567 Unlikely 
Providing a better quality of care would be 
Extremely good 1234567 Extremely bad 
12. People who are important to me think that 
I should 12345671 should not 
follow the secondary prevention guideline recommendations on prescribing statins over the next three months. 
13. People whose opinions I value would 
approve 1234567 disapprove 
of my prescribing statins in accordance with the secondary prevention guidelines over the next three months. 
14. Our practice nurse thinks 
I should 12345671 should not 
follow the secondary prevention guideline recommendations on prescribing statins. 
When prescribing how much do you want to do what your practice nurses think you should? 
Not at all 1234567 Very much 
15. My GP colleagues in the practice think 
I should 12345671 should not 
follow the secondary prevention guideline recommendations on prescribing statins. 
When prescribing how much do you want to do what your GP colleagues think you should? 
Not at all 1234567 Very much 
16. The local hospital consultants think 
I should 12345671 should not 
follow the guideline recommendations on prescribing statins for secondary prevention. 
When prescribing how much do you want to do what the local hospital consultants think you should? 
Not at all 1234567 Very much 
17. The Primary Care Organisation advisers think 
I should 12345671 should not 
follow the secondary prevention guideline recommendations on prescribing statins. 
When prescribing how much do you want to do what the PCT advisors think you should? 
Not at all 1234567 Very mut: , 
18. If I wanted to, I could easily prescribe statins for secondary prevention according to the clinical guidelines in 
my practice over the next three months. 
Definitely true 1234567 Definitely false 
19.1 don't know if I can follow the secondary prevention guideline recommendations on prescribing statins in 
my practice over the next three months. 
Strongly agree 1234567 Strongly disagree 
3 
20. Whether or not I follow the secondary prevention guideline recommendations on the use of statins in my 
practice over the next three months is entirely up to me 
Strongly agree 1234567 Strongly disagree 
21. The guidelines for the use of statins in secondary prevention of CHID are in accordance with evidence. 
Strongly agree 1234567 Strongly disagree 
Evidence-based clinical guidelines would make following good prescribing practice 
More difficult 1234567 Easier 
22. The guidelines for secondary prevention have substantially changed their statin prescribing recommendations. 
Strongly agree 1234567 Strongly disagree 
Such changes to clinical guidelines would make it 
more difficult 1234567 easier 
to prescribe according to their recommendations. 
23. I'm always under time pressure to care for my CHID patients. 
Strongly agree 1234567 Strongly disagree 
Lack of time makes it 
more difficult 1234567 easier 
to follow the secondary prevention guideline recommendations on prescribing statins over the next 'three months. 
24. It is appropriate to include the secondary prevention guidelines for the use of statins in the BNF. 
Strongly agree 1234567 Strongly disagree 
The addition of the clinical guidelines to the BNF would make me 
less likely 1234567 more likely 
to following their prescribing recommendations over the next three months. 
25. The National Service Framework (NSF) for coronary heart disease advocates the implementation of the 
secondary prevention guidelines on the use of statins. 
Strongly agree 1234567 Strongly disagree 
NSFs are powerful influences on prescribing patterns in general practice. 
Definitely not 1234567 Definitely 
26. Prescribing statins as recommended by guidelines for secondary prevention could exhaust the prescribing budget of our practice. 
Likely 1234567 Unlikely 
Budgetary limitations makes it 
more difficult 1234567 easier 
for me to follow the clinical guidelines' prescribing recommendations over the next three months. 
27. Doing an audit of our current practice for secondary prevention of ischaemic heart disease makes it 
less likely 1234567 more likely 
that I will follow the guideline recommendations on the use of statins over the next three months. 
28.1 see myself as an evidence based practitioner. 
Strongly agree 1234567 Strongly disagree 
29.1 see myself as a patient-centred practitioner. 
Strongly agree 1234567 Strongly disagree 
Many thanks for your valuable time in filling in this questionnaire. Please 
use the enclosed pre-paid envelope to return the questionnaire to us. 
Please use this spacefor yourfurther comments (continue at the back of the information sheet, if required. ) 
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Perceptions and Practice of Asthma Treatment 
WE SHALL KEEP ALL RESPONSES STRICTLY CONFIDENTIAL 
We want to analyse your responses in the context of your prescribing practice. We 
should therefore be most grateful for permission to use your Prescribing And CosT 
[PACT) data on asthma and statin prescribing for one year from last quarter. Please 
sign here if you are willing to give access to those data solely for this research. 
1. Do you permit us to access PACT data on your personal prescribing for asthma and 
of statins? Yes No 
2. Are you the senior partner in the practice? Yes No 
3. If yes, do you permit us to access PACT data for your practice? Yes No 
ture ....................................................... 
Date ...................... 
fill in the questionnaire even if you do not wish us to access your PACT data. 
We shall include all returned questionnaires in a lottery. 
The winner will receive a digital camera early next year. 
This is a token of our gratitude for your valued contribution. 
Please tick whichever applies or write the answer where applicable 
1. Age: ..... 2. Sex: FEI m F-I 3. Year of graduation from medical school? 
4. Are you: 5. Practice status: a. Dispensing 1: 1 
Principal in practice Yes r-] No (please tick aft that apply) b. Previously fund-holding El 
Salaried GP (PMS contract) Yes 0 NoE] c. Training 1: 1 
Other (specify) 
....................... d. Computerised El 
6. How many general practitioners work in the practice? Full-time ...... Part-time ...... @ ........ 
7. What is the average length of a routine consultation (booking interval) in your practice? ...... minutes 
8. Do you have special clinics for: a. Asthma El b. CHD prevention El 
9. If computerised, do you have any guidelines for asthma treatment on your computer? 
a. No F1 b. Yes F-1 
10. Do you have a special interest in asthma? a. No 0 b. Yes F-1 
11. Which version of the BTS asthma guidelines do you use in your practice? 
a. None Fý b, I don't know F-] c--------- (specify the publication year) 
12. When was the last time that you read or consulted the BTS asthma guidelines? 
a. Never 0 b. less than a month ago c. one to three months ago 
d. 3 to 6 months ago [: ] e. 6 to 12 months ago f. more than 12 months ago 
13. Please estimate the number of the patients on your practice list who suffer from asthma: 
a. I don't know E-1 b--------- (number of patients) 
ase read questions carerully and tick or draw a circle on wmicr? ever applies 
Ail patients 
1. Over the past three months, for 
Almost all patients 
h M h lf h i 
what proportion of your asthma 
ore t an a t e pat ents 
About half the patients patients did you prescribe drugs in 
accordance with the BTS asthma Fewer than half the patients 
guideline recommendations? Very few patients 
No patients 
2. Please estimate how often in the past three months you considered the BTS asthma guidelines when 
prescribing asthmatic drugs in your practice? 
Never 1234567 Very frequently 
3.1 intend to follow the BTS asthma guidelines' prescribing recommendations in my practice over the next 
three months. 
Definitely 1234567 Definitely not 
4. How likely is it that you will prescribe drugs for your patents in accordance with the BTS guideline 
recommendations over the next three months? 
Very likely 1234567 Very unlikely 
5.1 want to prescribe drugs for my patients in accordance with the BTS guideline recommendations over the 
next three months. 
Certainly not 1234567 Certainly 
6. For me to prescribe the drugs recommended by BTS asthma guidelines over the next three months will be 
Harmful 1234567 Beneficial 
Unhelpful 1234567 Helpful 
Valuable 1234567 Worthless 
Useless 1234567 Useful 
Good 1234567 Bad 
Appropriate 1234567 inappropriate 
7. If I prescribe in accordance with the BTS asthma guidelines over the next three months, my patents will be 
healthier. 
Unlikely 1234567 Likely 
Better health for my patients would be 
Extremely bad 1234567 Extremely good 
8. If I don't prescribe in accordance with the BTS asthma guidelines over the next three months, I won't get 
my "quality markers". 
Likely 1234567 Unlikely 
Getting "quality markers' would be 
Extremely good 1234567 Extremely bad 
9. If I don't follow the BTS prescribing recommendations for asthma over the next three months, the standard 
of care I provide to my patients might be judged to be negligent. 
Likely 1234567 Unlikely 
Being judged negligent would be 
Extremely bad 1234567 Extremely good 
2 
10. Following prescribing recommendations in the BTS asthma guidelines over the next three months will 
prevent harm to my patents. 
Unlikely 1234567 Likely 
Preventing harm to patents would be 
Extremely bad 1234567 Extremely good 
11. Following the BTS asthma guidelines' prescribing recommendations over the next three months will 
provide a better quality of care for my patients 
Likely 1234567 Unlikely 
Providing a better quality of care would be 
Extremely good 1234567 Extremely bad 
12.1 am expected to follow the BTS prescribing recommendations for my asthmatic patients over the next 
three months. 
True 1234567 False 
13. People whose opinions I value would 
approve 1234567 disapprove 
of my prescribing in accordance with the BTS asthma guidelines over the next three months. 
14. Our practice nurse thinks 
I should 12345671 should not 
follow the BTS asthma guidelines' prescribing recommendations. 
When prescribing how much do you want to do what your practice nurses think you should? 
Not at all 1234567 Very much 
15. My GP colleagues in the practice think 
I should 12346671 should not 
follow the BTS asthma guidelines' prescribing recommendations. 
When prescribing how much do you want to do what your GP colleagues think you should? 
Not at all 1234567 Very much 
16. The local hospital consultants think 
I should 12345671 should not 
follow the BTS asthma guidelines' prescribing recommendations. 
When prescribing how much do you want to do what the local hospital consultants think you should? 
Not at all 1234567 Very much 
17. The Primary Care Organisation advisers think 
I should 12345671 should not 
follow the BTS asthma guidelines' prescribing recommendations. 
When prescribing how much do you want to do what the PCT advisors think you should? 
Not at all 1234567 Very much 
18. For me to prescribe medicines for asthmatic patients according to the BTS guideline recommendations 
over the next three months would be 
Difficult 1234567 Easy 
19.1 don't know if I can follow the BTS asthma guidelines' prescribing recommendations in my practice over 
the next three months. 
Strongly agree 1234567 Strongly disagree 
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20. How much control do you feel you have over prescribing medicines in accordance with the BTS asthma 
guidelines over the next three months? 
No control 1234567 Complete control 
21. The BTS asthma guidelines are in accordance with evidence. 
Strongly agree 1234567 Strongly disagree 
Evidence-based clinical guidelines would make good prescribing 
More difficult 1234567 Easier 
22. The BTS asthma guidelines have substantially changed their prescribing recommendations. 
Strongly agree 1234567 Strongly disagree 
Such changes to clinical guidelines would make it 
more difficult 1234567 easier 
to prescdbe according to their recommendations. 
23. I'm always under time pressure to care for my asthmatic patients. 
Strongly disagree 1234567 Strongly agree 
Lack of time makes it 
more difficult 1234567 easier 
for me to follow the BTS asthma guidelines prescribing recommendations over the next three months. 
24. The BTS asthma guidelines are not flexible enough to help an individual patient. 
Strongly agree 1234567 Strongly disagree 
Limited options within the clinical guidelines make my prescribing for individual patients 
less likely 1234567 more likely 
to accord with their recommendations over the next three months. 
25. It is appropriate to include the BTS asthma guidelines in the British National Formulary (BNF). 
Strongly agree 1234567 Strongly disagree 
The addition of the clinical guidelines to the BNF would make me 
less likely 1234567 more likely 
to follow their prescribing recommendations over the next three months. 
26.1 continually hear about the BTS asthma guidelines. 
Strongly agree 1234567 Strongly disagree 
Hearing about the clinical guidelines from different sources makes me 
less likely 1234567 more likely 
to follow their prescribing recommendations. 
27.1 see myself as an evidence based practitioner. 
Strongly agree 1234567 Strongly disagree 
28.1 see myself as a patient-centred practitioner. 
Strongly agree 1234567 Strongly disagree 
Many thanks for your valuable time in filling in this questionnaire. Please 
use the enclosed pre-paid envelope to return the questionnaire to us. 
Please use thisspace /oryour. /urther commenis (continue at the back of the informationsheet, if required) 
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Questions and answers about this study 
What is the background to this survey? 
Clinical guidelines are increasingly used to influence the behaviour of health professionals in primary 
care. However, previous studies have revealed that general practitioners have some concerns about the 
clinical guidelines. This national survey aims to inform the future development and use of clinical guidelines in 
primary care in the UK. It forms a major part of the project we call Studying Adherence to Guidelines and 
Evidence (SAGE). 
Who are the researchers? 
The researchers are independent, un ivers ity- based academics. Arash Rashiclian is a medical 
practitioner and Health Services Pesearcher at University of York Department of Health Sciences. Ion 
Russell is a Fellow of Royal College of General Practitioners and Founding Professor of Health Sciences in the 
some department. 
We developed the questionnaire with the generous help of several GPs who took part in a qualitative 
study and others who piloted the questionnaire. It focuses mainly on prescribing stafins for secondary 
prevention of coronary heart disease and the influence of clinical guidelines. We used the Theory of Planned 
Behaviour as a base for the questionnaire. 
What is the Theory of Planned Behaviour? 
This theory has been successfully used to explain many health related behaviours of patients. 
However, few researchers have used it to explain health professionals' behaviour. We believe this is the 
first use of the TPB to study the influence of clinical guidelines on prescribing behaviour of GPs. The 
advantage of this approach is its ability to reveal GPs' attitudes towards, and concerns about, clinical 
guidelines in a rigorous way. 
How many doctors are being studied? 
In this survey 1000 GPs from 50 Primary Care Organisations (PCOs) in England will receive the 
questionnaires. They are a random sample of all GPs working in England, stratified by the demographic 
characteristics of PCOs in which they work. 
No, the choice is yours. But we hope you will help. If you are uncertain about some of the questions, 
please try your best to choose the most appropriate answer. If you are unwilling to take part, please say so 
and we will not send you any reminders. 
Will I be paid for filling in the questionnaire? 
Unfortunately not. Instead we shall include all returned questionnaires in a lottery. The winner will 
receive a digital camera early next year. This is a token of our gratitude for your valued contribution. 
What is the number on the questionnaire for? 
We shall use these numbers to log the questionnaires as they return. This will prevent us from sending 
reminders to GPs who have replied. 
Why do you need my PACT clata? 
These data will enable us to analyse your questionnaire in the context of your prescribing practice. 
They will be used solely for this purpose. Please fill in the questionnaire even if you do not wish us to access 
your PACT data. 
How shall you protect my patients' confidentiality? 
PACT data can not be linked to the individual patients. 
All information about individuals or practices will be held strictly confidential and will not be disclosed 
or released to others outside the research team. All reports and publications will aggregate data to prevent 
identification of individuals or practices. 
How the results will be used? 
The results will be disseminated through presentation at relevant conferences and submitting to peer 
reviewed international journals. We hope they will improve the use of clinical guidelines in f uture. 
P/ease use this space for your further comments, if required, and return it with the questionnaire. 
THE UNIVERSITY ýJ-*k 
Studying Adherence to Guidelines 
and Evidence (SAGE) 
Arash Rashidian, MD 
Health Services Research Scholar 
Ian Russell, Phl), FRCGP, FRCP Edin 
Founding Professor of Health Sciences 
Dr,, GPINITIALS,, cGPSURNAME- 
-Addl,, 
,, Add2,, 
-Add3- 
,, Add4), 
,, Postcode,, 
bear Or <<GP5URNAME>> 
DEPARTMENT OF 
HEALTH SCIENCES 
Donald Irvine Wing 
Alcuin College 
Heslington, York Y010 5DD 
Telephone (01904) 434498 
Fax(01904)434517 
Email arl30@york. ac. uk 
22 January 2002 
National Survey of Statin Prescribing by General Practitioners 
We should be most grateful for your help with this survey. Our primary aim is to help 
general practice and general practitioners. We are keen to improve the development and 
use of clinical guidelines in primary care in the UK. 
We know the profession is under increasing pressure. So we should be especially grateful if 
you would give us (and thus, we hope, your profession! ) a little of your valuable time to 
complete the enclosed questionnaire. The questionnaire focuses mainly on statin 
prescribing for secondary prevention of CHE). With your co-operation we believe that it 
can improve understanding of &Ps'attitudes to, and concerns about, guidelines. So please 
take ten minutes to f ill in the questionnaire and use the enclosed business reply envelope to 
send it back to us. 
We should also be most grateful for access to your Prescribing And CosT (PACT) data on 
asthma and statin prescribing for one year f rom last quarter. This will enable us to analyse 
your questionnaire in the context of your prescribing practice. We shall take great care 
with this analysis. In particular we shall keep strictly confidential all information that 
would permit identification of an individual or practice. 
As a token of our gratitude we shall include all returned questionnaires in a lottery. The 
winner will receive a digital camera early this year. 
Many thanks and kind regards 
Yours sincerely 
Prof Ian Russell FRCGP Dr Arash Rashidian MD 
Appendix Vill. Research proposak A theory-based 
approach for promoting uptake of clinical guidelines: a 
case-study of osteoporosis 
Summary 
Introduction Clinical guidelines are increasingly used to promote improved 
general practitioners (GPs) prescribing, however GPs'adherence varies widely. 
An approach based on psychological theories such as the TPB may enhance 
understanding of this variation and identify more effective methods of changing 
behaviour. However the utility of this theory in explaining and changing doctors' 
behaviour has not been rigorously evaluated. 
Alm This study will explore and test the ability of a psychological model of 
behaviour to explain, predict and improve GPs' adherence to national clinical 
guidelines. 
Main objectives 
1 To explain and predict variation in GlPs' prescribing intentions and 
prescribing behaviour of drugs covered in the forthcoming National 
Institute of Clinical Excellence (NICE) clinical guideline for 
osteoporosis using TPB. 
2. To evaluate the effect of a behavioural intervention on prescribing 
intentions and behaviour in accordance with this NICE clinical 
guideline. 
3. To evaluate the cost-effectiveness of this intervention in changing 
GPs' prescribing. 
Design and setting A randomised controlled trial in English and Welsh 
general practice. 
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Participants and methods A small qualitative study of GPs will be used 
to identify the salient beliefs about prescribing for osteoporosis. These will be 
used to develop and pilot a TPB questionnaire to elicit GPs' beliefs, attitudes, 
subjective norms and perceived behavioural controls and other factors related 
to the osteoporosis prescribing. We shall explore their stated osteoporosis 
prescribing intentions and behaviour using vignettes. The questionnaire and 
prescribing data will be used to obtain the baseline data of a random sample of 
500 GPs. We shall use the results to develop an appropriate behavioural 
intervention to improve GPs' uptake of the NICE osteoporosis guideline. We 
shall evaluate this intervention through stratified random allocation of 
participating GPs to control (receiving NICE guideline) and intervention 
(receiving NICE guideline and intervention) groups. GPs will be followed up 
using both repeating the questionnaire and analysis of their prescribing data. 
We shall expect to obtain complete data for 400 GPs. The analysis will a) 
assess the utility of TPB in explaining, predicting and improving Gl3s' 
prescribing, b) estimate the incremental improvement in osteoporosis 
prescribing as a result of this intervention, and c) estimate costs of the 
intervention. 
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Full proposal: 
1. Title 
A theory-based approach for promoting uptake of clinical guidelines: a 
case-study of osteoporosis 
2. Purpose 
Study aim This study will explore and test the ability of a psychological model 
of behaviour change to explain, predict and improve GPs'adherence to national 
clinical guidelines. 
Objectives 
1. To use the TPB to explain and predict variation in G Ps' prescribing 
intentions and prescribing behaviour of drugs covered in the forthcoming 
National Institute of Clinical Excellence (NICE) clinical guideline for 
osteoporosis. 
2. To evaluate the effect of a behavioural intervention based on the TPB, on 
prescribing intentions and behaviour in accordance with this NICE clinical 
guideline. 
3. To evaluate the cost-effectiveness of this behavioural intervention in 
changing prescribing. 
This research project will incorporate five of. health services research 
disciplines: health psychology, epidemiology, health economics, biostatistics 
and health policy. It has the potential to develop a theoretically sound 
evidence-based approach which can be used by primary care organisations for 
future implementation strategies and by guideline producing organisations to 
improve the uptake of guidelines. 
3. Background 
Clinical guidelines and change in behaviour Recent reviews(NHS 
Centre for Reviews and Dissemination, 1999) have shown that changing 
professional behaviour is difficult (Bero et al, 1998; NHS Centre for Reviews 
and Dissemination, 1999). Clinical guidelines are increasingly used to try to 
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improve prescribing by GPs, however GPs vary widely in their adherence to 
clinical guidelines. Nevertheless some interventions are more successful than 
others in improving their uptake (NHS Centre for Reviews and Dissemination, 
1994; Wensing et al, 1998). 
Theoretical approach to prescribing behaviour change Much of clinical 
behaviour change literature is based on the nalive assumption that clinicians will 
change if they are given information (information deficit model) and few studies 
have tested the theoretical models that acknowledge the psychological and 
organisational processes which precede behaviour (Grol, 1997; Marteau et al, 
2002). Using theory informed approaches might enhance the effectiveness of 
guideline implementation in general and appropriate prescribing in particular 
(Raisch, 1990b; Grol, 1997; Rashidian and Russell, 2003). TPB(Conner and 
Sparks, 1996) states that "individuals make behavioural decisions based upon 
consideration of available information" (Ajzen, 1991; Conner and Sparks, 1996). 
According to TPB human behaviour is guided by three kinds of considerations: 
beliefs about the likely consequences of the behaviour, beliefs about the 
normative expectations of others, and beliefs about the presence of factors that 
may facilitate or impede (control) the behaviour (Ajzen, 1991; Ajzen, 2002b). 
These three types of beliefs produce 'attitudes', perceived social pressure 
('subjective norms') and 'perceived behavioural controls', respectively. These in 
turn will form 'intentions' and predict actual behaviour (Ajzen, 1991; Conner and 
Sparks, 1996; Ajzen, 2002b). Some evidence suggests that TPB might explain 
variation in health professionals' intentions (including GPs' prescribing 
intentions) and self-reported behaviours (Millstein, 1996; Lambert et al, 1997; 
Levin, 1999; Walker et al, 2001; Puffer and Rashidian, 2004). The applicant 
has performed two cross-sectional surveys to test the utility of TPB in explaining 
GPs prescribing (data entry and analysis in progress). The Medical Research 
Council recently funded a project to compare utility of six different psychological 
theories in predicting GPs and dental practitioners behaviour using seven cross- 
sectional surveys (Eccles et al, 2001 a). Although there are several studies 
which indicate this theory may have potential in explaining variance (Armitage 
and Conner, 2001) and developing behaviour change interventions (Hardeman 
et al, 2002), the utility of TPB in explaining and changing health professionals' 
behaviour has not been rigorously evaluated. This study has the potential to 
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improve our understanding of theories of health professional behaviour change 
and their value as the basis of interventions for changing prescribing behaviour 
in a few fronts. 
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I simplified summary 
S-e 
Osteoporosis as a tracer condition Prevention and treatment of 
osteoporosis is among the NHS priorities (Department of Health, 2001 a). Up to 
14,000 people a year die in the UK as a result of an osteoporotic hip fracture 
and 1 in 3 women and 1 in 12 men over 50 are affected by osteoporosis and 
almost half of all women experience an osteoporotic fracture by the time they 
reach the age of 70 (Department of Health, 2001 a). The estimated social and 
acute care costs of hip fractures are more than 21.7 billion annually (Dolan and 
Torgerson, 1998; Torgerson et al, 2001). Osteoporosis is often missed by 
patients and GPs in their consultations. It is most prevalent in post-menopausal 
women who may also suffer from other age related diseases. GPs' potential 
conflicting treatment intentions (i. e. treating more than one disease or risk 
factor), short period of consultation and patients' own agenda all suggest that 
psychological processes might play an important role in osteoporosis prevention 
and treatment. The introduction by NICE of an osteoporosis clinical guideline is 
also timely for this application and our proposed research plan (see section 4.5. 
- project milestones). 
4. Study design and methods 
This study is a randomised controlled trial in English and Welsh general 
practice. 
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Participants We shall recruit GPs who are practicing in North & East Yorkshire 
& North Lincolnshire (the catchment area of the Hull York Medical School) and 
North'& West of Wales (the catchment areas of the North Wales & Swansea 
Clinical Schools) and whose practice list size is larger than 1000. 
4.1. First phase 
Developing the questionnaire We shall undertake 10-15 semi-structured 
interviews to identify the salient items in the care of osteoporosis (Ajzen, 
2002b). We shall also conduct a literature review to identify other variables to 
include in the questionnaire. Each interviewee will be offered E50 for 
participating. We shall then pilot the questionnaire on a judgemental sample of 
40 GPs. The questionnaire will include questions about the GP, practice 
organisational characteristics and psychological items and will take about 15 
minutes to complete. Psychological items will include osteoporosis prescribing 
specific intentions, attitudes, subjective norms, and perceived behavioural 
controls and their relevant beliefs (Ajzen, 1991; Conner and Sparks, 1996; 
Gollwitzer, 1999). We shall measure stated behaviour based on responses to 
vignettes. Through these interviews and the literature review we shall seek to 
improve the predictive utility of TPB by inclusion of other psychological items 
relevant to osteoporosis prescribing (Conner and Armitage, 1998; Terry et al, 
1999). 
First survey We shall approach 1000 GPS- AIIGPswillbesentthe 
questionnaire, a covering letter, an information sheet and a business reply 
envelope. We shall ask of GPs consent for access to their osteoporosis related 
prescribing data for a period of two years and the intervention, and inform them 
of our planned second survey. We anticipate this will yield 500 completed 
questionnaires. 
4.2. Second phase 
Intervention We shall use the results of the first survey to develop an 
appropriate behavioural intervention (Ajzen, 2002a) to improve GPs' uptake of 
NICE osteoporosis guideline. Those 500 GPs who have responded to the first 
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survey will be stratified and randomised to control (receiving NICE guideline) 
and intervention (receiving NICE guideline and intervention) groups. We shall 
use practice list size and a TPB indicator variable for stratification. The 
intervention will include the delivery by post of educational leaflets and other 
items, based on TPB in order to promote the uptake of the osteoporosis 
guideline. In collaboration with NICE, we shall arrange to have access to the 
earlier drafts of the guideline before its final publication to prepare the 
intervention, so that it can be undertaken soon after the introduction of the 
guideline. 
Second survey GPs will be followed up by repeating the questionnaire 
and analysis of their prescribing data. We anticipate 400 of the 500 GPs 
responding to the questionnaire. 
4.3. Proposed sample size and response rate We aim to recruit 400 GPs to 
complete both of the first and second surveys. This way we shall have 80% 
power at 5% significance level to detect a mean change of 0.1 in osteoporosis 
prescribing rate (prescribed item per weighted practice list size) at a standard 
deviation of 0.35. Following Green suggestions we shall require a minimum 
sample of 50+8m=l 30 (m=1 0 is number of predictor variables in the regression 
equation) for testing the multiple correlation (Green, 1991; Tabachnick and 
Fidell, 2001). We have also previously suggested that a sample size of 191 is 
adequate for a TPB survey of health professionals (Rashidian et al, 2002). In 
recent years the response rate has been failing within general practice (Kaner 
et al, 1998), and some surveys achieve less than the average response rate of 
54% observed in 'published studies' (Asch et al, 1997). Considering different 
strategies to improve response rate (McColl et al, 2001) (including sending two 
reminders for each survey), we shall aim to achieve a 50% response rate in our 
first survey and 80% when we survey the respondents for the second time. 
Therefore we will approach 1000 GPs to receive 500 completed questionnaires 
in first survey and 400 in second one (200 per group). For every returned 
questionnaire we shall offer E20. 
4.4. Outcomes and analysis Prescribing outcomes are change in 
prescribed items and their costs (numerators) from weighted practice list size 
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(denominator), in the year before and after the intervention. Practice list size 
will be weighted using age-sex specific categories (e. g. restricting to women 
over 50). We shall obtain osteoporosis related prescribing recorded in 
Prescriptions And CosT (PACT) data as a (proxy) measure of prescribing 
behaviour. Those include calcium, Vitamin D, selective oestrogen receptor 
modulators, bisphosphonates and parathyroid hormone (subject to licensing). 
Choice of target medicines depends on the clinical guideline recommendations. 
We shall measure prescribing at the practice level and will use a practice level 
deprivation index to adjust the findings (Lloyd et al, 1995b). To assess the 
utility of TPB in explaining and predicting GPs' prescribing behaviour in 
accordance with the clinical guideline, we shall use multiple regression to 
regress proxy measure of prescribing behaviour on indicator variables within the 
TPB-based model measured by questionnaire. We shall use regression 
analysis and structural equation modelling (Baron and Kenny, 1986; Hankins et 
al, 2000; Tabachnick and Fidell, 2001), using SPSS and LISREL software 
packages (Hayduk, 1987). We shall perform an economic evaluation on our 
intervention using cost-effectiveness analysis. Costs are the incremental costs 
of the intervention. Effectiveness will be measured in terms of improvement in 
prescribing behaviour and also intention to prescribe in accordance with the 
guideline. This is particularly important as it is unlikely to be cost-effective to 
seek to achieve complete compliance with clinical guidelines (Mason et al, 
2001). We shall use sensitivity analysis and other modelling techniques to 
address uncertainties in the data and to estimate the potential improvement in 
patients health as a result of observed change in prescribing (Buxton et al, 
1997; Brennan and Akehurst, 2000; Weinstein et al, 2001). Owing to the 
clustered nature of our data, we shall perform multi-level analysis (Rice and 
Leyland, 1996; Rice and Jones, 1997) and allow for panel nature of our surveys 
(Tabachnick and Fidell, 2001). 
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4.5. Project milestones 
Dates Months Stage 
Oct 03 - Jan 04 4 Establishing contact with guideline developers. Review of 
relevant osteoporosis literature. Negotiating populations 
for the main survey. 
Feb - May 04 4 Semi-structured interviews and developing questionnaire 
for first survey of GPs. 
Jun - Sep 04 4 Pilot survey and revision of questionnaire for first survey. 
Oct - Nov 04 2 First survey, 1 st reminder after 20 days and 2 nd reminder 
after 40 days. 
Dec 04 - May 05 6 Data entry and preliminary analysis of first survey. 
Randomisation of participants to control and intervention 
groups. Preparation of educational package. 
Jun 05 1 Distribution of educational package to intervention group 
and simpler related material to control group. 
Jul - Oct 05 4 Start writing-up first survey. Refine prescribing and cost 
data. Plan for economic modelling and sensitivity 
analysis. 
Nov - Dec 05 
nd 2 Second survey, 1 st reminder after 20 days and 2 
reminder after 40 days. 
Jan- Apr06 4 Data entry and preliminary analysis of second survey. 
Collect data for economic modelling and sensitivity 
analysis. 
May -Jun 06 2 Final refining and preliminary analysis of prescribing data. 
Jul - Sep 06 3 Final data analysis and writing up. 
5. Research team This protocol has been developed in collaboration 
with the applicant's proposed supervisors (Prof Ian Russell and Prof Ian Watt), 
Head of York Department of Health Sciences (Prof Trevor Sheldon, on 
methodology and planning) and his advisers and collaborators who are Dr 
David Torgerson (York, on economic evaluation and osteoporosis), Prof Marie 
Johnston (St Andrews, on psychological theories of behaviour change), Dr Nigel 
Rice (York, on multi-level analysis) and Prof Martin Eccles (Newcastle, on 
clinical guideline implementation). 
6. Ethics approval We shall approach one of the Northern & Yorkshire 
or Wales Multi-centre Research Ethics Committees (MREC) in May 2003. This 
is due to the fact that MRECs no longer accept applications for ethical review 
unless funding has been agreed. We shall then apply to all relevant Local 
Research Ethics Committees for locality assessment only. 
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Abbreviations 
ACE Angiotensin Converting Enzyme 
ADQ Adequate Daily Quantity 
AIDS Acquired Immunodeficiency Syndrome 
ASTRO-PUs Age, Sex, and Temporary Resident Originated Prescribing 
Units 
ATT Attitude 
BA Before-After (study design) 
BEH Behaviour 
BI Behavioural Intention 
BIB Balanced Incomplete Block (study design) 
BMA British Medical Association 
BMJ British Medical Journal 
BNF British National Formulary 
BTS British Thoracic Society 
CBA Controlled Before-After trial 
CCT Controlled Clinical Trial 
CDSS Clinical Decision Support Systems 
CME Continuous Medical Education 
CHD Coronary Heart Disease 
CI Confidence Interval 
COPD Chronic Obstructive Pulmonary Disease 
CPD Continuous Professional Development 
CPG Clinical Practice Guideline 
CQl Continuous Quality Improvement 
CRD Centre for Reviews and Dissemination (University of York, UK) 
CRCT Cluster-Randomised Controlled Trial 
DARE Database of Abstracts of Reviews of Effects 
DIN Doctors Independent Network 
DDD Defined Daily Dose 
DUE Drug Use Evaluation 
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DUR Drug Utillsation Review 
EBM Evidence-based Medicine 
EBHC Evidence-based Health Care 
EPOC Effective Practice and Organisation of Care (Cochrane Review 
Group) 
ESRC Economic & Social Research Council 
FDA Food and Drug Administration (USA body) 
GMS General Medical Services 
GP General Practitioner 
GPRD General Practice Research Database 
HDL High-Density Lipoprotein 
HIV Human Immunodeficiency Virus 
HMGCoA 3-hydroxy-3-methylglutaryl coenzyme A 
HMO Health Maintenance Organisation 
HTA Health Technology Assessment 
ICC Intra-Cluster Coefficient 
IP Inter-professional 
ISTAHC the International Society for Technology Assessment in Health 
Care 
JBR Joint British Recommendations 
LDL Low-Density Lipoprotein 
LSHTIVI the London School of Hygiene & Tropical Medicine 
MI Myocardial Infarction 
MRC Medical Research Council 
N/A Not Applicable 
N/R Not Reported 
NHS National Health Service 
NIC Net Ingredient Cost 
NICE the National Institute for Clinical Excellence (UK NHS Special 
Health Authority) 
NS Non Significant 
NSAID Non-Steroidal Anti- I nf lammatory Drug 
NSF National Service Framework 
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OLS Ordinary Least Square 
ORS Oral Re-hydration Solution 
OTC Over The Counter 
PACT Prescribing Analyses and CosT 
PBC Perceived Behavioural Control 
PCG Primary Care Group 
PCO Primary Care Organisation 
PCP Primary Care Physician 
PCT Primary Care Trust 
PIVIS Personal Medical Services 
PPA the Prescription Pricing Authority (UK NHS Special Health 
Authority) 
PPI Proton Pump Inhibitor 
PRODIGY Prescribing Rationally with Decision support in General 
Practice (computer software) 
PSA Prostate Specific Antigen 
PSU the Prescribing Support Unit (UK body) 
PU Prescribing Unit 
RCT Randomised Controlled Trial 
R&D Research and Development 
SAGE Study of Adherence to Guidelines and Evidence 
SD Standard Deviation 
SE Standard Error 
SEM Structural Equation Modelling 
SIGN the Scottish Intercollegiate Guideline Network 
SN Subjective Norm 
SSRI Selective Serotonin Reuptake Inhibitor 
STAR-PUs Specific therapeutic group age-sex related prescribing units 
STD Sexually Transmitted Disease 
STG Standard Treatment Guideline 
TPB the Theory of Planned Behaviour 
TOM Total Quality Management 
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TRA the Theory of Reasoned Action 
UK the United Kingdom 
USA the United States of America 
UTI Urinary Tract Infection 
VIF Variance Inflation Factor 
WHO World Health Organisation 
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Glossary 
Academic detailing See 'educational outreach' 
Adequate Daily Quantity ADO. It is the British equivalent of DDD. An 
analytical unit produced in order to compare more 
accurately the prescribing activity of primary care 
practitioners (Prescribing Support Unit, 2002) 
Adoption Health care providers' commitment and decision 
to change their practices; the actual change in 
practice (Davis and Taylor-Vaisey, 1997) 
Audit and feedback Any summary of clinical performance of health 
care over a specified period of time. The summary 
may also include recommendations for clinical 
action. The information may be given in a written, 
verbal or electronic format (Thomson O'Brien et 
al, 1997) 
Clinical decision support systems See'computer-based CDSS' and 'medical 
decision aids' 
Clinical guidelines See 'clinical practice guideline' 
Clinical practice guidelines Systematically developed statements to assist 
decisions about appropriate care for specific 
clinical circumstances (Field and Lohr, 1990) p 38. 
See also 'medical review criteria' and 'standard of 
quality' 
Computer-based CDSS Computer software using a knowledge base 
designed for use by a clinician involved in patient 
care as a direct aid to clinical decision making. 
Characteristics of an individual patient are 
matched to information in the knowledge base. 
Patient-specific information in the form of 
assessments or recommendations is presented to 
the clinician (Johnston et al, 1994). See also 
'medical decision aids' 
Conferences See 'educational meetings' (Freemantle et al, 
1997) 
Continuous quality improvement A philosophy of continual improvement of the 
processes associated with providing a good or 
service that meets or exceeds consumer 
expectations (Shortell et al, 1998) 
Defined Daily Doses DDD. A measure of the amount of drug prescribed 
based on standard therapeutic units. The number 
of defined daily doses is calculated by dividing the 
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total amount of a drug prescribed by the defined 
daily dose for the drug (Majeed et al, 1997) OR 
the assumed average maintenance dose per day 
for a drug used on its main indication in adults 
(WHO Collaborating Centre for Drug Statistics 
Methodology, 1999) 
Diffusion Distribution of information and practitioners' 
natural, unaided adoption of policies and practices 
(Davis and Taylor-Vaisey, 1997) 
Dissemination Communication of information to clinicians to 
improve their knowledge or skills; more active 
than diffusion, dissemination targets a specific 
clinical audience (Davis and Taylor-Vaisey, 1997) 
Educational materials Distribution of published or printed 
recommendations for clinical care, including 
clinical practice guidelines, audio-visual materials 
and electronic publications (Jamtvedt et al, 2003) 
Educational meetings Participation of health care providers in 
conferences, lectures, workshops or traineeships 
outside the providers' practice settings (Jamtvedt 
et al, 2003) 
Educational outreach Short, one-to-one conversations between a 
detailer and a practitioner, with a goal of 
persuading the detailee to change behaviour 
through useful information and evidence (Gross 
and Pujat, 2001) 
OR 
Use of a trained person who meets with providers 
in their practice settings to provide information 
with the intent of changing the provider's 
performance. The information given may include 
feedback about performance (Thomson O'Brien et 
al, 1997) 
Educationally influentials See'local opinion leaders'(Lomas and Haynes, 
1988) 
Evidence-based health care See'evidence-based medicine' 
Evidence-based medicine Evidence-based medicine is the conscientious, 
explicit, and judicious use of current best evidence 
in making decisions about the care of individual 
patients. The practice of evidence-based medicine 
means integrating individual clinical expertise with 
the best available external clinical evidence from 
systematic research (Sackett et al, 1996) (p 71) 
Expert systems See 'computer-based CDSS' and 'medical 
decision aids' 
General practice See 'general practitioner' 
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General practitioner The general practitioner is a specialist trained to 
work in the front line of a healthcare system and 
to take the initial steps to provide care for any 
health problem(s) that patients may have. The 
general practitioner takes care of individuals in a 
society, irrespective of the patient's type of 
disease or other personal and social 
characteristics, and organises the resources 
available in the healthcare system to the best 
advantage of the patients. The general 
practitioner engages with autonomous individuals 
across the fields of prevention, diagnosis, cure, 
care, and palliation, using and integrating the 
sciences of biomedicine, medical psychology, and 
medical sociology (Olesen et al, 2000, p355). 
Health services research Health services research is the multidisciplinary 
field of scientific investigation that studies how 
social factors, financing systems, organisational 
structures and processes, health technologies, 
and personal behaviours affect access to health 
care, the quality and cost of health care, and 
ultimately our health and well-being. Its research 
domains are individuals, families, organisations, 
institutions, communities, and populations (Lohr 
and Steinwachs, 2002) 
Implementation Putting a guideline in place; more active than 
dissemination, it involves effective communication 
strategies and identifies and overcomes barriers 
to change by using administrative and educational 
techniques that are effective in the practice setting 
(Davis and Taylor-Vaisey, 1997) 
Individual instruction See'educational outreach'(Grol, 1992; Wensing 
and Grol, 1994) 
Knowledge translation The exchange, synthesis and ethically sound 
application of knowledge-within a complex 
system of interactions among researchers and 
users-to accelerate the capture of the benefits of 
research ... through improved health, more 
effective services and products, and a 
strengthened health care system (Davis et al, 
2003) 
Local consensus processes Inclusion of participating providers in discussion to 
ensure that they agreed that the chosen clinical 
problem was important and the approach to 
managing the problem was appropriate (Jamtvedt 
et al, 2003) 
Local opinion leader Use of providers nominated by their colleagues as 
'educationally influential'. The investigators must 
explicitly state that the opinion leaders were 
identified by their colleagues (Freemantle et a[, 
1997) 
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Marketing See 'tailoring' (Freemantle et al, 1997) 
Medical decision aids Active knowledge systems which use two or more 
items of patient data to generate case specific 
advice (Johnston et al, 1994). See also'computer- 
based CDSS' 
Medical review criteria Systematically developed statements that can be 
used to assess the appropriateness of specific 
health care decisions, services, and outcomes 
(Field and Lohr, 1990) p 44 
Net Ingredient Cost NIC. Cost of the drug before discounts excluding 
any dispensing costs or fees. It also excludes any 
adjustment for income obtained where a 
prescription charge is paid at the time the 
prescription is dispensed or where the patient has 
purchased a pre-payment certificate 
NICE National Institute for Clinical Excellence. A special 
NHS authority involved in introduction new 
guidelines and guidance for the NHS. 
Outreach visits See 'educational outreach' 
PACT data Prescribing Analyses and Cost. Information on 
GPs'prescribing obtained from prescriptions 
dispensed by community pharmacists, dispensing 
GPs, and appliance contractors (Majeed et al, 
1997) 
Patient-centred care A philosophy of care that encourages: (a) shared 
control of the consultation, decisions about 
interventions or management of the health 
problems with the patient, and/or (b) a focus in the 
consultation on the patient as a whole person who 
has individual preferences situated within social 
contexts (in contrast to a focus in the consultation 
on a body part or disease) (Lewin et al, 2001) 
Patient mediated interventions Any intervention aimed at changing the 
performance of health care providers indirectly by 
providing information, prompts, or support to the 
patient (Gill et al, 1999; Jamtvedt et al, 2003) 
PPA Prescription Prescribing Authority. A special NHS 
authority located in Newcastle, England. The PPA 
is the source of PACT data 
Primary care physician Primary care physicians are medically qualified 
physicians who provide primary health care. 
Primary health care provides integrated, easy to 
access, health care services by clinicians who are 
accountable for addressing a large majority of 
personal health care needs, developing a 
sustained and continuous relationship with 
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patients, and practising in the context of family 
and community (Vanselow et al, 1995) 
OR 
Medical health care professionals providing first 
contact and on-going care to patients, regardless 
of the patient's age, gender or presenting problem 
(Bower and Sibbald, 1999) 
Prescribing support unit PSU. It is located in Leeds and funded by the 
Department of Health for conducting research on, 
and analysis of UK prescribing data. 
Protocol A comprehensive set of criteria for a single clinical 
condition or aspects of organisation (Baker and 
Fraser, 1995) (p 370). For 'criteria' see 'medical 
review criteria' 
Prescribing unit PU. A measure of patients' needs for prescribed 
drugs weighted for age; patients aged under 65 
years count as one unit, patients aged 65 and 
over count as three units (Majeed et al, 1997) 
Providers Health care professionals, including physicians 
Public interest detailing See 'educational outreach' (Thomson O'Brien et 
al, 1997) 
Quality of care Quality of care is the degree to which health 
services for individuals and populations increase 
the likelihood of desired health outcomes and are 
consistent with current professional knowledge 
(Lohr and Institute of Medicine, 1990) (p 21) 
Rational use of drugs The rational use of drugs requires that patients 
receive medications appropriate to their clinical 
needs, in doses that meet their own individual 
requirements for an adequate period of time, and 
at the lowest cost to them and their community 
(Le Grand et al, 1999) from WHO conference of 
experts Nairobi 1985' 
Reminders Any intervention, manual or computerised, that 
prompts the health care provider to perform a 
clinical action (Jamtvedt et al, 2003) 
Research utilisation A process directed toward transfer of specific 
research-based knowledge into practice through 
systematic use of a series of activities (Logan and 
Graham, 1998) 
Review criteria See 'medical review criteria' 
Setting The practice site - not so much its location, 
although this may be important, as its type - the 
setting may also imply, but not define, aspects of 
workload, relevant health care team members, 
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mix of patients. and funding mechanisms (Davis 
and Taylor-Vaisey, 1997) 
Standard See 'standard of quality'. Also: the percentage of 
events that should comply with the criterion 
(Baker and Fraser, 1995) p 370. For 'criterion' see 
'medical review criteria' 
Standard treatment guidelines See 'clinical practice guidelines'. This term is 
commonly used in the literature from developing 
countries instead of clinical practice guidelines. 
Standard of quality Authoritative statement of minimum levels of 
acceptable performance or results, excellent 
levels of performance or results, or the range of 
acceptable performance or results (Field and 
Lohr, 1990) p 50 
Tailoring Use of personal interviewing, group discussion 
('focus groups'), or a survey of targeted providers 
to identify barriers to change and subsequent 
design of an intervention that addresses identified 
barriers (Jamtvedt et al, 2003) 
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